<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Glucocorticoids for croup in children - Aregbesola, A - 2023 | Cochrane Library</title> <meta content="Glucocorticoids for croup in children - Aregbesola, A - 2023 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001955.pub5/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Glucocorticoids for croup in children - Aregbesola, A - 2023 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001955.pub5/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD001955.pub5" name="dc.identifier" scheme="DOI"/> <meta content="Glucocorticoids for croup in children" name="citation_title"/> <meta content="Alex Aregbesola" name="citation_author"/> <meta content="alex.aregbesola@umanitoba.ca" name="citation_author_email"/> <meta content="Clara M Tam" name="citation_author"/> <meta content="Children’s Hospital Research Institute of Manitoba" name="citation_author_institution"/> <meta content="Asha Kothari" name="citation_author"/> <meta content="Children’s Hospital Research Institute of Manitoba" name="citation_author_institution"/> <meta content="Me-Linh Le" name="citation_author"/> <meta content="University of Manitoba" name="citation_author_institution"/> <meta content="Mirna Ragheb" name="citation_author"/> <meta content="Children’s Hospital Research Institute of Manitoba" name="citation_author_institution"/> <meta content="Terry P Klassen" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="1" name="citation_issue"/> <meta content="10.1002/14651858.CD001955.pub5" name="citation_doi"/> <meta content="2023" name="citation_date"/> <meta content="2023/01/10" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001955.pub5/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001955.pub5/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001955.pub5/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Croup [drug therapy]; Dexamethasone [therapeutic use]; Epinephrine [therapeutic use]; Glucocorticoids [therapeutic use]; Prednisolone [therapeutic use]; Randomized Controlled Trials as Topic; *Respiratory Tract Infections" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001955.pub5&amp;doi=10.1002/14651858.CD001955.pub5&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001955.pub5&amp;doi=10.1002/14651858.CD001955.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001955.pub5&amp;doi=10.1002/14651858.CD001955.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001955.pub5&amp;doi=10.1002/14651858.CD001955.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001955.pub5&amp;doi=10.1002/14651858.CD001955.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001955.pub5&amp;doi=10.1002/14651858.CD001955.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001955.pub5&amp;doi=10.1002/14651858.CD001955.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001955.pub5&amp;doi=10.1002/14651858.CD001955.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001955.pub5&amp;doi=10.1002/14651858.CD001955.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001955.pub5&amp;doi=10.1002/14651858.CD001955.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001955.pub5&amp;doi=10.1002/14651858.CD001955.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001955.pub5&amp;doi=10.1002/14651858.CD001955.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001955.pub5&amp;doi=10.1002/14651858.CD001955.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001955.pub5&amp;doi=10.1002/14651858.CD001955.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001955.pub5&amp;doi=10.1002/14651858.CD001955.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001955.pub5&amp;doi=10.1002/14651858.CD001955.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001955.pub5&amp;doi=10.1002/14651858.CD001955.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001955.pub5&amp;doi=10.1002/14651858.CD001955.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001955.pub5&amp;doi=10.1002/14651858.CD001955.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001955.pub5&amp;doi=10.1002/14651858.CD001955.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001955.pub5&amp;doi=10.1002/14651858.CD001955.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001955.pub5&amp;doi=10.1002/14651858.CD001955.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001955.pub5&amp;doi=10.1002/14651858.CD001955.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="ZDBB8PHY";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD001955\x2epub5\x26doi\x3d10\x2e1002\x2f14651858\x2eCD001955\x2epub5\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001955\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001955\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANT","th","ms","ja","hr","fa","id","fr","pl","hu"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD001955.pub5",title:"Glucocorticoids for croup in children",firstPublishedDate:"Jan 10, 2023 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Acute Respiratory Infections Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ZDBB8PHY&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001955.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001955.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD001955.pub5/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD001955.pub5/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001955.pub5%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD001955.PUB5" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;hu&quot;,&quot;title&quot;:&quot;Összefoglalás közérthető nyelven&quot;},{&quot;language&quot;:&quot;id&quot;,&quot;title&quot;:&quot;Saripati tinjauan sistematik&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD001955.pub5/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD001955.PUB5" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD001955.pub5/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD001955.pub5/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>8481 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD001955.pub5" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-sec-0196"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-sec-0039"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-sec-0184"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/appendices#CD001955-sec-0201"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/supinfo/CD001955StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/supinfo/CD001955StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2023 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Glucocorticoids for croup in children</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/information#CD001955-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Alex Aregbesola</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/information#CD001955-cr-0005">Clara M Tam</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/information#CD001955-cr-0006">Asha Kothari</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/information#CD001955-cr-0007">Me-Linh Le</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/information#CD001955-cr-0008">Mirna Ragheb</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001955.pub5/information#CD001955-cr-0009">Terry P Klassen</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/information/en#CD001955-sec-0218">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 10 January 2023 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD001955.pub5">https://doi.org/10.1002/14651858.CD001955.pub5</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD001955-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001955-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001955-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001955-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD001955-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD001955-abs-0005">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD001955-abs-0001" lang="en"> <section id="CD001955-sec-0001"> <h3 class="title" id="CD001955-sec-0001">Background</h3> <p>Glucocorticoids are the mainstay for the treatment of croup. The existing evidence demonstrates that glucocorticoids are effective in the treatment of croup in children. However, updating the evidence on their clinical relevance in croup is imperative. This is an update to a review first published in 1999, and updated in 2004, 2011, and 2018. </p> </section> <section id="CD001955-sec-0002"> <h3 class="title" id="CD001955-sec-0002">Objectives</h3> <p>To investigate the effects and safety of glucocorticoids in the treatment of croup in children aged 18 years and below. </p> </section> <section id="CD001955-sec-0003"> <h3 class="title" id="CD001955-sec-0003">Search methods</h3> <p>We searched the Cochrane Library, which includes the Cochrane Central Register of Controlled Trials (CENTRAL; 2022 Issue 9), Ovid MEDLINE Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations and Ovid MEDLINE (1946 to 4 March 2022), Embase (Ovid) (1974 to 4 March 2022). We also searched the WHO ICTRP and ClinicalTrials.gov on 4 March 2022. </p> </section> <section id="CD001955-sec-0004"> <h3 class="title" id="CD001955-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) in children (aged 18 years and below) with croup. We assessed the effect of glucocorticoids compared to the following: placebo, any other pharmacologic agents, any other glucocorticoids, any combination of other glucocorticoids, given by different modes of administration, or given in different doses. The included studies must have assessed at least one of our primary outcomes (defined as the change in croup score or return visits, (re)admissions to the hospital or both) or secondary outcomes (defined as the length of stay in hospital or emergency departments, patient improvement, use of additional treatments, or adverse events). </p> </section> <section id="CD001955-sec-0005"> <h3 class="title" id="CD001955-sec-0005">Data collection and analysis</h3> <p>Review authors independently extracted data, with another review author verified. We entered the data into Review Manager 5 for meta‐analysis. Two review authors independently assessed studies for risk of bias using the Cochrane risk of bias tool. Two review authors assessed the certainty of the evidence for the primary outcomes using the GRADE approach. </p> </section> <section id="CD001955-sec-0006"> <h3 class="title" id="CD001955-sec-0006">Main results</h3> <p>This updated review includes 45 RCTs with a total of 5888 children, an increase of two RCTs with 1323 children since the last update. We also identified one ongoing study and one study awaiting classification. We assessed most studies (98%) as at high or unclear risk of bias.  </p> <p><b>Any glucocorticoid compared to placebo </b> </p> <p>Compared to placebo, glucocorticoids may result in greater reductions in croup score after two hours (standardised mean difference (SMD) −0.65, 95% confidence interval (CI) −1.13 to −0.18; 7 RCTs, 426 children; low‐certainty evidence); six hours (SMD −0.76, 95% CI −1.12 to −0.40; 11 RCTs, 959 children; low‐certainty evidence); and 12 hours (SMD −1.03, 95% CI −1.53 to ‐0.53; 8 RCTs, 571 children; low‐certainty evidence). The evidence for change in croup score after 24 hours is very uncertain (SMD −0.86, 95% CI −1.40 to −0.31; 8 RCTs, 351 children; very low‐certainty evidence).  </p> <p><b>One glucocorticoid compared to another glucocorticoid</b> </p> <p>There was little to no difference between prednisolone and dexamethasone for reduction in croup score at two‐hour post‐baseline score (SMD 0.06, 95% CI −0.06 to 0.18; 1 RCT, 1231 children; high‐certainty evidence). There was likely little to no difference between prednisolone and dexamethasone for reduction in croup score at six‐hour post‐baseline score (SMD 0.21, 95% CI −0.21 to 0.62; 1 RCT, 99 children; moderate‐certainty evidence). However, dexamethasone probably reduced the return visits or (re)admissions for croup by almost half (risk ratio (RR) 0.55, 95% CI 0.28 to 1.11; 4 RCTs, 1537 children; moderate‐certainty evidence), and showed a 28% reduction in the use of supplemental glucocorticoids as an additional treatment (RR 0.72, 95% CI 0.53 to 0.97; 2 RCTs, 926 children).  </p> <p><b>Dexamethasone given in different doses</b> </p> <p>Compared to 0.15 mg/kg, 0.60 mg/kg dexamethasone probably reduced the severity of croup as assessed by the croup scoring scale at 24‐hour postbaseline score (SMD 0.63, 95% CI 0.16 to 1.10; 1 RCT, 72 children; moderate‐certainty evidence); however, this was not the case at two hours (SMD −0.27, 95% CI −0.76 to 0.22; 2 RCTs, 861 children; high‐certainty evidence). There was probably no reduction at six hours (SMD −0.45, 95% CI −1.26 to 0.35; 3 RCTs, 178 children; moderate‐certainty evidence), and the evidence at 12 hours is very uncertain (SMD −0.60, 95% CI −4.39 to 3.19; 2 RCTs, 113 children; very low‐certainty evidence). There was little to no difference between doses of dexamethasone in return visits or (re)admissions of children or both (RR 0.91, 95% CI 0.71 to 1.17; 3 RCTs, 949 children; high‐certainty evidence) or length of stay in the hospital or emergency department (mean difference 0.12, 95% CI −0.32 to 0.56; 2 RCTs, 892 children). The need for additional treatments, such as epinephrine (RR 0.78, 95% CI 0.34 to 1.75; 2 RCTs, 885 children); intubation (risk difference 0.00, 95% CI −0.00 to 0.00; 2 RCTs, 861 children); or use of supplemental glucocorticoids (RR 0.77, 95% CI 0.51 to 1.15; 2 RCTs, 617 children), also did not differ between doses of dexamethasone.  </p> <p>There were moderate to high levels of heterogeneity in the analyses for most comparisons. Adverse events were observed for some of the comparisons reported in the review. </p> </section> <section id="CD001955-sec-0007"> <h3 class="title" id="CD001955-sec-0007">Authors' conclusions</h3> <p>The evidence that glucocorticoids reduce symptoms of croup at two hours, shorten hospital stays, and reduce the rate of return visits or (re)admissions has not changed in this update. A smaller dose of 0.15 mg/kg of dexamethasone may be as effective as the standard dose of 0.60 mg/kg. More RCTs are needed to strengthen the evidence for effectiveness of low‐dose dexamethasone at 0.15 mg/kg to treat croup.  </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD001955-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001955-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD001955-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD001955-abs-0018">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001955-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD001955-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD001955-abs-0009">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/hu#CD001955-abs-0016">Magyar</a> </li> <li class="section-language"> <a class="" href="full/id#CD001955-abs-0012">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="full/ja#CD001955-abs-0008">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD001955-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD001955-abs-0015">Polski</a> </li> <li class="section-language"> <a class="" href="full/th#CD001955-abs-0006">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD001955-abs-0004">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD001955-abs-0002" lang="en"> <h3>Glucocorticoids for croup in children</h3> <p><b>Review question</b> </p> <p>What is the effectiveness and safety of glucocorticoids when treating children with croup? </p> <p><b>Background</b> </p> <p>Respiratory viruses are the main cause of croup in children. Croup leads to a swelling of the throat and airway, which can make breathing difficult. Children also present with a special type of cough called a barking cough. Glucocorticoids are types of steroids that help reduce the swelling, thereby making it easier for children with croup to breathe.  </p> <p>This is an update of a review first published in 1999 and updated in 2004, 2011, and 2018. </p> <p><b>Search date</b> </p> <p>The evidence is current to 4 March 2022.</p> <p><b>Study characteristics</b> </p> <p>We included 2 new studies with 1323 children, for a total of 45 studies with 5888 children aged 0 to 18 years published between 1964 and 2021. The three types of glucocorticoids used in the new studies were budesonide, dexamethasone, and prednisolone. The most recent study compared the effectiveness of budesonide and dexamethasone. The other new study compared the effectiveness of dexamethasone and prednisolone, as well as a small dose of dexamethasone (0.15 mg/kg) versus 0.60 mg/kg dexamethasone. We added the data from the new study that compared the doses of dexamethasone to previously included studies looking at the same comparison. </p> <p><b>Study funding sources</b> </p> <p>Funding sources included government (11%), academic or research institute (7%), industry (18%), or foundations (9%). More than half of the studies (55%) did not report funding sources. </p> <p><b>Key results</b> </p> <p>Compared to prednisolone, dexamethasone showed no improvement in croup score at two and six hours after presenting to the hospital or emergency department, and probably reduced return visits or (re)admissions for croup by almost half. The addition of supplemental glucocorticoid favoured dexamethasone versus prednisolone. Compared to 0.15 mg/kg dexamethasone, the standard dose of 0.60 mg/kg probably reduced the severity of croup as assessed by the croup scoring scale at 24 hours after presenting to the hospital or emergency department. However, we did not find any important difference between groups in croup scoring scale at 2, 6, or 12 hours, return visits or (re)admissions of children, or length of stay in the hospital or emergency department. The need for additional treatments such as the use of other drugs like epinephrine, supplemental glucocorticoid, or the use of a tube to help breathing did not differ between 0.15 mg/kg and 0.60 mg/kg dexamethasone. No serious adverse events from the use of the glucocorticoids were reported in the newly included studies. </p> <p><b>Conclusions</b> </p> <p>The evidence has not changed that glucocorticoids reduce symptoms of croup at two hours, shorten hospital stays, and reduce the rate of return visits or (re)admissions compared to placebo (dummy treatment). A small dose of dexamethasone at 0.15 mg/kg may be as effective as the standard dose of 0.60 mg/kg. More studies are needed to strengthen the evidence for the effectiveness of low‐dose dexamethasone at 0.15 mg/kg to treat croup. We conclude that glucocorticoids are effective in the treatment of croup in children. </p> <p><b>Certainty of evidence</b> </p> <p>Most studies (98%) had problems related to their methods, reporting issues, or both. For any glucocorticoid compared to placebo, we downgraded the certainty of the evidence for change in croup score after 2, 6, 12, and 24 hours and return visits or (re)admissions due to study variability, imprecision and inconsistency of study results, and risk of bias. There is little evidence that reporting bias influenced our results for return visits or (re)admissions, or both. Similar threats to the certainty of the evidence were present in the other comparisons in this review, including concerns related to risk of bias and inconsistency and imprecision of study results. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD001955-sec-0196" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD001955-sec-0196"></div> <h3 class="title" id="CD001955-sec-0197">Implications for practice</h3> <section id="CD001955-sec-0197"> <p>The evidence has not changed that glucocorticoids reduce symptoms of croup at two hours, which may last up until 24 hours; shorten hospital stays; and reduce the rate of return visits or (re)admission. </p> <p>Apart from dexamethasone and prednisolone, we found insufficient data to draw conclusions about the role of other glucocorticoids (e.g. fluticasone, beclomethasone) for reducing the symptoms of croup. Adverse events were reported from the use of glucocorticoids in some of the included studies. </p> </section> <h3 class="title" id="CD001955-sec-0198">Implications for research</h3> <section id="CD001955-sec-0198"> <p>This update further strengthens the evidence base for the effectiveness of glucocorticoids in the treatment of croup. Dexamethasone reduces return visits or (re)admission of croup by about half. A small dose of dexamethasone at 0.15 mg/kg may be as effective as the current standard dose of 0.60 mg/kg. More randomised controlled trials are needed to strengthen the evidence for the effectiveness of low‐dose dexamethasone at 0.15 mg/kg to treat croup.  </p> <p>The findings of this update review are in keeping with previous versions of the review which asserted that additional trials assessing the effectiveness of dexamethasone and budesonide compared to placebo are not warranted. The cumulative meta‐graph by year for change in croup score six hours after treatment shows that the standardised mean difference for the effect of glucocorticoids compared to placebo has been stable (<a href="#CD001955-fig-0004">Figure 4</a>). Accordingly, we also found no new studies published since 1999 that reported on this outcome for this comparison. For return visits or (re)admissions or both, the cumulative meta‐graph by year indicates that the pooled risk ratio has also been relatively constant (<a href="#CD001955-fig-0005">Figure 5</a>). No new trials reporting on this outcome for this comparison have been published since 2004. </p> </section> <div class="figure" id="CD001955-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Cumulative meta‐graph by year for change in croup score six hours after treatment for any glucocorticoid compared to placebo." data-id="CD001955-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-FIG-04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Cumulative meta‐graph by year for change in croup score six hours after treatment for any glucocorticoid compared to placebo. </p> </div> </div> </div> <div class="figure" id="CD001955-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Cumulative meta‐graph by year for return visits or (re)admissions or both for any glucocorticoid compared to placebo." data-id="CD001955-fig-0005" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-FIG-05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Cumulative meta‐graph by year for return visits or (re)admissions or both for any glucocorticoid compared to placebo. </p> </div> </div> </div> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD001955-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD001955-sec-0008"></div> <div class="table" id="CD001955-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Any glucocorticoid compared to placebo for croup</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Any glucocorticoid compared to placebo for croup</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> any glucocorticoid<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments**</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Placebo</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Any glucocorticoid</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with different scores in different studies. Lower scores mean fewer symptoms.  </p> <p>(Follow‐up: 2 hours) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−1.50 to −0.81</b>. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.65 standard deviations in favour</b><br/>(1.13 more to 0.18 more). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>426<br/>(7 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A standard deviation of 0.65 represents a moderate difference between groups. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with different scores in different studies. Lower scores mean fewer symptoms. </p> <p>(Follow‐up: 6 hours)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−3.23 to −0.65</b>. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.76 standard deviations in favour</b><br/>(1.12 more to 0.40 more). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>‐</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>959<br/>(11 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A standard deviation of 0.76 represents a large difference between groups. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with different scores in different studies. Lower scores mean fewer symptoms.  </p> <p>(Follow‐up: 12 hours)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−7.62 to −1.00</b>. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>1.03 standard deviations in favour</b><br/>(1.53 more to 0.53 more). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>571<br/>(8 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>e,f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A standard deviation of 1.03 represents a large difference between groups.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with different scores in different studies. Lower scores mean fewer symptoms.  </p> <p>(Follow‐up: 24 hours)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−2.56 to −1.05</b>. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.86 standard deviations in favour</b><br/>(1.40 more to 0.31 more). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>‐</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>351<br/>(8 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>g,h</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A standard deviation of 0.86 represents a large difference between groups. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>204 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>106 per 1000</b><br/>(74 to 153) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.52</b><br/>(0.36 to 0.75) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1679<br/>(10 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>i,j</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>13/26 (50%) studies reported collecting adverse events data, and 8/13 (62%) reported no serious adverse events. <a href="./references#CD001955-bbs2-0003" title="BjornsonC , KlassenTP , WilliamsonJ , BrantR , PlintA , BullochB , et al. A randomized trial of single dose of oral dexamethasone for mild croup. New England Journal of Medicine2004;351(13):1306-13. ">Bjornson 2004</a> reported 7 instances of pneumonia (3/359, 0.83% in the dexamethasone group and 4/361, 1.11% in the placebo group). <a href="./references#CD001955-bbs2-0025" title="JohnsonDW , SchuhS , KorenG , JaffeeDM . Outpatient treatment of croup with nebulized dexamethasone. Archives of Pediatrics &amp; Adolescent Medicine1996;150(4):349-55. ">Johnson 1996</a> reported 1 child with neutropenia consistent with bacterial tracheitis in the dexamethasone group (1/28, 3.57%). <a href="./references#CD001955-bbs2-0031" title="KuuselaAL , VesikariT . A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatrica Scandinavica1988;77(1):99-104. ">Kuusela 1988</a> reported 7 secondary bacterial infections (pneumonia, sinusitis, otitis media) requiring antibiotic therapy: 5/35, 14% in the dexamethasone group and 2/16, 12.5% in the placebo group. <a href="./references#CD001955-bbs2-0045" title="SuperDM , CartelliNA , BrooksLJ , LemboRM , KumarML . A prospective randomized double‐blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. Journal of Pediatrics1989;115(2):323-9. ">Super 1989</a> reported 1 child with pneumonitis in the placebo group (1/13, 7.7%) and 2 children with pneumonia in the dexamethasone group (2/16, 12.5%). <a href="./references#CD001955-bbs2-0038" title="RobertsGW , MasterVV , StaugasRE , RaftosJV , ParsonsDW , CoulthardKP , et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. Journal of Paediatrics and Child Health1999;35(2):170-4. ">Roberts 1999</a> reported 1 instance of exacerbated symptoms, 5 children with emotional distress, 2 with vomiting, and 1 instance of eye irritation in the budesonide group (9/42, 21.4%), and 3 instances of exacerbated symptoms, 6 children with emotional distress, 3 with vomiting, 2 rashes, and 1 instance each of eye irritation and tongue irritation in the placebo group (16/40, 40%).  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1399</p> <p>(13 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>k,l</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/>**We used Cohen's interpretation of effect sizes to determine the magnitude of the difference between groups (0.2 represents a small effect, 0.5 represents a medium effect, 0.8 represents a large effect).  </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for inconsistency. There was considerable heterogeneity (I² = 81%), and variation in point estimates.<br/><sup>b</sup>We downgraded by one level for risk of bias. The contributing studies were at high (n = 3) and unclear (n = 4) risk of bias.<br/><sup>c</sup>We downgraded by one level for inconsistency. There was considerable heterogeneity (I² = 83%), and variation in point estimates and in direction of effects for one study.<br/><sup>d</sup>We downgraded by one level for risk of bias. The contributing studies were at high (n = 3) and unclear (n = 8) risk of bias.<br/><sup>e</sup>We downgraded by one level for inconsistency. There was considerable heterogeneity (I² = 86%), and variation in point estimates.<br/><sup>f</sup>We downgraded by one level for risk of bias. The contributing studies were at high (n = 2) and unclear (n = 6) risk of bias.<br/><sup>g</sup>We downgraded by two levels for inconsistency. There was considerable heterogeneity (I² = 81%), and variation in point estimates. The confidence intervals did not overlap for some studies. There was variation in the direction of effects.<br/><sup>h</sup>We downgraded by one level for risk of bias. The contributing studies were at high (n = 2) and unclear (n = 6) risk of bias.<br/><sup>i</sup>We downgraded by one level for inconsistency. There was substantial heterogeneity (I² = 52%), and variation in point estimates.<br/><sup>j</sup>We downgraded by one level for risk of bias. The contributing studies were at high (n = 3) and unclear (n = 7) risk of bias.<br/><sup>k</sup>We downgraded by one level for imprecision. Narrative synthesis conducted, estimates are not precise.<br/><sup>l</sup>We downgraded by one level for risk of bias. The contributing studies were at high (n = 2) and unclear (n = 11) risk of bias. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001955-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Any glucocorticoid compared to epinephrine for croup </span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Any glucocorticoid compared to epinephrine for croup</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> any glucocorticoid<br/><b>Comparison:</b> epinephrine </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments**</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Epinephrine</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Any glucocorticoid</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with different scores in different studies. Lower scores mean fewer symptoms.  </p> <p>(Follow‐up: 2 hours)<br/>  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−4.24 to −3.74</b>. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.77 standard deviations not in favour</b><br/>(0.24 more to 1.77 less). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A standard deviation of 0.77 represents a large difference between groups.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with different scores in different studies. Lower scores mean fewer symptoms. </p> <p>(Follow‐up: 6 hours)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−1.25 to −1.10</b>. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.10 standard deviations in favour</b><br/>(1.18 more to 0.97 less). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>‐</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>d,e,f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A standard deviation of 0.10 represents a minimal difference between groups.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with different scores in different studies. Lower scores mean fewer symptoms.  </p> <p>(Follow‐up: 12 hours)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−3.86 to −1.45</b>. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.07 standard deviations in favour</b><br/>(0.57 more to 0.43 less). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>g,h</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A standard deviation of 0.07 represents a minimal difference between groups.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with different scores in different studies. Lower scores mean fewer symptoms.  </p> <p>(Follow‐up: 24 hours)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−4.40 to −2.01</b>. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.17 standard deviations not in favour</b><br/>(0.18 more to 0.51 less). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>g,i</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A standard deviation of 0.17 represents a small difference between groups.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/>(0 to 0) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RD 0.00</b><br/>(−0.04 to 0.04) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>g,j</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>3/4 (75%) studies reported collecting adverse events data. <a href="./references#CD001955-bbs2-0014" title="FitzgeraldD , MellisC , JohnsonM , AllenH , CooperP , Van AsperenP . Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics1996;97(5):722-5. ">Fitzgerald 1996</a> reported no serious adverse events. <a href="./references#CD001955-bbs2-0031" title="KuuselaAL , VesikariT . A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatrica Scandinavica1988;77(1):99-104. ">Kuusela 1988</a> reported 5 cases of secondary bacterial infections (pneumonia, sinusitis, otitis media) requiring antibiotic therapy in the dexamethasone group (5/16, 31.3%). <a href="./references#CD001955-bbs2-0010" title="EboriadouM , ChryssanthopoulouD , StamoulisP , DamianidouL , HaidopoulouK . The effectiveness of local corticosteroids therapy in the management of mild to moderate viral croup. Minerva Pediatrica2010;62(1):23-8. ">Eboriadou 2010</a> reported 4 cases of tremor and tachycardia (4/25, 16%) in the epinephrine group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>162<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>k,l,</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/>**We used Cohen's interpretation of effect sizes to determine the magnitude of the difference between groups (0.2 represents a small effect, 0.5 represents a medium effect, 0.8 represents a large effect).  </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RD:</b> risk difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for inconsistency. There was considerable heterogeneity (I² = 87%), and variation in point estimates. There was minimal overlap of the confidence intervals.<br/><sup>b</sup>We downgraded by one level for imprecision. The sample size was small (did not meet the optimal information size). The effect estimate included both the null effect and a clinically important benefit for epinephrine compared to glucocorticoids.<br/><sup>c</sup>We downgraded by one level for risk of bias. The contributing studies were at high risk of bias (n = 2).<br/><sup>d</sup>We downgraded by two levels for inconsistency. There was considerable heterogeneity (I² = 78%), and variation in point estimates and in the direction of effects.<br/><sup>e</sup>We downgraded by one level for imprecision. The sample size was small (did not meet optimal information size). The effect estimate included both the null effect and a clinically important effect for glucocorticoids compared to epinephrine.<br/><sup>f</sup>We downgraded by one level for risk of bias. The contributing studies were at unclear risk of bias (n = 2).<br/><sup>g</sup>We downgraded by one level for imprecision. The sample size was small (did not meet optimal information size).<br/><sup>h</sup>We downgraded by one level for risk of bias. The contributing studies were at high (n = 1) and unclear (n = 2) risk of bias.<br/><sup>i</sup>We downgraded by one level for risk of bias. The contributing studies were at high (n = 1) and unclear (n = 2) risk of bias.<br/><sup>j</sup>We downgraded by one level for risk of bias. The contributing studies were at high risk of bias (n = 2).<br/><sup>k</sup>We downgraded by one level for imprecision. Narrative synthesis was conducted, estimates are not precise.<br/><sup>l</sup>We downgraded by one level for risk of bias. The contributing studies were at high (n = 2) and unclear (n = 1) risk of bias. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD001955-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD001955-sec-0009"></div> <section id="CD001955-sec-0010"> <h3 class="title" id="CD001955-sec-0010">Description of the condition</h3> <p>Croup is a common childhood respiratory disease that often leads to frequent emergency department (ED) visits (<a href="./references#CD001955-bbs2-0093" title="BjornsonC , JohnsonDW . Croup. Lancet2008;371(9609):329-39.">Bjornson 2008</a>). It is a spectrum of diseases including laryngotracheitis, laryngotracheobronchitis, and laryngotracheobronchopneumonitis (<a href="./references#CD001955-bbs2-0121" title="SizarO , CarrB . Croup. www.ncbi.nlm.nih.gov/books/NBK431070/?report=classic (accessed prior to 23 November 2022).">Sizar 2021</a>). Patients may present with sudden onset of a seal‐like barking cough, often accompanied by stridor, voice hoarseness, and respiratory distress (<a href="./references#CD001955-bbs2-0093" title="BjornsonC , JohnsonDW . Croup. Lancet2008;371(9609):329-39.">Bjornson 2008</a>). As with many other acute respiratory diseases, croup can be mild, moderate, or severe in presentation. In brief, the pathophysiology of croup involves upper‐airway obstruction due to generalised inflammation of the airways, triggered by viral infection (especially the parainfluenza virus, which accounts for over 75% of infections) (<a href="./references#CD001955-bbs2-0094" title="BjornsonCL , JohnsonDW . Croup in children. CMAJ: Journal de l'Association Medicale Canadienne2013;185(15):1317-23.">Bjornson 2013</a>). Whilst croup is a self‐limiting viral infection, the burden of frequent hospitalisation contributes significantly to healthcare utilisation (<a href="./references#CD001955-bbs2-0094" title="BjornsonCL , JohnsonDW . Croup in children. CMAJ: Journal de l'Association Medicale Canadienne2013;185(15):1317-23.">Bjornson 2013</a>; <a href="./references#CD001955-bbs2-0100" title="DennyFW , MurphyTF , Clyde WA Jr, CollierAM , HendersonFW . Croup: an 11-year study in a pediatric practice. Pediatrics1983;71(6):871-6.">Denny 1983</a>). Croup accounts for 7% and 3% of hospitalisation in children under five and children between six months and three years in North America (<a href="./references#CD001955-bbs2-0113" title="JohnsonDW . Croup. BMJ Clinical Evidence2014;2014:0321.">Johnson 2014</a>; <a href="./references#CD001955-bbs2-0123" title="WeinbergGA , HallCB , IwaneMK , PoehlingKA , EdwardsKM , GriffinMR , et al. Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization. Journal of Pediatrics2009;154(5):694-9.">Weinberg 2009</a>). Likewise, one European study found that 16% of children aged five to eight years old had suffered from croup at least once, and 5% had experienced recurrent croup (<a href="./references#CD001955-bbs2-0122" title="Van BeverHP , WieringaMH , WeylerJJ , NelenVJ , FortuinM , VermeirePA . Croup and recurrent croup: their association with asthma and allergy. An epidemiological study on 5-8-year-old children. European Journal of Pediatrics1999;158(3):253-7.">Van Bever 1999</a>). </p> </section> <section id="CD001955-sec-0011"> <h3 class="title" id="CD001955-sec-0011">Description of the intervention</h3> <p>The clinical benefits of glucocorticoids in the management of croup are well documented in the literature (<a href="./references#CD001955-bbs2-0109" title="GriffinS , EllisS , Fitzgerald-BarronA , RoseJ , EggerM . Nebulized steroid in the treatment of croup: a systematic review of randomised controlled trials. British Journal of General Practice2000;50(451):135-41.">Griffin 2000</a>; <a href="./references#CD001955-bbs2-0115" title="KairysSW , OlmsteadEM , O'ConnorGT . Steroid treatment of laryngotracheitis: a meta-analysis of the evidence from randomized trials. Pediatrics1989;83(5):683-93.">Kairys 1989</a>). Unlike the controversies that existed in the 1970s concerning the treatment of croup (<a href="./references#CD001955-bbs2-0098" title="CherryJD . The treatment of croup: continued controversy due to failure of recognition of historic, ecologic, etiologic and clinical perspectives. Journal of Pediatrics1979;94(2):352-4.">Cherry 1979</a>), many clinical guidelines now support the use of glucocorticoids (<a href="./references#CD001955-bbs2-0090" title="Alberta Medical Association Toward Optimized Practice Working Group for Croup. Guideline for the diagnosis and management of croup. actt.albertadoctors.org/CPGs/Lists/CPGDocumentList/croup-guideline.pdf (accessed prior to 22 December 2022).">Alberta Medical Association 2008</a>). Glucocorticoids have also been shown to decrease the rate and length of hospitalisation, return visits, and admission to intensive care unit in children with croup (<a href="./references#CD001955-bbs2-0096" title="BrownJC . The management of croup. British Medical Bulletin2002;61:189-202.">Brown 2002</a>; <a href="./references#CD001955-bbs2-0107" title="GeelhoedGC , TurnerJ , MacdonaldWB . Efficacy of a small single dose of oral dexamethasone for outpatient croup: a double blind placebo controlled clinical trial. BMJ (Clinical Research Ed.)1996;313(7050):140-2.">Geelhoed 1996b</a>; <a href="./references#CD001955-bbs2-0115" title="KairysSW , OlmsteadEM , O'ConnorGT . Steroid treatment of laryngotracheitis: a meta-analysis of the evidence from randomized trials. Pediatrics1989;83(5):683-93.">Kairys 1989</a>). Studies have also continued to highlight the effectiveness of glucocorticoids in reducing the severity of croup (<a href="./references#CD001955-bbs2-0096" title="BrownJC . The management of croup. British Medical Bulletin2002;61:189-202.">Brown 2002</a>). </p> </section> <section id="CD001955-sec-0012"> <h3 class="title" id="CD001955-sec-0012">How the intervention might work</h3> <p>One of the cardinal features of inflammation is oedema or swelling. Whilst there are associated generalised swellings of the airway in croup, inflammation and oedema of the subglottic larynx (the narrowest part of the paediatric airway) and trachea, especially near the cricoid cartilage, are most clinically significant (<a href="./references#CD001955-bbs2-0099" title="CherryJD . Clinical practice. Croup. New England Journal of Medicine2008;358(4):384-91.">Cherry 2008</a>). Glucocorticoids have anti‐inflammatory properties through which they reduce croup‐related mucosal oedema and inflammation and as such reduce the associated difficulty in breathing (<a href="./references#CD001955-bbs2-0099" title="CherryJD . Clinical practice. Croup. New England Journal of Medicine2008;358(4):384-91.">Cherry 2008</a>). </p> </section> <section id="CD001955-sec-0013"> <h3 class="title" id="CD001955-sec-0013">Why it is important to do this review</h3> <p>Systematic reviews of randomised controlled trials (RCTs) on the use of glucocorticoid for the treatment of croup have contributed significantly to the evidence around the management of croup to date. The first Cochrane Review on this study question included 24 RCTs that examined the effectiveness of treating croup with glucocorticoids (<a href="./references#CD001955-bbs2-0127" title="AusejoM , SaenzA , PhamB , KellnerJD , JohnsonDW , MoherD , et al. Glucocorticoids for croup. Cochrane Database of Systematic Reviews2000, Issue 1. Art. No: CD001955. [DOI: 10.1002/14651858.CD001955.pub2]">Ausejo 2000</a>). A few other reviews have been conducted since to update the existing evidence (<a href="./references#CD001955-bbs2-0128" title="GatesA , GatesM , VandermeerB , JohnsonC , HartlingL , JohnsonDW , et al. Glucocorticoids for croup in children. Cochrane Database of Systematic Reviews2018, Issue 8. Art. No: CD001955. [DOI: 10.1002/14651858.CD001955.pub4]">Gates 2018</a>; <a href="./references#CD001955-bbs2-0130" title="RussellK , WiebeN , SaenzA , Ausejo SeguraM , JohnsonD , HartlingL , et al. Glucocorticoids for croup. Cochrane Database of Systematic Reviews2004, Issue 1. Art. No: CD001955. [DOI: 10.1002/14651858.CD001955.pub2]">Russell 2004</a>; <a href="./references#CD001955-bbs2-0131" title="RussellKF , LiangY , O'GormanK , JohnsonDW , KlassenTP . Glucocorticoids for croup. Cochrane Database of Systematic Reviews2011, Issue 1. Art. No: CD001955. [DOI: 10.1002/14651858.CD001955.pub3]">Russell 2011</a>). The current review is necessary to incorporate new evidence to help strengthen or refute the findings of previous reviews on this study question. As there is a growing debate about the lowest effective dose of glucocorticoid in the management of croup (<a href="./references#CD001955-bbs2-0001" title="AlshehrM , AlmegamsiT , HammdiA . Efficacy of a small dose of oral dexamethasone in croup. Biomedical Research2005;65(1):65-72. ">Alshehr 2005</a>; <a href="./references#CD001955-bbs2-0005" title="Chub-UppakarnS , SangsupawanichP . A randomized comparison of dexamethasone 0.15 mg/kg versus 0.6 mg/kg for the treatment of moderate to severe croup. International Journal of Pediatric Otorhinolaryngology2007;71(3):473-7. ">Chub‐Uppakarn 2007</a>; <a href="./references#CD001955-bbs2-0101" title="DobrovoljacM , GeelhoedGC . 27 years of croup: an update highlighting the effectiveness of 0.15 mg/kg of dexamethasone. Emergency Medicine Australasia2009;21(4):309-14.">Dobrovoljac 2009</a>), this review aimed to address this, and to update the existing evidence on the effect of glucocorticoids on croup.  </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD001955-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD001955-sec-0014"></div> <p>To investigate the effects and safety of glucocorticoids in the treatment of croup in children aged 18 years and below. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD001955-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD001955-sec-0015"></div> <section id="CD001955-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD001955-sec-0017"> <h4 class="title">Types of studies</h4> <p>We included RCTs in child health research that met our inclusion criteria irrespective of language, publication status, trial conduct and reporting quality, or risk of bias. We excluded all other study designs. </p> </section> <section id="CD001955-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included RCTs on children aged 18 years and below diagnosed with croup, pseudo croup, or laryngotracheitis. We defined croup as a syndrome consisting of hoarseness, barking cough, and stridor, where an alternative diagnosis of acute stridor had been excluded. We included both inpatients and outpatients, and defined children admitted to the emergency department as outpatients. </p> </section> <section id="CD001955-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We included studies where the intervention was the use of one or more glucocorticoids via any route of drug administration. There were no restrictions on the type or dose of glucocorticoid administered. We defined the control as the use of a placebo or any other active pharmacologic agent. We considered the following scenarios: the use of any glucocorticoid compared to placebo, glucocorticoid compared to epinephrine, or one glucocorticoid compared to one or a combination of other glucocorticoids, or glucocorticoids given by different modes of administration, or<b> </b>glucocorticoids given in different doses. We excluded studies if none of the treatment groups received one or more glucocorticoids. </p> </section> <section id="CD001955-sec-0020"> <h4 class="title">Types of outcome measures</h4> <p>We included RCTs that measured on one or more of our primary or secondary outcomes. We excluded studies that failed to meet all of our inclusion criteria. </p> <section id="CD001955-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD001955-list-0001"> <li> <p>Change in clinical croup score from baseline to 2, 6, 12, and/or 24 hours.</p> </li> <li> <p>Return visits or (re)admissions to the hospital, or both.</p> </li> </ol> </p> </section> <section id="CD001955-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD001955-list-0002"> <li> <p>Length of stay in the hospital or emergency department.</p> </li> <li> <p>Patient improvement at 2, 6, 12, and/or 24 hours (yes or no, as reported in the individual studies). </p> </li> <li> <p>The use of additional treatments, including: antibiotics, epinephrine, intubation/tracheostomy, mist tent, and/or supplemental glucocorticoids. </p> </li> <li> <p>Any adverse events.</p> </li> </ol> </p> </section> </section> </section> <section id="CD001955-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD001955-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We adopted the search strategy developed by a research librarian in the previous review (<a href="./references#CD001955-bbs2-0128" title="GatesA , GatesM , VandermeerB , JohnsonC , HartlingL , JohnsonDW , et al. Glucocorticoids for croup in children. Cochrane Database of Systematic Reviews2018, Issue 8. Art. No: CD001955. [DOI: 10.1002/14651858.CD001955.pub4]">Gates 2018</a>) on 4 March 2022 (<a href="./appendices#CD001955-sec-0202">Appendix 1</a>). The update searches were conducted by the librarian Mê‐Linh Lê. We included subject headings and keywords for croup and glucocorticoids and restricted the search to RCTs. We searched the Cochrane Library, which includes the Cochrane Central Register of Controlled Trials (CENTRAL; 2022, Issue 9), Ovid MEDLINE Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations and Ovid MEDLINE (1946 to 4 March 2022), and Embase (Ovid) (1974 to 4 March 2022). </p> </section> <section id="CD001955-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We searched the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) (<a href="https://trialsearch.who.int/" target="_blank">trialsearch.who.int/</a>) and ClinicalTrials.gov (<a href="https://clinicaltrials.gov" target="_blank">clinicaltrials.gov</a>) on 4 March 2022 (<a href="./appendices#CD001955-sec-0202">Appendix 1</a>). We scanned the reference lists of relevant systematic reviews identified during screening and the included studies to identify additional relevant primary studies. </p> </section> </section> <section id="CD001955-sec-0026"> <h3 class="title" id="CD001955-sec-0026">Data collection and analysis</h3> <section id="CD001955-sec-0027"> <h4 class="title">Selection of studies</h4> <p>We transferred the citations identified via the search to Rayyan software after de‐duplication (<a href="./references#CD001955-bbs2-0118" title="OuzzaniM , HammadyH , FedorowiczZ , ElmagarmidA . Rayyan — a web and mobile app for systematic reviews. Systematic Reviews2016;5:210. [DOI: 10.1186/s13643-016-0384-4]">Ouzzani 2016</a>). Three review authors (CT, AK, MR) independently screened the identified citations for eligibility using a two‐stage sifting approach to review the title, abstract, and full‐text article. Any disagreements were resolved by discussion or by involving another review author (AA) when necessary. </p> </section> <section id="CD001955-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>Three review authors (CT, AK, MR) independently extracted the data, which were all in the English language. We used Microsoft Excel to manage data extraction (<a href="./references#CD001955-bbs2-0117" title="Microsoft Excel. Redmond (WA): Microsoft Corporation, 2016.">Microsoft Excel</a>). We leveraged the data extraction form used in our previous review (<a href="./references#CD001955-bbs2-0128" title="GatesA , GatesM , VandermeerB , JohnsonC , HartlingL , JohnsonDW , et al. Glucocorticoids for croup in children. Cochrane Database of Systematic Reviews2018, Issue 8. Art. No: CD001955. [DOI: 10.1002/14651858.CD001955.pub4]">Gates 2018</a>). The details of the data extracted based on participant characteristics, experimental and control interventions, and primary and secondary outcomes have all been previously published (<a href="./references#CD001955-bbs2-0128" title="GatesA , GatesM , VandermeerB , JohnsonC , HartlingL , JohnsonDW , et al. Glucocorticoids for croup in children. Cochrane Database of Systematic Reviews2018, Issue 8. Art. No: CD001955. [DOI: 10.1002/14651858.CD001955.pub4]">Gates 2018</a>). Any disagreements during data extraction were resolved by discussion or by involving another review author (AA) when necessary. </p> </section> <section id="CD001955-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We used the Cochrane risk of bias tool to assess risk of bias of the included studies (<a href="./references#CD001955-bbs2-0112" title="HigginsJP , AltmanDG , GotzschePC , JuniP , MoherD , OxmanAD , et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ2011;343:d5928. [DOI: 10.1136/bmj.d5928]">Higgins 2011b</a>). We judged the risk of bias for each study as low, high, or unclear for seven domains: random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessors, incomplete outcome data, selective reporting, and other bias. We determined the overall risk of bias as follows: low when all domains were judged as low risk; unclear when one or more domains were judged as unclear risk; and high when one or more domains were judged as high risk. Two review authors (CT, MR) independently assessed risk of bias, resolving any disagreements by discussion or by involving another review author (AA) when necessary. </p> </section> <section id="CD001955-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>We added relevant data from the included studies into Review Manager 5 for analysis (<a href="./references#CD001955-bbs2-0119" title="Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: The Cochrane Collaboration, 2020.">Review Manager 2020</a>). We computed the effect of treatment using the random‐effects model. </p> <p>Croup scores were reported as the Westley score (<a href="./references#CD001955-bbs2-0124" title="WestleyCR , CottonEK , BrooksJG . Nebulized racemicepinephrine by IPPB for the treatment of croup. American Journal of Diseases in Children1978;132(5):484-7.">Westley 1978</a>), the telephone outpatient (TOP) score (<a href="./references#CD001955-bbs2-0095" title="BjornsonC , WilliamsonJ , JohnsonD . Telephone Out Patient Score: the derivation and validation of a telephone follow-up assessment tool for use in clinical research in children with croup. Pediatric Emergency Care2016;32(5):290-7.">Bjornson 2016</a>), the Downes and Raphaelly score (<a href="./references#CD001955-bbs2-0102" title="DownesJJ , RaphaellyRC . Pediatric intensive care. Anesthesiology1975;43:238-50.">Downes 1975</a>), or various author‐created scales. We therefore used standardised mean differences (SMDs) to combine the outcome for any croup score. A treatment effect (difference between treatment means) divided by its measurement variation (e.g. a pooled standard deviation) gives the SMD. We did not find effect estimates to be significantly different between Westley and other croup scores, so we included studies that reported any croup score in the subgroup analyses. Of note, a decrease in Westley score of one point from baseline is thought to be a clinically important change. </p> <p>We expressed length of stay as mean differences (MDs) and calculated an overall MD. We calculated risk ratios (RRs) for binary data (i.e. return visits or (re)admissions (or both), patient improvement, use of additional treatments). We calculated risk differences (RDs) where outcomes had zero events in both groups. For return visits or (re)admissions (or both), we calculated the number needed to treat for an additional beneficial outcome (NNTB) for significant results. Because there was substantial variation in control group event rates between studies, we reported the NNTB for the mean control group rate, as well as for the smallest and largest control group rate observed. </p> <p>We reported data on adverse events narratively.</p> </section> <section id="CD001955-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>As reported in <a href="./references#CD001955-bbs2-0128" title="GatesA , GatesM , VandermeerB , JohnsonC , HartlingL , JohnsonDW , et al. Glucocorticoids for croup in children. Cochrane Database of Systematic Reviews2018, Issue 8. Art. No: CD001955. [DOI: 10.1002/14651858.CD001955.pub4]">Gates 2018</a>, we calculated the change from baseline croup score in 28 (62%) studies where the change from baseline measures was not reported directly (<a href="./references#CD001955-bbs2-0001" title="AlshehrM , AlmegamsiT , HammdiA . Efficacy of a small dose of oral dexamethasone in croup. Biomedical Research2005;65(1):65-72. ">Alshehr 2005</a>; <a href="./references#CD001955-bbs2-0002" title="AmirL , HubermannH , HaleviA , MorM , MimouniM , WaismanY . Oral betamethasone versus intramuscular dexamethasone for the treatment of mild to moderate viral croup. Pediatric Emergency Care2006;22(8):541-4. ">Amir 2006</a>; <a href="./references#CD001955-bbs2-0004" title="CetinkayaF , TufekciBS , KutlukG . A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup. International Journal of Pediatric Otorhinolaryngology2004;68(4):453-6. ">Cetinkaya 2004</a>; <a href="./references#CD001955-bbs2-0005" title="Chub-UppakarnS , SangsupawanichP . A randomized comparison of dexamethasone 0.15 mg/kg versus 0.6 mg/kg for the treatment of moderate to severe croup. International Journal of Pediatric Otorhinolaryngology2007;71(3):473-7. ">Chub‐Uppakarn 2007</a>; <a href="./references#CD001955-bbs2-0007" title="DobrovoljacM , GeelhoedG . How fast does oral dexamethasone work in mild to moderately severe croup? A randomized double-blinded clinical trial. Emergency Medicine Australasia2012;24(1):79-85. ">Dobrovoljac 2012</a>; <a href="./references#CD001955-bbs2-0009" title="DumanM , OzdemirD , AtaseverS . Nebulized L-epinephrine and steroid combination in the treatment of moderate to severe croup. Clinical Drug Investigation2005;25(3):183-9. ">Duman 2005</a>; <a href="./references#CD001955-bbs2-0010" title="EboriadouM , ChryssanthopoulouD , StamoulisP , DamianidouL , HaidopoulouK . The effectiveness of local corticosteroids therapy in the management of mild to moderate viral croup. Minerva Pediatrica2010;62(1):23-8. ">Eboriadou 2010</a>; <a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a>; <a href="./references#CD001955-bbs2-0014" title="FitzgeraldD , MellisC , JohnsonM , AllenH , CooperP , Van AsperenP . Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics1996;97(5):722-5. ">Fitzgerald 1996</a>; <a href="./references#CD001955-bbs2-0016" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995a</a>; <a href="./references#CD001955-bbs2-0017" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995b</a>; <a href="./references#CD001955-bbs2-0018" title="GeelhoedGC , MacdonaldWB . Oral and inhaled steroids in croup: a randomized, placebo‐controlled trial. Pediatric Pulmonology1995;20(6):355-61. ">Geelhoed 1995c</a>; <a href="./references#CD001955-bbs2-0020" title="GeelhoedGC . Budesonide offers no advantage when added to oral dexamethasone in the treatment of croup. Pediatric Emergency Care2005;21(6):359-62. ">Geelhoed 2005</a>; <a href="./references#CD001955-bbs2-0021" title="GoddenCW , CampbellMJ , HusseyM , CogswellJJ . Double blind placebo controlled trial of nebulised budesonide for croup. Archives of Disease in Childhood1997;76(2):155-8. ">Godden 1997</a>; <a href="./references#CD001955-bbs2-0023" title="HusbyS , AgertoftL , MortensenS , PedersenS . Treatment of croup with nebulised steroid (budesonide): a double blind, placebo controlled study. Archives of Disease in Childhood1993;68(3):352-5. MortensenS , AgertoftL , HusbyS , PedersenS . Pseudocroup treated with inhaled steroid (budesonide). A double-blind placebo-controlled trial. Ugeskrift for Laeger1994;156(45):6661-3. ">Husby 1993</a>; <a href="./references#CD001955-bbs2-0025" title="JohnsonDW , SchuhS , KorenG , JaffeeDM . Outpatient treatment of croup with nebulized dexamethasone. Archives of Pediatrics &amp; Adolescent Medicine1996;150(4):349-55. ">Johnson 1996</a>; <a href="./references#CD001955-bbs2-0027" title="KlassenTP , FeldmanME , WattersLK , SutcliffeT , RowePC . Nebulized budesonide for children with mild-to-moderate croup. New England Journal of Medicine1994;331(5):285-9. ">Klassen 1994</a>; <a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a>; <a href="./references#CD001955-bbs2-0031" title="KuuselaAL , VesikariT . A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatrica Scandinavica1988;77(1):99-104. ">Kuusela 1988</a>; <a href="./references#CD001955-bbs2-0032" title="LeipzigB , OskiFA , CummingsCW , StockmanJA , SwenderP . A prospective randomized study to determine the efficacy of steroids in treatment of croup. Journal of Pediatrics1979;94(2):194-6. ">Leipzig 1979</a>; <a href="./references#CD001955-bbs2-0034" title="Martinez FernandezA , SanchezGE , RicaEI , EchanizUI , AlonsoDM , VilellaCM , et al. Randomized double-blind study of treatment of croup with adrenaline and/or dexamethasone in children. Anales Españoles de Pediatria1993;38:29-32. ">Martinez Fernandez 1993</a>; <a href="./references#CD001955-bbs2-0035" title="MassicotteP , TetreaultL . Evaluation of methyl‐prednisolone in the treatment of acute laryngitis in children. Unión Médicale du Canada1973;102(10):2064-72. ">Massicotte 1973</a>; <a href="./references#CD001955-bbs2-0037" title="RittichierKK , LedwithCA . Outpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing. Pediatrics2000;106(6):1344-8. ">Rittichier 2000</a>; <a href="./references#CD001955-bbs2-0038" title="RobertsGW , MasterVV , StaugasRE , RaftosJV , ParsonsDW , CoulthardKP , et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. Journal of Paediatrics and Child Health1999;35(2):170-4. ">Roberts 1999</a>; <a href="./references#CD001955-bbs2-0039" title="RoordaRJ , WalhofCM . Effects of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report. Pediatric Pulmonology1998;25(2):114-7. ">Roorda 1998</a>; <a href="./references#CD001955-bbs2-0045" title="SuperDM , CartelliNA , BrooksLJ , LemboRM , KumarML . A prospective randomized double‐blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. Journal of Pediatrics1989;115(2):323-9. ">Super 1989</a>; <a href="./references#CD001955-bbs2-0047" title="Vad PedersenL , DahlM , Falk-PetersenHE , LarsenSE . Inhaled budesonide versus intramuscular dexamethasone in the treatment of pseudocroup [Inhaleret budesonid versus dexamethasone i.m. til behandling at pseudocroup]. Ugeskrift for Laeger1998;160(15):2253-6. ">Vad Pedersen 1998</a>; <a href="./references#CD001955-bbs2-0048" title="Von MühlendahlKE , KahnD , SpohrHL , DresslerF . Steroid treatment of pseudo‐croup. Helvetica Paediatrica Acta1982;37(5):431-6. ">Von Mühlendahl 1982</a>). </p> <p>We pooled counts, means, and variances using standard formulae for seven (15%) studies that contained more than one experimental treatment group (<a href="./references#CD001955-bbs2-0004" title="CetinkayaF , TufekciBS , KutlukG . A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup. International Journal of Pediatric Otorhinolaryngology2004;68(4):453-6. ">Cetinkaya 2004</a>; <a href="./references#CD001955-bbs2-0010" title="EboriadouM , ChryssanthopoulouD , StamoulisP , DamianidouL , HaidopoulouK . The effectiveness of local corticosteroids therapy in the management of mild to moderate viral croup. Minerva Pediatrica2010;62(1):23-8. ">Eboriadou 2010</a>; <a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a>; <a href="./references#CD001955-bbs2-0018" title="GeelhoedGC , MacdonaldWB . Oral and inhaled steroids in croup: a randomized, placebo‐controlled trial. Pediatric Pulmonology1995;20(6):355-61. ">Geelhoed 1995c</a>; <a href="./references#CD001955-bbs2-0026" title="JohnsonDW , JacobsonS , EdneyPC , HadfieldP , MundyME , SchuhS . A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. New England Journal of Medicine1998;339(8):498-503. ">Johnson 1998</a>; <a href="./references#CD001955-bbs2-0033" title="LuriaJW , Gonzalez-del-ReyJA , DiGuilioGA , McAneneyCM , OlsenJJ , RuddyRM . Effectiveness of oral or nebulized dexamethasone for children with mild croup. Archives of Pediatrics &amp; Adolescent Medicine2001;155(12):1340-5. ">Luria 2001</a>; <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a>). One study by Geelhoed (<a href="./references#CD001955-bbs2-0016" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995a</a>; <a href="./references#CD001955-bbs2-0017" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995b</a>), and another by Skowron (<a href="./references#CD001955-bbs2-0040" title="SkowronPN , TurnerJA , McNaughtonGA . The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Canadian Medical Association Journal1966;94(11):528-31. ">Skowron 1966a</a>; <a href="./references#CD001955-bbs2-0041" title="SkowronPN , TurnerJA , McNaughtonGA . The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Canadian Medical Association Journal1966;94(11):528-31. ">Skowron 1966a and b</a>; <a href="./references#CD001955-bbs2-0042" title="SkowronPN , TurnerJA , McNaughtonGA . The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Canadian Medical Association Journal1966;94(11):528-31. ">Skowron 1966b</a>), presented the results of two individual trials in one publication. We treated these as separate comparisons in the analyses and used pooled counts only when they were reported as such in the publications. </p> </section> <section id="CD001955-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>When they were not directly reported, we estimated the variances for continuous data in accordance with the work of <a href="./references#CD001955-bbs2-0089" title="AbramsKR , GilliesCL , LambertPC . Meta-analysis of heterogeneously reported trials assessing change from baseline. Statistics in Medicine2005;24:3823-44.">Abrams 2005</a> and <a href="./references#CD001955-bbs2-0104" title="FollmannD , ElliottP , Suh l, CutlerJ . Variance imputation for overviews of clinical trials with continuous response. Journal of Clinical Epidemiology1992;45(2):769-73.">Follmann 1992</a>. Using standard formulae, we imputed standard deviations from standard errors in three (7%) studies (<a href="./references#CD001955-bbs2-0001" title="AlshehrM , AlmegamsiT , HammdiA . Efficacy of a small dose of oral dexamethasone in croup. Biomedical Research2005;65(1):65-72. ">Alshehr 2005</a>; <a href="./references#CD001955-bbs2-0026" title="JohnsonDW , JacobsonS , EdneyPC , HadfieldP , MundyME , SchuhS . A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. New England Journal of Medicine1998;339(8):498-503. ">Johnson 1998</a>; <a href="./references#CD001955-bbs2-0048" title="Von MühlendahlKE , KahnD , SpohrHL , DresslerF . Steroid treatment of pseudo‐croup. Helvetica Paediatrica Acta1982;37(5):431-6. ">Von Mühlendahl 1982</a>), ranges in three (7%) studies (<a href="./references#CD001955-bbs2-0001" title="AlshehrM , AlmegamsiT , HammdiA . Efficacy of a small dose of oral dexamethasone in croup. Biomedical Research2005;65(1):65-72. ">Alshehr 2005</a>; <a href="./references#CD001955-bbs2-0039" title="RoordaRJ , WalhofCM . Effects of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report. Pediatric Pulmonology1998;25(2):114-7. ">Roorda 1998</a>; <a href="./references#CD001955-bbs2-0045" title="SuperDM , CartelliNA , BrooksLJ , LemboRM , KumarML . A prospective randomized double‐blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. Journal of Pediatrics1989;115(2):323-9. ">Super 1989</a>), 95% confidence intervals (CIs) in two (4%) studies (<a href="./references#CD001955-bbs2-0014" title="FitzgeraldD , MellisC , JohnsonM , AllenH , CooperP , Van AsperenP . Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics1996;97(5):722-5. ">Fitzgerald 1996</a>; <a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a>), and interquartile ranges (IQRs) in three (7%) studies (<a href="./references#CD001955-bbs2-0025" title="JohnsonDW , SchuhS , KorenG , JaffeeDM . Outpatient treatment of croup with nebulized dexamethasone. Archives of Pediatrics &amp; Adolescent Medicine1996;150(4):349-55. ">Johnson 1996</a>; <a href="./references#CD001955-bbs2-0027" title="KlassenTP , FeldmanME , WattersLK , SutcliffeT , RowePC . Nebulized budesonide for children with mild-to-moderate croup. New England Journal of Medicine1994;331(5):285-9. ">Klassen 1994</a>; <a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a>). When the change in croup score from baseline was not directly reported (n = 14, 31%), we derived the variance of the change assuming a correlation of 0.5 between pre‐ and post‐treatment scores (<a href="./references#CD001955-bbs2-0001" title="AlshehrM , AlmegamsiT , HammdiA . Efficacy of a small dose of oral dexamethasone in croup. Biomedical Research2005;65(1):65-72. ">Alshehr 2005</a>; <a href="./references#CD001955-bbs2-0002" title="AmirL , HubermannH , HaleviA , MorM , MimouniM , WaismanY . Oral betamethasone versus intramuscular dexamethasone for the treatment of mild to moderate viral croup. Pediatric Emergency Care2006;22(8):541-4. ">Amir 2006</a>; <a href="./references#CD001955-bbs2-0005" title="Chub-UppakarnS , SangsupawanichP . A randomized comparison of dexamethasone 0.15 mg/kg versus 0.6 mg/kg for the treatment of moderate to severe croup. International Journal of Pediatric Otorhinolaryngology2007;71(3):473-7. ">Chub‐Uppakarn 2007</a>; <a href="./references#CD001955-bbs2-0014" title="FitzgeraldD , MellisC , JohnsonM , AllenH , CooperP , Van AsperenP . Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics1996;97(5):722-5. ">Fitzgerald 1996</a>; <a href="./references#CD001955-bbs2-0025" title="JohnsonDW , SchuhS , KorenG , JaffeeDM . Outpatient treatment of croup with nebulized dexamethasone. Archives of Pediatrics &amp; Adolescent Medicine1996;150(4):349-55. ">Johnson 1996</a>; <a href="./references#CD001955-bbs2-0027" title="KlassenTP , FeldmanME , WattersLK , SutcliffeT , RowePC . Nebulized budesonide for children with mild-to-moderate croup. New England Journal of Medicine1994;331(5):285-9. ">Klassen 1994</a>; <a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a>; <a href="./references#CD001955-bbs2-0031" title="KuuselaAL , VesikariT . A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatrica Scandinavica1988;77(1):99-104. ">Kuusela 1988</a>; <a href="./references#CD001955-bbs2-0032" title="LeipzigB , OskiFA , CummingsCW , StockmanJA , SwenderP . A prospective randomized study to determine the efficacy of steroids in treatment of croup. Journal of Pediatrics1979;94(2):194-6. ">Leipzig 1979</a>; <a href="./references#CD001955-bbs2-0034" title="Martinez FernandezA , SanchezGE , RicaEI , EchanizUI , AlonsoDM , VilellaCM , et al. Randomized double-blind study of treatment of croup with adrenaline and/or dexamethasone in children. Anales Españoles de Pediatria1993;38:29-32. ">Martinez Fernandez 1993</a>; <a href="./references#CD001955-bbs2-0039" title="RoordaRJ , WalhofCM . Effects of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report. Pediatric Pulmonology1998;25(2):114-7. ">Roorda 1998</a>; <a href="./references#CD001955-bbs2-0045" title="SuperDM , CartelliNA , BrooksLJ , LemboRM , KumarML . A prospective randomized double‐blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. Journal of Pediatrics1989;115(2):323-9. ">Super 1989</a>; <a href="./references#CD001955-bbs2-0047" title="Vad PedersenL , DahlM , Falk-PetersenHE , LarsenSE . Inhaled budesonide versus intramuscular dexamethasone in the treatment of pseudocroup [Inhaleret budesonid versus dexamethasone i.m. til behandling at pseudocroup]. Ugeskrift for Laeger1998;160(15):2253-6. ">Vad Pedersen 1998</a>; <a href="./references#CD001955-bbs2-0048" title="Von MühlendahlKE , KahnD , SpohrHL , DresslerF . Steroid treatment of pseudo‐croup. Helvetica Paediatrica Acta1982;37(5):431-6. ">Von Mühlendahl 1982</a>).  </p> <p>In 11 (26%) studies, data from which to impute variances for change in croup score or length of stay were inadequate; for these studies we substituted average variances from other studies in the main analysis (<a href="./references#CD001955-bbs2-0004" title="CetinkayaF , TufekciBS , KutlukG . A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup. International Journal of Pediatric Otorhinolaryngology2004;68(4):453-6. ">Cetinkaya 2004</a>; <a href="./references#CD001955-bbs2-0007" title="DobrovoljacM , GeelhoedG . How fast does oral dexamethasone work in mild to moderately severe croup? A randomized double-blinded clinical trial. Emergency Medicine Australasia2012;24(1):79-85. ">Dobrovoljac 2012</a>; <a href="./references#CD001955-bbs2-0010" title="EboriadouM , ChryssanthopoulouD , StamoulisP , DamianidouL , HaidopoulouK . The effectiveness of local corticosteroids therapy in the management of mild to moderate viral croup. Minerva Pediatrica2010;62(1):23-8. ">Eboriadou 2010</a>; <a href="./references#CD001955-bbs2-0018" title="GeelhoedGC , MacdonaldWB . Oral and inhaled steroids in croup: a randomized, placebo‐controlled trial. Pediatric Pulmonology1995;20(6):355-61. ">Geelhoed 1995c</a>; <a href="./references#CD001955-bbs2-0020" title="GeelhoedGC . Budesonide offers no advantage when added to oral dexamethasone in the treatment of croup. Pediatric Emergency Care2005;21(6):359-62. ">Geelhoed 2005</a>; <a href="./references#CD001955-bbs2-0021" title="GoddenCW , CampbellMJ , HusseyM , CogswellJJ . Double blind placebo controlled trial of nebulised budesonide for croup. Archives of Disease in Childhood1997;76(2):155-8. ">Godden 1997</a>; <a href="./references#CD001955-bbs2-0023" title="HusbyS , AgertoftL , MortensenS , PedersenS . Treatment of croup with nebulised steroid (budesonide): a double blind, placebo controlled study. Archives of Disease in Childhood1993;68(3):352-5. MortensenS , AgertoftL , HusbyS , PedersenS . Pseudocroup treated with inhaled steroid (budesonide). A double-blind placebo-controlled trial. Ugeskrift for Laeger1994;156(45):6661-3. ">Husby 1993</a>; <a href="./references#CD001955-bbs2-0031" title="KuuselaAL , VesikariT . A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatrica Scandinavica1988;77(1):99-104. ">Kuusela 1988</a>; <a href="./references#CD001955-bbs2-0035" title="MassicotteP , TetreaultL . Evaluation of methyl‐prednisolone in the treatment of acute laryngitis in children. Unión Médicale du Canada1973;102(10):2064-72. ">Massicotte 1973</a>; <a href="./references#CD001955-bbs2-0038" title="RobertsGW , MasterVV , StaugasRE , RaftosJV , ParsonsDW , CoulthardKP , et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. Journal of Paediatrics and Child Health1999;35(2):170-4. ">Roberts 1999</a>; <a href="./references#CD001955-bbs2-0040" title="SkowronPN , TurnerJA , McNaughtonGA . The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Canadian Medical Association Journal1966;94(11):528-31. ">Skowron 1966a</a>; <a href="./references#CD001955-bbs2-0042" title="SkowronPN , TurnerJA , McNaughtonGA . The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Canadian Medical Association Journal1966;94(11):528-31. ">Skowron 1966b</a>). Furukawa and colleagues assert that when the number of studies with imputed data within a meta‐analysis is relatively small, variance data can be safely borrowed from other studies and still provide accurate results (<a href="./references#CD001955-bbs2-0105" title="FurukawaTA , BarbuiC , CiprianiA , BrambillaP , WatanabeN . Imputing missing standard deviations in meta-analyses can provide accurate results. Journal of Clinical Epidemiology2006;59(1):7-10. [DOI: 10.1016/j.jclinepi.2005.06.006]">Furukawa 2006</a>). For certain outcomes only one study was included in the comparison, and that study did not report a variance estimate; in such a case we did not calculate a point estimate of effect (<a href="./references#CD001955-bbs2-0004" title="CetinkayaF , TufekciBS , KutlukG . A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup. International Journal of Pediatric Otorhinolaryngology2004;68(4):453-6. ">Cetinkaya 2004</a>; <a href="./references#CD001955-bbs2-0009" title="DumanM , OzdemirD , AtaseverS . Nebulized L-epinephrine and steroid combination in the treatment of moderate to severe croup. Clinical Drug Investigation2005;25(3):183-9. ">Duman 2005</a>; <a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a>; <a href="./references#CD001955-bbs2-0016" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995a</a>; <a href="./references#CD001955-bbs2-0017" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995b</a>; <a href="./references#CD001955-bbs2-0018" title="GeelhoedGC , MacdonaldWB . Oral and inhaled steroids in croup: a randomized, placebo‐controlled trial. Pediatric Pulmonology1995;20(6):355-61. ">Geelhoed 1995c</a>; <a href="./references#CD001955-bbs2-0020" title="GeelhoedGC . Budesonide offers no advantage when added to oral dexamethasone in the treatment of croup. Pediatric Emergency Care2005;21(6):359-62. ">Geelhoed 2005</a>; <a href="./references#CD001955-bbs2-0037" title="RittichierKK , LedwithCA . Outpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing. Pediatrics2000;106(6):1344-8. ">Rittichier 2000</a>).  </p> <p>We substituted medians for means in nine (20%) studies (<a href="./references#CD001955-bbs2-0001" title="AlshehrM , AlmegamsiT , HammdiA . Efficacy of a small dose of oral dexamethasone in croup. Biomedical Research2005;65(1):65-72. ">Alshehr 2005</a>; <a href="./references#CD001955-bbs2-0016" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995a</a>; <a href="./references#CD001955-bbs2-0017" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995b</a>; <a href="./references#CD001955-bbs2-0018" title="GeelhoedGC , MacdonaldWB . Oral and inhaled steroids in croup: a randomized, placebo‐controlled trial. Pediatric Pulmonology1995;20(6):355-61. ">Geelhoed 1995c</a>; <a href="./references#CD001955-bbs2-0025" title="JohnsonDW , SchuhS , KorenG , JaffeeDM . Outpatient treatment of croup with nebulized dexamethasone. Archives of Pediatrics &amp; Adolescent Medicine1996;150(4):349-55. ">Johnson 1996</a>; <a href="./references#CD001955-bbs2-0027" title="KlassenTP , FeldmanME , WattersLK , SutcliffeT , RowePC . Nebulized budesonide for children with mild-to-moderate croup. New England Journal of Medicine1994;331(5):285-9. ">Klassen 1994</a>; <a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a>; <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a>; <a href="./references#CD001955-bbs2-0045" title="SuperDM , CartelliNA , BrooksLJ , LemboRM , KumarML . A prospective randomized double‐blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. Journal of Pediatrics1989;115(2):323-9. ">Super 1989</a>; <a href="./references#CD001955-bbs2-0048" title="Von MühlendahlKE , KahnD , SpohrHL , DresslerF . Steroid treatment of pseudo‐croup. Helvetica Paediatrica Acta1982;37(5):431-6. ">Von Mühlendahl 1982</a>). When data for our prespecified time points (2, 6, 12, and 24 hours from baseline) were not reported, we used time points close to these if available. We substituted one hour for two hours in one study (<a href="./references#CD001955-bbs2-0007" title="DobrovoljacM , GeelhoedG . How fast does oral dexamethasone work in mild to moderately severe croup? A randomized double-blinded clinical trial. Emergency Medicine Australasia2012;24(1):79-85. ">Dobrovoljac 2012</a>); four hours for six hours in 12 (28%) studies (<a href="./references#CD001955-bbs2-0001" title="AlshehrM , AlmegamsiT , HammdiA . Efficacy of a small dose of oral dexamethasone in croup. Biomedical Research2005;65(1):65-72. ">Alshehr 2005</a>; <a href="./references#CD001955-bbs2-0002" title="AmirL , HubermannH , HaleviA , MorM , MimouniM , WaismanY . Oral betamethasone versus intramuscular dexamethasone for the treatment of mild to moderate viral croup. Pediatric Emergency Care2006;22(8):541-4. ">Amir 2006</a>; <a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a>; <a href="./references#CD001955-bbs2-0016" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995a</a>; <a href="./references#CD001955-bbs2-0017" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995b</a>; <a href="./references#CD001955-bbs2-0018" title="GeelhoedGC , MacdonaldWB . Oral and inhaled steroids in croup: a randomized, placebo‐controlled trial. Pediatric Pulmonology1995;20(6):355-61. ">Geelhoed 1995c</a>; <a href="./references#CD001955-bbs2-0020" title="GeelhoedGC . Budesonide offers no advantage when added to oral dexamethasone in the treatment of croup. Pediatric Emergency Care2005;21(6):359-62. ">Geelhoed 2005</a>; <a href="./references#CD001955-bbs2-0021" title="GoddenCW , CampbellMJ , HusseyM , CogswellJJ . Double blind placebo controlled trial of nebulised budesonide for croup. Archives of Disease in Childhood1997;76(2):155-8. ">Godden 1997</a>; <a href="./references#CD001955-bbs2-0025" title="JohnsonDW , SchuhS , KorenG , JaffeeDM . Outpatient treatment of croup with nebulized dexamethasone. Archives of Pediatrics &amp; Adolescent Medicine1996;150(4):349-55. ">Johnson 1996</a>; <a href="./references#CD001955-bbs2-0027" title="KlassenTP , FeldmanME , WattersLK , SutcliffeT , RowePC . Nebulized budesonide for children with mild-to-moderate croup. New England Journal of Medicine1994;331(5):285-9. ">Klassen 1994</a>; <a href="./references#CD001955-bbs2-0028" title="KlassenTP , WattersLK , FeldmanME , SutcliffeT , RowePC . The efficacy of nebulized budesonide in dexamethasone‐treated outpatients with croup. Pediatrics1996;97(4):463-6. ">Klassen 1996</a>; <a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a>; <a href="./references#CD001955-bbs2-0035" title="MassicotteP , TetreaultL . Evaluation of methyl‐prednisolone in the treatment of acute laryngitis in children. Unión Médicale du Canada1973;102(10):2064-72. ">Massicotte 1973</a>); five hours or discharge for six hours in one study (<a href="./references#CD001955-bbs2-0026" title="JohnsonDW , JacobsonS , EdneyPC , HadfieldP , MundyME , SchuhS . A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. New England Journal of Medicine1998;339(8):498-503. ">Johnson 1998</a>); and 14 hours for 12 hours in one study (<a href="./references#CD001955-bbs2-0035" title="MassicotteP , TetreaultL . Evaluation of methyl‐prednisolone in the treatment of acute laryngitis in children. Unión Médicale du Canada1973;102(10):2064-72. ">Massicotte 1973</a>). </p> </section> <section id="CD001955-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>In keeping with <a href="./references#CD001955-bbs2-0128" title="GatesA , GatesM , VandermeerB , JohnsonC , HartlingL , JohnsonDW , et al. Glucocorticoids for croup in children. Cochrane Database of Systematic Reviews2018, Issue 8. Art. No: CD001955. [DOI: 10.1002/14651858.CD001955.pub4]">Gates 2018</a>, we assessed heterogeneity quantitatively with the Chi² test for heterogeneity and the I² statistic (<a href="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001955.pub4/references#CD001955-bbs2-0099" target="_blank">Higgins 2002</a>). The I² statistic indicates the per cent variability due to between‐study (or interstudy) variability as opposed to within‐study (or intrastudy) variability. We considered an I² of less than 40% to be low (potentially unimportant), 30% to 60% to be moderate, 50% to 90% to be substantial, and 75% to 100% to be considerable (<a href="./references#CD001955-bbs2-0111" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011a</a>, Section 9.5.2). </p> </section> <section id="CD001955-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>In addition to visually inspecting the funnel plots, we used the rank correlation test and weighted regression for the detection of publication bias (<a href="./references#CD001955-bbs2-0092" title="BeggCB , MazumdarM . Operating characteristics of a rank correlation test for publication bias. Biometrics1994;50(4):1088-101.">Begg 1994</a>; <a href="./references#CD001955-bbs2-0103" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta-analysis detected by a simple, graphical test. BMJ1997;315(7109):629-34.">Egger 1997</a>; <a href="./references#CD001955-bbs2-0116" title="LightRS , PillemarDB . Summing Up: The Science of Reviewing Research. Cambridge: Harvard University Press, 1984.">Light 1984</a>). We used more than one method because the relative merits of the methods are not well established. </p> </section> <section id="CD001955-sec-0035"> <h4 class="title">Data synthesis</h4> <p>We used random‐effects models to combine treatment effects regardless of quantified heterogeneity for the analyses of all outcomes. </p> </section> <section id="CD001955-sec-0036"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We explored heterogeneity between studies using subgroup analyses for the primary outcomes of change in croup score from baseline to 2, 6, 12, and 24 hours, and return visits or (re)admissions or both, using the Chi² test for subgroup differences in meta‐analysis. We explored heterogeneity by croup score, by inpatient or outpatient status, and by glucocorticoid. </p> </section> <section id="CD001955-sec-0037"> <h4 class="title">Sensitivity analysis</h4> <p>In some analyses, we imputed variance data for most of the included RCTs (e.g. any glucocorticoid compared to placebo, change in croup score after two hours). We undertook sensitivity analyses for these and all other analyses containing imputed variance data using the largest, smallest, and average variances from the other included RCTs. As per protocol, we did not undertake any additional sensitivity analyses.  </p> </section> <section id="CD001955-sec-0038"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We created summary of findings tables for our two main comparisons (any glucocorticoid compared to placebo and any glucocorticoid compared to epinephrine) for the primary outcomes: change in croup score at 2, 6, 12, and 24 hours from baseline, and return visits or (re)admissions or both<i>.</i> The findings for the two main comparisons have not changed since the previous version of the review, as no new data were identified in the current update (<a href="./references#CD001955-bbs2-0128" title="GatesA , GatesM , VandermeerB , JohnsonC , HartlingL , JohnsonDW , et al. Glucocorticoids for croup in children. Cochrane Database of Systematic Reviews2018, Issue 8. Art. No: CD001955. [DOI: 10.1002/14651858.CD001955.pub4]">Gates 2018</a>). As per protocol, we created summary of findings tables for the remaining comparisons; however, in order not to detract from the two main comparisons, these are included in the Additional tables section. We used the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness, and publication bias) to assess the certainty of the body of evidence as it relates to the studies that contributed data to the meta‐analyses (<a href="./references#CD001955-bbs2-0091" title="AtkinsD , BestD , BrissPA , EcclesM , Falck-YtterY , FlottorpS , et al. GRADE Working Group. Grade quality of evidence and strength of recommendations. BMJ2004;328(7457):1490.">Atkins 2004</a>). We used the methods and recommendations described in Section 8.5 and Chapter 12 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD001955-bbs2-0111" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011a</a>), employing GRADEpro GDT software (<a href="./references#CD001955-bbs2-0108" title="GRADEpro GDT. Version accessed 23 February 2022. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEpro GDT</a>). We justified all decisions to downgrade the certainty of the evidence using footnotes, and made comments to aid the reader's understanding where necessary. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD001955-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD001955-sec-0039"></div> <section id="CD001955-sec-0040"> <h3 class="title">Description of studies</h3> <section id="CD001955-sec-0041"> <h4 class="title">Results of the search</h4> <p>We identified 100 records in the 2022 update search (<a href="#CD001955-fig-0001">Figure 1</a>). We retrieved 83 citations from the database searches and 17 records from trial registers, from which we identified and removed 41 duplicates. We screened 59 records by title and abstract and excluded 49 citations. We screened 10 full‐text articles of which six were excluded, with reasons for their exclusion provided. A flow diagram illustrating the 2022 update selection process is shown in <a href="#CD001955-fig-0001">Figure 1</a>. We added two new RCTs with 1323 children (<a href="./references#CD001955-bbs2-0022" title="HuangT , XiaZ , LiW . Efficacy of inhaled budesonide on serum inflammatory factors and quality of life among children with acute infectious laryngitis. American Journal of Otolaryngology - Head and Neck Medicine and Surgery2021;42(1):102820. ">Huang 2021</a>; <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a>), one ongoing study (<a href="./references#CD001955-bbs2-0088" title="IRCT20190914044765N1. Comparison the effect of oral and intravenous dexamethasone effect on the mild and moderate croup treatment in children. www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT20190914044765N1 (first received 24 September 2019). ">IRCT20190914044765N1</a>), and one study awaiting classification (<a href="./references#CD001955-bbs2-0087" title="ChenQP , ZhouRF , ZhangYM , YangL . Efficacy of systemic glucocorticoids combined with inhaled steroid on children with acute laryngitis. Zhonghua er bi yan hou tou jing wai ke za zhi [Chinese Journal of Otorhinolaryngology Head and Neck Surgery]2018;53(1):53-6. ">Chen 2018</a>). This updated review includes 45 RCTs with a total of 5888 children. </p> <div class="figure" id="CD001955-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Flow diagram of study selection for this review." data-id="CD001955-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Flow diagram of study selection for this review.</p> </div> </div> </div> </section> <section id="CD001955-sec-0042"> <h4 class="title">Included studies</h4> <section id="CD001955-sec-0043"> <h5 class="title">Participant and trial characteristics</h5> <p>We identified 42 studies (93%) published in English, and one each in French (<a href="./references#CD001955-bbs2-0035" title="MassicotteP , TetreaultL . Evaluation of methyl‐prednisolone in the treatment of acute laryngitis in children. Unión Médicale du Canada1973;102(10):2064-72. ">Massicotte 1973</a>), Spanish (<a href="./references#CD001955-bbs2-0034" title="Martinez FernandezA , SanchezGE , RicaEI , EchanizUI , AlonsoDM , VilellaCM , et al. Randomized double-blind study of treatment of croup with adrenaline and/or dexamethasone in children. Anales Españoles de Pediatria1993;38:29-32. ">Martinez Fernandez 1993</a>), and Danish (<a href="./references#CD001955-bbs2-0047" title="Vad PedersenL , DahlM , Falk-PetersenHE , LarsenSE . Inhaled budesonide versus intramuscular dexamethasone in the treatment of pseudocroup [Inhaleret budesonid versus dexamethasone i.m. til behandling at pseudocroup]. Ugeskrift for Laeger1998;160(15):2253-6. ">Vad Pedersen 1998</a>). Four studies (9%) included children with mild croup (<a href="./references#CD001955-bbs2-0003" title="BjornsonC , KlassenTP , WilliamsonJ , BrantR , PlintA , BullochB , et al. A randomized trial of single dose of oral dexamethasone for mild croup. New England Journal of Medicine2004;351(13):1306-13. ">Bjornson 2004</a>; <a href="./references#CD001955-bbs2-0019" title="GeelhoedGC , TurnerJ , MacdonaldWB . Efficacy of a small single dose of oral dexamethasone for outpatient croup: a double blind placebo controlled clinical trial. BMJ1996;313(7050):140-2. ">Geelhoed 1996a</a>; <a href="./references#CD001955-bbs2-0033" title="LuriaJW , Gonzalez-del-ReyJA , DiGuilioGA , McAneneyCM , OlsenJJ , RuddyRM . Effectiveness of oral or nebulized dexamethasone for children with mild croup. Archives of Pediatrics &amp; Adolescent Medicine2001;155(12):1340-5. ">Luria 2001</a>, <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a>). Twenty‐three studies (51%) assessed outpatient children (n = 22 emergency department visits, n = 1 physician office visits) (<a href="./references#CD001955-bbs2-0001" title="AlshehrM , AlmegamsiT , HammdiA . Efficacy of a small dose of oral dexamethasone in croup. Biomedical Research2005;65(1):65-72. ">Alshehr 2005</a>; <a href="./references#CD001955-bbs2-0002" title="AmirL , HubermannH , HaleviA , MorM , MimouniM , WaismanY . Oral betamethasone versus intramuscular dexamethasone for the treatment of mild to moderate viral croup. Pediatric Emergency Care2006;22(8):541-4. ">Amir 2006</a>; <a href="./references#CD001955-bbs2-0003" title="BjornsonC , KlassenTP , WilliamsonJ , BrantR , PlintA , BullochB , et al. A randomized trial of single dose of oral dexamethasone for mild croup. New England Journal of Medicine2004;351(13):1306-13. ">Bjornson 2004</a>; <a href="./references#CD001955-bbs2-0004" title="CetinkayaF , TufekciBS , KutlukG . A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup. International Journal of Pediatric Otorhinolaryngology2004;68(4):453-6. ">Cetinkaya 2004</a>; <a href="./references#CD001955-bbs2-0006" title="CruzMN , StewartG , RosenbergN . Use of dexamethasone in the outpatient management of acute laryngotracheitis. Pediatrics1995;96(2 Pt 1):220-3. ">Cruz 1995</a>; <a href="./references#CD001955-bbs2-0007" title="DobrovoljacM , GeelhoedG . How fast does oral dexamethasone work in mild to moderately severe croup? A randomized double-blinded clinical trial. Emergency Medicine Australasia2012;24(1):79-85. ">Dobrovoljac 2012</a>; <a href="./references#CD001955-bbs2-0008" title="DonaldsonD , PoleskiD , KnippleE , FilipsK , ReetzL , PasculaRG , et al. Intramuscular versus oral dexamethasone for the treatment of moderate-to-severe croup: a randomized double-blind trial. Academy of Emergency Medicine2003;10(1):16-21. ">Donaldson 2003</a>; <a href="./references#CD001955-bbs2-0009" title="DumanM , OzdemirD , AtaseverS . Nebulized L-epinephrine and steroid combination in the treatment of moderate to severe croup. Clinical Drug Investigation2005;25(3):183-9. ">Duman 2005</a>; <a href="./references#CD001955-bbs2-0010" title="EboriadouM , ChryssanthopoulouD , StamoulisP , DamianidouL , HaidopoulouK . The effectiveness of local corticosteroids therapy in the management of mild to moderate viral croup. Minerva Pediatrica2010;62(1):23-8. ">Eboriadou 2010</a>; <a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a>; <a href="./references#CD001955-bbs2-0015" title="GarbuttJM , ConionB , SterkelR , BatyJ , SchechtmanKB , MandrellK , et al. The comparative effectiveness of prednisolone and dexamethasone for children with croup: a community-based randomized trial. Clinical Pediatrics2013;52(11):1014-21. ">Garbutt 2013</a>; <a href="./references#CD001955-bbs2-0016" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995a</a>; <a href="./references#CD001955-bbs2-0017" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995b</a>; <a href="./references#CD001955-bbs2-0019" title="GeelhoedGC , TurnerJ , MacdonaldWB . Efficacy of a small single dose of oral dexamethasone for outpatient croup: a double blind placebo controlled clinical trial. BMJ1996;313(7050):140-2. ">Geelhoed 1996a</a>; <a href="./references#CD001955-bbs2-0025" title="JohnsonDW , SchuhS , KorenG , JaffeeDM . Outpatient treatment of croup with nebulized dexamethasone. Archives of Pediatrics &amp; Adolescent Medicine1996;150(4):349-55. ">Johnson 1996</a>; <a href="./references#CD001955-bbs2-0026" title="JohnsonDW , JacobsonS , EdneyPC , HadfieldP , MundyME , SchuhS . A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. New England Journal of Medicine1998;339(8):498-503. ">Johnson 1998</a>; <a href="./references#CD001955-bbs2-0027" title="KlassenTP , FeldmanME , WattersLK , SutcliffeT , RowePC . Nebulized budesonide for children with mild-to-moderate croup. New England Journal of Medicine1994;331(5):285-9. ">Klassen 1994</a>; <a href="./references#CD001955-bbs2-0028" title="KlassenTP , WattersLK , FeldmanME , SutcliffeT , RowePC . The efficacy of nebulized budesonide in dexamethasone‐treated outpatients with croup. Pediatrics1996;97(4):463-6. ">Klassen 1996</a>; <a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a>; <a href="./references#CD001955-bbs2-0033" title="LuriaJW , Gonzalez-del-ReyJA , DiGuilioGA , McAneneyCM , OlsenJJ , RuddyRM . Effectiveness of oral or nebulized dexamethasone for children with mild croup. Archives of Pediatrics &amp; Adolescent Medicine2001;155(12):1340-5. ">Luria 2001</a>; <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a>; <a href="./references#CD001955-bbs2-0037" title="RittichierKK , LedwithCA . Outpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing. Pediatrics2000;106(6):1344-8. ">Rittichier 2000</a>; <a href="./references#CD001955-bbs2-0043" title="SoleimaniG , DaryadelA , MoghadamAA , SharifMR . The comparison of oral and IM dexamethasone efficacy in croup treatment. Journal of Comprehensive Pediatrics2013;4(4):175-8. ">Soleimani 2013</a>; <a href="./references#CD001955-bbs2-0044" title="SparrowA , GeelhoedG . Prednisolone versus dexamethasone in croup: a randomised equivalence trial. Archives of Disease in Childhood2006;91(7):580-3. ">Sparrow 2006</a>). Twenty‐three studies (51%) assessed hospitalised children (<a href="./references#CD001955-bbs2-0005" title="Chub-UppakarnS , SangsupawanichP . A randomized comparison of dexamethasone 0.15 mg/kg versus 0.6 mg/kg for the treatment of moderate to severe croup. International Journal of Pediatric Otorhinolaryngology2007;71(3):473-7. ">Chub‐Uppakarn 2007</a>; <a href="./references#CD001955-bbs2-0011" title="EdenA , LarkinVP . Corticosteroid treatment of croup. Pediatrics1964;33:768-9. ">Eden 1964</a>; <a href="./references#CD001955-bbs2-0012" title="EdenAN , KaufmanA , YuR . Corticosteroids and croup. Controlled double-blind study. JAMA1967;200(5):403-4. ">Eden 1967</a>; <a href="./references#CD001955-bbs2-0014" title="FitzgeraldD , MellisC , JohnsonM , AllenH , CooperP , Van AsperenP . Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics1996;97(5):722-5. ">Fitzgerald 1996</a>; <a href="./references#CD001955-bbs2-0018" title="GeelhoedGC , MacdonaldWB . Oral and inhaled steroids in croup: a randomized, placebo‐controlled trial. Pediatric Pulmonology1995;20(6):355-61. ">Geelhoed 1995c</a>; <a href="./references#CD001955-bbs2-0020" title="GeelhoedGC . Budesonide offers no advantage when added to oral dexamethasone in the treatment of croup. Pediatric Emergency Care2005;21(6):359-62. ">Geelhoed 2005</a>; <a href="./references#CD001955-bbs2-0021" title="GoddenCW , CampbellMJ , HusseyM , CogswellJJ . Double blind placebo controlled trial of nebulised budesonide for croup. Archives of Disease in Childhood1997;76(2):155-8. ">Godden 1997</a>; <a href="./references#CD001955-bbs2-0022" title="HuangT , XiaZ , LiW . Efficacy of inhaled budesonide on serum inflammatory factors and quality of life among children with acute infectious laryngitis. American Journal of Otolaryngology - Head and Neck Medicine and Surgery2021;42(1):102820. ">Huang 2021</a>; <a href="./references#CD001955-bbs2-0023" title="HusbyS , AgertoftL , MortensenS , PedersenS . Treatment of croup with nebulised steroid (budesonide): a double blind, placebo controlled study. Archives of Disease in Childhood1993;68(3):352-5. MortensenS , AgertoftL , HusbyS , PedersenS . Pseudocroup treated with inhaled steroid (budesonide). A double-blind placebo-controlled trial. Ugeskrift for Laeger1994;156(45):6661-3. ">Husby 1993</a>; <a href="./references#CD001955-bbs2-0024" title="JamesJA . Dexamethasone in croup. A controlled study. American Journal of Diseases of Children1969;117(5):511-6. ">James 1969</a>; <a href="./references#CD001955-bbs2-0030" title="KorenGF . Corticosteroid treatment of laryngotracheitis v spasmodic croup in children. American Journal of Diseases of Children1983;137(10):941-4. ">Koren 1983</a>; <a href="./references#CD001955-bbs2-0031" title="KuuselaAL , VesikariT . A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatrica Scandinavica1988;77(1):99-104. ">Kuusela 1988</a>; <a href="./references#CD001955-bbs2-0032" title="LeipzigB , OskiFA , CummingsCW , StockmanJA , SwenderP . A prospective randomized study to determine the efficacy of steroids in treatment of croup. Journal of Pediatrics1979;94(2):194-6. ">Leipzig 1979</a>; <a href="./references#CD001955-bbs2-0034" title="Martinez FernandezA , SanchezGE , RicaEI , EchanizUI , AlonsoDM , VilellaCM , et al. Randomized double-blind study of treatment of croup with adrenaline and/or dexamethasone in children. Anales Españoles de Pediatria1993;38:29-32. ">Martinez Fernandez 1993</a>; <a href="./references#CD001955-bbs2-0035" title="MassicotteP , TetreaultL . Evaluation of methyl‐prednisolone in the treatment of acute laryngitis in children. Unión Médicale du Canada1973;102(10):2064-72. ">Massicotte 1973</a>; <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a>; <a href="./references#CD001955-bbs2-0038" title="RobertsGW , MasterVV , StaugasRE , RaftosJV , ParsonsDW , CoulthardKP , et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. Journal of Paediatrics and Child Health1999;35(2):170-4. ">Roberts 1999</a>; <a href="./references#CD001955-bbs2-0039" title="RoordaRJ , WalhofCM . Effects of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report. Pediatric Pulmonology1998;25(2):114-7. ">Roorda 1998</a>; <a href="./references#CD001955-bbs2-0040" title="SkowronPN , TurnerJA , McNaughtonGA . The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Canadian Medical Association Journal1966;94(11):528-31. ">Skowron 1966a</a>; <a href="./references#CD001955-bbs2-0042" title="SkowronPN , TurnerJA , McNaughtonGA . The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Canadian Medical Association Journal1966;94(11):528-31. ">Skowron 1966b</a>; <a href="./references#CD001955-bbs2-0045" title="SuperDM , CartelliNA , BrooksLJ , LemboRM , KumarML . A prospective randomized double‐blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. Journal of Pediatrics1989;115(2):323-9. ">Super 1989</a>; <a href="./references#CD001955-bbs2-0046" title="TibballsJ , ShannFA , LandauLI . Placebo-controlled trial of prednisolone in children intubated for croup. Lancet1992;340(8822):745-8. ">Tibballs 1992</a>; <a href="./references#CD001955-bbs2-0047" title="Vad PedersenL , DahlM , Falk-PetersenHE , LarsenSE . Inhaled budesonide versus intramuscular dexamethasone in the treatment of pseudocroup [Inhaleret budesonid versus dexamethasone i.m. til behandling at pseudocroup]. Ugeskrift for Laeger1998;160(15):2253-6. ">Vad Pedersen 1998</a>; <a href="./references#CD001955-bbs2-0048" title="Von MühlendahlKE , KahnD , SpohrHL , DresslerF . Steroid treatment of pseudo‐croup. Helvetica Paediatrica Acta1982;37(5):431-6. ">Von Mühlendahl 1982</a>). </p> <p>Thirty‐two studies (71%) were two‐armed trials (<a href="./references#CD001955-bbs2-0001" title="AlshehrM , AlmegamsiT , HammdiA . Efficacy of a small dose of oral dexamethasone in croup. Biomedical Research2005;65(1):65-72. ">Alshehr 2005</a>; <a href="./references#CD001955-bbs2-0002" title="AmirL , HubermannH , HaleviA , MorM , MimouniM , WaismanY . Oral betamethasone versus intramuscular dexamethasone for the treatment of mild to moderate viral croup. Pediatric Emergency Care2006;22(8):541-4. ">Amir 2006</a>; <a href="./references#CD001955-bbs2-0003" title="BjornsonC , KlassenTP , WilliamsonJ , BrantR , PlintA , BullochB , et al. A randomized trial of single dose of oral dexamethasone for mild croup. New England Journal of Medicine2004;351(13):1306-13. ">Bjornson 2004</a>; <a href="./references#CD001955-bbs2-0005" title="Chub-UppakarnS , SangsupawanichP . A randomized comparison of dexamethasone 0.15 mg/kg versus 0.6 mg/kg for the treatment of moderate to severe croup. International Journal of Pediatric Otorhinolaryngology2007;71(3):473-7. ">Chub‐Uppakarn 2007</a>; <a href="./references#CD001955-bbs2-0006" title="CruzMN , StewartG , RosenbergN . Use of dexamethasone in the outpatient management of acute laryngotracheitis. Pediatrics1995;96(2 Pt 1):220-3. ">Cruz 1995</a>; <a href="./references#CD001955-bbs2-0007" title="DobrovoljacM , GeelhoedG . How fast does oral dexamethasone work in mild to moderately severe croup? A randomized double-blinded clinical trial. Emergency Medicine Australasia2012;24(1):79-85. ">Dobrovoljac 2012</a>; <a href="./references#CD001955-bbs2-0008" title="DonaldsonD , PoleskiD , KnippleE , FilipsK , ReetzL , PasculaRG , et al. Intramuscular versus oral dexamethasone for the treatment of moderate-to-severe croup: a randomized double-blind trial. Academy of Emergency Medicine2003;10(1):16-21. ">Donaldson 2003</a>; <a href="./references#CD001955-bbs2-0011" title="EdenA , LarkinVP . Corticosteroid treatment of croup. Pediatrics1964;33:768-9. ">Eden 1964</a>; <a href="./references#CD001955-bbs2-0012" title="EdenAN , KaufmanA , YuR . Corticosteroids and croup. Controlled double-blind study. JAMA1967;200(5):403-4. ">Eden 1967</a>; <a href="./references#CD001955-bbs2-0014" title="FitzgeraldD , MellisC , JohnsonM , AllenH , CooperP , Van AsperenP . Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics1996;97(5):722-5. ">Fitzgerald 1996</a>; <a href="./references#CD001955-bbs2-0015" title="GarbuttJM , ConionB , SterkelR , BatyJ , SchechtmanKB , MandrellK , et al. The comparative effectiveness of prednisolone and dexamethasone for children with croup: a community-based randomized trial. Clinical Pediatrics2013;52(11):1014-21. ">Garbutt 2013</a>; <a href="./references#CD001955-bbs2-0019" title="GeelhoedGC , TurnerJ , MacdonaldWB . Efficacy of a small single dose of oral dexamethasone for outpatient croup: a double blind placebo controlled clinical trial. BMJ1996;313(7050):140-2. ">Geelhoed 1996a</a>; <a href="./references#CD001955-bbs2-0020" title="GeelhoedGC . Budesonide offers no advantage when added to oral dexamethasone in the treatment of croup. Pediatric Emergency Care2005;21(6):359-62. ">Geelhoed 2005</a>; <a href="./references#CD001955-bbs2-0021" title="GoddenCW , CampbellMJ , HusseyM , CogswellJJ . Double blind placebo controlled trial of nebulised budesonide for croup. Archives of Disease in Childhood1997;76(2):155-8. ">Godden 1997</a>; <a href="./references#CD001955-bbs2-0022" title="HuangT , XiaZ , LiW . Efficacy of inhaled budesonide on serum inflammatory factors and quality of life among children with acute infectious laryngitis. American Journal of Otolaryngology - Head and Neck Medicine and Surgery2021;42(1):102820. ">Huang 2021</a>; <a href="./references#CD001955-bbs2-0023" title="HusbyS , AgertoftL , MortensenS , PedersenS . Treatment of croup with nebulised steroid (budesonide): a double blind, placebo controlled study. Archives of Disease in Childhood1993;68(3):352-5. MortensenS , AgertoftL , HusbyS , PedersenS . Pseudocroup treated with inhaled steroid (budesonide). A double-blind placebo-controlled trial. Ugeskrift for Laeger1994;156(45):6661-3. ">Husby 1993</a>; <a href="./references#CD001955-bbs2-0024" title="JamesJA . Dexamethasone in croup. A controlled study. American Journal of Diseases of Children1969;117(5):511-6. ">James 1969</a>; <a href="./references#CD001955-bbs2-0025" title="JohnsonDW , SchuhS , KorenG , JaffeeDM . Outpatient treatment of croup with nebulized dexamethasone. Archives of Pediatrics &amp; Adolescent Medicine1996;150(4):349-55. ">Johnson 1996</a>; <a href="./references#CD001955-bbs2-0027" title="KlassenTP , FeldmanME , WattersLK , SutcliffeT , RowePC . Nebulized budesonide for children with mild-to-moderate croup. New England Journal of Medicine1994;331(5):285-9. ">Klassen 1994</a>; <a href="./references#CD001955-bbs2-0028" title="KlassenTP , WattersLK , FeldmanME , SutcliffeT , RowePC . The efficacy of nebulized budesonide in dexamethasone‐treated outpatients with croup. Pediatrics1996;97(4):463-6. ">Klassen 1996</a>; <a href="./references#CD001955-bbs2-0030" title="KorenGF . Corticosteroid treatment of laryngotracheitis v spasmodic croup in children. American Journal of Diseases of Children1983;137(10):941-4. ">Koren 1983</a>; <a href="./references#CD001955-bbs2-0032" title="LeipzigB , OskiFA , CummingsCW , StockmanJA , SwenderP . A prospective randomized study to determine the efficacy of steroids in treatment of croup. Journal of Pediatrics1979;94(2):194-6. ">Leipzig 1979</a>; <a href="./references#CD001955-bbs2-0035" title="MassicotteP , TetreaultL . Evaluation of methyl‐prednisolone in the treatment of acute laryngitis in children. Unión Médicale du Canada1973;102(10):2064-72. ">Massicotte 1973</a>; <a href="./references#CD001955-bbs2-0037" title="RittichierKK , LedwithCA . Outpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing. Pediatrics2000;106(6):1344-8. ">Rittichier 2000</a>; <a href="./references#CD001955-bbs2-0038" title="RobertsGW , MasterVV , StaugasRE , RaftosJV , ParsonsDW , CoulthardKP , et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. Journal of Paediatrics and Child Health1999;35(2):170-4. ">Roberts 1999</a>; <a href="./references#CD001955-bbs2-0039" title="RoordaRJ , WalhofCM . Effects of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report. Pediatric Pulmonology1998;25(2):114-7. ">Roorda 1998</a>; <a href="./references#CD001955-bbs2-0043" title="SoleimaniG , DaryadelA , MoghadamAA , SharifMR . The comparison of oral and IM dexamethasone efficacy in croup treatment. Journal of Comprehensive Pediatrics2013;4(4):175-8. ">Soleimani 2013</a>; <a href="./references#CD001955-bbs2-0044" title="SparrowA , GeelhoedG . Prednisolone versus dexamethasone in croup: a randomised equivalence trial. Archives of Disease in Childhood2006;91(7):580-3. ">Sparrow 2006</a>; <a href="./references#CD001955-bbs2-0045" title="SuperDM , CartelliNA , BrooksLJ , LemboRM , KumarML . A prospective randomized double‐blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. Journal of Pediatrics1989;115(2):323-9. ">Super 1989</a>; <a href="./references#CD001955-bbs2-0046" title="TibballsJ , ShannFA , LandauLI . Placebo-controlled trial of prednisolone in children intubated for croup. Lancet1992;340(8822):745-8. ">Tibballs 1992</a>; <a href="./references#CD001955-bbs2-0047" title="Vad PedersenL , DahlM , Falk-PetersenHE , LarsenSE . Inhaled budesonide versus intramuscular dexamethasone in the treatment of pseudocroup [Inhaleret budesonid versus dexamethasone i.m. til behandling at pseudocroup]. Ugeskrift for Laeger1998;160(15):2253-6. ">Vad Pedersen 1998</a>; <a href="./references#CD001955-bbs2-0048" title="Von MühlendahlKE , KahnD , SpohrHL , DresslerF . Steroid treatment of pseudo‐croup. Helvetica Paediatrica Acta1982;37(5):431-6. ">Von Mühlendahl 1982</a>); eight studies (18%) were three‐armed trials (<a href="./references#CD001955-bbs2-0009" title="DumanM , OzdemirD , AtaseverS . Nebulized L-epinephrine and steroid combination in the treatment of moderate to severe croup. Clinical Drug Investigation2005;25(3):183-9. ">Duman 2005</a>; <a href="./references#CD001955-bbs2-0010" title="EboriadouM , ChryssanthopoulouD , StamoulisP , DamianidouL , HaidopoulouK . The effectiveness of local corticosteroids therapy in the management of mild to moderate viral croup. Minerva Pediatrica2010;62(1):23-8. ">Eboriadou 2010</a>; <a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a>; <a href="./references#CD001955-bbs2-0018" title="GeelhoedGC , MacdonaldWB . Oral and inhaled steroids in croup: a randomized, placebo‐controlled trial. Pediatric Pulmonology1995;20(6):355-61. ">Geelhoed 1995c</a>; <a href="./references#CD001955-bbs2-0026" title="JohnsonDW , JacobsonS , EdneyPC , HadfieldP , MundyME , SchuhS . A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. New England Journal of Medicine1998;339(8):498-503. ">Johnson 1998</a>; <a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a>; <a href="./references#CD001955-bbs2-0033" title="LuriaJW , Gonzalez-del-ReyJA , DiGuilioGA , McAneneyCM , OlsenJJ , RuddyRM . Effectiveness of oral or nebulized dexamethasone for children with mild croup. Archives of Pediatrics &amp; Adolescent Medicine2001;155(12):1340-5. ">Luria 2001</a>; <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a>); and three studies (7%) were four‐armed trials (<a href="./references#CD001955-bbs2-0004" title="CetinkayaF , TufekciBS , KutlukG . A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup. International Journal of Pediatric Otorhinolaryngology2004;68(4):453-6. ">Cetinkaya 2004</a>; <a href="./references#CD001955-bbs2-0031" title="KuuselaAL , VesikariT . A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatrica Scandinavica1988;77(1):99-104. ">Kuusela 1988</a>; <a href="./references#CD001955-bbs2-0034" title="Martinez FernandezA , SanchezGE , RicaEI , EchanizUI , AlonsoDM , VilellaCM , et al. Randomized double-blind study of treatment of croup with adrenaline and/or dexamethasone in children. Anales Españoles de Pediatria1993;38:29-32. ">Martinez Fernandez 1993</a>). Two studies (4%) included two individual two‐armed trials each (<a href="./references#CD001955-bbs2-0016" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995a</a>; <a href="./references#CD001955-bbs2-0017" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995b</a>; <a href="./references#CD001955-bbs2-0040" title="SkowronPN , TurnerJA , McNaughtonGA . The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Canadian Medical Association Journal1966;94(11):528-31. ">Skowron 1966a</a>; <a href="./references#CD001955-bbs2-0042" title="SkowronPN , TurnerJA , McNaughtonGA . The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Canadian Medical Association Journal1966;94(11):528-31. ">Skowron 1966b</a>). </p> </section> <section id="CD001955-sec-0044"> <h5 class="title">Characteristics of the comparisons</h5> <p>Twenty‐six studies (58%) investigated any glucocorticoid compared to placebo. Of these, 15 (58%) investigated dexamethasone (<a href="./references#CD001955-bbs2-0003" title="BjornsonC , KlassenTP , WilliamsonJ , BrantR , PlintA , BullochB , et al. A randomized trial of single dose of oral dexamethasone for mild croup. New England Journal of Medicine2004;351(13):1306-13. ">Bjornson 2004</a>; <a href="./references#CD001955-bbs2-0006" title="CruzMN , StewartG , RosenbergN . Use of dexamethasone in the outpatient management of acute laryngotracheitis. Pediatrics1995;96(2 Pt 1):220-3. ">Cruz 1995</a>; <a href="./references#CD001955-bbs2-0007" title="DobrovoljacM , GeelhoedG . How fast does oral dexamethasone work in mild to moderately severe croup? A randomized double-blinded clinical trial. Emergency Medicine Australasia2012;24(1):79-85. ">Dobrovoljac 2012</a>; <a href="./references#CD001955-bbs2-0012" title="EdenAN , KaufmanA , YuR . Corticosteroids and croup. Controlled double-blind study. JAMA1967;200(5):403-4. ">Eden 1967</a>; <a href="./references#CD001955-bbs2-0019" title="GeelhoedGC , TurnerJ , MacdonaldWB . Efficacy of a small single dose of oral dexamethasone for outpatient croup: a double blind placebo controlled clinical trial. BMJ1996;313(7050):140-2. ">Geelhoed 1996a</a>; <a href="./references#CD001955-bbs2-0024" title="JamesJA . Dexamethasone in croup. A controlled study. American Journal of Diseases of Children1969;117(5):511-6. ">James 1969</a>; <a href="./references#CD001955-bbs2-0025" title="JohnsonDW , SchuhS , KorenG , JaffeeDM . Outpatient treatment of croup with nebulized dexamethasone. Archives of Pediatrics &amp; Adolescent Medicine1996;150(4):349-55. ">Johnson 1996</a>; <a href="./references#CD001955-bbs2-0030" title="KorenGF . Corticosteroid treatment of laryngotracheitis v spasmodic croup in children. American Journal of Diseases of Children1983;137(10):941-4. ">Koren 1983</a>; <a href="./references#CD001955-bbs2-0031" title="KuuselaAL , VesikariT . A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatrica Scandinavica1988;77(1):99-104. ">Kuusela 1988</a>; <a href="./references#CD001955-bbs2-0032" title="LeipzigB , OskiFA , CummingsCW , StockmanJA , SwenderP . A prospective randomized study to determine the efficacy of steroids in treatment of croup. Journal of Pediatrics1979;94(2):194-6. ">Leipzig 1979</a>; <a href="./references#CD001955-bbs2-0033" title="LuriaJW , Gonzalez-del-ReyJA , DiGuilioGA , McAneneyCM , OlsenJJ , RuddyRM . Effectiveness of oral or nebulized dexamethasone for children with mild croup. Archives of Pediatrics &amp; Adolescent Medicine2001;155(12):1340-5. ">Luria 2001</a>; <a href="./references#CD001955-bbs2-0034" title="Martinez FernandezA , SanchezGE , RicaEI , EchanizUI , AlonsoDM , VilellaCM , et al. Randomized double-blind study of treatment of croup with adrenaline and/or dexamethasone in children. Anales Españoles de Pediatria1993;38:29-32. ">Martinez Fernandez 1993</a>; <a href="./references#CD001955-bbs2-0041" title="SkowronPN , TurnerJA , McNaughtonGA . The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Canadian Medical Association Journal1966;94(11):528-31. ">Skowron 1966a and b</a>; <a href="./references#CD001955-bbs2-0045" title="SuperDM , CartelliNA , BrooksLJ , LemboRM , KumarML . A prospective randomized double‐blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. Journal of Pediatrics1989;115(2):323-9. ">Super 1989</a>; <a href="./references#CD001955-bbs2-0048" title="Von MühlendahlKE , KahnD , SpohrHL , DresslerF . Steroid treatment of pseudo‐croup. Helvetica Paediatrica Acta1982;37(5):431-6. ">Von Mühlendahl 1982</a>); four (15%) investigated budesonide (<a href="./references#CD001955-bbs2-0021" title="GoddenCW , CampbellMJ , HusseyM , CogswellJJ . Double blind placebo controlled trial of nebulised budesonide for croup. Archives of Disease in Childhood1997;76(2):155-8. ">Godden 1997</a>; <a href="./references#CD001955-bbs2-0023" title="HusbyS , AgertoftL , MortensenS , PedersenS . Treatment of croup with nebulised steroid (budesonide): a double blind, placebo controlled study. Archives of Disease in Childhood1993;68(3):352-5. MortensenS , AgertoftL , HusbyS , PedersenS . Pseudocroup treated with inhaled steroid (budesonide). A double-blind placebo-controlled trial. Ugeskrift for Laeger1994;156(45):6661-3. ">Husby 1993</a>; <a href="./references#CD001955-bbs2-0027" title="KlassenTP , FeldmanME , WattersLK , SutcliffeT , RowePC . Nebulized budesonide for children with mild-to-moderate croup. New England Journal of Medicine1994;331(5):285-9. ">Klassen 1994</a>; <a href="./references#CD001955-bbs2-0038" title="RobertsGW , MasterVV , StaugasRE , RaftosJV , ParsonsDW , CoulthardKP , et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. Journal of Paediatrics and Child Health1999;35(2):170-4. ">Roberts 1999</a>); three (12%) investigated prednisolone (<a href="./references#CD001955-bbs2-0011" title="EdenA , LarkinVP . Corticosteroid treatment of croup. Pediatrics1964;33:768-9. ">Eden 1964</a>; <a href="./references#CD001955-bbs2-0035" title="MassicotteP , TetreaultL . Evaluation of methyl‐prednisolone in the treatment of acute laryngitis in children. Unión Médicale du Canada1973;102(10):2064-72. ">Massicotte 1973</a>; <a href="./references#CD001955-bbs2-0046" title="TibballsJ , ShannFA , LandauLI . Placebo-controlled trial of prednisolone in children intubated for croup. Lancet1992;340(8822):745-8. ">Tibballs 1992</a>); one (4%) investigated fluticasone (<a href="./references#CD001955-bbs2-0039" title="RoordaRJ , WalhofCM . Effects of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report. Pediatric Pulmonology1998;25(2):114-7. ">Roorda 1998</a>); and three (12%) investigated both dexamethasone and budesonide (<a href="./references#CD001955-bbs2-0004" title="CetinkayaF , TufekciBS , KutlukG . A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup. International Journal of Pediatric Otorhinolaryngology2004;68(4):453-6. ">Cetinkaya 2004</a>; <a href="./references#CD001955-bbs2-0018" title="GeelhoedGC , MacdonaldWB . Oral and inhaled steroids in croup: a randomized, placebo‐controlled trial. Pediatric Pulmonology1995;20(6):355-61. ">Geelhoed 1995c</a>; <a href="./references#CD001955-bbs2-0026" title="JohnsonDW , JacobsonS , EdneyPC , HadfieldP , MundyME , SchuhS . A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. New England Journal of Medicine1998;339(8):498-503. ">Johnson 1998</a>). Four studies (10%) investigated any glucocorticoid compared to epinephrine. Of these, one investigated budesonide (<a href="./references#CD001955-bbs2-0014" title="FitzgeraldD , MellisC , JohnsonM , AllenH , CooperP , Van AsperenP . Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics1996;97(5):722-5. ">Fitzgerald 1996</a>); two investigated dexamethasone (<a href="./references#CD001955-bbs2-0031" title="KuuselaAL , VesikariT . A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatrica Scandinavica1988;77(1):99-104. ">Kuusela 1988</a>; <a href="./references#CD001955-bbs2-0034" title="Martinez FernandezA , SanchezGE , RicaEI , EchanizUI , AlonsoDM , VilellaCM , et al. Randomized double-blind study of treatment of croup with adrenaline and/or dexamethasone in children. Anales Españoles de Pediatria1993;38:29-32. ">Martinez Fernandez 1993</a>); and one investigated both dexamethasone and beclomethasone (<a href="./references#CD001955-bbs2-0010" title="EboriadouM , ChryssanthopoulouD , StamoulisP , DamianidouL , HaidopoulouK . The effectiveness of local corticosteroids therapy in the management of mild to moderate viral croup. Minerva Pediatrica2010;62(1):23-8. ">Eboriadou 2010</a>). </p> <p>Thirteen studies (29%) investigated one glucocorticoid compared to another glucocorticoid. Of these, one investigated budesonide compared to dexamethasone (<a href="./references#CD001955-bbs2-0022" title="HuangT , XiaZ , LiW . Efficacy of inhaled budesonide on serum inflammatory factors and quality of life among children with acute infectious laryngitis. American Journal of Otolaryngology - Head and Neck Medicine and Surgery2021;42(1):102820. ">Huang 2021</a>); six investigated dexamethasone compared to budesonide (<a href="./references#CD001955-bbs2-0004" title="CetinkayaF , TufekciBS , KutlukG . A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup. International Journal of Pediatric Otorhinolaryngology2004;68(4):453-6. ">Cetinkaya 2004</a>; <a href="./references#CD001955-bbs2-0009" title="DumanM , OzdemirD , AtaseverS . Nebulized L-epinephrine and steroid combination in the treatment of moderate to severe croup. Clinical Drug Investigation2005;25(3):183-9. ">Duman 2005</a>; <a href="./references#CD001955-bbs2-0018" title="GeelhoedGC , MacdonaldWB . Oral and inhaled steroids in croup: a randomized, placebo‐controlled trial. Pediatric Pulmonology1995;20(6):355-61. ">Geelhoed 1995c</a>; <a href="./references#CD001955-bbs2-0026" title="JohnsonDW , JacobsonS , EdneyPC , HadfieldP , MundyME , SchuhS . A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. New England Journal of Medicine1998;339(8):498-503. ">Johnson 1998</a>; <a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a>; <a href="./references#CD001955-bbs2-0047" title="Vad PedersenL , DahlM , Falk-PetersenHE , LarsenSE . Inhaled budesonide versus intramuscular dexamethasone in the treatment of pseudocroup [Inhaleret budesonid versus dexamethasone i.m. til behandling at pseudocroup]. Ugeskrift for Laeger1998;160(15):2253-6. ">Vad Pedersen 1998</a>); one investigated dexamethasone compared to betamethasone (<a href="./references#CD001955-bbs2-0002" title="AmirL , HubermannH , HaleviA , MorM , MimouniM , WaismanY . Oral betamethasone versus intramuscular dexamethasone for the treatment of mild to moderate viral croup. Pediatric Emergency Care2006;22(8):541-4. ">Amir 2006</a>); one investigated dexamethasone compared to beclomethasone (<a href="./references#CD001955-bbs2-0010" title="EboriadouM , ChryssanthopoulouD , StamoulisP , DamianidouL , HaidopoulouK . The effectiveness of local corticosteroids therapy in the management of mild to moderate viral croup. Minerva Pediatrica2010;62(1):23-8. ">Eboriadou 2010</a>); and four investigated dexamethasone compared to prednisolone (<a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a>; <a href="./references#CD001955-bbs2-0015" title="GarbuttJM , ConionB , SterkelR , BatyJ , SchechtmanKB , MandrellK , et al. The comparative effectiveness of prednisolone and dexamethasone for children with croup: a community-based randomized trial. Clinical Pediatrics2013;52(11):1014-21. ">Garbutt 2013</a>; <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a>; <a href="./references#CD001955-bbs2-0044" title="SparrowA , GeelhoedG . Prednisolone versus dexamethasone in croup: a randomised equivalence trial. Archives of Disease in Childhood2006;91(7):580-3. ">Sparrow 2006</a>). Three studies investigated one glucocorticoid compared to a combination of glucocorticoids. Of these, one investigated dexamethasone and budesonide compared to a combination of dexamethasone and budesonide (<a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a>), and two investigated dexamethasone compared to a combination of dexamethasone and budesonide (<a href="./references#CD001955-bbs2-0020" title="GeelhoedGC . Budesonide offers no advantage when added to oral dexamethasone in the treatment of croup. Pediatric Emergency Care2005;21(6):359-62. ">Geelhoed 2005</a>; <a href="./references#CD001955-bbs2-0028" title="KlassenTP , WattersLK , FeldmanME , SutcliffeT , RowePC . The efficacy of nebulized budesonide in dexamethasone‐treated outpatients with croup. Pediatrics1996;97(4):463-6. ">Klassen 1996</a>). </p> <p>Five studies (11%) investigated dexamethasone using different modes of administration. Of these, four investigated oral compared to intramuscular dexamethasone (<a href="./references#CD001955-bbs2-0004" title="CetinkayaF , TufekciBS , KutlukG . A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup. International Journal of Pediatric Otorhinolaryngology2004;68(4):453-6. ">Cetinkaya 2004</a>; <a href="./references#CD001955-bbs2-0008" title="DonaldsonD , PoleskiD , KnippleE , FilipsK , ReetzL , PasculaRG , et al. Intramuscular versus oral dexamethasone for the treatment of moderate-to-severe croup: a randomized double-blind trial. Academy of Emergency Medicine2003;10(1):16-21. ">Donaldson 2003</a>; <a href="./references#CD001955-bbs2-0037" title="RittichierKK , LedwithCA . Outpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing. Pediatrics2000;106(6):1344-8. ">Rittichier 2000</a>; <a href="./references#CD001955-bbs2-0043" title="SoleimaniG , DaryadelA , MoghadamAA , SharifMR . The comparison of oral and IM dexamethasone efficacy in croup treatment. Journal of Comprehensive Pediatrics2013;4(4):175-8. ">Soleimani 2013</a>), and one investigated oral compared to nebulised dexamethasone (<a href="./references#CD001955-bbs2-0033" title="LuriaJW , Gonzalez-del-ReyJA , DiGuilioGA , McAneneyCM , OlsenJJ , RuddyRM . Effectiveness of oral or nebulized dexamethasone for children with mild croup. Archives of Pediatrics &amp; Adolescent Medicine2001;155(12):1340-5. ">Luria 2001</a>). Four studies investigated dexamethasone given in different doses. Of these, three investigated 0.60 mg/kg compared to 0.15 mg/kg dexamethasone (<a href="./references#CD001955-bbs2-0001" title="AlshehrM , AlmegamsiT , HammdiA . Efficacy of a small dose of oral dexamethasone in croup. Biomedical Research2005;65(1):65-72. ">Alshehr 2005</a>; <a href="./references#CD001955-bbs2-0005" title="Chub-UppakarnS , SangsupawanichP . A randomized comparison of dexamethasone 0.15 mg/kg versus 0.6 mg/kg for the treatment of moderate to severe croup. International Journal of Pediatric Otorhinolaryngology2007;71(3):473-7. ">Chub‐Uppakarn 2007</a>; <a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a>), and one investigated both 0.60 mg/kg compared to 0.30 mg/kg and 0.30 mg/kg compared to 0.15 mg/kg dexamethasone (<a href="./references#CD001955-bbs2-0016" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995a</a>; <a href="./references#CD001955-bbs2-0017" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995b</a>). </p> </section> <section id="CD001955-sec-0045"> <h5 class="title">Reported outcomes: primary outcomes</h5> <p>Sixteen studies (35%) reported a two‐hour change in croup score (<a href="./references#CD001955-bbs2-0002" title="AmirL , HubermannH , HaleviA , MorM , MimouniM , WaismanY . Oral betamethasone versus intramuscular dexamethasone for the treatment of mild to moderate viral croup. Pediatric Emergency Care2006;22(8):541-4. ">Amir 2006</a>; <a href="./references#CD001955-bbs2-0005" title="Chub-UppakarnS , SangsupawanichP . A randomized comparison of dexamethasone 0.15 mg/kg versus 0.6 mg/kg for the treatment of moderate to severe croup. International Journal of Pediatric Otorhinolaryngology2007;71(3):473-7. ">Chub‐Uppakarn 2007</a>; <a href="./references#CD001955-bbs2-0007" title="DobrovoljacM , GeelhoedG . How fast does oral dexamethasone work in mild to moderately severe croup? A randomized double-blinded clinical trial. Emergency Medicine Australasia2012;24(1):79-85. ">Dobrovoljac 2012</a>; <a href="./references#CD001955-bbs2-0009" title="DumanM , OzdemirD , AtaseverS . Nebulized L-epinephrine and steroid combination in the treatment of moderate to severe croup. Clinical Drug Investigation2005;25(3):183-9. ">Duman 2005</a>; <a href="./references#CD001955-bbs2-0010" title="EboriadouM , ChryssanthopoulouD , StamoulisP , DamianidouL , HaidopoulouK . The effectiveness of local corticosteroids therapy in the management of mild to moderate viral croup. Minerva Pediatrica2010;62(1):23-8. ">Eboriadou 2010</a>; <a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a>; <a href="./references#CD001955-bbs2-0014" title="FitzgeraldD , MellisC , JohnsonM , AllenH , CooperP , Van AsperenP . Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics1996;97(5):722-5. ">Fitzgerald 1996</a>; <a href="./references#CD001955-bbs2-0016" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995a</a>; <a href="./references#CD001955-bbs2-0017" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995b</a>; <a href="./references#CD001955-bbs2-0018" title="GeelhoedGC , MacdonaldWB . Oral and inhaled steroids in croup: a randomized, placebo‐controlled trial. Pediatric Pulmonology1995;20(6):355-61. ">Geelhoed 1995c</a>; <a href="./references#CD001955-bbs2-0020" title="GeelhoedGC . Budesonide offers no advantage when added to oral dexamethasone in the treatment of croup. Pediatric Emergency Care2005;21(6):359-62. ">Geelhoed 2005</a>; <a href="./references#CD001955-bbs2-0021" title="GoddenCW , CampbellMJ , HusseyM , CogswellJJ . Double blind placebo controlled trial of nebulised budesonide for croup. Archives of Disease in Childhood1997;76(2):155-8. ">Godden 1997</a>; <a href="./references#CD001955-bbs2-0023" title="HusbyS , AgertoftL , MortensenS , PedersenS . Treatment of croup with nebulised steroid (budesonide): a double blind, placebo controlled study. Archives of Disease in Childhood1993;68(3):352-5. MortensenS , AgertoftL , HusbyS , PedersenS . Pseudocroup treated with inhaled steroid (budesonide). A double-blind placebo-controlled trial. Ugeskrift for Laeger1994;156(45):6661-3. ">Husby 1993</a>; <a href="./references#CD001955-bbs2-0025" title="JohnsonDW , SchuhS , KorenG , JaffeeDM . Outpatient treatment of croup with nebulized dexamethasone. Archives of Pediatrics &amp; Adolescent Medicine1996;150(4):349-55. ">Johnson 1996</a>; <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a>; <a href="./references#CD001955-bbs2-0038" title="RobertsGW , MasterVV , StaugasRE , RaftosJV , ParsonsDW , CoulthardKP , et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. Journal of Paediatrics and Child Health1999;35(2):170-4. ">Roberts 1999</a>; <a href="./references#CD001955-bbs2-0039" title="RoordaRJ , WalhofCM . Effects of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report. Pediatric Pulmonology1998;25(2):114-7. ">Roorda 1998</a>); 20 studies (44%) reported a six‐hour change in croup score (<a href="./references#CD001955-bbs2-0001" title="AlshehrM , AlmegamsiT , HammdiA . Efficacy of a small dose of oral dexamethasone in croup. Biomedical Research2005;65(1):65-72. ">Alshehr 2005</a>; <a href="./references#CD001955-bbs2-0002" title="AmirL , HubermannH , HaleviA , MorM , MimouniM , WaismanY . Oral betamethasone versus intramuscular dexamethasone for the treatment of mild to moderate viral croup. Pediatric Emergency Care2006;22(8):541-4. ">Amir 2006</a>; <a href="./references#CD001955-bbs2-0005" title="Chub-UppakarnS , SangsupawanichP . A randomized comparison of dexamethasone 0.15 mg/kg versus 0.6 mg/kg for the treatment of moderate to severe croup. International Journal of Pediatric Otorhinolaryngology2007;71(3):473-7. ">Chub‐Uppakarn 2007</a>; <a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a>; <a href="./references#CD001955-bbs2-0016" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995a</a>; <a href="./references#CD001955-bbs2-0017" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995b</a>; <a href="./references#CD001955-bbs2-0018" title="GeelhoedGC , MacdonaldWB . Oral and inhaled steroids in croup: a randomized, placebo‐controlled trial. Pediatric Pulmonology1995;20(6):355-61. ">Geelhoed 1995c</a>; <a href="./references#CD001955-bbs2-0021" title="GoddenCW , CampbellMJ , HusseyM , CogswellJJ . Double blind placebo controlled trial of nebulised budesonide for croup. Archives of Disease in Childhood1997;76(2):155-8. ">Godden 1997</a>; <a href="./references#CD001955-bbs2-0025" title="JohnsonDW , SchuhS , KorenG , JaffeeDM . Outpatient treatment of croup with nebulized dexamethasone. Archives of Pediatrics &amp; Adolescent Medicine1996;150(4):349-55. ">Johnson 1996</a>; <a href="./references#CD001955-bbs2-0026" title="JohnsonDW , JacobsonS , EdneyPC , HadfieldP , MundyME , SchuhS . A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. New England Journal of Medicine1998;339(8):498-503. ">Johnson 1998</a>; <a href="./references#CD001955-bbs2-0027" title="KlassenTP , FeldmanME , WattersLK , SutcliffeT , RowePC . Nebulized budesonide for children with mild-to-moderate croup. New England Journal of Medicine1994;331(5):285-9. ">Klassen 1994</a>; <a href="./references#CD001955-bbs2-0028" title="KlassenTP , WattersLK , FeldmanME , SutcliffeT , RowePC . The efficacy of nebulized budesonide in dexamethasone‐treated outpatients with croup. Pediatrics1996;97(4):463-6. ">Klassen 1996</a>; <a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a>; <a href="./references#CD001955-bbs2-0031" title="KuuselaAL , VesikariT . A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatrica Scandinavica1988;77(1):99-104. ">Kuusela 1988</a>; <a href="./references#CD001955-bbs2-0034" title="Martinez FernandezA , SanchezGE , RicaEI , EchanizUI , AlonsoDM , VilellaCM , et al. Randomized double-blind study of treatment of croup with adrenaline and/or dexamethasone in children. Anales Españoles de Pediatria1993;38:29-32. ">Martinez Fernandez 1993</a>; <a href="./references#CD001955-bbs2-0035" title="MassicotteP , TetreaultL . Evaluation of methyl‐prednisolone in the treatment of acute laryngitis in children. Unión Médicale du Canada1973;102(10):2064-72. ">Massicotte 1973</a>; <a href="./references#CD001955-bbs2-0038" title="RobertsGW , MasterVV , StaugasRE , RaftosJV , ParsonsDW , CoulthardKP , et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. Journal of Paediatrics and Child Health1999;35(2):170-4. ">Roberts 1999</a>; <a href="./references#CD001955-bbs2-0039" title="RoordaRJ , WalhofCM . Effects of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report. Pediatric Pulmonology1998;25(2):114-7. ">Roorda 1998</a>; <a href="./references#CD001955-bbs2-0047" title="Vad PedersenL , DahlM , Falk-PetersenHE , LarsenSE . Inhaled budesonide versus intramuscular dexamethasone in the treatment of pseudocroup [Inhaleret budesonid versus dexamethasone i.m. til behandling at pseudocroup]. Ugeskrift for Laeger1998;160(15):2253-6. ">Vad Pedersen 1998</a>; <a href="./references#CD001955-bbs2-0048" title="Von MühlendahlKE , KahnD , SpohrHL , DresslerF . Steroid treatment of pseudo‐croup. Helvetica Paediatrica Acta1982;37(5):431-6. ">Von Mühlendahl 1982</a>); 12 studies (27%) reported a 12‐hour change in croup score (<a href="./references#CD001955-bbs2-0001" title="AlshehrM , AlmegamsiT , HammdiA . Efficacy of a small dose of oral dexamethasone in croup. Biomedical Research2005;65(1):65-72. ">Alshehr 2005</a>; <a href="./references#CD001955-bbs2-0005" title="Chub-UppakarnS , SangsupawanichP . A randomized comparison of dexamethasone 0.15 mg/kg versus 0.6 mg/kg for the treatment of moderate to severe croup. International Journal of Pediatric Otorhinolaryngology2007;71(3):473-7. ">Chub‐Uppakarn 2007</a>; <a href="./references#CD001955-bbs2-0014" title="FitzgeraldD , MellisC , JohnsonM , AllenH , CooperP , Van AsperenP . Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics1996;97(5):722-5. ">Fitzgerald 1996</a>; <a href="./references#CD001955-bbs2-0018" title="GeelhoedGC , MacdonaldWB . Oral and inhaled steroids in croup: a randomized, placebo‐controlled trial. Pediatric Pulmonology1995;20(6):355-61. ">Geelhoed 1995c</a>; <a href="./references#CD001955-bbs2-0021" title="GoddenCW , CampbellMJ , HusseyM , CogswellJJ . Double blind placebo controlled trial of nebulised budesonide for croup. Archives of Disease in Childhood1997;76(2):155-8. ">Godden 1997</a>; <a href="./references#CD001955-bbs2-0031" title="KuuselaAL , VesikariT . A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatrica Scandinavica1988;77(1):99-104. ">Kuusela 1988</a>; <a href="./references#CD001955-bbs2-0034" title="Martinez FernandezA , SanchezGE , RicaEI , EchanizUI , AlonsoDM , VilellaCM , et al. Randomized double-blind study of treatment of croup with adrenaline and/or dexamethasone in children. Anales Españoles de Pediatria1993;38:29-32. ">Martinez Fernandez 1993</a>; <a href="./references#CD001955-bbs2-0035" title="MassicotteP , TetreaultL . Evaluation of methyl‐prednisolone in the treatment of acute laryngitis in children. Unión Médicale du Canada1973;102(10):2064-72. ">Massicotte 1973</a>; <a href="./references#CD001955-bbs2-0038" title="RobertsGW , MasterVV , StaugasRE , RaftosJV , ParsonsDW , CoulthardKP , et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. Journal of Paediatrics and Child Health1999;35(2):170-4. ">Roberts 1999</a>; <a href="./references#CD001955-bbs2-0045" title="SuperDM , CartelliNA , BrooksLJ , LemboRM , KumarML . A prospective randomized double‐blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. Journal of Pediatrics1989;115(2):323-9. ">Super 1989</a>; <a href="./references#CD001955-bbs2-0047" title="Vad PedersenL , DahlM , Falk-PetersenHE , LarsenSE . Inhaled budesonide versus intramuscular dexamethasone in the treatment of pseudocroup [Inhaleret budesonid versus dexamethasone i.m. til behandling at pseudocroup]. Ugeskrift for Laeger1998;160(15):2253-6. ">Vad Pedersen 1998</a>; <a href="./references#CD001955-bbs2-0048" title="Von MühlendahlKE , KahnD , SpohrHL , DresslerF . Steroid treatment of pseudo‐croup. Helvetica Paediatrica Acta1982;37(5):431-6. ">Von Mühlendahl 1982</a>); and 11 studies (24%) reported a 24‐hour change in croup score (<a href="./references#CD001955-bbs2-0001" title="AlshehrM , AlmegamsiT , HammdiA . Efficacy of a small dose of oral dexamethasone in croup. Biomedical Research2005;65(1):65-72. ">Alshehr 2005</a>; <a href="./references#CD001955-bbs2-0004" title="CetinkayaF , TufekciBS , KutlukG . A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup. International Journal of Pediatric Otorhinolaryngology2004;68(4):453-6. ">Cetinkaya 2004</a>; <a href="./references#CD001955-bbs2-0014" title="FitzgeraldD , MellisC , JohnsonM , AllenH , CooperP , Van AsperenP . Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics1996;97(5):722-5. ">Fitzgerald 1996</a>; <a href="./references#CD001955-bbs2-0021" title="GoddenCW , CampbellMJ , HusseyM , CogswellJJ . Double blind placebo controlled trial of nebulised budesonide for croup. Archives of Disease in Childhood1997;76(2):155-8. ">Godden 1997</a>; <a href="./references#CD001955-bbs2-0031" title="KuuselaAL , VesikariT . A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatrica Scandinavica1988;77(1):99-104. ">Kuusela 1988</a>; <a href="./references#CD001955-bbs2-0032" title="LeipzigB , OskiFA , CummingsCW , StockmanJA , SwenderP . A prospective randomized study to determine the efficacy of steroids in treatment of croup. Journal of Pediatrics1979;94(2):194-6. ">Leipzig 1979</a>; <a href="./references#CD001955-bbs2-0034" title="Martinez FernandezA , SanchezGE , RicaEI , EchanizUI , AlonsoDM , VilellaCM , et al. Randomized double-blind study of treatment of croup with adrenaline and/or dexamethasone in children. Anales Españoles de Pediatria1993;38:29-32. ">Martinez Fernandez 1993</a>; <a href="./references#CD001955-bbs2-0037" title="RittichierKK , LedwithCA . Outpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing. Pediatrics2000;106(6):1344-8. ">Rittichier 2000</a>; <a href="./references#CD001955-bbs2-0038" title="RobertsGW , MasterVV , StaugasRE , RaftosJV , ParsonsDW , CoulthardKP , et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. Journal of Paediatrics and Child Health1999;35(2):170-4. ">Roberts 1999</a>; <a href="./references#CD001955-bbs2-0039" title="RoordaRJ , WalhofCM . Effects of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report. Pediatric Pulmonology1998;25(2):114-7. ">Roorda 1998</a>; <a href="./references#CD001955-bbs2-0045" title="SuperDM , CartelliNA , BrooksLJ , LemboRM , KumarML . A prospective randomized double‐blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. Journal of Pediatrics1989;115(2):323-9. ">Super 1989</a>). Of the 30 studies (67%) that reported a change in croup score, 18 (60%) used a validated score (the Westley score or a modified Westley score) (<a href="./references#CD001955-bbs2-0001" title="AlshehrM , AlmegamsiT , HammdiA . Efficacy of a small dose of oral dexamethasone in croup. Biomedical Research2005;65(1):65-72. ">Alshehr 2005</a>; <a href="./references#CD001955-bbs2-0002" title="AmirL , HubermannH , HaleviA , MorM , MimouniM , WaismanY . Oral betamethasone versus intramuscular dexamethasone for the treatment of mild to moderate viral croup. Pediatric Emergency Care2006;22(8):541-4. ">Amir 2006</a>; <a href="./references#CD001955-bbs2-0004" title="CetinkayaF , TufekciBS , KutlukG . A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup. International Journal of Pediatric Otorhinolaryngology2004;68(4):453-6. ">Cetinkaya 2004</a>; <a href="./references#CD001955-bbs2-0005" title="Chub-UppakarnS , SangsupawanichP . A randomized comparison of dexamethasone 0.15 mg/kg versus 0.6 mg/kg for the treatment of moderate to severe croup. International Journal of Pediatric Otorhinolaryngology2007;71(3):473-7. ">Chub‐Uppakarn 2007</a>; <a href="./references#CD001955-bbs2-0007" title="DobrovoljacM , GeelhoedG . How fast does oral dexamethasone work in mild to moderately severe croup? A randomized double-blinded clinical trial. Emergency Medicine Australasia2012;24(1):79-85. ">Dobrovoljac 2012</a>; <a href="./references#CD001955-bbs2-0009" title="DumanM , OzdemirD , AtaseverS . Nebulized L-epinephrine and steroid combination in the treatment of moderate to severe croup. Clinical Drug Investigation2005;25(3):183-9. ">Duman 2005</a>; <a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a>; <a href="./references#CD001955-bbs2-0021" title="GoddenCW , CampbellMJ , HusseyM , CogswellJJ . Double blind placebo controlled trial of nebulised budesonide for croup. Archives of Disease in Childhood1997;76(2):155-8. ">Godden 1997</a>; <a href="./references#CD001955-bbs2-0023" title="HusbyS , AgertoftL , MortensenS , PedersenS . Treatment of croup with nebulised steroid (budesonide): a double blind, placebo controlled study. Archives of Disease in Childhood1993;68(3):352-5. MortensenS , AgertoftL , HusbyS , PedersenS . Pseudocroup treated with inhaled steroid (budesonide). A double-blind placebo-controlled trial. Ugeskrift for Laeger1994;156(45):6661-3. ">Husby 1993</a>; <a href="./references#CD001955-bbs2-0025" title="JohnsonDW , SchuhS , KorenG , JaffeeDM . Outpatient treatment of croup with nebulized dexamethasone. Archives of Pediatrics &amp; Adolescent Medicine1996;150(4):349-55. ">Johnson 1996</a>; <a href="./references#CD001955-bbs2-0026" title="JohnsonDW , JacobsonS , EdneyPC , HadfieldP , MundyME , SchuhS . A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. New England Journal of Medicine1998;339(8):498-503. ">Johnson 1998</a>; <a href="./references#CD001955-bbs2-0027" title="KlassenTP , FeldmanME , WattersLK , SutcliffeT , RowePC . Nebulized budesonide for children with mild-to-moderate croup. New England Journal of Medicine1994;331(5):285-9. ">Klassen 1994</a>; <a href="./references#CD001955-bbs2-0028" title="KlassenTP , WattersLK , FeldmanME , SutcliffeT , RowePC . The efficacy of nebulized budesonide in dexamethasone‐treated outpatients with croup. Pediatrics1996;97(4):463-6. ">Klassen 1996</a>; <a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a>; <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a>; <a href="./references#CD001955-bbs2-0037" title="RittichierKK , LedwithCA . Outpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing. Pediatrics2000;106(6):1344-8. ">Rittichier 2000</a>; <a href="./references#CD001955-bbs2-0039" title="RoordaRJ , WalhofCM . Effects of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report. Pediatric Pulmonology1998;25(2):114-7. ">Roorda 1998</a>; <a href="./references#CD001955-bbs2-0045" title="SuperDM , CartelliNA , BrooksLJ , LemboRM , KumarML . A prospective randomized double‐blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. Journal of Pediatrics1989;115(2):323-9. ">Super 1989</a>); 11 (37%) used author‐created scales (<a href="./references#CD001955-bbs2-0014" title="FitzgeraldD , MellisC , JohnsonM , AllenH , CooperP , Van AsperenP . Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics1996;97(5):722-5. ">Fitzgerald 1996</a>; <a href="./references#CD001955-bbs2-0016" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995a</a>; <a href="./references#CD001955-bbs2-0017" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995b</a>; <a href="./references#CD001955-bbs2-0020" title="GeelhoedGC . Budesonide offers no advantage when added to oral dexamethasone in the treatment of croup. Pediatric Emergency Care2005;21(6):359-62. ">Geelhoed 2005</a>; <a href="./references#CD001955-bbs2-0031" title="KuuselaAL , VesikariT . A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatrica Scandinavica1988;77(1):99-104. ">Kuusela 1988</a>; <a href="./references#CD001955-bbs2-0032" title="LeipzigB , OskiFA , CummingsCW , StockmanJA , SwenderP . A prospective randomized study to determine the efficacy of steroids in treatment of croup. Journal of Pediatrics1979;94(2):194-6. ">Leipzig 1979</a>; <a href="./references#CD001955-bbs2-0034" title="Martinez FernandezA , SanchezGE , RicaEI , EchanizUI , AlonsoDM , VilellaCM , et al. Randomized double-blind study of treatment of croup with adrenaline and/or dexamethasone in children. Anales Españoles de Pediatria1993;38:29-32. ">Martinez Fernandez 1993</a>; <a href="./references#CD001955-bbs2-0035" title="MassicotteP , TetreaultL . Evaluation of methyl‐prednisolone in the treatment of acute laryngitis in children. Unión Médicale du Canada1973;102(10):2064-72. ">Massicotte 1973</a>; <a href="./references#CD001955-bbs2-0038" title="RobertsGW , MasterVV , StaugasRE , RaftosJV , ParsonsDW , CoulthardKP , et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. Journal of Paediatrics and Child Health1999;35(2):170-4. ">Roberts 1999</a>; <a href="./references#CD001955-bbs2-0047" title="Vad PedersenL , DahlM , Falk-PetersenHE , LarsenSE . Inhaled budesonide versus intramuscular dexamethasone in the treatment of pseudocroup [Inhaleret budesonid versus dexamethasone i.m. til behandling at pseudocroup]. Ugeskrift for Laeger1998;160(15):2253-6. ">Vad Pedersen 1998</a>; <a href="./references#CD001955-bbs2-0048" title="Von MühlendahlKE , KahnD , SpohrHL , DresslerF . Steroid treatment of pseudo‐croup. Helvetica Paediatrica Acta1982;37(5):431-6. ">Von Mühlendahl 1982</a>); and one used the score by <a href="./references#CD001955-bbs2-0102" title="DownesJJ , RaphaellyRC . Pediatric intensive care. Anesthesiology1975;43:238-50.">Downes 1975</a> (<a href="./references#CD001955-bbs2-0010" title="EboriadouM , ChryssanthopoulouD , StamoulisP , DamianidouL , HaidopoulouK . The effectiveness of local corticosteroids therapy in the management of mild to moderate viral croup. Minerva Pediatrica2010;62(1):23-8. ">Eboriadou 2010</a>). The studies by <a href="./references#CD001955-bbs2-0003" title="BjornsonC , KlassenTP , WilliamsonJ , BrantR , PlintA , BullochB , et al. A randomized trial of single dose of oral dexamethasone for mild croup. New England Journal of Medicine2004;351(13):1306-13. ">Bjornson 2004</a> and <a href="./references#CD001955-bbs2-0015" title="GarbuttJM , ConionB , SterkelR , BatyJ , SchechtmanKB , MandrellK , et al. The comparative effectiveness of prednisolone and dexamethasone for children with croup: a community-based randomized trial. Clinical Pediatrics2013;52(11):1014-21. ">Garbutt 2013</a> used another validated score, the telephone outpatient (TOP) score, to measure clinical improvement. The TOP score is a two‐item, three‐point score used to assess the presence of stridor and barky cough by asking parents about their child's symptoms in the previous 24 hours (<a href="./references#CD001955-bbs2-0095" title="BjornsonC , WilliamsonJ , JohnsonD . Telephone Out Patient Score: the derivation and validation of a telephone follow-up assessment tool for use in clinical research in children with croup. Pediatric Emergency Care2016;32(5):290-7.">Bjornson 2016</a>). Twenty‐seven studies (60%) reported return visits or (re)admissions to the hospital or both (<a href="./references#CD001955-bbs2-0001" title="AlshehrM , AlmegamsiT , HammdiA . Efficacy of a small dose of oral dexamethasone in croup. Biomedical Research2005;65(1):65-72. ">Alshehr 2005</a>; <a href="./references#CD001955-bbs2-0002" title="AmirL , HubermannH , HaleviA , MorM , MimouniM , WaismanY . Oral betamethasone versus intramuscular dexamethasone for the treatment of mild to moderate viral croup. Pediatric Emergency Care2006;22(8):541-4. ">Amir 2006</a>; <a href="./references#CD001955-bbs2-0003" title="BjornsonC , KlassenTP , WilliamsonJ , BrantR , PlintA , BullochB , et al. A randomized trial of single dose of oral dexamethasone for mild croup. New England Journal of Medicine2004;351(13):1306-13. ">Bjornson 2004</a>; <a href="./references#CD001955-bbs2-0006" title="CruzMN , StewartG , RosenbergN . Use of dexamethasone in the outpatient management of acute laryngotracheitis. Pediatrics1995;96(2 Pt 1):220-3. ">Cruz 1995</a>; <a href="./references#CD001955-bbs2-0008" title="DonaldsonD , PoleskiD , KnippleE , FilipsK , ReetzL , PasculaRG , et al. Intramuscular versus oral dexamethasone for the treatment of moderate-to-severe croup: a randomized double-blind trial. Academy of Emergency Medicine2003;10(1):16-21. ">Donaldson 2003</a>; <a href="./references#CD001955-bbs2-0009" title="DumanM , OzdemirD , AtaseverS . Nebulized L-epinephrine and steroid combination in the treatment of moderate to severe croup. Clinical Drug Investigation2005;25(3):183-9. ">Duman 2005</a>; <a href="./references#CD001955-bbs2-0010" title="EboriadouM , ChryssanthopoulouD , StamoulisP , DamianidouL , HaidopoulouK . The effectiveness of local corticosteroids therapy in the management of mild to moderate viral croup. Minerva Pediatrica2010;62(1):23-8. ">Eboriadou 2010</a>; <a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a>; <a href="./references#CD001955-bbs2-0014" title="FitzgeraldD , MellisC , JohnsonM , AllenH , CooperP , Van AsperenP . Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics1996;97(5):722-5. ">Fitzgerald 1996</a>; <a href="./references#CD001955-bbs2-0015" title="GarbuttJM , ConionB , SterkelR , BatyJ , SchechtmanKB , MandrellK , et al. The comparative effectiveness of prednisolone and dexamethasone for children with croup: a community-based randomized trial. Clinical Pediatrics2013;52(11):1014-21. ">Garbutt 2013</a>; <a href="./references#CD001955-bbs2-0016" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995a</a>; <a href="./references#CD001955-bbs2-0017" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995b</a>; <a href="./references#CD001955-bbs2-0018" title="GeelhoedGC , MacdonaldWB . Oral and inhaled steroids in croup: a randomized, placebo‐controlled trial. Pediatric Pulmonology1995;20(6):355-61. ">Geelhoed 1995c</a>; <a href="./references#CD001955-bbs2-0019" title="GeelhoedGC , TurnerJ , MacdonaldWB . Efficacy of a small single dose of oral dexamethasone for outpatient croup: a double blind placebo controlled clinical trial. BMJ1996;313(7050):140-2. ">Geelhoed 1996a</a>; <a href="./references#CD001955-bbs2-0020" title="GeelhoedGC . Budesonide offers no advantage when added to oral dexamethasone in the treatment of croup. Pediatric Emergency Care2005;21(6):359-62. ">Geelhoed 2005</a>; <a href="./references#CD001955-bbs2-0025" title="JohnsonDW , SchuhS , KorenG , JaffeeDM . Outpatient treatment of croup with nebulized dexamethasone. Archives of Pediatrics &amp; Adolescent Medicine1996;150(4):349-55. ">Johnson 1996</a>; <a href="./references#CD001955-bbs2-0026" title="JohnsonDW , JacobsonS , EdneyPC , HadfieldP , MundyME , SchuhS . A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. New England Journal of Medicine1998;339(8):498-503. ">Johnson 1998</a>; <a href="./references#CD001955-bbs2-0027" title="KlassenTP , FeldmanME , WattersLK , SutcliffeT , RowePC . Nebulized budesonide for children with mild-to-moderate croup. New England Journal of Medicine1994;331(5):285-9. ">Klassen 1994</a>; <a href="./references#CD001955-bbs2-0028" title="KlassenTP , WattersLK , FeldmanME , SutcliffeT , RowePC . The efficacy of nebulized budesonide in dexamethasone‐treated outpatients with croup. Pediatrics1996;97(4):463-6. ">Klassen 1996</a>; <a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a>; <a href="./references#CD001955-bbs2-0033" title="LuriaJW , Gonzalez-del-ReyJA , DiGuilioGA , McAneneyCM , OlsenJJ , RuddyRM . Effectiveness of oral or nebulized dexamethasone for children with mild croup. Archives of Pediatrics &amp; Adolescent Medicine2001;155(12):1340-5. ">Luria 2001</a>; <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a>; <a href="./references#CD001955-bbs2-0037" title="RittichierKK , LedwithCA . Outpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing. Pediatrics2000;106(6):1344-8. ">Rittichier 2000</a>; <a href="./references#CD001955-bbs2-0038" title="RobertsGW , MasterVV , StaugasRE , RaftosJV , ParsonsDW , CoulthardKP , et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. Journal of Paediatrics and Child Health1999;35(2):170-4. ">Roberts 1999</a>; <a href="./references#CD001955-bbs2-0040" title="SkowronPN , TurnerJA , McNaughtonGA . The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Canadian Medical Association Journal1966;94(11):528-31. ">Skowron 1966a</a>; <a href="./references#CD001955-bbs2-0041" title="SkowronPN , TurnerJA , McNaughtonGA . The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Canadian Medical Association Journal1966;94(11):528-31. ">Skowron 1966a and b</a>; <a href="./references#CD001955-bbs2-0042" title="SkowronPN , TurnerJA , McNaughtonGA . The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Canadian Medical Association Journal1966;94(11):528-31. ">Skowron 1966b</a>; <a href="./references#CD001955-bbs2-0043" title="SoleimaniG , DaryadelA , MoghadamAA , SharifMR . The comparison of oral and IM dexamethasone efficacy in croup treatment. Journal of Comprehensive Pediatrics2013;4(4):175-8. ">Soleimani 2013</a>; <a href="./references#CD001955-bbs2-0044" title="SparrowA , GeelhoedG . Prednisolone versus dexamethasone in croup: a randomised equivalence trial. Archives of Disease in Childhood2006;91(7):580-3. ">Sparrow 2006</a>; <a href="./references#CD001955-bbs2-0047" title="Vad PedersenL , DahlM , Falk-PetersenHE , LarsenSE . Inhaled budesonide versus intramuscular dexamethasone in the treatment of pseudocroup [Inhaleret budesonid versus dexamethasone i.m. til behandling at pseudocroup]. Ugeskrift for Laeger1998;160(15):2253-6. ">Vad Pedersen 1998</a>). </p> </section> <section id="CD001955-sec-0046"> <h5 class="title">Reported outcomes: secondary outcomes</h5> <p>A total of 13 studies (29%) reported length of stay in the hospital or emergency department (<a href="./references#CD001955-bbs2-0001" title="AlshehrM , AlmegamsiT , HammdiA . Efficacy of a small dose of oral dexamethasone in croup. Biomedical Research2005;65(1):65-72. ">Alshehr 2005</a>; <a href="./references#CD001955-bbs2-0016" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995a</a>; <a href="./references#CD001955-bbs2-0017" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995b</a>; <a href="./references#CD001955-bbs2-0018" title="GeelhoedGC , MacdonaldWB . Oral and inhaled steroids in croup: a randomized, placebo‐controlled trial. Pediatric Pulmonology1995;20(6):355-61. ">Geelhoed 1995c</a>; <a href="./references#CD001955-bbs2-0020" title="GeelhoedGC . Budesonide offers no advantage when added to oral dexamethasone in the treatment of croup. Pediatric Emergency Care2005;21(6):359-62. ">Geelhoed 2005</a>; <a href="./references#CD001955-bbs2-0021" title="GoddenCW , CampbellMJ , HusseyM , CogswellJJ . Double blind placebo controlled trial of nebulised budesonide for croup. Archives of Disease in Childhood1997;76(2):155-8. ">Godden 1997</a>; <a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a>; <a href="./references#CD001955-bbs2-0031" title="KuuselaAL , VesikariT . A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatrica Scandinavica1988;77(1):99-104. ">Kuusela 1988</a>; <a href="./references#CD001955-bbs2-0032" title="LeipzigB , OskiFA , CummingsCW , StockmanJA , SwenderP . A prospective randomized study to determine the efficacy of steroids in treatment of croup. Journal of Pediatrics1979;94(2):194-6. ">Leipzig 1979</a>; <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a>; <a href="./references#CD001955-bbs2-0039" title="RoordaRJ , WalhofCM . Effects of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report. Pediatric Pulmonology1998;25(2):114-7. ">Roorda 1998</a>; <a href="./references#CD001955-bbs2-0040" title="SkowronPN , TurnerJA , McNaughtonGA . The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Canadian Medical Association Journal1966;94(11):528-31. ">Skowron 1966a</a>; <a href="./references#CD001955-bbs2-0041" title="SkowronPN , TurnerJA , McNaughtonGA . The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Canadian Medical Association Journal1966;94(11):528-31. ">Skowron 1966a and b</a>; <a href="./references#CD001955-bbs2-0042" title="SkowronPN , TurnerJA , McNaughtonGA . The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Canadian Medical Association Journal1966;94(11):528-31. ">Skowron 1966b</a>; <a href="./references#CD001955-bbs2-0044" title="SparrowA , GeelhoedG . Prednisolone versus dexamethasone in croup: a randomised equivalence trial. Archives of Disease in Childhood2006;91(7):580-3. ">Sparrow 2006</a>; <a href="./references#CD001955-bbs2-0045" title="SuperDM , CartelliNA , BrooksLJ , LemboRM , KumarML . A prospective randomized double‐blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. Journal of Pediatrics1989;115(2):323-9. ">Super 1989</a>). Twelve studies (27%) reported patient improvement; of these, one reported improvement after two hours (<a href="./references#CD001955-bbs2-0038" title="RobertsGW , MasterVV , StaugasRE , RaftosJV , ParsonsDW , CoulthardKP , et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. Journal of Paediatrics and Child Health1999;35(2):170-4. ">Roberts 1999</a>); eight reported improvement after six hours (<a href="./references#CD001955-bbs2-0011" title="EdenA , LarkinVP . Corticosteroid treatment of croup. Pediatrics1964;33:768-9. ">Eden 1964</a>; <a href="./references#CD001955-bbs2-0012" title="EdenAN , KaufmanA , YuR . Corticosteroids and croup. Controlled double-blind study. JAMA1967;200(5):403-4. ">Eden 1967</a>; <a href="./references#CD001955-bbs2-0025" title="JohnsonDW , SchuhS , KorenG , JaffeeDM . Outpatient treatment of croup with nebulized dexamethasone. Archives of Pediatrics &amp; Adolescent Medicine1996;150(4):349-55. ">Johnson 1996</a>; <a href="./references#CD001955-bbs2-0027" title="KlassenTP , FeldmanME , WattersLK , SutcliffeT , RowePC . Nebulized budesonide for children with mild-to-moderate croup. New England Journal of Medicine1994;331(5):285-9. ">Klassen 1994</a>; <a href="./references#CD001955-bbs2-0028" title="KlassenTP , WattersLK , FeldmanME , SutcliffeT , RowePC . The efficacy of nebulized budesonide in dexamethasone‐treated outpatients with croup. Pediatrics1996;97(4):463-6. ">Klassen 1996</a>; <a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a>; <a href="./references#CD001955-bbs2-0035" title="MassicotteP , TetreaultL . Evaluation of methyl‐prednisolone in the treatment of acute laryngitis in children. Unión Médicale du Canada1973;102(10):2064-72. ">Massicotte 1973</a>; <a href="./references#CD001955-bbs2-0038" title="RobertsGW , MasterVV , StaugasRE , RaftosJV , ParsonsDW , CoulthardKP , et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. Journal of Paediatrics and Child Health1999;35(2):170-4. ">Roberts 1999</a>); six reported improvement after 12 hours (<a href="./references#CD001955-bbs2-0011" title="EdenA , LarkinVP . Corticosteroid treatment of croup. Pediatrics1964;33:768-9. ">Eden 1964</a>; <a href="./references#CD001955-bbs2-0012" title="EdenAN , KaufmanA , YuR . Corticosteroids and croup. Controlled double-blind study. JAMA1967;200(5):403-4. ">Eden 1967</a>; <a href="./references#CD001955-bbs2-0024" title="JamesJA . Dexamethasone in croup. A controlled study. American Journal of Diseases of Children1969;117(5):511-6. ">James 1969</a>; <a href="./references#CD001955-bbs2-0035" title="MassicotteP , TetreaultL . Evaluation of methyl‐prednisolone in the treatment of acute laryngitis in children. Unión Médicale du Canada1973;102(10):2064-72. ">Massicotte 1973</a>; <a href="./references#CD001955-bbs2-0038" title="RobertsGW , MasterVV , StaugasRE , RaftosJV , ParsonsDW , CoulthardKP , et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. Journal of Paediatrics and Child Health1999;35(2):170-4. ">Roberts 1999</a>; <a href="./references#CD001955-bbs2-0045" title="SuperDM , CartelliNA , BrooksLJ , LemboRM , KumarML . A prospective randomized double‐blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. Journal of Pediatrics1989;115(2):323-9. ">Super 1989</a>); and seven reported improvement after 24 hours (<a href="./references#CD001955-bbs2-0006" title="CruzMN , StewartG , RosenbergN . Use of dexamethasone in the outpatient management of acute laryngotracheitis. Pediatrics1995;96(2 Pt 1):220-3. ">Cruz 1995</a>; <a href="./references#CD001955-bbs2-0008" title="DonaldsonD , PoleskiD , KnippleE , FilipsK , ReetzL , PasculaRG , et al. Intramuscular versus oral dexamethasone for the treatment of moderate-to-severe croup: a randomized double-blind trial. Academy of Emergency Medicine2003;10(1):16-21. ">Donaldson 2003</a>; <a href="./references#CD001955-bbs2-0011" title="EdenA , LarkinVP . Corticosteroid treatment of croup. Pediatrics1964;33:768-9. ">Eden 1964</a>; <a href="./references#CD001955-bbs2-0012" title="EdenAN , KaufmanA , YuR . Corticosteroids and croup. Controlled double-blind study. JAMA1967;200(5):403-4. ">Eden 1967</a>; <a href="./references#CD001955-bbs2-0024" title="JamesJA . Dexamethasone in croup. A controlled study. American Journal of Diseases of Children1969;117(5):511-6. ">James 1969</a>; <a href="./references#CD001955-bbs2-0038" title="RobertsGW , MasterVV , StaugasRE , RaftosJV , ParsonsDW , CoulthardKP , et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. Journal of Paediatrics and Child Health1999;35(2):170-4. ">Roberts 1999</a>; <a href="./references#CD001955-bbs2-0045" title="SuperDM , CartelliNA , BrooksLJ , LemboRM , KumarML . A prospective randomized double‐blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. Journal of Pediatrics1989;115(2):323-9. ">Super 1989</a>). About two‐thirds of the included studies (n = 30) reported the use of additional treatments; of these, 12 reported intubation/tracheotomies (<a href="./references#CD001955-bbs2-0005" title="Chub-UppakarnS , SangsupawanichP . A randomized comparison of dexamethasone 0.15 mg/kg versus 0.6 mg/kg for the treatment of moderate to severe croup. International Journal of Pediatric Otorhinolaryngology2007;71(3):473-7. ">Chub‐Uppakarn 2007</a>; <a href="./references#CD001955-bbs2-0012" title="EdenAN , KaufmanA , YuR . Corticosteroids and croup. Controlled double-blind study. JAMA1967;200(5):403-4. ">Eden 1967</a>; <a href="./references#CD001955-bbs2-0014" title="FitzgeraldD , MellisC , JohnsonM , AllenH , CooperP , Van AsperenP . Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics1996;97(5):722-5. ">Fitzgerald 1996</a>; <a href="./references#CD001955-bbs2-0018" title="GeelhoedGC , MacdonaldWB . Oral and inhaled steroids in croup: a randomized, placebo‐controlled trial. Pediatric Pulmonology1995;20(6):355-61. ">Geelhoed 1995c</a>; <a href="./references#CD001955-bbs2-0021" title="GoddenCW , CampbellMJ , HusseyM , CogswellJJ . Double blind placebo controlled trial of nebulised budesonide for croup. Archives of Disease in Childhood1997;76(2):155-8. ">Godden 1997</a>; <a href="./references#CD001955-bbs2-0024" title="JamesJA . Dexamethasone in croup. A controlled study. American Journal of Diseases of Children1969;117(5):511-6. ">James 1969</a>; <a href="./references#CD001955-bbs2-0025" title="JohnsonDW , SchuhS , KorenG , JaffeeDM . Outpatient treatment of croup with nebulized dexamethasone. Archives of Pediatrics &amp; Adolescent Medicine1996;150(4):349-55. ">Johnson 1996</a>; <a href="./references#CD001955-bbs2-0026" title="JohnsonDW , JacobsonS , EdneyPC , HadfieldP , MundyME , SchuhS . A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. New England Journal of Medicine1998;339(8):498-503. ">Johnson 1998</a>; <a href="./references#CD001955-bbs2-0032" title="LeipzigB , OskiFA , CummingsCW , StockmanJA , SwenderP . A prospective randomized study to determine the efficacy of steroids in treatment of croup. Journal of Pediatrics1979;94(2):194-6. ">Leipzig 1979</a>; <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a>; <a href="./references#CD001955-bbs2-0039" title="RoordaRJ , WalhofCM . Effects of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report. Pediatric Pulmonology1998;25(2):114-7. ">Roorda 1998</a>; <a href="./references#CD001955-bbs2-0040" title="SkowronPN , TurnerJA , McNaughtonGA . The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Canadian Medical Association Journal1966;94(11):528-31. ">Skowron 1966a</a>; <a href="./references#CD001955-bbs2-0041" title="SkowronPN , TurnerJA , McNaughtonGA . The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Canadian Medical Association Journal1966;94(11):528-31. ">Skowron 1966a and b</a>; <a href="./references#CD001955-bbs2-0042" title="SkowronPN , TurnerJA , McNaughtonGA . The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Canadian Medical Association Journal1966;94(11):528-31. ">Skowron 1966b</a>); four reported the use of antibiotics (<a href="./references#CD001955-bbs2-0023" title="HusbyS , AgertoftL , MortensenS , PedersenS . Treatment of croup with nebulised steroid (budesonide): a double blind, placebo controlled study. Archives of Disease in Childhood1993;68(3):352-5. MortensenS , AgertoftL , HusbyS , PedersenS . Pseudocroup treated with inhaled steroid (budesonide). A double-blind placebo-controlled trial. Ugeskrift for Laeger1994;156(45):6661-3. ">Husby 1993</a>; <a href="./references#CD001955-bbs2-0024" title="JamesJA . Dexamethasone in croup. A controlled study. American Journal of Diseases of Children1969;117(5):511-6. ">James 1969</a>; <a href="./references#CD001955-bbs2-0030" title="KorenGF . Corticosteroid treatment of laryngotracheitis v spasmodic croup in children. American Journal of Diseases of Children1983;137(10):941-4. ">Koren 1983</a>; <a href="./references#CD001955-bbs2-0037" title="RittichierKK , LedwithCA . Outpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing. Pediatrics2000;106(6):1344-8. ">Rittichier 2000</a>); 14 reported the use of supplemental glucocorticoids (<a href="./references#CD001955-bbs2-0007" title="DobrovoljacM , GeelhoedG . How fast does oral dexamethasone work in mild to moderately severe croup? A randomized double-blinded clinical trial. Emergency Medicine Australasia2012;24(1):79-85. ">Dobrovoljac 2012</a>; <a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a>; <a href="./references#CD001955-bbs2-0014" title="FitzgeraldD , MellisC , JohnsonM , AllenH , CooperP , Van AsperenP . Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics1996;97(5):722-5. ">Fitzgerald 1996</a>; <a href="./references#CD001955-bbs2-0016" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995a</a>; <a href="./references#CD001955-bbs2-0017" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995b</a>; <a href="./references#CD001955-bbs2-0018" title="GeelhoedGC , MacdonaldWB . Oral and inhaled steroids in croup: a randomized, placebo‐controlled trial. Pediatric Pulmonology1995;20(6):355-61. ">Geelhoed 1995c</a>; <a href="./references#CD001955-bbs2-0025" title="JohnsonDW , SchuhS , KorenG , JaffeeDM . Outpatient treatment of croup with nebulized dexamethasone. Archives of Pediatrics &amp; Adolescent Medicine1996;150(4):349-55. ">Johnson 1996</a>; <a href="./references#CD001955-bbs2-0027" title="KlassenTP , FeldmanME , WattersLK , SutcliffeT , RowePC . Nebulized budesonide for children with mild-to-moderate croup. New England Journal of Medicine1994;331(5):285-9. ">Klassen 1994</a>; <a href="./references#CD001955-bbs2-0028" title="KlassenTP , WattersLK , FeldmanME , SutcliffeT , RowePC . The efficacy of nebulized budesonide in dexamethasone‐treated outpatients with croup. Pediatrics1996;97(4):463-6. ">Klassen 1996</a>; <a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a>; <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a>; <a href="./references#CD001955-bbs2-0037" title="RittichierKK , LedwithCA . Outpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing. Pediatrics2000;106(6):1344-8. ">Rittichier 2000</a>; <a href="./references#CD001955-bbs2-0039" title="RoordaRJ , WalhofCM . Effects of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report. Pediatric Pulmonology1998;25(2):114-7. ">Roorda 1998</a>; <a href="./references#CD001955-bbs2-0045" title="SuperDM , CartelliNA , BrooksLJ , LemboRM , KumarML . A prospective randomized double‐blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. Journal of Pediatrics1989;115(2):323-9. ">Super 1989</a>; <a href="./references#CD001955-bbs2-0047" title="Vad PedersenL , DahlM , Falk-PetersenHE , LarsenSE . Inhaled budesonide versus intramuscular dexamethasone in the treatment of pseudocroup [Inhaleret budesonid versus dexamethasone i.m. til behandling at pseudocroup]. Ugeskrift for Laeger1998;160(15):2253-6. ">Vad Pedersen 1998</a>); 22 reported the use of epinephrine (<a href="./references#CD001955-bbs2-0002" title="AmirL , HubermannH , HaleviA , MorM , MimouniM , WaismanY . Oral betamethasone versus intramuscular dexamethasone for the treatment of mild to moderate viral croup. Pediatric Emergency Care2006;22(8):541-4. ">Amir 2006</a>; <a href="./references#CD001955-bbs2-0007" title="DobrovoljacM , GeelhoedG . How fast does oral dexamethasone work in mild to moderately severe croup? A randomized double-blinded clinical trial. Emergency Medicine Australasia2012;24(1):79-85. ">Dobrovoljac 2012</a>; <a href="./references#CD001955-bbs2-0008" title="DonaldsonD , PoleskiD , KnippleE , FilipsK , ReetzL , PasculaRG , et al. Intramuscular versus oral dexamethasone for the treatment of moderate-to-severe croup: a randomized double-blind trial. Academy of Emergency Medicine2003;10(1):16-21. ">Donaldson 2003</a>; <a href="./references#CD001955-bbs2-0009" title="DumanM , OzdemirD , AtaseverS . Nebulized L-epinephrine and steroid combination in the treatment of moderate to severe croup. Clinical Drug Investigation2005;25(3):183-9. ">Duman 2005</a>; <a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a>; <a href="./references#CD001955-bbs2-0014" title="FitzgeraldD , MellisC , JohnsonM , AllenH , CooperP , Van AsperenP . Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics1996;97(5):722-5. ">Fitzgerald 1996</a>; <a href="./references#CD001955-bbs2-0016" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995a</a>; <a href="./references#CD001955-bbs2-0017" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995b</a>; <a href="./references#CD001955-bbs2-0018" title="GeelhoedGC , MacdonaldWB . Oral and inhaled steroids in croup: a randomized, placebo‐controlled trial. Pediatric Pulmonology1995;20(6):355-61. ">Geelhoed 1995c</a>; <a href="./references#CD001955-bbs2-0020" title="GeelhoedGC . Budesonide offers no advantage when added to oral dexamethasone in the treatment of croup. Pediatric Emergency Care2005;21(6):359-62. ">Geelhoed 2005</a>; <a href="./references#CD001955-bbs2-0021" title="GoddenCW , CampbellMJ , HusseyM , CogswellJJ . Double blind placebo controlled trial of nebulised budesonide for croup. Archives of Disease in Childhood1997;76(2):155-8. ">Godden 1997</a>; <a href="./references#CD001955-bbs2-0025" title="JohnsonDW , SchuhS , KorenG , JaffeeDM . Outpatient treatment of croup with nebulized dexamethasone. Archives of Pediatrics &amp; Adolescent Medicine1996;150(4):349-55. ">Johnson 1996</a>; <a href="./references#CD001955-bbs2-0026" title="JohnsonDW , JacobsonS , EdneyPC , HadfieldP , MundyME , SchuhS . A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. New England Journal of Medicine1998;339(8):498-503. ">Johnson 1998</a>; <a href="./references#CD001955-bbs2-0027" title="KlassenTP , FeldmanME , WattersLK , SutcliffeT , RowePC . Nebulized budesonide for children with mild-to-moderate croup. New England Journal of Medicine1994;331(5):285-9. ">Klassen 1994</a>; <a href="./references#CD001955-bbs2-0028" title="KlassenTP , WattersLK , FeldmanME , SutcliffeT , RowePC . The efficacy of nebulized budesonide in dexamethasone‐treated outpatients with croup. Pediatrics1996;97(4):463-6. ">Klassen 1996</a>; <a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a>; <a href="./references#CD001955-bbs2-0030" title="KorenGF . Corticosteroid treatment of laryngotracheitis v spasmodic croup in children. American Journal of Diseases of Children1983;137(10):941-4. ">Koren 1983</a>; <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a>; <a href="./references#CD001955-bbs2-0037" title="RittichierKK , LedwithCA . Outpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing. Pediatrics2000;106(6):1344-8. ">Rittichier 2000</a>; <a href="./references#CD001955-bbs2-0038" title="RobertsGW , MasterVV , StaugasRE , RaftosJV , ParsonsDW , CoulthardKP , et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. Journal of Paediatrics and Child Health1999;35(2):170-4. ">Roberts 1999</a>; <a href="./references#CD001955-bbs2-0044" title="SparrowA , GeelhoedG . Prednisolone versus dexamethasone in croup: a randomised equivalence trial. Archives of Disease in Childhood2006;91(7):580-3. ">Sparrow 2006</a>; <a href="./references#CD001955-bbs2-0045" title="SuperDM , CartelliNA , BrooksLJ , LemboRM , KumarML . A prospective randomized double‐blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. Journal of Pediatrics1989;115(2):323-9. ">Super 1989</a>; <a href="./references#CD001955-bbs2-0046" title="TibballsJ , ShannFA , LandauLI . Placebo-controlled trial of prednisolone in children intubated for croup. Lancet1992;340(8822):745-8. ">Tibballs 1992</a>); and five reported the use of a mist tent (<a href="./references#CD001955-bbs2-0001" title="AlshehrM , AlmegamsiT , HammdiA . Efficacy of a small dose of oral dexamethasone in croup. Biomedical Research2005;65(1):65-72. ">Alshehr 2005</a>; <a href="./references#CD001955-bbs2-0025" title="JohnsonDW , SchuhS , KorenG , JaffeeDM . Outpatient treatment of croup with nebulized dexamethasone. Archives of Pediatrics &amp; Adolescent Medicine1996;150(4):349-55. ">Johnson 1996</a>; <a href="./references#CD001955-bbs2-0028" title="KlassenTP , WattersLK , FeldmanME , SutcliffeT , RowePC . The efficacy of nebulized budesonide in dexamethasone‐treated outpatients with croup. Pediatrics1996;97(4):463-6. ">Klassen 1996</a>; <a href="./references#CD001955-bbs2-0037" title="RittichierKK , LedwithCA . Outpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing. Pediatrics2000;106(6):1344-8. ">Rittichier 2000</a>; <a href="./references#CD001955-bbs2-0045" title="SuperDM , CartelliNA , BrooksLJ , LemboRM , KumarML . A prospective randomized double‐blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. Journal of Pediatrics1989;115(2):323-9. ">Super 1989</a>). Twenty‐four studies reported collecting adverse events data, of which eight reported serious adverse events following the administration of glucocorticoids (namely secondary bacterial infections, e.g. pneumonia, otitis media) (<a href="./references#CD001955-bbs2-0001" title="AlshehrM , AlmegamsiT , HammdiA . Efficacy of a small dose of oral dexamethasone in croup. Biomedical Research2005;65(1):65-72. ">Alshehr 2005</a>; <a href="./references#CD001955-bbs2-0003" title="BjornsonC , KlassenTP , WilliamsonJ , BrantR , PlintA , BullochB , et al. A randomized trial of single dose of oral dexamethasone for mild croup. New England Journal of Medicine2004;351(13):1306-13. ">Bjornson 2004</a>; <a href="./references#CD001955-bbs2-0025" title="JohnsonDW , SchuhS , KorenG , JaffeeDM . Outpatient treatment of croup with nebulized dexamethasone. Archives of Pediatrics &amp; Adolescent Medicine1996;150(4):349-55. ">Johnson 1996</a>; <a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a>; <a href="./references#CD001955-bbs2-0031" title="KuuselaAL , VesikariT . A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatrica Scandinavica1988;77(1):99-104. ">Kuusela 1988</a>; <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a>; <a href="./references#CD001955-bbs2-0038" title="RobertsGW , MasterVV , StaugasRE , RaftosJV , ParsonsDW , CoulthardKP , et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. Journal of Paediatrics and Child Health1999;35(2):170-4. ">Roberts 1999</a>; <a href="./references#CD001955-bbs2-0045" title="SuperDM , CartelliNA , BrooksLJ , LemboRM , KumarML . A prospective randomized double‐blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. Journal of Pediatrics1989;115(2):323-9. ">Super 1989</a>), and 16 reported no serious adverse events (<a href="./references#CD001955-bbs2-0005" title="Chub-UppakarnS , SangsupawanichP . A randomized comparison of dexamethasone 0.15 mg/kg versus 0.6 mg/kg for the treatment of moderate to severe croup. International Journal of Pediatric Otorhinolaryngology2007;71(3):473-7. ">Chub‐Uppakarn 2007</a>; <a href="./references#CD001955-bbs2-0009" title="DumanM , OzdemirD , AtaseverS . Nebulized L-epinephrine and steroid combination in the treatment of moderate to severe croup. Clinical Drug Investigation2005;25(3):183-9. ">Duman 2005</a>; <a href="./references#CD001955-bbs2-0012" title="EdenAN , KaufmanA , YuR . Corticosteroids and croup. Controlled double-blind study. JAMA1967;200(5):403-4. ">Eden 1967</a>; <a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a>; <a href="./references#CD001955-bbs2-0014" title="FitzgeraldD , MellisC , JohnsonM , AllenH , CooperP , Van AsperenP . Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics1996;97(5):722-5. ">Fitzgerald 1996</a>; <a href="./references#CD001955-bbs2-0015" title="GarbuttJM , ConionB , SterkelR , BatyJ , SchechtmanKB , MandrellK , et al. The comparative effectiveness of prednisolone and dexamethasone for children with croup: a community-based randomized trial. Clinical Pediatrics2013;52(11):1014-21. ">Garbutt 2013</a>; <a href="./references#CD001955-bbs2-0022" title="HuangT , XiaZ , LiW . Efficacy of inhaled budesonide on serum inflammatory factors and quality of life among children with acute infectious laryngitis. American Journal of Otolaryngology - Head and Neck Medicine and Surgery2021;42(1):102820. ">Huang 2021</a>; <a href="./references#CD001955-bbs2-0023" title="HusbyS , AgertoftL , MortensenS , PedersenS . Treatment of croup with nebulised steroid (budesonide): a double blind, placebo controlled study. Archives of Disease in Childhood1993;68(3):352-5. MortensenS , AgertoftL , HusbyS , PedersenS . Pseudocroup treated with inhaled steroid (budesonide). A double-blind placebo-controlled trial. Ugeskrift for Laeger1994;156(45):6661-3. ">Husby 1993</a>; <a href="./references#CD001955-bbs2-0024" title="JamesJA . Dexamethasone in croup. A controlled study. American Journal of Diseases of Children1969;117(5):511-6. ">James 1969</a>; <a href="./references#CD001955-bbs2-0026" title="JohnsonDW , JacobsonS , EdneyPC , HadfieldP , MundyME , SchuhS . A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. New England Journal of Medicine1998;339(8):498-503. ">Johnson 1998</a>; <a href="./references#CD001955-bbs2-0027" title="KlassenTP , FeldmanME , WattersLK , SutcliffeT , RowePC . Nebulized budesonide for children with mild-to-moderate croup. New England Journal of Medicine1994;331(5):285-9. ">Klassen 1994</a>; <a href="./references#CD001955-bbs2-0032" title="LeipzigB , OskiFA , CummingsCW , StockmanJA , SwenderP . A prospective randomized study to determine the efficacy of steroids in treatment of croup. Journal of Pediatrics1979;94(2):194-6. ">Leipzig 1979</a>; <a href="./references#CD001955-bbs2-0039" title="RoordaRJ , WalhofCM . Effects of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report. Pediatric Pulmonology1998;25(2):114-7. ">Roorda 1998</a>; <a href="./references#CD001955-bbs2-0044" title="SparrowA , GeelhoedG . Prednisolone versus dexamethasone in croup: a randomised equivalence trial. Archives of Disease in Childhood2006;91(7):580-3. ">Sparrow 2006</a>; <a href="./references#CD001955-bbs2-0046" title="TibballsJ , ShannFA , LandauLI . Placebo-controlled trial of prednisolone in children intubated for croup. Lancet1992;340(8822):745-8. ">Tibballs 1992</a>; <a href="./references#CD001955-bbs2-0047" title="Vad PedersenL , DahlM , Falk-PetersenHE , LarsenSE . Inhaled budesonide versus intramuscular dexamethasone in the treatment of pseudocroup [Inhaleret budesonid versus dexamethasone i.m. til behandling at pseudocroup]. Ugeskrift for Laeger1998;160(15):2253-6. ">Vad Pedersen 1998</a>). </p> </section> <section id="CD001955-sec-0047"> <h5 class="title">Funding</h5> <p>The included studies received funding from government (11%), academic (7%), industry (18%), and foundations (9%) sources. However, more than half (55%) of the included studies did not report any funding sources.  </p> </section> </section> <section id="CD001955-sec-0048"> <h4 class="title">Excluded studies</h4> <p>We excluded six studies following the searches in 2022 (<a href="#CD001955-fig-0001">Figure 1</a>). <a href="./references#CD001955-bbs2-0061" title="GursansckyL . Prednisolone versus dexamethasone for croup. Journal of Paediatrics and Child Health2019;55(12):1511. ">Gursanscky 2019</a> and <a href="./references#CD001955-bbs2-0085" title="TylerA , BryanMA , ZhouC , Mangione-SmithR , WilliamsD , JohnsonDP , et al. Variation in dexamethasone dosing and use outcomes for inpatient croup. Hospital Pediatrics2022;12(1):22-9. ">Tyler 2022</a> were not randomised trials; <a href="./references#CD001955-bbs2-0068" title="LeeJH , JungJY , LeeHJ , KimDK , KwakYH , ChangI , et al. Efficacy of low-dose nebulized epinephrine as treatment for croup: a randomized, placebo-controlled, double-blind trial. American Journal of Emergency Medicine2019;31(12):2171-6. ">Lee 2019</a> and <a href="./references#CD001955-bbs2-0071" title="MeskinaER , KhadisovaMK , TselipanovaEE . Efficacy of a homeopathic drug in combination treatment of acute obstructive laryngitis in children. Voprosy Prakticheskoi Pediatrii2019;14(4):36-43. ">Meskina 2019</a> were randomised trials that did not investigate glucocorticoids; and <a href="./references#CD001955-bbs2-0056" title="Faraji-GoodarziM , TaeeN , Mohammadi-KamalvandM . Comparison of the effect of cold drink and dexamethasone, and their combined effect on children with croup. Drug Research2018;68(4):185-8. ">Faraji‐Goodarzi 2018</a> was a randomised trial that did not report any relevant outcomes. See <a href="./references#CD001955-sec-0225" title="">Characteristics of excluded studies</a> table. </p> <p>We edited the excluded studies list to remove legacy excluded studies that evidently did not meet the inclusion criteria (e.g. letters, commentaries, summaries, case studies). We made this change to comply with current Cochrane standards for methods and reporting. We excluded 38 studies in this 2022 updated review. </p> </section> <section id="CD001955-sec-0049"> <h4 class="title">Ongoing studies</h4> <p>We identified one ongoing study, <a href="./references#CD001955-bbs2-0088" title="IRCT20190914044765N1. Comparison the effect of oral and intravenous dexamethasone effect on the mild and moderate croup treatment in children. www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT20190914044765N1 (first received 24 September 2019). ">IRCT20190914044765N1</a>, and one study awaiting classification, <a href="./references#CD001955-bbs2-0087" title="ChenQP , ZhouRF , ZhangYM , YangL . Efficacy of systemic glucocorticoids combined with inhaled steroid on children with acute laryngitis. Zhonghua er bi yan hou tou jing wai ke za zhi [Chinese Journal of Otorhinolaryngology Head and Neck Surgery]2018;53(1):53-6. ">Chen 2018</a> (<a href="#CD001955-fig-0001">Figure 1</a>). We will assess these studies for inclusion in a future update.  </p> </section> </section> <section id="CD001955-sec-0050"> <h3 class="title">Risk of bias in included studies</h3> <p>We presented the risk of bias of all included studies as assessed using the Cochrane risk of bias tool in <a href="#CD001955-fig-0002">Figure 2</a> and <a href="#CD001955-fig-0003">Figure 3</a>. We judged the overall risk of bias to be low in one study (<a href="./references#CD001955-bbs2-0015" title="GarbuttJM , ConionB , SterkelR , BatyJ , SchechtmanKB , MandrellK , et al. The comparative effectiveness of prednisolone and dexamethasone for children with croup: a community-based randomized trial. Clinical Pediatrics2013;52(11):1014-21. ">Garbutt 2013</a>), unclear in 32 studies (<a href="./references#CD001955-bbs2-0001" title="AlshehrM , AlmegamsiT , HammdiA . Efficacy of a small dose of oral dexamethasone in croup. Biomedical Research2005;65(1):65-72. ">Alshehr 2005</a>; <a href="./references#CD001955-bbs2-0003" title="BjornsonC , KlassenTP , WilliamsonJ , BrantR , PlintA , BullochB , et al. A randomized trial of single dose of oral dexamethasone for mild croup. New England Journal of Medicine2004;351(13):1306-13. ">Bjornson 2004</a>; <a href="./references#CD001955-bbs2-0005" title="Chub-UppakarnS , SangsupawanichP . A randomized comparison of dexamethasone 0.15 mg/kg versus 0.6 mg/kg for the treatment of moderate to severe croup. International Journal of Pediatric Otorhinolaryngology2007;71(3):473-7. ">Chub‐Uppakarn 2007</a>; <a href="./references#CD001955-bbs2-0006" title="CruzMN , StewartG , RosenbergN . Use of dexamethasone in the outpatient management of acute laryngotracheitis. Pediatrics1995;96(2 Pt 1):220-3. ">Cruz 1995</a>; <a href="./references#CD001955-bbs2-0008" title="DonaldsonD , PoleskiD , KnippleE , FilipsK , ReetzL , PasculaRG , et al. Intramuscular versus oral dexamethasone for the treatment of moderate-to-severe croup: a randomized double-blind trial. Academy of Emergency Medicine2003;10(1):16-21. ">Donaldson 2003</a>; <a href="./references#CD001955-bbs2-0011" title="EdenA , LarkinVP . Corticosteroid treatment of croup. Pediatrics1964;33:768-9. ">Eden 1964</a>; <a href="./references#CD001955-bbs2-0012" title="EdenAN , KaufmanA , YuR . Corticosteroids and croup. Controlled double-blind study. JAMA1967;200(5):403-4. ">Eden 1967</a>; <a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a>; <a href="./references#CD001955-bbs2-0016" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995a</a>; <a href="./references#CD001955-bbs2-0017" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995b</a>; <a href="./references#CD001955-bbs2-0019" title="GeelhoedGC , TurnerJ , MacdonaldWB . Efficacy of a small single dose of oral dexamethasone for outpatient croup: a double blind placebo controlled clinical trial. BMJ1996;313(7050):140-2. ">Geelhoed 1996a</a>; <a href="./references#CD001955-bbs2-0020" title="GeelhoedGC . Budesonide offers no advantage when added to oral dexamethasone in the treatment of croup. Pediatric Emergency Care2005;21(6):359-62. ">Geelhoed 2005</a>; <a href="./references#CD001955-bbs2-0021" title="GoddenCW , CampbellMJ , HusseyM , CogswellJJ . Double blind placebo controlled trial of nebulised budesonide for croup. Archives of Disease in Childhood1997;76(2):155-8. ">Godden 1997</a>; <a href="./references#CD001955-bbs2-0022" title="HuangT , XiaZ , LiW . Efficacy of inhaled budesonide on serum inflammatory factors and quality of life among children with acute infectious laryngitis. American Journal of Otolaryngology - Head and Neck Medicine and Surgery2021;42(1):102820. ">Huang 2021</a>; <a href="./references#CD001955-bbs2-0023" title="HusbyS , AgertoftL , MortensenS , PedersenS . Treatment of croup with nebulised steroid (budesonide): a double blind, placebo controlled study. Archives of Disease in Childhood1993;68(3):352-5. MortensenS , AgertoftL , HusbyS , PedersenS . Pseudocroup treated with inhaled steroid (budesonide). A double-blind placebo-controlled trial. Ugeskrift for Laeger1994;156(45):6661-3. ">Husby 1993</a>; <a href="./references#CD001955-bbs2-0024" title="JamesJA . Dexamethasone in croup. A controlled study. American Journal of Diseases of Children1969;117(5):511-6. ">James 1969</a>; <a href="./references#CD001955-bbs2-0025" title="JohnsonDW , SchuhS , KorenG , JaffeeDM . Outpatient treatment of croup with nebulized dexamethasone. Archives of Pediatrics &amp; Adolescent Medicine1996;150(4):349-55. ">Johnson 1996</a>; <a href="./references#CD001955-bbs2-0026" title="JohnsonDW , JacobsonS , EdneyPC , HadfieldP , MundyME , SchuhS . A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. New England Journal of Medicine1998;339(8):498-503. ">Johnson 1998</a>; <a href="./references#CD001955-bbs2-0028" title="KlassenTP , WattersLK , FeldmanME , SutcliffeT , RowePC . The efficacy of nebulized budesonide in dexamethasone‐treated outpatients with croup. Pediatrics1996;97(4):463-6. ">Klassen 1996</a>; <a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a>; <a href="./references#CD001955-bbs2-0030" title="KorenGF . Corticosteroid treatment of laryngotracheitis v spasmodic croup in children. American Journal of Diseases of Children1983;137(10):941-4. ">Koren 1983</a>; <a href="./references#CD001955-bbs2-0031" title="KuuselaAL , VesikariT . A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatrica Scandinavica1988;77(1):99-104. ">Kuusela 1988</a>; <a href="./references#CD001955-bbs2-0032" title="LeipzigB , OskiFA , CummingsCW , StockmanJA , SwenderP . A prospective randomized study to determine the efficacy of steroids in treatment of croup. Journal of Pediatrics1979;94(2):194-6. ">Leipzig 1979</a>; <a href="./references#CD001955-bbs2-0033" title="LuriaJW , Gonzalez-del-ReyJA , DiGuilioGA , McAneneyCM , OlsenJJ , RuddyRM . Effectiveness of oral or nebulized dexamethasone for children with mild croup. Archives of Pediatrics &amp; Adolescent Medicine2001;155(12):1340-5. ">Luria 2001</a>; <a href="./references#CD001955-bbs2-0034" title="Martinez FernandezA , SanchezGE , RicaEI , EchanizUI , AlonsoDM , VilellaCM , et al. Randomized double-blind study of treatment of croup with adrenaline and/or dexamethasone in children. Anales Españoles de Pediatria1993;38:29-32. ">Martinez Fernandez 1993</a>; <a href="./references#CD001955-bbs2-0035" title="MassicotteP , TetreaultL . Evaluation of methyl‐prednisolone in the treatment of acute laryngitis in children. Unión Médicale du Canada1973;102(10):2064-72. ">Massicotte 1973</a>; <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a>; <a href="./references#CD001955-bbs2-0039" title="RoordaRJ , WalhofCM . Effects of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report. Pediatric Pulmonology1998;25(2):114-7. ">Roorda 1998</a>; <a href="./references#CD001955-bbs2-0041" title="SkowronPN , TurnerJA , McNaughtonGA . The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Canadian Medical Association Journal1966;94(11):528-31. ">Skowron 1966a and b</a>; <a href="./references#CD001955-bbs2-0044" title="SparrowA , GeelhoedG . Prednisolone versus dexamethasone in croup: a randomised equivalence trial. Archives of Disease in Childhood2006;91(7):580-3. ">Sparrow 2006</a>; <a href="./references#CD001955-bbs2-0045" title="SuperDM , CartelliNA , BrooksLJ , LemboRM , KumarML . A prospective randomized double‐blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. Journal of Pediatrics1989;115(2):323-9. ">Super 1989</a>; <a href="./references#CD001955-bbs2-0046" title="TibballsJ , ShannFA , LandauLI . Placebo-controlled trial of prednisolone in children intubated for croup. Lancet1992;340(8822):745-8. ">Tibballs 1992</a>; <a href="./references#CD001955-bbs2-0048" title="Von MühlendahlKE , KahnD , SpohrHL , DresslerF . Steroid treatment of pseudo‐croup. Helvetica Paediatrica Acta1982;37(5):431-6. ">Von Mühlendahl 1982</a>), and high in 12 studies (<a href="./references#CD001955-bbs2-0002" title="AmirL , HubermannH , HaleviA , MorM , MimouniM , WaismanY . Oral betamethasone versus intramuscular dexamethasone for the treatment of mild to moderate viral croup. Pediatric Emergency Care2006;22(8):541-4. ">Amir 2006</a>; <a href="./references#CD001955-bbs2-0004" title="CetinkayaF , TufekciBS , KutlukG . A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup. International Journal of Pediatric Otorhinolaryngology2004;68(4):453-6. ">Cetinkaya 2004</a>; <a href="./references#CD001955-bbs2-0007" title="DobrovoljacM , GeelhoedG . How fast does oral dexamethasone work in mild to moderately severe croup? A randomized double-blinded clinical trial. Emergency Medicine Australasia2012;24(1):79-85. ">Dobrovoljac 2012</a>; <a href="./references#CD001955-bbs2-0009" title="DumanM , OzdemirD , AtaseverS . Nebulized L-epinephrine and steroid combination in the treatment of moderate to severe croup. Clinical Drug Investigation2005;25(3):183-9. ">Duman 2005</a>; <a href="./references#CD001955-bbs2-0010" title="EboriadouM , ChryssanthopoulouD , StamoulisP , DamianidouL , HaidopoulouK . The effectiveness of local corticosteroids therapy in the management of mild to moderate viral croup. Minerva Pediatrica2010;62(1):23-8. ">Eboriadou 2010</a>; <a href="./references#CD001955-bbs2-0014" title="FitzgeraldD , MellisC , JohnsonM , AllenH , CooperP , Van AsperenP . Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics1996;97(5):722-5. ">Fitzgerald 1996</a>; <a href="./references#CD001955-bbs2-0018" title="GeelhoedGC , MacdonaldWB . Oral and inhaled steroids in croup: a randomized, placebo‐controlled trial. Pediatric Pulmonology1995;20(6):355-61. ">Geelhoed 1995c</a>; <a href="./references#CD001955-bbs2-0027" title="KlassenTP , FeldmanME , WattersLK , SutcliffeT , RowePC . Nebulized budesonide for children with mild-to-moderate croup. New England Journal of Medicine1994;331(5):285-9. ">Klassen 1994</a>; <a href="./references#CD001955-bbs2-0037" title="RittichierKK , LedwithCA . Outpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing. Pediatrics2000;106(6):1344-8. ">Rittichier 2000</a>; <a href="./references#CD001955-bbs2-0038" title="RobertsGW , MasterVV , StaugasRE , RaftosJV , ParsonsDW , CoulthardKP , et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. Journal of Paediatrics and Child Health1999;35(2):170-4. ">Roberts 1999</a>; <a href="./references#CD001955-bbs2-0043" title="SoleimaniG , DaryadelA , MoghadamAA , SharifMR . The comparison of oral and IM dexamethasone efficacy in croup treatment. Journal of Comprehensive Pediatrics2013;4(4):175-8. ">Soleimani 2013</a>; <a href="./references#CD001955-bbs2-0047" title="Vad PedersenL , DahlM , Falk-PetersenHE , LarsenSE . Inhaled budesonide versus intramuscular dexamethasone in the treatment of pseudocroup [Inhaleret budesonid versus dexamethasone i.m. til behandling at pseudocroup]. Ugeskrift for Laeger1998;160(15):2253-6. ">Vad Pedersen 1998</a>). Rationales for our risk of bias judgements are provided in the risk of bias tables in the <a href="./references#CD001955-sec-0224" title="">Characteristics of included studies</a> table. </p> <div class="figure" id="CD001955-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph for studies included in the 2022 update synthesis: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD001955-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph for studies included in the 2022 update synthesis: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD001955-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary for studies included in the 2022 update synthesis: review authors' judgements about each risk of bias item for each included study." data-id="CD001955-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary for studies included in the 2022 update synthesis: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD001955-sec-0051"> <h4 class="title">Allocation</h4> <p>We judged risk of bias for random sequence generation to be low in 27 studies (60%) and unclear in 18 studies (40%). The 17 studies at unclear risk of bias were described as randomised; however, the method for generating the randomisation sequence was unclear or not reported (<a href="./references#CD001955-bbs2-0004" title="CetinkayaF , TufekciBS , KutlukG . A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup. International Journal of Pediatric Otorhinolaryngology2004;68(4):453-6. ">Cetinkaya 2004</a>; <a href="./references#CD001955-bbs2-0006" title="CruzMN , StewartG , RosenbergN . Use of dexamethasone in the outpatient management of acute laryngotracheitis. Pediatrics1995;96(2 Pt 1):220-3. ">Cruz 1995</a>; <a href="./references#CD001955-bbs2-0007" title="DobrovoljacM , GeelhoedG . How fast does oral dexamethasone work in mild to moderately severe croup? A randomized double-blinded clinical trial. Emergency Medicine Australasia2012;24(1):79-85. ">Dobrovoljac 2012</a>; <a href="./references#CD001955-bbs2-0014" title="FitzgeraldD , MellisC , JohnsonM , AllenH , CooperP , Van AsperenP . Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics1996;97(5):722-5. ">Fitzgerald 1996</a>; <a href="./references#CD001955-bbs2-0016" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995a</a>; <a href="./references#CD001955-bbs2-0017" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995b</a>; <a href="./references#CD001955-bbs2-0018" title="GeelhoedGC , MacdonaldWB . Oral and inhaled steroids in croup: a randomized, placebo‐controlled trial. Pediatric Pulmonology1995;20(6):355-61. ">Geelhoed 1995c</a>; <a href="./references#CD001955-bbs2-0019" title="GeelhoedGC , TurnerJ , MacdonaldWB . Efficacy of a small single dose of oral dexamethasone for outpatient croup: a double blind placebo controlled clinical trial. BMJ1996;313(7050):140-2. ">Geelhoed 1996a</a>; <a href="./references#CD001955-bbs2-0021" title="GoddenCW , CampbellMJ , HusseyM , CogswellJJ . Double blind placebo controlled trial of nebulised budesonide for croup. Archives of Disease in Childhood1997;76(2):155-8. ">Godden 1997</a>; <a href="./references#CD001955-bbs2-0022" title="HuangT , XiaZ , LiW . Efficacy of inhaled budesonide on serum inflammatory factors and quality of life among children with acute infectious laryngitis. American Journal of Otolaryngology - Head and Neck Medicine and Surgery2021;42(1):102820. ">Huang 2021</a>; <a href="./references#CD001955-bbs2-0023" title="HusbyS , AgertoftL , MortensenS , PedersenS . Treatment of croup with nebulised steroid (budesonide): a double blind, placebo controlled study. Archives of Disease in Childhood1993;68(3):352-5. MortensenS , AgertoftL , HusbyS , PedersenS . Pseudocroup treated with inhaled steroid (budesonide). A double-blind placebo-controlled trial. Ugeskrift for Laeger1994;156(45):6661-3. ">Husby 1993</a>; <a href="./references#CD001955-bbs2-0024" title="JamesJA . Dexamethasone in croup. A controlled study. American Journal of Diseases of Children1969;117(5):511-6. ">James 1969</a>; <a href="./references#CD001955-bbs2-0030" title="KorenGF . Corticosteroid treatment of laryngotracheitis v spasmodic croup in children. American Journal of Diseases of Children1983;137(10):941-4. ">Koren 1983</a>; <a href="./references#CD001955-bbs2-0031" title="KuuselaAL , VesikariT . A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatrica Scandinavica1988;77(1):99-104. ">Kuusela 1988</a>; <a href="./references#CD001955-bbs2-0034" title="Martinez FernandezA , SanchezGE , RicaEI , EchanizUI , AlonsoDM , VilellaCM , et al. Randomized double-blind study of treatment of croup with adrenaline and/or dexamethasone in children. Anales Españoles de Pediatria1993;38:29-32. ">Martinez Fernandez 1993</a>; <a href="./references#CD001955-bbs2-0039" title="RoordaRJ , WalhofCM . Effects of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report. Pediatric Pulmonology1998;25(2):114-7. ">Roorda 1998</a>; <a href="./references#CD001955-bbs2-0041" title="SkowronPN , TurnerJA , McNaughtonGA . The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Canadian Medical Association Journal1966;94(11):528-31. ">Skowron 1966a and b</a>; <a href="./references#CD001955-bbs2-0043" title="SoleimaniG , DaryadelA , MoghadamAA , SharifMR . The comparison of oral and IM dexamethasone efficacy in croup treatment. Journal of Comprehensive Pediatrics2013;4(4):175-8. ">Soleimani 2013</a>; <a href="./references#CD001955-bbs2-0048" title="Von MühlendahlKE , KahnD , SpohrHL , DresslerF . Steroid treatment of pseudo‐croup. Helvetica Paediatrica Acta1982;37(5):431-6. ">Von Mühlendahl 1982</a>). Randomisation was adequately described in the remaining 27 studies. We judged risk of bias for allocation concealment to be low in 19 studies (42%) and unclear in 26 studies (58%); in the latter studies, there was insufficient information reported in the publication to determine whether or not the groups to which the children were allocated could have been foreseen (<a href="./references#CD001955-bbs2-0002" title="AmirL , HubermannH , HaleviA , MorM , MimouniM , WaismanY . Oral betamethasone versus intramuscular dexamethasone for the treatment of mild to moderate viral croup. Pediatric Emergency Care2006;22(8):541-4. ">Amir 2006</a>; <a href="./references#CD001955-bbs2-0004" title="CetinkayaF , TufekciBS , KutlukG . A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup. International Journal of Pediatric Otorhinolaryngology2004;68(4):453-6. ">Cetinkaya 2004</a>; <a href="./references#CD001955-bbs2-0006" title="CruzMN , StewartG , RosenbergN . Use of dexamethasone in the outpatient management of acute laryngotracheitis. Pediatrics1995;96(2 Pt 1):220-3. ">Cruz 1995</a>; <a href="./references#CD001955-bbs2-0008" title="DonaldsonD , PoleskiD , KnippleE , FilipsK , ReetzL , PasculaRG , et al. Intramuscular versus oral dexamethasone for the treatment of moderate-to-severe croup: a randomized double-blind trial. Academy of Emergency Medicine2003;10(1):16-21. ">Donaldson 2003</a>; <a href="./references#CD001955-bbs2-0009" title="DumanM , OzdemirD , AtaseverS . Nebulized L-epinephrine and steroid combination in the treatment of moderate to severe croup. Clinical Drug Investigation2005;25(3):183-9. ">Duman 2005</a>; <a href="./references#CD001955-bbs2-0010" title="EboriadouM , ChryssanthopoulouD , StamoulisP , DamianidouL , HaidopoulouK . The effectiveness of local corticosteroids therapy in the management of mild to moderate viral croup. Minerva Pediatrica2010;62(1):23-8. ">Eboriadou 2010</a>; <a href="./references#CD001955-bbs2-0011" title="EdenA , LarkinVP . Corticosteroid treatment of croup. Pediatrics1964;33:768-9. ">Eden 1964</a>; <a href="./references#CD001955-bbs2-0012" title="EdenAN , KaufmanA , YuR . Corticosteroids and croup. Controlled double-blind study. JAMA1967;200(5):403-4. ">Eden 1967</a>; <a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a>; <a href="./references#CD001955-bbs2-0014" title="FitzgeraldD , MellisC , JohnsonM , AllenH , CooperP , Van AsperenP . Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics1996;97(5):722-5. ">Fitzgerald 1996</a>; <a href="./references#CD001955-bbs2-0016" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995a</a>; <a href="./references#CD001955-bbs2-0017" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995b</a>; <a href="./references#CD001955-bbs2-0018" title="GeelhoedGC , MacdonaldWB . Oral and inhaled steroids in croup: a randomized, placebo‐controlled trial. Pediatric Pulmonology1995;20(6):355-61. ">Geelhoed 1995c</a>; <a href="./references#CD001955-bbs2-0019" title="GeelhoedGC , TurnerJ , MacdonaldWB . Efficacy of a small single dose of oral dexamethasone for outpatient croup: a double blind placebo controlled clinical trial. BMJ1996;313(7050):140-2. ">Geelhoed 1996a</a>; <a href="./references#CD001955-bbs2-0020" title="GeelhoedGC . Budesonide offers no advantage when added to oral dexamethasone in the treatment of croup. Pediatric Emergency Care2005;21(6):359-62. ">Geelhoed 2005</a>; <a href="./references#CD001955-bbs2-0021" title="GoddenCW , CampbellMJ , HusseyM , CogswellJJ . Double blind placebo controlled trial of nebulised budesonide for croup. Archives of Disease in Childhood1997;76(2):155-8. ">Godden 1997</a>; <a href="./references#CD001955-bbs2-0022" title="HuangT , XiaZ , LiW . Efficacy of inhaled budesonide on serum inflammatory factors and quality of life among children with acute infectious laryngitis. American Journal of Otolaryngology - Head and Neck Medicine and Surgery2021;42(1):102820. ">Huang 2021</a>; <a href="./references#CD001955-bbs2-0023" title="HusbyS , AgertoftL , MortensenS , PedersenS . Treatment of croup with nebulised steroid (budesonide): a double blind, placebo controlled study. Archives of Disease in Childhood1993;68(3):352-5. MortensenS , AgertoftL , HusbyS , PedersenS . Pseudocroup treated with inhaled steroid (budesonide). A double-blind placebo-controlled trial. Ugeskrift for Laeger1994;156(45):6661-3. ">Husby 1993</a>; <a href="./references#CD001955-bbs2-0030" title="KorenGF . Corticosteroid treatment of laryngotracheitis v spasmodic croup in children. American Journal of Diseases of Children1983;137(10):941-4. ">Koren 1983</a>; <a href="./references#CD001955-bbs2-0032" title="LeipzigB , OskiFA , CummingsCW , StockmanJA , SwenderP . A prospective randomized study to determine the efficacy of steroids in treatment of croup. Journal of Pediatrics1979;94(2):194-6. ">Leipzig 1979</a>; <a href="./references#CD001955-bbs2-0037" title="RittichierKK , LedwithCA . Outpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing. Pediatrics2000;106(6):1344-8. ">Rittichier 2000</a>; <a href="./references#CD001955-bbs2-0039" title="RoordaRJ , WalhofCM . Effects of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report. Pediatric Pulmonology1998;25(2):114-7. ">Roorda 1998</a>; <a href="./references#CD001955-bbs2-0041" title="SkowronPN , TurnerJA , McNaughtonGA . The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Canadian Medical Association Journal1966;94(11):528-31. ">Skowron 1966a and b</a>; <a href="./references#CD001955-bbs2-0043" title="SoleimaniG , DaryadelA , MoghadamAA , SharifMR . The comparison of oral and IM dexamethasone efficacy in croup treatment. Journal of Comprehensive Pediatrics2013;4(4):175-8. ">Soleimani 2013</a>; <a href="./references#CD001955-bbs2-0044" title="SparrowA , GeelhoedG . Prednisolone versus dexamethasone in croup: a randomised equivalence trial. Archives of Disease in Childhood2006;91(7):580-3. ">Sparrow 2006</a>; <a href="./references#CD001955-bbs2-0047" title="Vad PedersenL , DahlM , Falk-PetersenHE , LarsenSE . Inhaled budesonide versus intramuscular dexamethasone in the treatment of pseudocroup [Inhaleret budesonid versus dexamethasone i.m. til behandling at pseudocroup]. Ugeskrift for Laeger1998;160(15):2253-6. ">Vad Pedersen 1998</a>; <a href="./references#CD001955-bbs2-0048" title="Von MühlendahlKE , KahnD , SpohrHL , DresslerF . Steroid treatment of pseudo‐croup. Helvetica Paediatrica Acta1982;37(5):431-6. ">Von Mühlendahl 1982</a>). Allocation concealment was adequate in the remaining 19 studies. </p> </section> <section id="CD001955-sec-0052"> <h4 class="title">Blinding</h4> <p>We judged risk of bias for blinding of participants and personnel to be low in 26 studies (58%), unclear in 11 studies (24%), and high in eight studies (18%). Of the eight studies at high risk of bias, four appeared to be open‐label (<a href="./references#CD001955-bbs2-0002" title="AmirL , HubermannH , HaleviA , MorM , MimouniM , WaismanY . Oral betamethasone versus intramuscular dexamethasone for the treatment of mild to moderate viral croup. Pediatric Emergency Care2006;22(8):541-4. ">Amir 2006</a>; <a href="./references#CD001955-bbs2-0009" title="DumanM , OzdemirD , AtaseverS . Nebulized L-epinephrine and steroid combination in the treatment of moderate to severe croup. Clinical Drug Investigation2005;25(3):183-9. ">Duman 2005</a>; <a href="./references#CD001955-bbs2-0037" title="RittichierKK , LedwithCA . Outpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing. Pediatrics2000;106(6):1344-8. ">Rittichier 2000</a>; <a href="./references#CD001955-bbs2-0047" title="Vad PedersenL , DahlM , Falk-PetersenHE , LarsenSE . Inhaled budesonide versus intramuscular dexamethasone in the treatment of pseudocroup [Inhaleret budesonid versus dexamethasone i.m. til behandling at pseudocroup]. Ugeskrift for Laeger1998;160(15):2253-6. ">Vad Pedersen 1998</a>). <a href="./references#CD001955-bbs2-0004" title="CetinkayaF , TufekciBS , KutlukG . A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup. International Journal of Pediatric Otorhinolaryngology2004;68(4):453-6. ">Cetinkaya 2004</a> did not explicitly describe any measures taken to blind participants and personnel from treatment assignment, and any blinding could have been broken. Personnel were not blinded in <a href="./references#CD001955-bbs2-0014" title="FitzgeraldD , MellisC , JohnsonM , AllenH , CooperP , Van AsperenP . Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics1996;97(5):722-5. ">Fitzgerald 1996</a>. In <a href="./references#CD001955-bbs2-0010" title="EboriadouM , ChryssanthopoulouD , StamoulisP , DamianidouL , HaidopoulouK . The effectiveness of local corticosteroids therapy in the management of mild to moderate viral croup. Minerva Pediatrica2010;62(1):23-8. ">Eboriadou 2010</a>, the treatments were clearly distinguishable, and the method for blinding was not described even though the study was termed "double‐blind". In <a href="./references#CD001955-bbs2-0043" title="SoleimaniG , DaryadelA , MoghadamAA , SharifMR . The comparison of oral and IM dexamethasone efficacy in croup treatment. Journal of Comprehensive Pediatrics2013;4(4):175-8. ">Soleimani 2013</a>, only the outcome assessor was blinded. Of the 11 studies assessed as at unclear risk of bias, seven were described as double‐blind without any further details regarding who was blinded or how blinding was achieved (<a href="./references#CD001955-bbs2-0011" title="EdenA , LarkinVP . Corticosteroid treatment of croup. Pediatrics1964;33:768-9. ">Eden 1964</a>; <a href="./references#CD001955-bbs2-0019" title="GeelhoedGC , TurnerJ , MacdonaldWB . Efficacy of a small single dose of oral dexamethasone for outpatient croup: a double blind placebo controlled clinical trial. BMJ1996;313(7050):140-2. ">Geelhoed 1996a</a>; <a href="./references#CD001955-bbs2-0022" title="HuangT , XiaZ , LiW . Efficacy of inhaled budesonide on serum inflammatory factors and quality of life among children with acute infectious laryngitis. American Journal of Otolaryngology - Head and Neck Medicine and Surgery2021;42(1):102820. ">Huang 2021</a>; <a href="./references#CD001955-bbs2-0023" title="HusbyS , AgertoftL , MortensenS , PedersenS . Treatment of croup with nebulised steroid (budesonide): a double blind, placebo controlled study. Archives of Disease in Childhood1993;68(3):352-5. MortensenS , AgertoftL , HusbyS , PedersenS . Pseudocroup treated with inhaled steroid (budesonide). A double-blind placebo-controlled trial. Ugeskrift for Laeger1994;156(45):6661-3. ">Husby 1993</a>; <a href="./references#CD001955-bbs2-0032" title="LeipzigB , OskiFA , CummingsCW , StockmanJA , SwenderP . A prospective randomized study to determine the efficacy of steroids in treatment of croup. Journal of Pediatrics1979;94(2):194-6. ">Leipzig 1979</a>; <a href="./references#CD001955-bbs2-0039" title="RoordaRJ , WalhofCM . Effects of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report. Pediatric Pulmonology1998;25(2):114-7. ">Roorda 1998</a>; <a href="./references#CD001955-bbs2-0048" title="Von MühlendahlKE , KahnD , SpohrHL , DresslerF . Steroid treatment of pseudo‐croup. Helvetica Paediatrica Acta1982;37(5):431-6. ">Von Mühlendahl 1982</a>). In <a href="./references#CD001955-bbs2-0008" title="DonaldsonD , PoleskiD , KnippleE , FilipsK , ReetzL , PasculaRG , et al. Intramuscular versus oral dexamethasone for the treatment of moderate-to-severe croup: a randomized double-blind trial. Academy of Emergency Medicine2003;10(1):16-21. ">Donaldson 2003</a>, <a href="./references#CD001955-bbs2-0016" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995a</a>, <a href="./references#CD001955-bbs2-0018" title="GeelhoedGC , MacdonaldWB . Oral and inhaled steroids in croup: a randomized, placebo‐controlled trial. Pediatric Pulmonology1995;20(6):355-61. ">Geelhoed 1995c</a>, and <a href="./references#CD001955-bbs2-0026" title="JohnsonDW , JacobsonS , EdneyPC , HadfieldP , MundyME , SchuhS . A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. New England Journal of Medicine1998;339(8):498-503. ">Johnson 1998</a>, blinding was attempted, but we judged that the blinding could have been broken; however, it was unclear how often this could have occurred. The remaining studies included satisfactory descriptions of how participants and personnel were blinded. </p> <p>We judged risk of bias for blinding of outcome assessment to be low in 27 studies (60%), unclear in 13 studies (29%), and high in five studies (11%). For 22 studies (49%), there was no mention of a third‐party outcome assessor, so the judgement for outcome assessment was carried over from blinding of participants and personnel (<a href="./references#CD001955-bbs2-0004" title="CetinkayaF , TufekciBS , KutlukG . A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup. International Journal of Pediatric Otorhinolaryngology2004;68(4):453-6. ">Cetinkaya 2004</a>; <a href="./references#CD001955-bbs2-0005" title="Chub-UppakarnS , SangsupawanichP . A randomized comparison of dexamethasone 0.15 mg/kg versus 0.6 mg/kg for the treatment of moderate to severe croup. International Journal of Pediatric Otorhinolaryngology2007;71(3):473-7. ">Chub‐Uppakarn 2007</a>; <a href="./references#CD001955-bbs2-0006" title="CruzMN , StewartG , RosenbergN . Use of dexamethasone in the outpatient management of acute laryngotracheitis. Pediatrics1995;96(2 Pt 1):220-3. ">Cruz 1995</a>; <a href="./references#CD001955-bbs2-0007" title="DobrovoljacM , GeelhoedG . How fast does oral dexamethasone work in mild to moderately severe croup? A randomized double-blinded clinical trial. Emergency Medicine Australasia2012;24(1):79-85. ">Dobrovoljac 2012</a>; <a href="./references#CD001955-bbs2-0009" title="DumanM , OzdemirD , AtaseverS . Nebulized L-epinephrine and steroid combination in the treatment of moderate to severe croup. Clinical Drug Investigation2005;25(3):183-9. ">Duman 2005</a>; <a href="./references#CD001955-bbs2-0010" title="EboriadouM , ChryssanthopoulouD , StamoulisP , DamianidouL , HaidopoulouK . The effectiveness of local corticosteroids therapy in the management of mild to moderate viral croup. Minerva Pediatrica2010;62(1):23-8. ">Eboriadou 2010</a>; <a href="./references#CD001955-bbs2-0011" title="EdenA , LarkinVP . Corticosteroid treatment of croup. Pediatrics1964;33:768-9. ">Eden 1964</a>; <a href="./references#CD001955-bbs2-0012" title="EdenAN , KaufmanA , YuR . Corticosteroids and croup. Controlled double-blind study. JAMA1967;200(5):403-4. ">Eden 1967</a>; <a href="./references#CD001955-bbs2-0016" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995a</a>; <a href="./references#CD001955-bbs2-0017" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995b</a>; <a href="./references#CD001955-bbs2-0018" title="GeelhoedGC , MacdonaldWB . Oral and inhaled steroids in croup: a randomized, placebo‐controlled trial. Pediatric Pulmonology1995;20(6):355-61. ">Geelhoed 1995c</a>; <a href="./references#CD001955-bbs2-0019" title="GeelhoedGC , TurnerJ , MacdonaldWB . Efficacy of a small single dose of oral dexamethasone for outpatient croup: a double blind placebo controlled clinical trial. BMJ1996;313(7050):140-2. ">Geelhoed 1996a</a>; <a href="./references#CD001955-bbs2-0020" title="GeelhoedGC . Budesonide offers no advantage when added to oral dexamethasone in the treatment of croup. Pediatric Emergency Care2005;21(6):359-62. ">Geelhoed 2005</a>; <a href="./references#CD001955-bbs2-0021" title="GoddenCW , CampbellMJ , HusseyM , CogswellJJ . Double blind placebo controlled trial of nebulised budesonide for croup. Archives of Disease in Childhood1997;76(2):155-8. ">Godden 1997</a>; <a href="./references#CD001955-bbs2-0022" title="HuangT , XiaZ , LiW . Efficacy of inhaled budesonide on serum inflammatory factors and quality of life among children with acute infectious laryngitis. American Journal of Otolaryngology - Head and Neck Medicine and Surgery2021;42(1):102820. ">Huang 2021</a>; <a href="./references#CD001955-bbs2-0023" title="HusbyS , AgertoftL , MortensenS , PedersenS . Treatment of croup with nebulised steroid (budesonide): a double blind, placebo controlled study. Archives of Disease in Childhood1993;68(3):352-5. MortensenS , AgertoftL , HusbyS , PedersenS . Pseudocroup treated with inhaled steroid (budesonide). A double-blind placebo-controlled trial. Ugeskrift for Laeger1994;156(45):6661-3. ">Husby 1993</a>; <a href="./references#CD001955-bbs2-0030" title="KorenGF . Corticosteroid treatment of laryngotracheitis v spasmodic croup in children. American Journal of Diseases of Children1983;137(10):941-4. ">Koren 1983</a>; <a href="./references#CD001955-bbs2-0031" title="KuuselaAL , VesikariT . A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatrica Scandinavica1988;77(1):99-104. ">Kuusela 1988</a>; <a href="./references#CD001955-bbs2-0033" title="LuriaJW , Gonzalez-del-ReyJA , DiGuilioGA , McAneneyCM , OlsenJJ , RuddyRM . Effectiveness of oral or nebulized dexamethasone for children with mild croup. Archives of Pediatrics &amp; Adolescent Medicine2001;155(12):1340-5. ">Luria 2001</a>; <a href="./references#CD001955-bbs2-0034" title="Martinez FernandezA , SanchezGE , RicaEI , EchanizUI , AlonsoDM , VilellaCM , et al. Randomized double-blind study of treatment of croup with adrenaline and/or dexamethasone in children. Anales Españoles de Pediatria1993;38:29-32. ">Martinez Fernandez 1993</a>; <a href="./references#CD001955-bbs2-0035" title="MassicotteP , TetreaultL . Evaluation of methyl‐prednisolone in the treatment of acute laryngitis in children. Unión Médicale du Canada1973;102(10):2064-72. ">Massicotte 1973</a>; <a href="./references#CD001955-bbs2-0044" title="SparrowA , GeelhoedG . Prednisolone versus dexamethasone in croup: a randomised equivalence trial. Archives of Disease in Childhood2006;91(7):580-3. ">Sparrow 2006</a>; <a href="./references#CD001955-bbs2-0046" title="TibballsJ , ShannFA , LandauLI . Placebo-controlled trial of prednisolone in children intubated for croup. Lancet1992;340(8822):745-8. ">Tibballs 1992</a>). Of the remaining studies, we judged two as at high risk of bias because outcome assessors were not blinded (<a href="./references#CD001955-bbs2-0002" title="AmirL , HubermannH , HaleviA , MorM , MimouniM , WaismanY . Oral betamethasone versus intramuscular dexamethasone for the treatment of mild to moderate viral croup. Pediatric Emergency Care2006;22(8):541-4. ">Amir 2006</a>; <a href="./references#CD001955-bbs2-0047" title="Vad PedersenL , DahlM , Falk-PetersenHE , LarsenSE . Inhaled budesonide versus intramuscular dexamethasone in the treatment of pseudocroup [Inhaleret budesonid versus dexamethasone i.m. til behandling at pseudocroup]. Ugeskrift for Laeger1998;160(15):2253-6. ">Vad Pedersen 1998</a>). We judged seven studies as at unclear risk of bias: in <a href="./references#CD001955-bbs2-0008" title="DonaldsonD , PoleskiD , KnippleE , FilipsK , ReetzL , PasculaRG , et al. Intramuscular versus oral dexamethasone for the treatment of moderate-to-severe croup: a randomized double-blind trial. Academy of Emergency Medicine2003;10(1):16-21. ">Donaldson 2003</a>, <a href="./references#CD001955-bbs2-0026" title="JohnsonDW , JacobsonS , EdneyPC , HadfieldP , MundyME , SchuhS . A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. New England Journal of Medicine1998;339(8):498-503. ">Johnson 1998</a>, and <a href="./references#CD001955-bbs2-0037" title="RittichierKK , LedwithCA . Outpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing. Pediatrics2000;106(6):1344-8. ">Rittichier 2000</a>, blinding of the outcome assessors was attempted, but we judged that the blinding could have been broken, although it was unclear how often this could have occurred; the studies by <a href="./references#CD001955-bbs2-0032" title="LeipzigB , OskiFA , CummingsCW , StockmanJA , SwenderP . A prospective randomized study to determine the efficacy of steroids in treatment of croup. Journal of Pediatrics1979;94(2):194-6. ">Leipzig 1979</a>, <a href="./references#CD001955-bbs2-0039" title="RoordaRJ , WalhofCM . Effects of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report. Pediatric Pulmonology1998;25(2):114-7. ">Roorda 1998</a>, and <a href="./references#CD001955-bbs2-0048" title="Von MühlendahlKE , KahnD , SpohrHL , DresslerF . Steroid treatment of pseudo‐croup. Helvetica Paediatrica Acta1982;37(5):431-6. ">Von Mühlendahl 1982</a> were described as double‐blind, but it was unclear if the outcome assessors were blinded; and in <a href="./references#CD001955-bbs2-0043" title="SoleimaniG , DaryadelA , MoghadamAA , SharifMR . The comparison of oral and IM dexamethasone efficacy in croup treatment. Journal of Comprehensive Pediatrics2013;4(4):175-8. ">Soleimani 2013</a>, the outcome assessor was described as blinded, but it was unclear how or if the blinding could have been broken. The remaining studies provided satisfactory descriptions of how outcome assessors were blinded. </p> </section> <section id="CD001955-sec-0053"> <h4 class="title">Incomplete outcome data</h4> <p>We judged risk of bias for incomplete outcome data to be low in 27 studies (60%), unclear in 14 studies (31%), and high in four studies (9%). The four studies at high risk of bias reported large losses to follow‐up that were imbalanced between groups (<a href="./references#CD001955-bbs2-0007" title="DobrovoljacM , GeelhoedG . How fast does oral dexamethasone work in mild to moderately severe croup? A randomized double-blinded clinical trial. Emergency Medicine Australasia2012;24(1):79-85. ">Dobrovoljac 2012</a>; <a href="./references#CD001955-bbs2-0018" title="GeelhoedGC , MacdonaldWB . Oral and inhaled steroids in croup: a randomized, placebo‐controlled trial. Pediatric Pulmonology1995;20(6):355-61. ">Geelhoed 1995c</a>; <a href="./references#CD001955-bbs2-0027" title="KlassenTP , FeldmanME , WattersLK , SutcliffeT , RowePC . Nebulized budesonide for children with mild-to-moderate croup. New England Journal of Medicine1994;331(5):285-9. ">Klassen 1994</a>; <a href="./references#CD001955-bbs2-0038" title="RobertsGW , MasterVV , StaugasRE , RaftosJV , ParsonsDW , CoulthardKP , et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. Journal of Paediatrics and Child Health1999;35(2):170-4. ">Roberts 1999</a>). <a href="./references#CD001955-bbs2-0007" title="DobrovoljacM , GeelhoedG . How fast does oral dexamethasone work in mild to moderately severe croup? A randomized double-blinded clinical trial. Emergency Medicine Australasia2012;24(1):79-85. ">Dobrovoljac 2012</a> and <a href="./references#CD001955-bbs2-0038" title="RobertsGW , MasterVV , StaugasRE , RaftosJV , ParsonsDW , CoulthardKP , et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. Journal of Paediatrics and Child Health1999;35(2):170-4. ">Roberts 1999</a> used the last observation carried forward (LOCF) method to estimate endpoint outcome values. Regarding the studies at unclear risk of bias, in one study the number of children analysed was not reported (<a href="./references#CD001955-bbs2-0002" title="AmirL , HubermannH , HaleviA , MorM , MimouniM , WaismanY . Oral betamethasone versus intramuscular dexamethasone for the treatment of mild to moderate viral croup. Pediatric Emergency Care2006;22(8):541-4. ">Amir 2006</a>), and in seven studies it was either unclear to which group the children who were lost to follow‐up had been allocated, or whether or not the losses to follow‐up were balanced between groups (<a href="./references#CD001955-bbs2-0006" title="CruzMN , StewartG , RosenbergN . Use of dexamethasone in the outpatient management of acute laryngotracheitis. Pediatrics1995;96(2 Pt 1):220-3. ">Cruz 1995</a>; <a href="./references#CD001955-bbs2-0011" title="EdenA , LarkinVP . Corticosteroid treatment of croup. Pediatrics1964;33:768-9. ">Eden 1964</a>; <a href="./references#CD001955-bbs2-0025" title="JohnsonDW , SchuhS , KorenG , JaffeeDM . Outpatient treatment of croup with nebulized dexamethasone. Archives of Pediatrics &amp; Adolescent Medicine1996;150(4):349-55. ">Johnson 1996</a>; <a href="./references#CD001955-bbs2-0022" title="HuangT , XiaZ , LiW . Efficacy of inhaled budesonide on serum inflammatory factors and quality of life among children with acute infectious laryngitis. American Journal of Otolaryngology - Head and Neck Medicine and Surgery2021;42(1):102820. ">Huang 2021</a>; <a href="./references#CD001955-bbs2-0031" title="KuuselaAL , VesikariT . A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatrica Scandinavica1988;77(1):99-104. ">Kuusela 1988</a>; <a href="./references#CD001955-bbs2-0037" title="RittichierKK , LedwithCA . Outpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing. Pediatrics2000;106(6):1344-8. ">Rittichier 2000</a>; <a href="./references#CD001955-bbs2-0043" title="SoleimaniG , DaryadelA , MoghadamAA , SharifMR . The comparison of oral and IM dexamethasone efficacy in croup treatment. Journal of Comprehensive Pediatrics2013;4(4):175-8. ">Soleimani 2013</a>; <a href="./references#CD001955-bbs2-0048" title="Von MühlendahlKE , KahnD , SpohrHL , DresslerF . Steroid treatment of pseudo‐croup. Helvetica Paediatrica Acta1982;37(5):431-6. ">Von Mühlendahl 1982</a>). In four studies, losses to follow‐up ranged from 13% to 17% (<a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a>; <a href="./references#CD001955-bbs2-0033" title="LuriaJW , Gonzalez-del-ReyJA , DiGuilioGA , McAneneyCM , OlsenJJ , RuddyRM . Effectiveness of oral or nebulized dexamethasone for children with mild croup. Archives of Pediatrics &amp; Adolescent Medicine2001;155(12):1340-5. ">Luria 2001</a>; <a href="./references#CD001955-bbs2-0043" title="SoleimaniG , DaryadelA , MoghadamAA , SharifMR . The comparison of oral and IM dexamethasone efficacy in croup treatment. Journal of Comprehensive Pediatrics2013;4(4):175-8. ">Soleimani 2013</a>; <a href="./references#CD001955-bbs2-0045" title="SuperDM , CartelliNA , BrooksLJ , LemboRM , KumarML . A prospective randomized double‐blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. Journal of Pediatrics1989;115(2):323-9. ">Super 1989</a>). In <a href="./references#CD001955-bbs2-0014" title="FitzgeraldD , MellisC , JohnsonM , AllenH , CooperP , Van AsperenP . Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics1996;97(5):722-5. ">Fitzgerald 1996</a>, loss to follow‐up was 5%, and the LOCF method was used to estimate endpoint outcome values. In <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a>, 11% of participants were missing at one‐hour croup assessment with unexplained exclusion reasons. We judged risk of bias due to incomplete outcome data not a concern for the remaining studies. </p> </section> <section id="CD001955-sec-0054"> <h4 class="title">Selective reporting</h4> <p>We judged risk of bias for selective reporting to be low in three studies (7%) and unclear in 42 studies (93%). In the three studies at low risk of bias, the outcomes in the trial registers matched those reported in the publications (<a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a>; <a href="./references#CD001955-bbs2-0015" title="GarbuttJM , ConionB , SterkelR , BatyJ , SchechtmanKB , MandrellK , et al. The comparative effectiveness of prednisolone and dexamethasone for children with croup: a community-based randomized trial. Clinical Pediatrics2013;52(11):1014-21. ">Garbutt 2013</a>; <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a>). For the remaining 42 studies, no protocol or trial registry was cited in the publication or located via online searches. In all cases, the outcomes reported in the methods matched those reported in the results section of the publications. </p> </section> <section id="CD001955-sec-0055"> <h4 class="title">Other potential sources of bias</h4> <p>We judged risk of bias from other sources to be low in 35 studies (78%), unclear in eight studies (18%), and high in two studies (4%). In the two studies at high risk of bias, there was a baseline imbalance in croup score (<a href="./references#CD001955-bbs2-0002" title="AmirL , HubermannH , HaleviA , MorM , MimouniM , WaismanY . Oral betamethasone versus intramuscular dexamethasone for the treatment of mild to moderate viral croup. Pediatric Emergency Care2006;22(8):541-4. ">Amir 2006</a>; <a href="./references#CD001955-bbs2-0047" title="Vad PedersenL , DahlM , Falk-PetersenHE , LarsenSE . Inhaled budesonide versus intramuscular dexamethasone in the treatment of pseudocroup [Inhaleret budesonid versus dexamethasone i.m. til behandling at pseudocroup]. Ugeskrift for Laeger1998;160(15):2253-6. ">Vad Pedersen 1998</a>). For six studies at unclear risk of bias, there was the potential for bias in participant selection because some children were not enrolled due to manpower constraints, failure of the emergency department to contact the research team, or because the emergency department was busy (<a href="./references#CD001955-bbs2-0016" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995a</a>; <a href="./references#CD001955-bbs2-0017" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995b</a>; <a href="./references#CD001955-bbs2-0021" title="GoddenCW , CampbellMJ , HusseyM , CogswellJJ . Double blind placebo controlled trial of nebulised budesonide for croup. Archives of Disease in Childhood1997;76(2):155-8. ">Godden 1997</a>; <a href="./references#CD001955-bbs2-0027" title="KlassenTP , FeldmanME , WattersLK , SutcliffeT , RowePC . Nebulized budesonide for children with mild-to-moderate croup. New England Journal of Medicine1994;331(5):285-9. ">Klassen 1994</a>; <a href="./references#CD001955-bbs2-0028" title="KlassenTP , WattersLK , FeldmanME , SutcliffeT , RowePC . The efficacy of nebulized budesonide in dexamethasone‐treated outpatients with croup. Pediatrics1996;97(4):463-6. ">Klassen 1996</a>; <a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a>; <a href="./references#CD001955-bbs2-0044" title="SparrowA , GeelhoedG . Prednisolone versus dexamethasone in croup: a randomised equivalence trial. Archives of Disease in Childhood2006;91(7):580-3. ">Sparrow 2006</a>). In one study at unclear risk of bias, baseline data were not presented, therefore it was not possible to estimate whether or not baseline imbalances existed between groups (<a href="./references#CD001955-bbs2-0041" title="SkowronPN , TurnerJA , McNaughtonGA . The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Canadian Medical Association Journal1966;94(11):528-31. ">Skowron 1966a and b</a>). For the remaining study at unclear risk of bias, participants were enrolled more than once (<a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a>). </p> </section> </section> <section id="CD001955-sec-0056"> <h3 class="title" id="CD001955-sec-0056">Effects of interventions</h3> <p>See: <a href="./full#CD001955-tbl-0001"><b>Summary of findings 1</b> Any glucocorticoid compared to placebo for croup</a>; <a href="./full#CD001955-tbl-0002"><b>Summary of findings 2</b> Any glucocorticoid compared to epinephrine for croup </a> </p> <p>See <a href="./full#CD001955-tbl-0001">summary of findings Table 1</a> and <a href="./full#CD001955-tbl-0002">summary of findings Table 2</a>. </p> <section id="CD001955-sec-0057"> <h4 class="title">Comparison 1: Any glucocorticoid compared to placebo </h4> <p>See <a href="./full#CD001955-tbl-0001">summary of findings Table 1</a>. </p> <section id="CD001955-sec-0058"> <h5 class="title">Primary outcomes</h5> <section id="CD001955-sec-0059"> <h6 class="title">1. Change in clinical croup score from baseline to 2, 6, 12, and/or 24 hours</h6> <p>Compared to placebo, glucocorticoids may have resulted in greater reductions in croup score after two hours (standardised mean difference (SMD) −0.65, 95% confidence interval (CI) −1.13 to −0.18; P = 0.007, I² = 81%; 7 RCTs, 426 children; low‐certainty evidence; <a href="./references#CD001955-fig-0006" title="">Analysis 1.1</a>); six hours (SMD −0.76, 95% CI −1.12 to −0.40; P &lt; 0.001, I² = 83%; 11 RCTs, 959 children; low‐certainty evidence; <a href="./references#CD001955-fig-0007" title="">Analysis 1.2</a>); and 12 hours (SMD −1.03, 95% CI −1.53 to −0.53; P &lt; 0.001, I² = 86%; 8 RCTs, 571 children; low‐certainty evidence; <a href="./references#CD001955-fig-0008" title="">Analysis 1.3</a>). The evidence for change in croup score after 24 hours is very uncertain (SMD −0.86, 95% CI −1.40 to −0.31; P = 0.002, I² = 81%; 8 RCTs, 351 children; very low‐certainty evidence; <a href="./references#CD001955-fig-0009" title="">Analysis 1.4</a>). </p> <p>There were no subgroup differences in reductions in croup score by score (<a href="./references#CD001955-bbs2-0124" title="WestleyCR , CottonEK , BrooksJG . Nebulized racemicepinephrine by IPPB for the treatment of croup. American Journal of Diseases in Children1978;132(5):484-7.">Westley 1978</a> or otherwise) (<a href="./references#CD001955-fig-0006" title="">Analysis 1.1</a>; <a href="./references#CD001955-fig-0007" title="">Analysis 1.2</a>; <a href="./references#CD001955-fig-0008" title="">Analysis 1.3</a>; <a href="./references#CD001955-fig-0009" title="">Analysis 1.4</a>) or by inpatient or outpatient status (<a href="./references#CD001955-fig-0010" title="">Analysis 1.5</a>; <a href="./references#CD001955-fig-0011" title="">Analysis 1.6</a>; <a href="./references#CD001955-fig-0012" title="">Analysis 1.7</a>) at any time point. At two hours, there was no subgroup difference in effect by glucocorticoid (Chi² = 5.65, P = 0.06, I² = 64.6%; <a href="./references#CD001955-fig-0013" title="">Analysis 1.8</a>). At six hours, there was a subgroup difference in effect by glucocorticoid (Chi² = 11.46, P = 0.009, I² = 73.8%; <a href="./references#CD001955-fig-0014" title="">Analysis 1.9</a>), accounted for by the larger reduction in croup score for prednisolone (SMD −1.87, 95% CI −2.62 to −1.13; P &lt; 0.001; 1 RCT, 42 children) compared to budesonide (SMD −0.81, 95% CI −1.04 to −0.58; P &lt; 0.001, I² = 0%; 5 RCTs, 333 children) and dexamethasone (SMD −0.62, 95% CI −1.17 to −0.08; P = 0.03, I² = 85%; 6 RCTs, 567 children). Fluticasone did not show an effect (SMD 0.06, 95% CI −0.89 to 1.02; P = 0.90; 1 RCT, 17 children). At 12 hours, there was a subgroup difference in effect by glucocorticoid (Chi² = 10.08, P = 0.006, I² = 80.2%; <a href="./references#CD001955-fig-0015" title="">Analysis 1.10</a>), accounted for by the larger reduction in croup score for prednisolone (SMD −2.40, 95% CI −3.26 to −1.55; P &lt; 0.001; 1 RCT, 39 children) compared to budesonide (SMD −0.97, 95% CI −1.26 to −0.68; P &lt; 0.001, I² = 0%; 3 RCTs, 209 children) and dexamethasone (SMD −0.85, 95% CI −1.55 to −0.15; P = 0.02, I² = 84%; 5 RCTs, 323 children). At 24 hours, there was a subgroup difference in effect by glucocorticoid (Chi² = 9.02, P = 0.01, I² = 77.8%; <a href="./references#CD001955-fig-0016" title="">Analysis 1.11</a>). Although larger reductions in croup score were observed with budesonide (SMD −1.40, 95% CI −1.88 to −0.93; P &lt; 0.001, I² = 0%; 2 RCTs, 89 children) and dexamethasone (SMD −0.89, 95% CI −1.55 to −0.22; P = 0.009, I² = 81%; 6 RCTs, 245 children) compared to placebo, fluticasone did not show an effect (SMD 0.21, 95% CI −0.75 to 1.17; P = 0.67; 1 RCT, 17 children). </p> </section> <section id="CD001955-sec-0060"> <h6 class="title">2. Return visits or (re)admissions to the hospital or both</h6> <p>Compared to placebo, glucocorticoids may have reduced the rate of return visits or (re)admissions to the hospital or both by almost half (risk ratio (RR) 0.52, 95% CI 0.36 to 0.75; P &lt; 0.001, I² = 52%; 10 RCTs, 1679 children; low‐certainty evidence; <a href="./references#CD001955-fig-0017" title="">Analysis 1.12</a>). There were no subgroup differences in effect by glucocorticoid (budesonide or dexamethasone, <a href="./references#CD001955-fig-0018" title="">Analysis 1.13</a>); by inpatient or outpatient status (<a href="./references#CD001955-fig-0017" title="">Analysis 1.12</a>); or by croup severity (mild or moderate croup, <a href="./references#CD001955-fig-0019" title="">Analysis 1.14</a>). </p> <p>The number needed to treat for an additional beneficial outcome (NNTB) is presented in <a href="#CD001955-tbl-0003">Table 1</a>. The NNTB was 7 children (95% CI 5 to 12) for the mean placebo group rate (30.62%). The NNTB was 102 children (95% CI 78 to 179) for the smallest placebo group rate (2.06%). Lastly, the NNTB was 3 children (95% CI 2 to 5) for the largest placebo group rate (72.00%). </p> <div class="table" id="CD001955-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Number needed to treat for an additional beneficial outcome for return visits or (re)admissions or both for any glucocorticoid compared to placebo </span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Baseline rate (%) </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>NNTB (95% CI)</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Mean baseline rate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30.62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 (5 to 12)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Smallest baseline rate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.06</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>102 (78 to 179)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Largest baseline rate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (2 to 5)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>NNTB: number needed to treat for an additional beneficial outcome</p> </div> </div> </section> </section> <section id="CD001955-sec-0061"> <h5 class="title">Secondary outcomes</h5> <section id="CD001955-sec-0062"> <h6 class="title">1. Length of stay in the hospital or emergency department </h6> <p>Compared to those given a placebo, children treated with glucocorticoids spent fewer hours in the hospital (mean difference (MD) −14.90, 95% CI −23.58 to −6.22; P &lt; 0.001, I² = 54%; 8 RCTs, 476 children; <a href="./references#CD001955-fig-0020" title="">Analysis 1.15</a>). All of the included studies investigated inpatients. There was no subgroup difference in effect by glucocorticoid (budesonide, dexamethasone, or fluticasone; <a href="./references#CD001955-fig-0021" title="">Analysis 1.16</a>). </p> </section> <section id="CD001955-sec-0063"> <h6 class="title">2. Patient improvement at 2, 6, 12, and/or 24 hours</h6> <p>Only one study investigated patient improvement two hours after the administration of glucocorticoids compared to placebo. <a href="./references#CD001955-bbs2-0038" title="RobertsGW , MasterVV , StaugasRE , RaftosJV , ParsonsDW , CoulthardKP , et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. Journal of Paediatrics and Child Health1999;35(2):170-4. ">Roberts 1999</a> studied 82 hospitalised children aged six months to eight years with moderate to severe croup who were given budesonide or placebo, and observed no difference in improvement after two hours (RR 1.81, 95% CI 0.96 to 3.40; P = 0.07; 1 RCT, 82 children; <a href="./references#CD001955-fig-0022" title="">Analysis 1.17</a>). Compared to placebo, glucocorticoids were associated with improvement in a greater proportion of children after six hours (RR 1.45, 95% CI 1.12 to 1.88; P = 0.005, I² = 34%; 6 RCTs, 332 children; <a href="./references#CD001955-fig-0023" title="">Analysis 1.18</a>); 12 hours (RR 1.33, 95% CI 1.09 to 1.62; P = 0.005, I² = 53%; 6 RCTs, 340 children; <a href="./references#CD001955-fig-0024" title="">Analysis 1.19</a>); and 24 hours (RR 1.28, 95% CI 1.01 to 1.61; P = 0.04, I² = 75%; 5 RCTs, 251 children; <a href="./references#CD001955-fig-0025" title="">Analysis 1.20</a>). </p> <p>Only inpatients were included in the 12‐hour analysis (<a href="./references#CD001955-fig-0024" title="">Analysis 1.19</a>). There were no subgroup differences in estimates of effect by inpatient or outpatient status at six or 24 hours (<a href="./references#CD001955-fig-0023" title="">Analysis 1.18</a>; <a href="./references#CD001955-fig-0025" title="">Analysis 1.20</a>). There were no subgroup differences in effect by glucocorticoid at six hours (budesonide, dexamethasone, or prednisolone; <a href="./references#CD001955-fig-0026" title="">Analysis 1.21</a>), 12 hours (budesonide, dexamethasone, or prednisolone; <a href="./references#CD001955-fig-0027" title="">Analysis 1.22</a>), or 24 hours (dexamethasone or prednisolone; <a href="./references#CD001955-fig-0028" title="">Analysis 1.23</a>). </p> </section> <section id="CD001955-sec-0064"> <h6 class="title">3. The use of additional treatments, including: antibiotics, epinephrine, intubation/tracheostomy, mist tent, and/or supplemental glucocorticoids </h6> <p>There was no difference between children treated with glucocorticoids and those given placebo in the use of antibiotics (risk difference (RD) 0.00, 95% CI −0.04 to 0.04; P = 1.00, I² = 0%; 3 RCTs, 202 children; <a href="./references#CD001955-fig-0029" title="">Analysis 1.24</a>); the use of epinephrine (RD −0.03, 95% CI −0.08 to 0.01; P = 0.16, I² = 45%; 9 RCTs, 709 children; <a href="./references#CD001955-fig-0030" title="">Analysis 1.25</a>); the rate of intubation/tracheostomy (RD 0.00, 95% CI −0.01 to 0.01; P = 0.79, I² = 0%; 11 RCTs, 1090 children; <a href="./references#CD001955-fig-0031" title="">Analysis 1.26</a>); the use of a mist tent (RD −0.20, 95% CI −0.87 to 0.47; P = 0.55, I² = 95%; 2 RCTs, 84 children; <a href="./references#CD001955-fig-0032" title="">Analysis 1.27</a>); or the use of supplemental glucocorticoids (RR 0.61, 95% CI 0.36 to 1.03; P = 0.07, I² = 10%; 6 RCTs, 305 children; <a href="./references#CD001955-fig-0033" title="">Analysis 1.28</a>). </p> </section> <section id="CD001955-sec-0065"> <h6 class="title">4. Any adverse events</h6> <p>Of the 26 studies that investigated any glucocorticoid compared to placebo, 13 reported collecting adverse events data. Of these, eight reported no serious adverse events (<a href="./references#CD001955-bbs2-0012" title="EdenAN , KaufmanA , YuR . Corticosteroids and croup. Controlled double-blind study. JAMA1967;200(5):403-4. ">Eden 1967</a>; <a href="./references#CD001955-bbs2-0023" title="HusbyS , AgertoftL , MortensenS , PedersenS . Treatment of croup with nebulised steroid (budesonide): a double blind, placebo controlled study. Archives of Disease in Childhood1993;68(3):352-5. MortensenS , AgertoftL , HusbyS , PedersenS . Pseudocroup treated with inhaled steroid (budesonide). A double-blind placebo-controlled trial. Ugeskrift for Laeger1994;156(45):6661-3. ">Husby 1993</a>; <a href="./references#CD001955-bbs2-0024" title="JamesJA . Dexamethasone in croup. A controlled study. American Journal of Diseases of Children1969;117(5):511-6. ">James 1969</a>; <a href="./references#CD001955-bbs2-0026" title="JohnsonDW , JacobsonS , EdneyPC , HadfieldP , MundyME , SchuhS . A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. New England Journal of Medicine1998;339(8):498-503. ">Johnson 1998</a>; <a href="./references#CD001955-bbs2-0027" title="KlassenTP , FeldmanME , WattersLK , SutcliffeT , RowePC . Nebulized budesonide for children with mild-to-moderate croup. New England Journal of Medicine1994;331(5):285-9. ">Klassen 1994</a>; <a href="./references#CD001955-bbs2-0032" title="LeipzigB , OskiFA , CummingsCW , StockmanJA , SwenderP . A prospective randomized study to determine the efficacy of steroids in treatment of croup. Journal of Pediatrics1979;94(2):194-6. ">Leipzig 1979</a>; <a href="./references#CD001955-bbs2-0039" title="RoordaRJ , WalhofCM . Effects of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report. Pediatric Pulmonology1998;25(2):114-7. ">Roorda 1998</a>; <a href="./references#CD001955-bbs2-0046" title="TibballsJ , ShannFA , LandauLI . Placebo-controlled trial of prednisolone in children intubated for croup. Lancet1992;340(8822):745-8. ">Tibballs 1992</a>). <a href="./references#CD001955-bbs2-0003" title="BjornsonC , KlassenTP , WilliamsonJ , BrantR , PlintA , BullochB , et al. A randomized trial of single dose of oral dexamethasone for mild croup. New England Journal of Medicine2004;351(13):1306-13. ">Bjornson 2004</a> reported seven instances of pneumonia (3/359, 0.83% in the dexamethasone group and 4/361, 1.11% in the placebo group). <a href="./references#CD001955-bbs2-0025" title="JohnsonDW , SchuhS , KorenG , JaffeeDM . Outpatient treatment of croup with nebulized dexamethasone. Archives of Pediatrics &amp; Adolescent Medicine1996;150(4):349-55. ">Johnson 1996</a> reported one child with neutropenia consistent with bacterial tracheitis in the dexamethasone group (1/28, 3.57%). <a href="./references#CD001955-bbs2-0031" title="KuuselaAL , VesikariT . A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatrica Scandinavica1988;77(1):99-104. ">Kuusela 1988</a> reported seven secondary bacterial infections (pneumonia, sinusitis, otitis media) requiring antibiotic therapy: 5/35, 14% in the dexamethasone group and 2/16, 12.5% in the placebo group. <a href="./references#CD001955-bbs2-0045" title="SuperDM , CartelliNA , BrooksLJ , LemboRM , KumarML . A prospective randomized double‐blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. Journal of Pediatrics1989;115(2):323-9. ">Super 1989</a> reported one child with pneumonitis in the placebo group (1/13, 7.7%) and two children with pneumonia in the dexamethasone group (2/16, 12.5%). <a href="./references#CD001955-bbs2-0038" title="RobertsGW , MasterVV , StaugasRE , RaftosJV , ParsonsDW , CoulthardKP , et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. Journal of Paediatrics and Child Health1999;35(2):170-4. ">Roberts 1999</a> reported one instance of exacerbated symptoms, five children with emotional distress, two with vomiting, and one instance of eye irritation in the budesonide group (9/42, 21.4%), and three instances of exacerbated symptoms, six children with emotional distress, three with vomiting, two rashes, and one instance each of eye irritation and tongue irritation in the placebo group (16/40, 40%). </p> </section> </section> </section> <section id="CD001955-sec-0066"> <h4 class="title">Comparison 2: Any glucocorticoid compared to epinephrine</h4> <p>See <a href="./full#CD001955-tbl-0002">summary of findings Table 2</a>.  </p> <section id="CD001955-sec-0067"> <h5 class="title">Primary outcomes</h5> <section id="CD001955-sec-0068"> <h6 class="title">1. Change in clinical croup score from baseline to 2, 6, 12, and/or 24 hours</h6> <p>Compared to epinephrine, we do not know if there was no difference in the change in croup score following treatment with glucocorticoids after two hours (SMD 0.77, 95% CI −0.24 to 1.77; P = 0.13, I² = 87%; 2 RCTs, 130 children; very low‐certainty evidence; <a href="./references#CD001955-fig-0034" title="">Analysis 2.1</a>) and six hours (SMD −0.10, 95% CI −1.18 to 0.97; P = 0.85, I² = 78%; 2 RCTs, 63 children; very low‐certainty evidence; <a href="./references#CD001955-fig-0035" title="">Analysis 2.2</a>). There may be no difference between groups at 12 hours (SMD −0.07, 95% CI −0.57 to 0.43; P = 0.78, I² = 47%; 3 RCTs, 129 children; low‐certainty evidence; <a href="./references#CD001955-fig-0036" title="">Analysis 2.3</a>) or 24 hours (SMD 0.17, 95% CI −0.18 to 0.51; P = 0.35, I² = 0%; 3 RCTs, 129 children; low‐certainty evidence; <a href="./references#CD001955-fig-0037" title="">Analysis 2.4</a>). </p> <p>The analyses at six hours (<a href="./references#CD001955-fig-0035" title="">Analysis 2.2</a>), 12 hours (<a href="./references#CD001955-fig-0036" title="">Analysis 2.3</a>), and 24 hours (<a href="./references#CD001955-fig-0037" title="">Analysis 2.4</a>) included only inpatients. At two hours, there was a subgroup difference in effect by inpatient or outpatient status (Chi² = 7.44, P = 0.006, I² = 86.6%; <a href="./references#CD001955-fig-0034" title="">Analysis 2.1</a>). For outpatients, glucocorticoids were less effective at reducing croup score compared to epinephrine after two hours (SMD 1.29, 95% CI 0.73 to 1.84; P &lt; 0.001; 1 RCT, 64 children). No difference was detected between the two treatments for inpatients (SMD 0.26, 95% CI −0.22 to 0.75; P = 0.29; 1 RCT, 66 children). </p> <p>At two hours, there was a subgroup difference in effect by glucocorticoid (Chi² = 7.37, P = 0.03, I² = 72.9%; <a href="./references#CD001955-fig-0038" title="">Analysis 2.5</a>). Epinephrine was more effective at reducing croup score compared to beclomethasone (SMD 1.41, 95% CI 0.62 to 2.19; P &lt; 0.001; 1 RCT, 33 children) and dexamethasone (SMD 1.13, 95% CI 0.35 to 1.91; P = 0.005; 1 RCT, 31 children). At this time point, there was no difference in reduction in croup score between budesonide and epinephrine (SMD 0.26, 95% CI −0.22 to 0.75; P = 0.29; 1 RCT, 66 children). The 12‐ and 24‐hour analyses investigated budesonide and dexamethasone, and there were no subgroup differences in effect (<a href="./references#CD001955-fig-0039" title="">Analysis 2.6</a>; <a href="./references#CD001955-fig-0040" title="">Analysis 2.7</a>). </p> </section> <section id="CD001955-sec-0069"> <h6 class="title">2. Return visits or (re)admissions to the hospital or both</h6> <p><a href="./references#CD001955-bbs2-0010" title="EboriadouM , ChryssanthopoulouD , StamoulisP , DamianidouL , HaidopoulouK . The effectiveness of local corticosteroids therapy in the management of mild to moderate viral croup. Minerva Pediatrica2010;62(1):23-8. ">Eboriadou 2010</a> and <a href="./references#CD001955-bbs2-0014" title="FitzgeraldD , MellisC , JohnsonM , AllenH , CooperP , Van AsperenP . Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics1996;97(5):722-5. ">Fitzgerald 1996</a> investigated return visits and (re)admissions, respectively, following the administration of glucocorticoids (dexamethasone and beclomethasone, and budesonide, respectively) compared to epinephrine. Both studies may not have reported any events (RD 0.00, 95% CI −0.04 to 0.04; P = 1.00, I² = 0%; 2 RCTs, 130 children; low‐certainty evidence; <a href="./references#CD001955-fig-0041" title="">Analysis 2.8</a>). </p> </section> </section> <section id="CD001955-sec-0070"> <h5 class="title">Secondary outcomes</h5> <section id="CD001955-sec-0071"> <h6 class="title">1. Length of stay in the hospital or emergency department </h6> <p><a href="./references#CD001955-bbs2-0031" title="KuuselaAL , VesikariT . A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatrica Scandinavica1988;77(1):99-104. ">Kuusela 1988</a> investigated length of stay for 32 children hospitalised with croup who were treated with dexamethasone, epinephrine, a combination of dexamethasone and epinephrine, or placebo. There was no difference in hours spent in the hospital between children treated with dexamethasone and those treated with epinephrine (MD −10.00, 95% CI −33.89 to 13.89; P = 0.41; 1 RCT, 32 children; <a href="./references#CD001955-fig-0042" title="">Analysis 2.9</a>). </p> </section> <section id="CD001955-sec-0072"> <h6 class="title">2. Patient improvement at 2, 6, 12, and/or 24 hours</h6> <p>No studies reported on patient improvement for this comparison.</p> </section> <section id="CD001955-sec-0073"> <h6 class="title">3. The use of additional treatments, including: antibiotics, epinephrine, intubation/tracheostomy, mist tent, and/or supplemental glucocorticoids </h6> <p><a href="./references#CD001955-bbs2-0014" title="FitzgeraldD , MellisC , JohnsonM , AllenH , CooperP , Van AsperenP . Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics1996;97(5):722-5. ">Fitzgerald 1996</a> investigated the use of additional treatments for children aged six months to six years admitted to the hospital with croup who were treated with budesonide or epinephrine. There was no difference in the proportion of children who required additional epinephrine between groups (RR 0.30, 95% CI 0.03 to 2.69; P = 0.28; 1 RCT, 66 children; <a href="./references#CD001955-fig-0043" title="">Analysis 2.10</a>). No child was intubated (RD 0.00, 95% CI −0.06 to 0.06; P = 1.00; 1 RCT, 66 children; <a href="./references#CD001955-fig-0044" title="">Analysis 2.11</a>). There was no difference between groups in the proportion of children who required supplemental glucocorticoids (RR 0.83, 95% CI 0.48 to 1.43; P = 0.49; 1 RCT, 66 children; <a href="./references#CD001955-fig-0045" title="">Analysis 2.12</a>). </p> </section> <section id="CD001955-sec-0074"> <h6 class="title">4. Any adverse events</h6> <p>Of the four studies that investigated glucocorticoids compared to epinephrine, three reported collecting adverse events data. <a href="./references#CD001955-bbs2-0014" title="FitzgeraldD , MellisC , JohnsonM , AllenH , CooperP , Van AsperenP . Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics1996;97(5):722-5. ">Fitzgerald 1996</a> reported no serious adverse events. <a href="./references#CD001955-bbs2-0031" title="KuuselaAL , VesikariT . A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatrica Scandinavica1988;77(1):99-104. ">Kuusela 1988</a> reported five cases of secondary bacterial infections (pneumonia, sinusitis, otitis media) requiring antibiotic therapy in the dexamethasone group (5/16, 31.3%). <a href="./references#CD001955-bbs2-0010" title="EboriadouM , ChryssanthopoulouD , StamoulisP , DamianidouL , HaidopoulouK . The effectiveness of local corticosteroids therapy in the management of mild to moderate viral croup. Minerva Pediatrica2010;62(1):23-8. ">Eboriadou 2010</a> reported four cases of tremor and tachycardia (4/25, 16%) in the epinephrine group. </p> </section> </section> </section> <section id="CD001955-sec-0075"> <h4 class="title">Comparison 3: Dexamethasone compared to budesonide </h4> <p>See <a href="#CD001955-tbl-0004">Table 2</a>. </p> <div class="table" id="CD001955-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Dexamethasone compared to budesonide for croup</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Dexamethasone compared to budesonide for croup</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> dexamethasone<br/><b>Comparison:</b> budesonide </p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments**</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Budesonide</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with different scores in different studies. Lower scores mean fewer symptoms.  </p> <p>(Follow‐up: 6 hours)<br/>  </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−2.93 to −2.00</b>. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.46 standard deviations in favour</b> (0.79 more to 0.13 more). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>326<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A standard deviation of 0.46 represents a moderate difference between groups.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with different scores in different studies. Lower scores mean fewer symptoms.  </p> <p>(Follow‐up: 12 hours)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−3.07 to −2.33</b>. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.75 standard deviations in favour</b> (1.19 more to 0.30 more). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A standard deviation of 0.75 represents a large difference between groups.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.69</b><br/>(0.40 to 1.22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>374<br/>(5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>122 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>84 per 1000</b> </p> <p>(49 to 149)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>4/6 (67%) studies reported collecting adverse events data, and 3/4 (75%) studies reported no serious adverse events (<a href="./references#CD001955-bbs2-0009" title="DumanM , OzdemirD , AtaseverS . Nebulized L-epinephrine and steroid combination in the treatment of moderate to severe croup. Clinical Drug Investigation2005;25(3):183-9. ">Duman 2005</a>; <a href="./references#CD001955-bbs2-0026" title="JohnsonDW , JacobsonS , EdneyPC , HadfieldP , MundyME , SchuhS . A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. New England Journal of Medicine1998;339(8):498-503. ">Johnson 1998</a>; <a href="./references#CD001955-bbs2-0047" title="Vad PedersenL , DahlM , Falk-PetersenHE , LarsenSE . Inhaled budesonide versus intramuscular dexamethasone in the treatment of pseudocroup [Inhaleret budesonid versus dexamethasone i.m. til behandling at pseudocroup]. Ugeskrift for Laeger1998;160(15):2253-6. ">Vad Pedersen 1998</a>). <a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a> reported 1 case of oral thrush in the budesonide group (1/65, 1.5%) and 1 case each of hives and violent behaviour in the dexamethasone group (2/69, 2.9%). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>335</p> <p>(4 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>f,g</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/>**We used Cohen's interpretation of effect sizes to determine the magnitude of the difference between groups (0.2 represents a small effect, 0.5 represents a medium effect, 0.8 represents a large effect).  </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for risk of bias. The contributing studies were at high (n = 2) and unclear (n = 2) risk of bias. Allocation concealment was unclear in two studies; blinding was unclear in two studies; and one study was unblinded. There was a baseline imbalance in croup score in one study.<br/><sup>b</sup>We downgraded by one level for inconsistency. There was substantial heterogeneity (I² = 51%), and variation in point estimates.<br/><sup>c</sup>We downgraded by one level for risk of bias. The contributing studies were at high risk of bias. Allocation concealment was unclear in both studies; blinding was unclear in one study, and the other study was unblinded. There was a baseline imbalance in croup score in one study.<br/><sup>d</sup>We downgraded by one level for imprecision. The sample size was small (did not meet the optimal information size).<br/><sup>e</sup>We downgraded by one level for imprecision. The sample size was small (did not meet the optimal information size). The effect estimate included a null effect as well as considerable benefit for dexamethasone compared to budesonide.<br/><sup>f</sup>We downgraded by one level for imprecision. Narrative synthesis was conducted, estimates are not precise.<br/><sup>g</sup>We downgraded by one level for risk of bias. The contributing studies were at high (n = 2) and unclear (n = 2) risk of bias. </p> </div> </div> <section id="CD001955-sec-0076"> <h5 class="title">Primary outcomes</h5> <section id="CD001955-sec-0077"> <h6 class="title">1. Change in clinical croup score from baseline to 2, 6, 12, and/or 24 hours</h6> <p>Compared to budesonide, dexamethasone may have resulted in a greater reduction in croup score after six hours (SMD −0.46, 95% CI −0.79 to −0.13; P = 0.006, I² = 51%; 4 RCTs, 326 children; low‐certainty evidence; <a href="./references#CD001955-fig-0046" title="">Analysis 3.1</a>) and 12 hours (SMD −0.75, 95% CI −1.19 to −0.30; P = 0.001, I² = 0%; 2 RCTs, 84 children; low‐certainty evidence; <a href="./references#CD001955-fig-0047" title="">Analysis 3.2</a>). The analysis at 12 hours included only inpatients (<a href="./references#CD001955-fig-0047" title="">Analysis 3.2</a>). At six hours, there was no subgroup difference in effect by inpatient or outpatient status (<a href="./references#CD001955-fig-0046" title="">Analysis 3.1</a>). </p> </section> <section id="CD001955-sec-0078"> <h6 class="title">2. Return visits or (re)admissions to the hospital or both</h6> <p>There was probably no difference in the rate of return visits or (re)admissions to the hospital (or both) between dexamethasone and budesonide groups (RR 0.69, 95% CI 0.40 to 1.22; P = 0.20, I² = 0%; 5 RCTs, 374 children; moderate‐certainty evidence; <a href="./references#CD001955-fig-0048" title="">Analysis 3.3</a>). There were no subgroup differences in effect by inpatient or outpatient status (<a href="./references#CD001955-fig-0048" title="">Analysis 3.3</a>). </p> </section> </section> <section id="CD001955-sec-0079"> <h5 class="title">Secondary outcomes</h5> <section id="CD001955-sec-0080"> <h6 class="title">1. Length of stay in the hospital or emergency department</h6> <p>There was no difference in hours spent in the hospital or emergency department between children treated with dexamethasone and those treated with budesonide (MD −0.51, 95% CI −1.28 to 0.25; P = 0.15, I² = 51%; 2 RCTs, 184 children; <a href="./references#CD001955-fig-0049" title="">Analysis 3.4</a>). There was no subgroup difference in effect by inpatient or outpatient status (<a href="./references#CD001955-fig-0049" title="">Analysis 3.4</a>). </p> </section> <section id="CD001955-sec-0081"> <h6 class="title">2. Patient improvement at 2, 6, 12, and/or 24 hours</h6> <p><a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a> investigated response to treatment, defined as a two‐point improvement in croup score, amongst 198 children aged three months to five years who were treated with budesonide, dexamethasone, or a combination of budesonide and dexamethasone in the emergency department for croup. There was no difference in response to treatment between those treated with dexamethasone and those treated with budesonide (RR 1.12, 95% CI 0.93 to 1.34; P = 0.22; 1 RCT, 134 children; <a href="./references#CD001955-fig-0050" title="">Analysis 3.5</a>). </p> </section> <section id="CD001955-sec-0082"> <h6 class="title">3. The use of additional treatments, including: antibiotics, epinephrine, intubation/tracheostomy, mist tent, and/or supplemental glucocorticoids </h6> <p>Compared to those treated with budesonide, children treated with dexamethasone were at a reduced risk of needing treatment with epinephrine (RR 0.45, 95% CI 0.21 to 0.96; P = 0.04, I² = 0%; 4 RCTs, 321 children; <a href="./references#CD001955-fig-0051" title="">Analysis 3.6</a>). <a href="./references#CD001955-bbs2-0018" title="GeelhoedGC , MacdonaldWB . Oral and inhaled steroids in croup: a randomized, placebo‐controlled trial. Pediatric Pulmonology1995;20(6):355-61. ">Geelhoed 1995c</a> and <a href="./references#CD001955-bbs2-0026" title="JohnsonDW , JacobsonS , EdneyPC , HadfieldP , MundyME , SchuhS . A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. New England Journal of Medicine1998;339(8):498-503. ">Johnson 1998</a> investigated the need for intubation/tracheostomy amongst children treated with dexamethasone or budesonide for croup. There were no events in either study (RD 0.00, 95% CI −0.04 to 0.04; P = 1.00, I² = 0%; 2 RCTs, 145 children; <a href="./references#CD001955-fig-0052" title="">Analysis 3.7</a>). There was no difference in the need for additional glucocorticoids between children treated with dexamethasone and those treated with budesonide (RR 0.48, 95% CI 0.18 to 1.32; P = 0.15, I² = 0%; 3 RCTs, 240 children; <a href="./references#CD001955-fig-0053" title="">Analysis 3.8</a>). </p> </section> <section id="CD001955-sec-0083"> <h6 class="title">4. Any adverse events</h6> <p>Of the six studies investigating dexamethasone compared to budesonide, three (50%) reported no serious adverse events (<a href="./references#CD001955-bbs2-0009" title="DumanM , OzdemirD , AtaseverS . Nebulized L-epinephrine and steroid combination in the treatment of moderate to severe croup. Clinical Drug Investigation2005;25(3):183-9. ">Duman 2005</a>; <a href="./references#CD001955-bbs2-0026" title="JohnsonDW , JacobsonS , EdneyPC , HadfieldP , MundyME , SchuhS . A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. New England Journal of Medicine1998;339(8):498-503. ">Johnson 1998</a>; <a href="./references#CD001955-bbs2-0047" title="Vad PedersenL , DahlM , Falk-PetersenHE , LarsenSE . Inhaled budesonide versus intramuscular dexamethasone in the treatment of pseudocroup [Inhaleret budesonid versus dexamethasone i.m. til behandling at pseudocroup]. Ugeskrift for Laeger1998;160(15):2253-6. ">Vad Pedersen 1998</a>). <a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a> reported one case of oral thrush in the budesonide group (1/65, 1.5%) and one case each of hives and violent behaviour in the dexamethasone group (2/69, 2.9%). </p> </section> </section> </section> <section id="CD001955-sec-0084"> <h4 class="title">Comparison 4: Dexamethasone compared to beclomethasone </h4> <p>See <a href="#CD001955-tbl-0005">Table 3</a>. </p> <div class="table" id="CD001955-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Dexamethasone compared to beclomethasone for croup </span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Dexamethasone compared to beclomethasone for croup</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> dexamethasone<br/><b>Comparison:</b> beclomethasone </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Beclomethasone</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RD 0.00</b><br/>(−0.09 to 0.09) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>39<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> <p>(0 to 0)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events (no events)</p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD001955-bbs2-0010" title="EboriadouM , ChryssanthopoulouD , StamoulisP , DamianidouL , HaidopoulouK . The effectiveness of local corticosteroids therapy in the management of mild to moderate viral croup. Minerva Pediatrica2010;62(1):23-8. ">Eboriadou 2010</a> reported no adverse events related to the glucocorticoids. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b,c</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RD:</b> risk difference </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for imprecision. The sample size was small (did not meet the optimal information size).<br/><sup>b</sup>We downgraded by one level for imprecision. Narrative synthesis was conducted, estimates are not precise.<br/><sup>c</sup>We downgraded by one level for risk of bias. The one contributing study was at high risk of bias. </p> </div> </div> <section id="CD001955-sec-0085"> <h5 class="title">Primary outcomes</h5> <section id="CD001955-sec-0086"> <h6 class="title">1. Change in clinical croup score from baseline to 2, 6, 12, and/or 24 hours</h6> <p>No studies investigated the change in croup score for this comparison.</p> </section> <section id="CD001955-sec-0087"> <h6 class="title">2. Return visits or (re)admissions to the hospital or both</h6> <p><a href="./references#CD001955-bbs2-0010" title="EboriadouM , ChryssanthopoulouD , StamoulisP , DamianidouL , HaidopoulouK . The effectiveness of local corticosteroids therapy in the management of mild to moderate viral croup. Minerva Pediatrica2010;62(1):23-8. ">Eboriadou 2010</a> investigated return visits to the emergency department amongst 39 children aged six months to five years treated with dexamethasone or beclomethasone for croup. There were probably no children that returned for additional care (RD 0.00, 95% CI −0.09 to 0.09; P = 1.00; 1 RCT, 39 children; moderate‐certainty evidence; <a href="./references#CD001955-fig-0054" title="">Analysis 4.1</a>). </p> </section> </section> <section id="CD001955-sec-0088"> <h5 class="title">Secondary outcomes</h5> <section id="CD001955-sec-0089"> <h6 class="title">1. Length of stay in the hospital or emergency department</h6> <p>No studies investigated length of stay in the hospital or emergency department for this comparison. </p> </section> <section id="CD001955-sec-0090"> <h6 class="title">2. Patient improvement at 2, 6, 12, and/or 24 hours</h6> <p>No studies investigated clinical improvement for this comparison.</p> </section> <section id="CD001955-sec-0091"> <h6 class="title">3. The use of additional treatments, including: antibiotics, epinephrine, intubation/tracheostomy, mist tent, and/or supplemental glucocorticoids </h6> <p>No studies investigated the use of additional treatments for this comparison.</p> </section> <section id="CD001955-sec-0092"> <h6 class="title">4. Any adverse events</h6> <p><a href="./references#CD001955-bbs2-0010" title="EboriadouM , ChryssanthopoulouD , StamoulisP , DamianidouL , HaidopoulouK . The effectiveness of local corticosteroids therapy in the management of mild to moderate viral croup. Minerva Pediatrica2010;62(1):23-8. ">Eboriadou 2010</a> investigated this comparison and reported no adverse events related to the glucocorticoids. </p> </section> </section> </section> <section id="CD001955-sec-0093"> <h4 class="title">Comparison 5: Dexamethasone compared to betamethasone </h4> <p>See <a href="#CD001955-tbl-0006">Table 4</a>. </p> <div class="table" id="CD001955-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Dexamethasone compared to betamethasone for croup </span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Dexamethasone compared to betamethasone for croup</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> dexamethasone<br/><b>Comparison:</b> betamethasone </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Betamethasone</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with the Westley croup score. Lower scores mean fewer symptoms.  </p> <p>(Follow‐up: 2 hours)<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score from 1 study was <b>−1.68</b>. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.62 units in favour</b> (1.17 more to 0.06 more). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,b</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with the Westley croup score. Lower scores mean fewer symptoms.  </p> <p>(Follow‐up: 6 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score from 1 study was <b>−1.89</b>. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.67 units in favour</b> (1.23 more to 0.11 more). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b,c</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.95</b><br/>(0.67 to 1.34) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>52<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>d</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>731 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>694 per 1000</b> </p> <p>(490 to 979)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD001955-bbs2-0002" title="AmirL , HubermannH , HaleviA , MorM , MimouniM , WaismanY . Oral betamethasone versus intramuscular dexamethasone for the treatment of mild to moderate viral croup. Pediatric Emergency Care2006;22(8):541-4. ">Amir 2006</a> did not report collecting adverse events data. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,e</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for risk of bias. The one contributing study was at high risk of bias. Allocation concealment was unclear, and the study was not blinded. There was a baseline imbalance in croup score.<br/><sup>b</sup>We downgraded by one level for imprecision. The sample size was small (did not meet the optimal information size).<br/><sup>c</sup>We downgraded by one level for risk of bias. The one contributing study was at high risk of bias. Allocation concealment was unclear, and the study was not blinded. There was a baseline imbalance in croup score.<br/><sup>d</sup>We downgraded by two levels for imprecision. The sample size was small (did not meet the optimal information size). The effect estimate included both the null effect and appreciable benefit or harm for dexamethasone compared to betamethasone.<br/><sup>e</sup>We downgraded by one level for imprecision. Narrative synthesis was conducted, estimates are not precise. </p> </div> </div> <section id="CD001955-sec-0094"> <h5 class="title">Primary outcomes</h5> <section id="CD001955-sec-0095"> <h6 class="title">1. Change in clinical croup score from baseline to 2, 6, 12, and/or 24 hours</h6> <p><a href="./references#CD001955-bbs2-0002" title="AmirL , HubermannH , HaleviA , MorM , MimouniM , WaismanY . Oral betamethasone versus intramuscular dexamethasone for the treatment of mild to moderate viral croup. Pediatric Emergency Care2006;22(8):541-4. ">Amir 2006</a> investigated reduction in croup score for 52 children aged six months to six years were treated with dexamethasone or betamethasone in the emergency department for croup. Compared to betamethasone, dexamethasone may have resulted in a greater reduction in croup score after two hours (SMD −0.62, 95% CI −1.17 to −0.06; P = 0.03; 1 RCT, 52 children; low‐certainty evidence; <a href="./references#CD001955-fig-0055" title="">Analysis 5.1</a>) and six hours (SMD −0.67, 95% CI −1.23 to −0.11; P = 0.02; 1 RCT, 52 children; low‐certainty evidence; <a href="./references#CD001955-fig-0056" title="">Analysis 5.2</a>). </p> </section> <section id="CD001955-sec-0096"> <h6 class="title">2. Return visits or (re)admissions to the hospital or both</h6> <p><a href="./references#CD001955-bbs2-0002" title="AmirL , HubermannH , HaleviA , MorM , MimouniM , WaismanY . Oral betamethasone versus intramuscular dexamethasone for the treatment of mild to moderate viral croup. Pediatric Emergency Care2006;22(8):541-4. ">Amir 2006</a> investigated re‐examinations by a primary care physician amongst 52 children aged six months to six years treated with dexamethasone or betamethasone in the emergency department for croup. There may have been no difference in the rate of re‐examinations between dexamethasone and betamethasone groups (RR 0.95, 95% CI 0.67 to 1.34; P = 0.76; 1 RCT, 52 children; low‐certainty evidence; <a href="./references#CD001955-fig-0057" title="">Analysis 5.3</a>). </p> </section> </section> <section id="CD001955-sec-0097"> <h5 class="title">Secondary outcomes</h5> <section id="CD001955-sec-0098"> <h6 class="title">1. Length of stay in the hospital or emergency department</h6> <p>No studies investigated length of stay in the hospital or emergency department for this comparison. </p> </section> <section id="CD001955-sec-0099"> <h6 class="title">2. Patient improvement at 2, 6, 12, and/or 24 hours</h6> <p>No studies investigated clinical improvement for this comparison.</p> </section> <section id="CD001955-sec-0100"> <h6 class="title">3. The use of additional treatments, including: antibiotics, epinephrine, intubation/tracheostomy, mist tent, and/or supplemental glucocorticoids </h6> <p><a href="./references#CD001955-bbs2-0002" title="AmirL , HubermannH , HaleviA , MorM , MimouniM , WaismanY . Oral betamethasone versus intramuscular dexamethasone for the treatment of mild to moderate viral croup. Pediatric Emergency Care2006;22(8):541-4. ">Amir 2006</a> investigated the need for epinephrine amongst 52 children aged six months to six years treated with dexamethasone or betamethasone in the emergency department for croup. The risk for needing epinephrine was higher for those treated with dexamethasone compared to those treated with betamethasone (RR 2.11, 95% CI 1.18 to 3.76; P = 0.01; 1 RCT, 52 children; <a href="./references#CD001955-fig-0058" title="">Analysis 5.4</a>). </p> </section> <section id="CD001955-sec-0101"> <h6 class="title">4. Any adverse events</h6> <p>No studies investigated adverse events for this comparison.</p> </section> </section> </section> <section id="CD001955-sec-0102"> <h4 class="title">Comparison 6: Dexamethasone compared to prednisolone</h4> <p>See <a href="#CD001955-tbl-0007">Table 5</a>. </p> <div class="table" id="CD001955-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Dexamethasone compared to prednisolone for croup</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Dexamethasone compared to prednisolone for croup</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> dexamethasone<br/><b>Comparison:</b> prednisolone </p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Prednisolone</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with the Westley croup score. Lower scores mean fewer symptoms. </p> <p>(Follow‐up: 2 hours)<br/>  </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score from 1 study was <b>−0.89</b>. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.06 units not in favour</b> (0.06 more to 0.18 less). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1231<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with the Westley croup score. Lower scores mean fewer symptoms. </p> <p>(Follow‐up: 6 hours)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score from 1 study was <b>−2.35</b>. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.21 units not in favour</b> (0.21 more to 0.62 less). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.55</b><br/>(0.28 to 1.11) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1537<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>b</sup> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>212 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>117 per 1000</b><br/>(59 to 236) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a>, <a href="./references#CD001955-bbs2-0015" title="GarbuttJM , ConionB , SterkelR , BatyJ , SchechtmanKB , MandrellK , et al. The comparative effectiveness of prednisolone and dexamethasone for children with croup: a community-based randomized trial. Clinical Pediatrics2013;52(11):1014-21. ">Garbutt 2013</a>, and <a href="./references#CD001955-bbs2-0044" title="SparrowA , GeelhoedG . Prednisolone versus dexamethasone in croup: a randomised equivalence trial. Archives of Disease in Childhood2006;91(7):580-3. ">Sparrow 2006</a> reported no serious adverse events related to the glucocorticoids. <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a> reported 1 case of insomnia (1/411, 0.24%) and 13 cases of vomiting (13/411, 3.3%) in the prednisolone group, and 29 cases of vomiting (29/820, 3.5%), 1 case of 30‐second febrile convulsion (1/820, 0.1%), and 1 case of hyperactivity (1/820, 0.1%) in the dexamethasone group. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1550<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>c</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for imprecision. The sample size was small (did not meet the optimal information size).<br/><sup>b</sup>We downgraded by one level for inconsistency. There was substantial heterogeneity (I² = 59%), and variation in point estimates.<br/><sup>c</sup>We downgraded by one level for imprecision. Narrative synthesis conducted, estimates are not precise. </p> </div> </div> <section id="CD001955-sec-0103"> <h5 class="title">Primary outcomes</h5> <section id="CD001955-sec-0104"> <h6 class="title">1. Change in clinical croup score from baseline to 2, 6, 12, and/or 24 hours</h6> <p>Two trials compared the effect of dexamethasone versus prednisolone. <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a> found little to no difference at two‐hour postbaseline croup score assessment (SMD 0.06, 95% CI −0.06 to 0.18; P = 0.32; 1 RCT, 1231 children; high‐certainty evidence; <a href="./references#CD001955-fig-0059" title="">Analysis 6.1</a>). <a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a> found likely little to no difference between groups at six‐hour postbaseline croup score assessment (SMD 0.21, 95% CI −0.21 to 0.62; P = 0.33; 1 RCT, 99 children; moderate‐certainty evidence; <a href="./references#CD001955-fig-0060" title="">Analysis 6.2</a>). </p> </section> <section id="CD001955-sec-0105"> <h6 class="title">2. Return visits or (re)admissions to the hospital or both</h6> <p>Dexamethasone probably reduced the rate of return visits or readmissions for croup by about half when compared to prednisolone (RR 0.55, 95% CI 0.28 to 1.11; P = 0.09, I² = 59%; 4 RCTs, 1537 children; moderate‐certainty evidence; <a href="./references#CD001955-fig-0061" title="">Analysis 6.3</a>). </p> </section> </section> <section id="CD001955-sec-0106"> <h5 class="title">Secondary outcomes</h5> <section id="CD001955-sec-0107"> <h6 class="title">1. Length of stay in the hospital or emergency department</h6> <p>There was little to no difference between groups in length of stay in the hospital or emergency department (MD −0.02, 95% CI −0.42 to 0.39; P = 0.94, I² = 12%; 2 RCTs, 1363 children; <a href="./references#CD001955-fig-0062" title="">Analysis 6.4</a>).  </p> </section> <section id="CD001955-sec-0108"> <h6 class="title">2. Patient improvement at 2, 6, 12, and/or 24 hours</h6> <p>No studies reported on patient improvement for this comparison.</p> </section> <section id="CD001955-sec-0109"> <h6 class="title">3. The use of additional treatments, including: antibiotics, epinephrine, intubation/tracheostomy, mist tent, and/or supplemental glucocorticoids </h6> <p>We found no difference in the addition of epinephrine to the treatment received by children treated with dexamethasone versus those treated with prednisolone (RR 0.90, 95% CI 0.50 to 1.64; P = 0.74, I² = 0%; 3 RCTs, 1463 children; high‐certainty evidence; <a href="./references#CD001955-fig-0063" title="">Analysis 6.5</a>). No child required intubation (RD 0.00, 95% CI −0.00 to 0.00; P = 1.00; 1 RCT, 1231 children; <a href="./references#CD001955-fig-0064" title="">Analysis 6.6</a>). However, there was a 28% reduction in the use of supplemental glucocorticoids as an additional treatment between children who received dexamethasone and those who received prednisolone (RR 0.72, 95% CI 0.53 to 0.97; P = 0.03, I² = 0%; 2 RCTs, 926 children; <a href="./references#CD001955-fig-0065" title="">Analysis 6.7</a>). </p> </section> <section id="CD001955-sec-0110"> <h6 class="title">4. Any adverse events</h6> <p>Although not specific to this comparison, <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a> reported a few adverse events in four participants: one participant in the dexamethasone group had a febrile convulsion, and one participant in the prednisolone group had insomnia. Unlike <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a>, three trials did not report serious adverse events (<a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a>; <a href="./references#CD001955-bbs2-0015" title="GarbuttJM , ConionB , SterkelR , BatyJ , SchechtmanKB , MandrellK , et al. The comparative effectiveness of prednisolone and dexamethasone for children with croup: a community-based randomized trial. Clinical Pediatrics2013;52(11):1014-21. ">Garbutt 2013</a>; <a href="./references#CD001955-bbs2-0044" title="SparrowA , GeelhoedG . Prednisolone versus dexamethasone in croup: a randomised equivalence trial. Archives of Disease in Childhood2006;91(7):580-3. ">Sparrow 2006</a>). </p> </section> </section> </section> <section id="CD001955-sec-0111"> <h4 class="title">Comparison 7: Budesonide compared to dexamethasone </h4> <p>See <a href="#CD001955-tbl-0008">Table 6</a>. </p> <div class="table" id="CD001955-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Budesonide compared to dexamethasone for croup</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Budesonide compared to dexamethasone for croup</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> budesonide<br/><b>Comparison:</b> dexamethasone </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Budesonide</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><a href="./references#CD001955-bbs2-0022" title="HuangT , XiaZ , LiW . Efficacy of inhaled budesonide on serum inflammatory factors and quality of life among children with acute infectious laryngitis. American Journal of Otolaryngology - Head and Neck Medicine and Surgery2021;42(1):102820. ">Huang 2021</a> reported no adverse events. </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>We downgraded one level for imprecision. Narrative synthesis was conducted, estimates are not precise. </p> </div> </div> <section id="CD001955-sec-0112"> <h5 class="title">Primary outcomes</h5> <section id="CD001955-sec-0113"> <h6 class="title">1. Change in clinical croup score from baseline to 2, 6, 12, and/or 24 hours</h6> <p>No studies reported on change in clinical croup score for this comparison.</p> </section> <section id="CD001955-sec-0114"> <h6 class="title">2. Return visits or (re)admissions to the hospital or both</h6> <p>No studies reported on return visits or (re)admission to the hospital (or both) for this comparison. </p> </section> </section> <section id="CD001955-sec-0115"> <h5 class="title">Secondary outcomes</h5> <section id="CD001955-sec-0116"> <h6 class="title">1. Length of stay in the hospital or emergency department </h6> <p>No studies reported on length of stay in the hospital or emergency department for this comparison. </p> </section> <section id="CD001955-sec-0117"> <h6 class="title">2. Patient improvement at 2, 6, 12, and/or 24 hours</h6> <p>No studies reported on patient improvement for this comparison.</p> </section> <section id="CD001955-sec-0118"> <h6 class="title">3. The use of additional treatments, including: antibiotics, epinephrine, intubation/tracheostomy, mist tent, and/or supplemental glucocorticoids </h6> <p>No studies reported on the use of additional treatments for this comparison.</p> </section> <section id="CD001955-sec-0119"> <h6 class="title">4. Any adverse events</h6> <p><a href="./references#CD001955-bbs2-0022" title="HuangT , XiaZ , LiW . Efficacy of inhaled budesonide on serum inflammatory factors and quality of life among children with acute infectious laryngitis. American Journal of Otolaryngology - Head and Neck Medicine and Surgery2021;42(1):102820. ">Huang 2021</a> investigated the effect of inhaled budesonide versus dexamethasone in children with acute infectious laryngitis and found no adverse condition following treatment. The study authors did not report on any other outcomes relevant to this review. </p> </section> </section> </section> <section id="CD001955-sec-0120"> <h4 class="title">Comparison 8: Budesonide and dexamethasone compared to dexamethasone </h4> <p>See <a href="#CD001955-tbl-0009">Table 7</a>. </p> <div class="table" id="CD001955-tbl-0009"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Budesonide and dexamethasone compared to dexamethasone</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Budesonide and dexamethasone compared to dexamethasone for croup</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> budesonide and dexamethasone<br/><b>Comparison:</b> dexamethasone </p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments**</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Budesonide and dexamethasone</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with different scores in different studies. Lower scores mean fewer symptoms. </p> <p>(Follow‐up: 6 hours)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−3.24 to −1.80</b>. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.05 standard deviations not in favour</b> (0.19 more to 0.30 less). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>255<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A standard deviation of 0.05 represents a minimal difference between groups.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.91</b><br/>(0.45 to 1.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>254<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>91 per 1000</b><br/>(45 to 183) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>1/3 (33%) studies reported collecting adverse events data. <a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a> reported no adverse events in either the dexamethasone group or the dexamethasone and budesonide group. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>133</p> <p>(1 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/>**We used Cohen's interpretation of effect sizes to determine the magnitude of the difference between groups (0.2 represents a small effect, 0.5 represents a medium effect, 0.8 represents a large effect). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for imprecision. The sample size was small (did not meet the optimal information size).<br/><sup>b</sup>We downgraded by two levels for imprecision. The sample size was small (did not meet the optimal information size). The effect estimate included both the null effect and a significant benefit or harm for dexamethasone and budesonide compared to dexamethasone alone.<br/><sup>c</sup>We downgraded by one level for imprecision. Narrative sythesis was conducted, estimates are not precise. </p> </div> </div> <section id="CD001955-sec-0121"> <h5 class="title">Primary outcomes</h5> <section id="CD001955-sec-0122"> <h6 class="title">1. Change in clinical croup score from baseline to 2, 6, 12, and/or 24 hours</h6> <p>There was probably no difference in reduction in croup score after six hours between children treated with combined dexamethasone and budesonide versus those treated with dexamethasone alone (SMD 0.05, 95% CI −0.19 to 0.30; P = 0.67, I² = 0%; 3 RCTs, 255 children; moderate‐certainty evidence; <a href="./references#CD001955-fig-0066" title="">Analysis 7.1</a>). There was no difference in effect by inpatient or outpatient status (<a href="./references#CD001955-fig-0066" title="">Analysis 7.1</a>). </p> </section> <section id="CD001955-sec-0123"> <h6 class="title">2. Return visits or (re)admissions to the hospital or both</h6> <p>There may have been no difference in the rate of admissions or return visits between children treated with combined dexamethasone and budesonide versus those treated with dexamethasone alone (RR 0.91, 95% CI 0.45 to 1.83; P = 0.79, I² = 0%; 3 RCTs, 254 children; low‐certainty evidence; <a href="./references#CD001955-fig-0067" title="">Analysis 7.2</a>). There was no subgroup difference in effect by inpatient or outpatient status (<a href="./references#CD001955-fig-0067" title="">Analysis 7.2</a>). </p> </section> </section> <section id="CD001955-sec-0124"> <h5 class="title">Secondary outcomes</h5> <section id="CD001955-sec-0125"> <h6 class="title">1. Length of stay in the hospital or emergency department</h6> <p>There was no difference in hours spent in the hospital or emergency department amongst children treated with dexamethasone and budesonide versus those treated with dexamethasone alone (MD 0.44, 95% CI −0.05 to 0.92; P = 0.08, I² = 0%; 2 RCTs, 204 children; <a href="./references#CD001955-fig-0068" title="">Analysis 7.3</a>). There were no subgroup differences in effect by inpatient or outpatient status (<a href="./references#CD001955-fig-0068" title="">Analysis 7.3</a>). </p> </section> <section id="CD001955-sec-0126"> <h6 class="title">2. Patient improvement at 2, 6, 12, and/or 24 hours</h6> <p>After six hours, there was no difference in the clinical improvement of children treated with dexamethasone and budesonide versus those treated with dexamethasone alone (RR 1.11, 95% CI 0.65 to 1.90; P = 0.70; 2 RCTs, 183 children; <a href="./references#CD001955-fig-0069" title="">Analysis 7.4</a>). This analysis only included outpatients (<a href="./references#CD001955-fig-0069" title="">Analysis 7.4</a>). </p> </section> <section id="CD001955-sec-0127"> <h6 class="title">3. The use of additional treatments, including: antibiotics, epinephrine, intubation/tracheostomy, mist tent, and/or supplemental glucocorticoids </h6> <p>There was no difference in the need for epinephrine (RR 1.42, 95% CI 0.27 to 7.39; P = 0.67, I² = 0%; 2 RCTs, 183 children; <a href="./references#CD001955-fig-0070" title="">Analysis 7.5</a>); a mist tent (RR 1.07, 95% CI 0.69 to 1.65; P = 0.77; 1 RCT, 50 children; <a href="./references#CD001955-fig-0071" title="">Analysis 7.6</a>); or supplemental glucocorticoids (RR 1.10, 95% CI 0.07 to 16.66; P = 0.95, I² = 66%; 2 RCTs, 182 children; <a href="./references#CD001955-fig-0072" title="">Analysis 7.7</a>) amongst children treated with dexamethasone and budesonide versus those treated with dexamethasone alone. </p> </section> <section id="CD001955-sec-0128"> <h6 class="title">4. Any adverse events</h6> <p><a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a> reported no adverse events in either the dexamethasone group or the dexamethasone and budesonide group. </p> </section> </section> </section> <section id="CD001955-sec-0129"> <h4 class="title">Comparison 9: Budesonide and dexamethasone compared to budesonide </h4> <p>See <a href="#CD001955-tbl-0010">Table 8</a>. </p> <div class="table" id="CD001955-tbl-0010"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Budesonide and dexamethasone compared to budesonide</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Budesonide and dexamethasone compared to budesonide for croup</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> budesonide and dexamethasone<br/><b>Comparison:</b> budesonide </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Budesonide</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Budesonide and dexamethasone</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with the Westley croup score. Lower scores mean fewer symptoms. </p> <p>(Follow‐up: 6 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score from 1 study was <b>−2.30</b>. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.18 units in favour</b> (0.52 more to 0.17 less). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RD 0.00</b><br/>(−0.03 to 0.03) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>129<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/>(0 to 0) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a> reported 1 case of oral thrush in the budesonide group (1/65, 1.5%) and no adverse events in the dexamethasone and budesonide group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>b</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RD:</b> risk difference </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for imprecision. The sample size was small (did not meet the optimal information size).<br/><sup>b</sup>We downgraded by one level for imprecision. Narrative synthesis was conducted, estimates are not precise. </p> </div> </div> <section id="CD001955-sec-0130"> <h5 class="title">Primary outcomes</h5> <section id="CD001955-sec-0131"> <h6 class="title">1. Change in clinical croup score from baseline to 2, 6, 12, and/or 24 hours</h6> <p><a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a> investigated children aged three months to five years treated in the emergency department with dexamethasone, budesonide, or a combination of the two for croup. There was probably no difference in reduction in croup score after six hours amongst children treated with combined dexamethasone and budesonide versus those treated with budesonide alone (SMD −0.18, 95% CI −0.52 to 0.17; P = 0.32; 1 RCT, 129 children; moderate‐certainty evidence; <a href="./references#CD001955-fig-0073" title="">Analysis 8.1</a>). </p> </section> <section id="CD001955-sec-0132"> <h6 class="title">2. Return visits or (re)admissions to the hospital or both</h6> <p><a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a> investigated return visits to the emergency department amongst children aged three months to five years treated with dexamethasone, budesonide, or a combination of the two for croup. There were probably no events in either treatment group (RD 0.00, 95% CI −0.03 to 0.03; P = 1.00; 1 RCT, 129 children; moderate‐certainty evidence; <a href="./references#CD001955-fig-0074" title="">Analysis 8.2</a>). </p> </section> </section> <section id="CD001955-sec-0133"> <h5 class="title">Secondary outcomes</h5> <section id="CD001955-sec-0134"> <h6 class="title">1. Length of stay in the hospital or emergency department</h6> <p><a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a> investigated hours spent in the emergency department amongst children aged three months to five years treated with dexamethasone, budesonide, or a combination of the two for croup. There was no difference in length of stay amongst children treated with dexamethasone and budesonide versus those treated with budesonide alone (MD 0.25, 95% CI −0.36 to 0.86; P = 0.42; 1 RCT, 129 children; <a href="./references#CD001955-fig-0075" title="">Analysis 8.3</a>). </p> </section> <section id="CD001955-sec-0135"> <h6 class="title">2. Patient improvement at 2, 6, 12, and/or 24 hours</h6> <p><a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a> investigated response to treatment, defined as a two‐point reduction in croup score, amongst children aged three months to five years treated in the emergency department with dexamethasone, budesonide, or a combination of the two for croup. There was no difference in response to treatment amongst children treated with dexamethasone and budesonide versus those treated with budesonide alone (RR 0.97, 95% CI 0.79 to 1.20; P = 0.80; 1 RCT, 129 children; <a href="./references#CD001955-fig-0076" title="">Analysis 8.4</a>). </p> </section> <section id="CD001955-sec-0136"> <h6 class="title">3. The use of additional treatments, including: antibiotics, epinephrine, intubation/tracheostomy, mist tent, and/or supplemental glucocorticoids </h6> <p><a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a> investigated the need for additional treatments amongst children aged three months to five years treated in the emergency department with dexamethasone, budesonide, or a combination of the two for croup. There was no difference between groups in the need for epinephrine (RR 1.02, 95% CI 0.15 to 6.99; P = 0.99; 1 RCT, 129 children; <a href="./references#CD001955-fig-0077" title="">Analysis 8.5</a>) or supplemental glucocorticoids (RR 1.31, 95% CI 0.52 to 3.29; P = 0.57; 1 RCT, 129 children; <a href="./references#CD001955-fig-0078" title="">Analysis 8.6</a>). </p> </section> <section id="CD001955-sec-0137"> <h6 class="title">4. Any adverse events</h6> <p><a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a> reported one case of oral thrush in the budesonide group (1/65, 1.5%) and no adverse events in the dexamethasone and budesonide group. </p> </section> </section> </section> <section id="CD001955-sec-0138"> <h4 class="title">Comparison 10: Oral compared to intramuscular dexamethasone </h4> <p>See <a href="#CD001955-tbl-0011">Table 9</a>. </p> <div class="table" id="CD001955-tbl-0011"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Oral dexamethasone compared to intramuscular dexamethasone for croup </span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Oral dexamethasone compared to intramuscular dexamethasone for croup</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> oral dexamethasone<br/><b>Comparison:</b> intramuscular dexamethasone </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intramuscular dexamethasone</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Oral dexamethasone</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.81</b><br/>(0.58 to 1.12) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>440<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>259 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>210 per 1000</b><br/>(150 to 290) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign="top"> <p>None of the studies reported collecting adverse events data.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for imprecision. The effect estimate included both a null effect and substantial benefit for oral compared to intramuscular dexamethasone. </p> </div> </div> <section id="CD001955-sec-0139"> <h5 class="title">Primary outcomes</h5> <section id="CD001955-sec-0140"> <h6 class="title">1. Change in clinical croup score from baseline to 2, 6, 12, and/or 24 hours</h6> <p>No studies investigated change in croup score for this comparison.</p> </section> <section id="CD001955-sec-0141"> <h6 class="title">2. Return visits or (re)admissions to the hospital or both</h6> <p>There was probably no difference in the rate of return visits or admissions following treatment with oral dexamethasone compared to intramuscular dexamethasone (RR 0.81, 95% CI 0.58 to 1.12; P = 0.21, I² = 0%; 3 RCTs, 440 children; moderate‐certainty evidence; <a href="./references#CD001955-fig-0079" title="">Analysis 9.1</a>). The analysis only included outpatients (<a href="./references#CD001955-fig-0079" title="">Analysis 9.1</a>). </p> </section> </section> <section id="CD001955-sec-0142"> <h5 class="title">Secondary outcomes</h5> <section id="CD001955-sec-0143"> <h6 class="title">1. Length of stay in the hospital or emergency department</h6> <p>No studies investigated length of stay in the hospital or emergency department for this comparison. </p> </section> <section id="CD001955-sec-0144"> <h6 class="title">2. Patient improvement at 2, 6, 12, and/or 24 hours</h6> <p><a href="./references#CD001955-bbs2-0008" title="DonaldsonD , PoleskiD , KnippleE , FilipsK , ReetzL , PasculaRG , et al. Intramuscular versus oral dexamethasone for the treatment of moderate-to-severe croup: a randomized double-blind trial. Academy of Emergency Medicine2003;10(1):16-21. ">Donaldson 2003</a> investigated clinical improvement, defined as parents' assessment that their child's condition had improved at least somewhat after 24 hours, amongst children aged three to 84 months treated in the emergency department with oral or intramuscular dexamethasone for croup. There was no difference between groups in rate of clinical improvement (RR 1.07, 95% CI 0.95 to 1.19; P = 0.27; 1 RCT, 95 children; <a href="./references#CD001955-fig-0080" title="">Analysis 9.2</a>). </p> </section> <section id="CD001955-sec-0145"> <h6 class="title">3. The use of additional treatments, including: antibiotics, epinephrine, intubation/tracheostomy, mist tent, and/or supplemental glucocorticoids </h6> <p>There was no difference in the need for antibiotics (RR 0.14, 95% CI 0.02 to 1.15; P = 0.07; 1 RCT, 277 children; <a href="./references#CD001955-fig-0081" title="">Analysis 9.3</a>); epinephrine (RR 0.94, 95% CI 0.71 to 1.24; P = 0.64, I² = 0%; 2 RCTs, 372 children; <a href="./references#CD001955-fig-0082" title="">Analysis 9.4</a>); a mist tent (RR 1.34, 95% CI 0.31 to 5.89; P = 0.70; 1 RCT, 277 children; <a href="./references#CD001955-fig-0083" title="">Analysis 9.5</a>); or supplemental glucocorticoids (RR 1.10, 95% CI 0.50 to 2.41; P = 0.81; 1 RCT, 277 children; <a href="./references#CD001955-fig-0084" title="">Analysis 9.6</a>) amongst children treated with oral dexamethasone versus those treated with intramuscular dexamethasone. </p> </section> <section id="CD001955-sec-0146"> <h6 class="title">4. Any adverse events</h6> <p>No studies investigated adverse events for this comparison.</p> </section> </section> </section> <section id="CD001955-sec-0147"> <h4 class="title">Comparison 11: Oral compared to nebulised dexamethasone </h4> <p>See <a href="#CD001955-tbl-0012">Table 10</a>. </p> <div class="table" id="CD001955-tbl-0012"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Oral dexamethasone compared to nebulised dexamethasone for croup</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Oral dexamethasone compared to nebulised dexamethasone for croup</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> oral dexamethasone<br/><b>Comparison:</b> nebulised dexamethasone </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies) </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Nebulised dexamethasone</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Oral dexamethasone</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.39</b><br/>(0.17 to 0.89) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>176<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>209 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>81 per 1000</b><br/>(35 to 186) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign="top"> <p>None of the studies reported collecting adverse events data.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for imprecision. The sample size was small (did not meet the optimal information size). </p> </div> </div> <section id="CD001955-sec-0148"> <h5 class="title">Primary outcomes</h5> <section id="CD001955-sec-0149"> <h6 class="title">1. Change in clinical croup score from baseline to 2, 6, 12, and/or 24 hours</h6> <p>No studies investigated change in croup score for this comparison.</p> </section> <section id="CD001955-sec-0150"> <h6 class="title">2. Return visits or (re)admissions to the hospital or both</h6> <p><a href="./references#CD001955-bbs2-0033" title="LuriaJW , Gonzalez-del-ReyJA , DiGuilioGA , McAneneyCM , OlsenJJ , RuddyRM . Effectiveness of oral or nebulized dexamethasone for children with mild croup. Archives of Pediatrics &amp; Adolescent Medicine2001;155(12):1340-5. ">Luria 2001</a> investigated returns to medical care of children aged six months to six years following treatment with oral or nebulised dexamethasone in the emergency department for croup. There were probably fewer return visits to medical care amongst those treated with oral dexamethasone versus those treated with nebulised dexamethasone (RR 0.39, 95% CI 0.17 to 0.89; P = 0.03; 1 RCT, 176 children; moderate‐certainty evidence; <a href="./references#CD001955-fig-0085" title="">Analysis 10.1</a>). </p> </section> </section> <section id="CD001955-sec-0151"> <h5 class="title">Secondary outcomes</h5> <section id="CD001955-sec-0152"> <h6 class="title">1. Length of stay in the hospital or emergency department</h6> <p>No studies investigated length of stay in the hospital or emergency department for this comparison. </p> </section> <section id="CD001955-sec-0153"> <h6 class="title">2. Patient improvement at 2, 6, 12, and/or 24 hours</h6> <p>No studies investigated clinical improvement for this comparison.</p> </section> <section id="CD001955-sec-0154"> <h6 class="title">3. The use of additional treatments, including: antibiotics, epinephrine, intubation/tracheostomy, mist tent, and/or supplemental glucocorticoids </h6> <p>No studies investigated the use of additional treatments for this comparison.</p> </section> <section id="CD001955-sec-0155"> <h6 class="title">4. Any adverse events</h6> <p>No studies investigated adverse events for this comparison.</p> </section> </section> </section> <section id="CD001955-sec-0156"> <h4 class="title">Comparison 12: Dexamethasone 0.30 mg/kg compared to 0.15 mg/kg </h4> <p>See <a href="#CD001955-tbl-0013">Table 11</a>. </p> <div class="table" id="CD001955-tbl-0013"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 11.</span> <span class="table-title">Dexamethasone 0.30 mg/kg compared to dexamethasone 0.15 mg/kg for croup</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Dexamethasone 0.30 mg/kg compared to dexamethasone 0.15 mg/kg for croup</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> dexamethasone 0.30 mg/kg<br/><b>Comparison:</b> dexamethasone 0.15 mg/kg </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI) </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone 0.15 mg/kg</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone 0.30 mg/kg</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.94</b><br/>(0.06 to 14.27) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>32 per 1000</b><br/>(2 to 492) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD001955-bbs2-0017" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995b</a> did not report collecting adverse events data. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,b</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>We downgraded by two levels for imprecision. The sample size was small (did not meet the optimal information size). The effect estimate included significant benefit, the null effect, and potential harm for 0.30 mg/kg compared to 0.15 mg/kg dexamethasone.<br/><sup>b</sup>We downgraded by one level for imprecision. Narrative synthesis was conducted, estimates are not precise. </p> </div> </div> <section id="CD001955-sec-0157"> <h5 class="title">Primary outcomes</h5> <section id="CD001955-sec-0158"> <h6 class="title">1. Change in clinical croup score from baseline to 2, 6, 12, and/or 24 hours</h6> <p>No studies investigated change in croup score for this comparison.</p> </section> <section id="CD001955-sec-0159"> <h6 class="title">2. Return visits or (re)admissions to the hospital or both</h6> <p><a href="./references#CD001955-bbs2-0017" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995b</a> investigated re‐presentations to medical care for croup amongst children aged greater than three months treated in the emergency department with 0.30 mg/kg or 0.15 mg/kg dexamethasone. There may have been no difference in the rate of re‐presentations to medical care between groups (RR 0.94, 95% CI 0.06 to 14.27; P = 0.96; 1 RCT, 60 children; low‐certainty evidence; <a href="./references#CD001955-fig-0086" title="">Analysis 11.1</a>). </p> </section> </section> <section id="CD001955-sec-0160"> <h5 class="title">Secondary outcomes</h5> <section id="CD001955-sec-0161"> <h6 class="title">1. Length of stay in the hospital or emergency department</h6> <p>No studies investigated length of stay in the hospital or emergency department for this comparison. </p> </section> <section id="CD001955-sec-0162"> <h6 class="title">2. Patient improvement at 2, 6, 12, and/or 24 hours</h6> <p>No studies investigated clinical improvement for this comparison.</p> </section> <section id="CD001955-sec-0163"> <h6 class="title">3. The use of additional treatments, including: antibiotics, epinephrine, intubation/tracheostomy, mist tent, and/or supplemental glucocorticoids </h6> <p><a href="./references#CD001955-bbs2-0017" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995b</a> investigated the need for additional treatments amongst children aged greater than three months treated in the emergency department with 0.30 mg/kg or 0.15 mg/kg dexamethasone for croup. There was no difference between the two treatments in the need for epinephrine (RR 0.43, 95% CI 0.19 to 0.98; P = 0.05; 1 RCT, 60 children; <a href="./references#CD001955-fig-0087" title="">Analysis 11.2</a>). No child required supplemental glucocorticoids (RD 0.00, 95% CI −0.06 to 0.06; P = 1.00; 1 RCT, 60 children; <a href="./references#CD001955-fig-0088" title="">Analysis 11.3</a>). </p> </section> <section id="CD001955-sec-0164"> <h6 class="title">4. Any adverse events</h6> <p>No studies investigated adverse events for this comparison.</p> </section> </section> </section> <section id="CD001955-sec-0165"> <h4 class="title">Comparison 13: Dexamethasone 0.60 mg/kg compared to 0.30 mg/kg </h4> <p>See <a href="#CD001955-tbl-0014">Table 12</a>. </p> <div class="table" id="CD001955-tbl-0014"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 12.</span> <span class="table-title">Dexamethasone 0.60 mg/kg compared to dexamethasone 0.30 mg/kg for croup</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Dexamethasone 0.60 mg/kg compared to dexamethasone 0.30 mg/kg for croup</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> dexamethasone 0.60 mg/kg<br/><b>Comparison:</b> dexamethasone 0.30 mg/kg </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI) </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone 0.30</b> mg/kg </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone 0.60</b> mg/kg </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.40</b><br/>(0.25 to 7.81) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>97 per 1000</b><br/>(17 to 539) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD001955-bbs2-0016" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995a</a> did not report collecting adverse events data. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,b</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>We downgraded by two levels for imprecision. The sample size was small (did not meet the optimal information size). The effect estimate included significant benefit, the null effect, and potential for harm for 0.60 mg/kg compared to 0.30 mg/kg dexamethasone.<br/><sup>b</sup>We downgraded by one level for imprecision. Narrative synthesis was conducted, estimates are not precise. </p> </div> </div> <section id="CD001955-sec-0166"> <h5 class="title">Primary outcomes</h5> <section id="CD001955-sec-0167"> <h6 class="title">1. Change in clinical croup score from baseline to 2, 6, 12, and/or 24 hours</h6> <p>No studies investigated change in croup score for this comparison.</p> </section> <section id="CD001955-sec-0168"> <h6 class="title">2. Return visits or (re)admissions to the hospital or both</h6> <p><a href="./references#CD001955-bbs2-0016" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995a</a> investigated re‐presentations to medical care for croup amongst children aged greater than three months treated in the emergency department with 0.60 mg/kg or 0.30 mg/kg dexamethasone. There may have been no difference in the rate of re‐presentations to medical care amongst children treated with 0.60 mg/kg versus 0.30 mg/kg dexamethasone (RR 1.40, 95% CI 0.25 to 7.81; P = 0.70; 1 RCT, 60 children; low‐certainty evidence; <a href="./references#CD001955-fig-0089" title="">Analysis 12.1</a>). </p> </section> </section> <section id="CD001955-sec-0169"> <h5 class="title">Secondary outcomes</h5> <section id="CD001955-sec-0170"> <h6 class="title">1. Length of stay in the hospital or emergency department</h6> <p>No studies investigated length of stay in the hospital or emergency department for this comparison. </p> </section> <section id="CD001955-sec-0171"> <h6 class="title">2. Patient improvement at 2, 6, 12, and/or 24 hours</h6> <p>No studies investigated clinical improvement for this comparison.</p> </section> <section id="CD001955-sec-0172"> <h6 class="title">3. The use of additional treatments, including: antibiotics, epinephrine, intubation/tracheostomy, mist tent, and/or supplemental glucocorticoids </h6> <p><a href="./references#CD001955-bbs2-0016" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995a</a> investigated the need for additional treatments amongst children aged greater than three months treated in the emergency department with 0.60 mg/kg or 0.30 mg/kg dexamethasone for croup. There was no difference between the two treatments in the need for epinephrine (RR 0.78, 95% CI 0.27 to 2.28; P = 0.65; 1 RCT, 60 children; <a href="./references#CD001955-fig-0090" title="">Analysis 12.2</a>) or supplemental glucocorticoids (RR 2.81, 95% CI 0.12 to 66.40; P = 0.52; 1 RCT, 60 children; <a href="./references#CD001955-fig-0091" title="">Analysis 12.3</a>). </p> </section> <section id="CD001955-sec-0173"> <h6 class="title">4. Any adverse events</h6> <p>No studies investigated adverse events for this comparison.</p> </section> </section> </section> <section id="CD001955-sec-0174"> <h4 class="title">Comparison 14: Dexamethasone 0.60 mg/kg compared to 0.15 mg/kg</h4> <p>See <a href="#CD001955-tbl-0015">Table 13</a>. </p> <div class="table" id="CD001955-tbl-0015"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 13.</span> <span class="table-title"> Dexamethasone 0.60 mg/kg compared to dexamethasone 0.15 mg/kg for croup</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Dexamethasone 0.60 mg/kg compared to dexamethasone 0.15 mg/kg for croup</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> dexamethasone 0.60 mg/kg<br/><b>Comparison:</b> dexamethasone 0.15 mg/kg </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments**</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone 0.15 mg/kg</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone 0.60 mg/kg</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with the Westley croup score. Lower scores mean fewer symptoms. </p> <p>(Follow‐up: 2 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−1.05 to −0.75</b>. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.27 standard deviations in favour</b><br/>(0.76 more to 0.22 less). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>861<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A standard deviation of 0.14 represents a small difference between groups.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with the Westley croup score. Lower scores mean fewer symptoms. </p> <p>(Follow‐up: 6 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−3.10 to −2.09</b>. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.45 units in favour</b> (1.26 more to 0.35 less). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>178<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with the Westley croup score. Lower scores mean fewer symptoms. </p> <p>(Follow‐up: 12 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−3.50 to −2.95</b>. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.60 units in favour</b> (4.39 more to 3.19 less). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>113<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very Low<sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with the Westley croup score. Lower scores mean fewer symptoms. </p> <p>(Follow‐up: 24 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score from 1 study was <b>−4.00</b>. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.63 units not in favour</b> (0.16 less to 1.10 less). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.91</b><br/>(0.71 to 1.17) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>949<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>208 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>189 per 1000</b><br/>(148 to 243) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a> reported 16 cases of vomiting (16/410, 4.0%) and 1 case of 30 seconds of febrile convulsion (1/410, 0.2%) in the 0.60 mg/kg dexamethasone group, and 13 cases of vomiting (13/410 (3.3%), 1 case of stridor (1/410, 0.2%), and 1 case of hyperactivity (1/410, 0.2%) in the 0.15 mg/kg dexamethasone group. <a href="./references#CD001955-bbs2-0001" title="AlshehrM , AlmegamsiT , HammdiA . Efficacy of a small dose of oral dexamethasone in croup. Biomedical Research2005;65(1):65-72. ">Alshehr 2005</a> reported 1 case of bacterial tracheitis and 2 cases of bronchopneumonia in the 0.60 mg/kg dexamethasone group (3/36, 8.3%) and no adverse events in the 0.15 mg/kg dexamethasone group. <a href="./references#CD001955-bbs2-0005" title="Chub-UppakarnS , SangsupawanichP . A randomized comparison of dexamethasone 0.15 mg/kg versus 0.6 mg/kg for the treatment of moderate to severe croup. International Journal of Pediatric Otorhinolaryngology2007;71(3):473-7. ">Chub‐Uppakarn 2007</a> and <a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a> reported no adverse events in either treatment group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/>**We used Cohen's interpretation of effect sizes to determine the magnitude of the difference between groups (0.2 represents a small effect, 0.5 represents a medium effect, 0.8 represents a large effect). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for imprecision. The sample size was small (did not meet the optimal information size).<br/><sup>b</sup>We downgraded by two levels level for inconsistency. There was considerable heterogeneity (I² = 99%), and variation in point estimates. The 95% confidence intervals did not overlap.<br/><sup>c</sup>We downgraded by two levels for imprecision. The sample size was small (did not meet the optimal information size). The effect estimate included both the null effect and appreciable benefit and harm for 0.60 mg/kg compared to 0.15 mg/kg dexamethasone.<br/><sup>d</sup>We downgraded by one level for imprecision. Narrative synthesis was conducted, estimates are not precise. </p> </div> </div> <section id="CD001955-sec-0175"> <h5 class="title">Primary outcomes</h5> <section id="CD001955-sec-0176"> <h6 class="title">1. Change in clinical croup score from baseline to 2, 6, 12, and/or 24 hours</h6> <p>There was no reduction at two hours (SMD −0.27, 95% CI −0.76 to 0.22; P = 0.28, I² = 62%; 2 RCTs, 861 children; high‐certainty evidence; <a href="./references#CD001955-fig-0092" title="">Analysis 13.1</a>). There was probably no difference at six hours (SMD −0.45, 95% CI −1.26 to 0.35; P = 0.27, I² = 85%; 3 RCTs, 178 children; moderate‐certainty evidence; <a href="./references#CD001955-fig-0093" title="">Analysis 13.2</a>). We do not know if there was no difference at 12 hours (SMD −0.60, 95% CI −4.39 to 3.19; P = 0.76, I² = 98%; 2 RCTs, 113 children; very low‐certainty evidence; <a href="./references#CD001955-fig-0094" title="">Analysis 13.3</a>). We found that treating children with 0.60 mg/kg versus 0.15 mg/kg dose of dexamethasone probably reduced the severity of croup scores at 24‐hour postbaseline score (SMD 0.63, 95% CI 0.16 to 1.10; P = 0.009; 1 RCT, 72 children; moderate‐certainty evidence; <a href="./references#CD001955-fig-0095" title="">Analysis 13.4</a>). </p> </section> <section id="CD001955-sec-0177"> <h6 class="title">2. Return visits or (re)admissions to the hospital or both</h6> <p>There was little to no difference in return visits or (re)admissions or both between children treated with dexamethasone 0.60 mg/kg versus 0.15 mg/kg (RR 0.91, 95% CI 0.71 to 1.17; P = 0.48, I² = 0%; 3 RCTs, 949 children; high‐certainty evidence; <a href="./references#CD001955-fig-0096" title="">Analysis 13.5</a>). </p> </section> </section> <section id="CD001955-sec-0178"> <h5 class="title">Secondary outcomes</h5> <section id="CD001955-sec-0179"> <h6 class="title">1. Length of stay in the hospital or emergency department</h6> <p>There was little to no difference in hours spent at the outpatient clinic between children treated with dexamethasone 0.60 mg/kg versus 0.15 mg/kg (MD 0.12, 95% CI −0.32 to 0.56; P = 0.59, I² = 0%; 2 RCTs, 892 children; <a href="./references#CD001955-fig-0097" title="">Analysis 13.6</a>). </p> </section> <section id="CD001955-sec-0180"> <h6 class="title">2. Patient improvement at 2, 6, 12, and/or 24 hours</h6> <p>No studies reported on patient improvement for this comparison.</p> </section> <section id="CD001955-sec-0181"> <h6 class="title">3. The use of additional treatments, including: antibiotics, epinephrine, intubation/tracheostomy, mist tent, and/or supplemental glucocorticoids </h6> <p>We found no difference in the need of additional treatments between treating children with croup with dexamethasone at 0.60 mg/kg versus 0.15 mg/kg in cases of epinephrine use (RR 0.78, 95% CI 0.34 to 1.75; P = 0.54, I² = 0%; 2 RCTs, 885 children; <a href="./references#CD001955-fig-0098" title="">Analysis 13.7</a>); intubation (RD 0.00, 95% CI −0.00 to 0.00; P = 1.00, I² = 0%; 2 RCTs, 861 children; <a href="./references#CD001955-fig-0099" title="">Analysis 13.8</a>); or use of supplemental glucocorticoids (RR 0.77, 95% CI 0.51 to 1.15; P = 0.19, I² = 0%; 2 RCTs, 617 children; <a href="./references#CD001955-fig-0100" title="">Analysis 13.9</a>). </p> </section> <section id="CD001955-sec-0182"> <h6 class="title">4. Any adverse events</h6> <p>Of the four studies investigating dexamethasone at 0.60 mg/kg versus dexamethasone at 0.15 mg/kg, two (50%) reported no adverse events in either treatment group (<a href="./references#CD001955-bbs2-0005" title="Chub-UppakarnS , SangsupawanichP . A randomized comparison of dexamethasone 0.15 mg/kg versus 0.6 mg/kg for the treatment of moderate to severe croup. International Journal of Pediatric Otorhinolaryngology2007;71(3):473-7. ">Chub‐Uppakarn 2007</a>; <a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a>). <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a> reported 16 cases of vomiting (16/410, 4.0%) and one case of 30 seconds of febrile convulsion (1/410, 0.2%) in the 0.60 mg/kg dexamethasone group, and 13 cases of vomiting (13/410, 3.3%), one case of stridor (1/410, 0.2%), and one case of hyperactivity 30 minutes after the dose (1/410, 0.2%) in the 0.15 mg/kg dexamethasone group. <a href="./references#CD001955-bbs2-0001" title="AlshehrM , AlmegamsiT , HammdiA . Efficacy of a small dose of oral dexamethasone in croup. Biomedical Research2005;65(1):65-72. ">Alshehr 2005</a> reported one case of bacterial tracheitis and two cases of bronchopneumonia in the 0.60 mg/kg dexamethasone group (3/36, 8.3%), and no adverse events in the 0.15 mg/kg dexamethasone group.  </p> </section> </section> </section> <section id="CD001955-sec-0183"> <h4 class="title">Publication bias</h4> <p>The publication bias for change in croup score (at six hours), and return visits or (re)admissions to the hospital (or both), for glucocorticoids compared to placebo remains the same as in the previous version of this review (<a href="./references#CD001955-bbs2-0128" title="GatesA , GatesM , VandermeerB , JohnsonC , HartlingL , JohnsonDW , et al. Glucocorticoids for croup in children. Cochrane Database of Systematic Reviews2018, Issue 8. Art. No: CD001955. [DOI: 10.1002/14651858.CD001955.pub4]">Gates 2018</a>). Insufficient numbers of included studies precluded testing for publication bias for any of the other comparisons or outcomes. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD001955-sec-0184" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD001955-sec-0184"></div> <p>This updated review includes 45 RCTs with a total of 5888 children. This is an increase of two RCTs with 1323 children from the last update (<a href="./references#CD001955-bbs2-0022" title="HuangT , XiaZ , LiW . Efficacy of inhaled budesonide on serum inflammatory factors and quality of life among children with acute infectious laryngitis. American Journal of Otolaryngology - Head and Neck Medicine and Surgery2021;42(1):102820. ">Huang 2021</a>; <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a>). <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a> reported relevant data to update the existing evidence on the effects of glucocorticoid compared to prednisolone, and the optimal dosage of glucocorticoid for the treatment of croup. <a href="./references#CD001955-bbs2-0022" title="HuangT , XiaZ , LiW . Efficacy of inhaled budesonide on serum inflammatory factors and quality of life among children with acute infectious laryngitis. American Journal of Otolaryngology - Head and Neck Medicine and Surgery2021;42(1):102820. ">Huang 2021</a> reported only on adverse events related to the use of budesonide compared to dexamethasone for croup. </p> <section id="CD001955-sec-0185"> <h3 class="title" id="CD001955-sec-0185">Summary of main results</h3> <section id="CD001955-sec-0186"> <h4 class="title">Any glucocorticoid compared to placebo </h4> <p>Twenty‐six studies investigated glucocorticoids compared to placebo. Glucocorticoids may have reduced the symptoms of croup within two hours of treatment, with the effect lasting at least 24 hours. The effect was dependent on the glucocorticoid administered. Budesonide and dexamethasone reduced the symptoms of croup within two hours of treatment, with the effect lasting at least 24 hours. One trial showed that prednisolone reduced the symptoms of croup within six hours, with the effect lasting at least 12 hours. One trial showed that fluticasone did not reduce the symptoms of croup after two, six, or 24 hours compared to placebo. The certainty of the evidence for the effect of glucocorticoids compared to placebo for reducing the symptoms of croup from two to 12 hours was low, as there was considerable between‐study heterogeneity in effect estimates (<a href="./full#CD001955-tbl-0001">summary of findings Table 1</a>). The certainty of the evidence for the effect of glucocorticoids compared to placebo for reducing the symptoms of croup after 24 hours was very low, as there was considerable between‐study heterogeneity in the magnitude and direction of the effect (<a href="./full#CD001955-tbl-0001">summary of findings Table 1</a>).  </p> <p>Compared to placebo, both budesonide and dexamethasone may have reduced the rate of return visits and/or (re)admissions to the hospital or emergency department. The certainty of the evidence for the effect of glucocorticoids in reducing the rate of return visits or (re)admissions or both was low, as there was considerable between‐study heterogeneity in the effect estimates (<a href="./full#CD001955-tbl-0001">summary of findings Table 1</a>). </p> <p>Compared to placebo, glucocorticoids reduced length of stay in the hospital by approximately 15 hours and resulted in clinical improvement in a greater proportion of children after six hours. The effect lasted at least 24 hours. There was little to no difference in the need for additional treatments between children treated with glucocorticoids and those treated with placebo. Treatment with glucocorticoids was infrequently associated with serious adverse events. </p> </section> <section id="CD001955-sec-0187"> <h4 class="title">Any glucocorticoid compared to epinephrine </h4> <p>Four studies investigated glucocorticoids compared to epinephrine. We do not know if there was no difference in the reduction in symptoms of croup for children treated with epinephrine compared to those treated with glucocorticoids at two and six hours. There may not have been a reduction in croup symptoms at 12 or 24 hours following administration of glucocorticoids or epinephrine. After two hours, the effect was dependent on the glucocorticoid administered. Epinephrine resulted in greater reductions in symptoms of croup compared to beclomethasone and dexamethasone. There was little no difference in reduction in croup symptoms between epinephrine and budesonide two hours after treatment. The certainty of the evidence for the effect of glucocorticoids compared to epinephrine for reducing the symptoms of croup was very low to low. The sample sizes for the six‐, 12‐, and 24‐hour analyses were small, and there was considerable between‐study heterogeneity in effect estimates for the six‐hour analysis. There was considerable between‐study heterogeneity in the magnitude and direction of the effect estimates for the two‐hour analysis; the sample size for the comparison was small; and the pooled effect estimate was imprecise (<a href="./full#CD001955-tbl-0002">summary of findings Table 2</a>). </p> <p>There may have been no difference in the rate of return visits or (re)admissions or both following treatment with glucocorticoids compared with epinephrine. The certainty of the evidence for the effect of glucocorticoids compared to epinephrine for reducing the rate of return visits or (re)admissions or both was low, as the sample size did not meet the optimal information size, and the contributing studies reported no events (<a href="./full#CD001955-tbl-0002">summary of findings Table 2</a>). </p> <p>There was little to no difference in length of stay in the hospital for children treated with glucocorticoids compared to those treated with epinephrine, nor were there any differences between groups in the need for additional treatments. One study reported a 31.3% rate of secondary bacterial infections amongst children treated with dexamethasone. Another study reported a 16% rate of tremor and tachycardia amongst children treated with epinephrine. </p> </section> <section id="CD001955-sec-0188"> <h4 class="title">One glucocorticoid compared to another glucocorticoid</h4> <p>Thirteen studies investigated one glucocorticoid compared to another glucocorticoid. Compared to budesonide, dexamethasone may have resulted in greater reductions in symptoms of croup after six and 12 hours. The certainty of the evidence for the effect of dexamethasone compared to budesonide for reducing the symptoms of croup was low, as the contributing studies were all at high or unclear risk of bias; there was substantial between‐study heterogeneity in effect estimates for the six‐hour analysis; and the sample size did not meet the optimal information size for the 12‐hour analysis (<a href="#CD001955-tbl-0004">Table 2</a>). Compared to betamethasone, dexamethasone may have resulted in greater reductions in symptoms of croup after two and six hours. The certainty of the evidence for the effect of dexamethasone compared to betamethasone for reducing the symptoms of croup was low, as the only study contributing to the analysis was at high risk of bias and had a small sample size (<a href="#CD001955-tbl-0006">Table 4</a>). There was no difference in the reduction in symptoms of croup two hours following treatment with dexamethasone or prednisolone, and likely no difference at six hours. The certainty of the evidence for the effect of dexamethasone compared to prednisolone for reducing the symptoms of croup was moderate, as the only study that contributed to the analysis had a small sample size (<a href="#CD001955-tbl-0007">Table 5</a>). </p> <p>There was probably no difference between dexamethasone and budesonide in the rate of return visits or (re)admissions or both. The certainty of the evidence for the effect of dexamethasone compared to budesonide for reducing the rate of return visits or (re)admissions or both was moderate, as few events were reported, and the effect estimate included the null effect as well as considerable benefit for dexamethasone compared to budesonide (<a href="#CD001955-tbl-0004">Table 2</a>). There was probably no difference between dexamethasone and beclomethasone, and there may have been no difference between dexamethasone and betamethasone in the rate of return visits or (re)admissions or both. The certainty of the evidence for the effect of dexamethasone compared to beclomethasone for reducing the rate of return visits or (re)admissions or both was moderate, as the only study that contributed to the analysis had a small sample size and reported no events (<a href="#CD001955-tbl-0005">Table 3</a>). The certainty of the evidence for the effect of dexamethasone compared to betamethasone for reducing the rate of return visits or (re)admissions or both was low, as only one small study contributed to the analysis, and the effect estimate included the null effect as well as appreciable benefit and harm (<a href="#CD001955-tbl-0006">Table 4</a>). Compared to prednisolone, dexamethasone probably reduced the rate of return visits or (re)admissions or both by about 50%. The certainty of the evidence for the effect of dexamethasone compared to prednisolone for reducing the rate of return visits or (re)admissions or both was moderate, as the sample size did not reach the optimal information size (<a href="#CD001955-tbl-0007">Table 5</a>). The addition of data from <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a> attenuated the magnitude of the difference (61%) previously reported in this comparison category.  </p> <p>There was no difference in length of stay in the hospital or emergency department between children treated with dexamethasone compared to budesonide, or dexamethasone compared to prednisolone. One study showed no difference in clinical improvement between children treated with dexamethasone and those treated with budesonide. Compared to those treated with budesonide, children treated with dexamethasone were at a reduced risk for needing epinephrine. There was no difference between children treated with dexamethasone and those treated with budesonide in need for intubation or supplemental glucocorticoids. Compared to those treated with betamethasone, children treated with dexamethasone were at a increased risk for needing epinephrine. There was no difference between children treated with dexamethasone and those treated with prednisolone in the need for epinephrine. However, there was a 28% reduction in the use of supplemental glucocorticoids as an additional treatment. Adverse events were infrequently reported. </p> <p><a href="./references#CD001955-bbs2-0022" title="HuangT , XiaZ , LiW . Efficacy of inhaled budesonide on serum inflammatory factors and quality of life among children with acute infectious laryngitis. American Journal of Otolaryngology - Head and Neck Medicine and Surgery2021;42(1):102820. ">Huang 2021</a> was the only study that investigated the effect of inhaled budesonide versus dexamethasone. The study authors found no adverse condition following the treatment of infectious laryngitis with inhaled budesonide or dexamethasone. They did not report on change in clinical croup scores between baseline and 2, 6, 12, and/or 24 hours, or any other outcomes relevant to this review. </p> </section> <section id="CD001955-sec-0189"> <h4 class="title">One glucocorticoid compared to a combination of glucocorticoids</h4> <p>Three studies investigated one glucocorticoid compared to a combination of glucocorticoids. There was probably no difference in reduction in symptoms of croup for children treated with dexamethasone compared to combined dexamethasone and budesonide, and probably no difference for children treated with budesonide compared to combined budesonide and dexamethasone. The certainty of the evidence for the effect of dexamethasone compared to dexamethasone and budesonide for reducing the symptoms of croup was moderate, as the sample size for the analysis did not meet the optimal information size (<a href="#CD001955-tbl-0010">Table 8</a>). The certainty of the evidence for the effect of budesonide compared to budesonide and dexamethasone for reducing the symptoms of croup was moderate (<a href="#CD001955-tbl-0010">Table 8</a>), as only one small study contributed to the analysis. </p> <p>There may have been no difference in rate of return visits or (re)admissions to the hospital or both following treatment with dexamethasone compared to combined dexamethasone and budesonide, and there was probably no difference for this outcome following treatment with budesonide compared to combined budesonide and dexamethasone. The certainty of the evidence for the effect of dexamethasone compared to dexamethasone and budesonide for reducing the rate of return visits or (re)admissions or both was low (<a href="#CD001955-tbl-0009">Table 7</a>), as the sample size for the analysis did not meet the optimal information size; there were few events; and the estimate was imprecise. The certainty of the evidence for the effect of budesonide compared to budesonide and dexamethasone for reducing the rate of return visits or (re)admissions or both was moderate (<a href="#CD001955-tbl-0010">Table 8</a>), as only one small study contributed to the analysis. </p> <p>There was no difference in hours spent in the hospital or emergency department, clinical improvement, or the need for additional treatments for children treated with dexamethasone compared to those treated with combined dexamethasone and budesonide, nor for children treated with budesonide compared to combined budesonide and dexamethasone. Only one study collected adverse events data, which included one case (1.5%) of oral thrush in the budesonide group and no events in the budesonide and dexamethasone group (<a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a>). </p> </section> <section id="CD001955-sec-0190"> <h4 class="title">Glucocorticoids given by different modes of administration</h4> <p>Five studies investigated dexamethasone given by different modes of administration. There was probably no difference in the rate of return visits or (re)admissions or both for children treated with oral dexamethasone compared to those treated with intramuscular dexamethasone. There was probably a reduced rate of return visits or (re)admissions or both for children treated with oral dexamethasone compared to those treated with nebulised dexamethasone. The certainty of the evidence for the effect of oral compared to intramuscular dexamethasone for reducing the rate of return visits or (re)admissions or both was moderate, as the contributing studies reported few events, and the estimate was imprecise (<a href="#CD001955-tbl-0011">Table 9</a>). The certainty of the evidence for the effect of oral compared to nebulised dexamethasone for reducing the rate of return visits or (re)admissions or both was moderate, as only one study contributed to the analysis, and the sample size did not meet the optimal information size (<a href="#CD001955-tbl-0012">Table 10</a>). </p> <p>There was no difference in clinical improvement or in the need for additional treatments between children treated with oral dexamethasone and those treated with intramuscular dexamethasone. None of the studies comparing dexamethasone given by different modes of administration reported collecting adverse events data. </p> </section> <section id="CD001955-sec-0191"> <h4 class="title">Dexamethasone given in different doses</h4> <p>Five studies investigated dexamethasone given in different doses. There was no reduction in croup score after two hours for inpatients treated with 0.60 mg/kg dexamethasone compared to those treated with 0.15 mg/kg dexamethasone. There was probably no reduction in croup score after six hours for children treated with 0.60 mg/kg dexamethasone compared to those treated with 0.15 mg/kg dexamethasone. After 12 hours, we do not know if there was no difference in the change in croup score amongst children treated with 0.60 mg/kg compared to 0.15 mg/kg dexamethasone. The effect differed by inpatient and outpatient status. One study showed that there was probably a reduction in croup score with 0.60 mg/kg after 24 hours (<a href="./references#CD001955-bbs2-0001" title="AlshehrM , AlmegamsiT , HammdiA . Efficacy of a small dose of oral dexamethasone in croup. Biomedical Research2005;65(1):65-72. ">Alshehr 2005</a>). </p> <p>In inpatients, the 0.60 mg/kg dose resulted in a greater reduction in croup score after 12 hours, whereas in outpatients, the 0.15 mg/kg dose was more effective. One study investigated change in croup score after 24 hours for inpatients treated with 0.60 mg/kg or 0.15 mg/kg dexamethasone (<a href="./references#CD001955-bbs2-0001" title="AlshehrM , AlmegamsiT , HammdiA . Efficacy of a small dose of oral dexamethasone in croup. Biomedical Research2005;65(1):65-72. ">Alshehr 2005</a>). Children treated with 0.15 mg/kg probably experienced greater reductions in croup score after 24 hours compared to those treated with 0.60 mg/kg dexamethasone. The certainty of the evidence for the effect of 0.60 mg/kg dexamethasone compared to 0.15 mg/kg dexamethasone for reducing croup score was very low to high (<a href="#CD001955-tbl-0015">Table 13</a>). The six‐hour analysis included three studies, but the sample size did not meet the optimal information size. In the 12‐hour analysis, there was considerable between‐study heterogeneity in effect estimates, and the sample sizes did not meet the optimal information size. In the 12‐hour analysis, the pooled effect estimate included the null effect as well as appreciable benefit and harm. The 24‐hour analysis included only one study with a small sample size. </p> <p>There may have been no difference in the rate of return visits or (re)admissions or both for children treated with 0.30 mg/kg compared to 0.15 mg/kg dexamethasone and 0.60 mg/kg compared to 0.30 mg/kg dexamethasone. There was no difference in the rate of return visits or (re)admissions for children treated with 0.60 mg/kg compared to 0.15 mg/kg dexamethasone. The certainty of the evidence was low for the effect of 0.30 mg/kg compared to 0.15 mg/kg dexamethasone (<a href="#CD001955-tbl-0013">Table 11</a>), and 0.60 mg/kg compared to 0.30 mg/kg dexamethasone (<a href="#CD001955-tbl-0014">Table 12</a>), for reducing the rate of return visits or (re)admissions or both for croup, as the analysis included only one small study that reported few events, and the effect estimate included benefit, the null effect, and potential for harm. The certainty of the evidence for the effect of 0.60 mg/kg compared to 0.15 mg/kg dexamethasone on return visits or (re)admissions or both was high (<a href="#CD001955-tbl-0015">Table 13</a>). </p> <p>Likewise, we found no difference in length of stay in the hospital or emergency department for children treated with 0.60 mg/kg compared to 0.15 mg/kg dexamethasone. There was no difference in the need for additional treatments between children treated with 0.30 mg/kg compared to 0.15 mg/kg dexamethasone; 0.60 mg/kg compared to 0.30 mg/kg dexamethasone; or 0.60 mg/kg compared to 0.15 mg/kg dexamethasone. Adverse events were infrequently reported for the 0.15 mg/kg and 0.60 mg/kg doses of dexamethasone. </p> </section> </section> <section id="CD001955-sec-0192"> <h3 class="title" id="CD001955-sec-0192">Overall completeness and applicability of evidence</h3> <p>We searched for RCTs that compared glucocorticoids to placebo, or any other active pharmacologic treatment for croup. However, in this update we found only two new studies that investigated one glucocorticoid compared to another glucocorticoid (<a href="./references#CD001955-bbs2-0022" title="HuangT , XiaZ , LiW . Efficacy of inhaled budesonide on serum inflammatory factors and quality of life among children with acute infectious laryngitis. American Journal of Otolaryngology - Head and Neck Medicine and Surgery2021;42(1):102820. ">Huang 2021</a>; <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a>), and one study that investigated glucocorticoids given in different doses (<a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a>). Overall, the number of included studies was large (n = 45), of which 26 (58%) investigated glucocorticoids compared to placebo. Only four studies investigated glucocorticoids compared to epinephrine; 13 investigated one glucocorticoid compared to another glucocorticoid; three investigated one glucocorticoid compared to a combination of glucocorticoids; five investigated glucocorticoids given by different modes of administration; and five investigated glucocorticoids given in different doses. Most studies (67%) reported a change in croup score for at least one time point, and 58% used the Westley croup score (<a href="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001955.pub4/references#CD001955-bbs2-0123" target="_blank">Westley 1978</a>), which has been shown to be a valid and reliable measure of croup severity. Most studies (51%) investigated outpatients presenting to emergency departments or outpatient clinics, generally with mild to moderate croup. In a study conducted by <a href="./references#CD001955-bbs2-0120" title="RosychukRJ , KlassenTP , MetesD , VoaklanderDC , SenthilselvanA , RoweBH . Croup presentations to emergency departments in Alberta, Canada: a large population-based study. Pediatric Pulmonology2010;45(1):83-91. [DOI: 10.1002/ppul.21162]">Rosychuk 2010</a> that described the epidemiology of croup presentation to emergency departments within the Alberta, Canada emergency databases, less than 6% of children presenting to the emergency department with croup symptoms required hospitalisation. We have therefore presented subgroup analyses by inpatient or outpatient setting as a form of sensitivity analysis because of the possible overrepresentation of studies with inpatient cases of croup. However, the findings from these subgroup analyses should be interpreted with caution. </p> <p>We found no evidence of publication bias for our two primary outcomes: change in croup score (at six hours), and return visits or (re)admissions to the hospital or both for glucocorticoids compared to placebo. </p> </section> <section id="CD001955-sec-0193"> <h3 class="title" id="CD001955-sec-0193">Certainty of the evidence</h3> <p>This systematic review included 45 RCTs of 5888 children. Most studies were at unclear or high overall risk of bias (98%). We assessed risk of bias for random sequence generation as low in 60% of studies. The allocation sequence was adequately concealed between randomisation and assignment to treatment groups in 42% of studies. We were unable to ascertain whether the conduct of these studies was methodologically flawed. However, based on the information provided in the publications, we cannot exclude the possibility of selection bias. Empirically, selection bias has been associated with exaggerated estimates of treatment effects (<a href="./references#CD001955-bbs2-0114" title="JüniP , AltmanDG , EggerM . Assessing the quality of controlled clinical trials. BMJ2001;323(7303):42-6.">Jüni 2001</a>; <a href="./references#CD001955-bbs2-0125" title="WoodL , EggerM , Lotte GluudL , SchulzKF , JüniP , AltmanDG , et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: a meta-epidemiological study. BMJ2008;336(7644):601-5.">Wood 2008</a>). Inadequate allocation concealment is more likely to result in biased estimates of treatment effects when the outcomes of a study are subjective (<a href="./references#CD001955-bbs2-0125" title="WoodL , EggerM , Lotte GluudL , SchulzKF , JüniP , AltmanDG , et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: a meta-epidemiological study. BMJ2008;336(7644):601-5.">Wood 2008</a>). Croup score, one of our primary outcomes, is typically assessed by the healthcare provider, and interobserver variability has been reported to be fair to moderate (<a href="./references#CD001955-bbs2-0097" title="ChanAK , LangleyJM , LeBlancJC . Interobserver variability of croup scoring in clinical practice. Paediatrics &amp; Child Health2001;6(6):347-51.">Chan 2001</a>). <a href="./references#CD001955-bbs2-0110" title="HartlingL , HammMP , FernandesRM , DrydenD , VandermeerB . Quantifying bias in randomized controlled trials in child health: a meta‐epidemiological study. PLOS ONE2014;9(2):e88008.">Hartling 2014</a> demonstrated that the association between selection bias and the estimate of treatment effects may not hold true for RCTs in child health. We are therefore uncertain as to how selection bias may have impacted our results. </p> <p>More than half (58%) of the included studies were at low risk of bias for blinding of participants and personnel, and 60% were at low risk for blinding of outcome assessors. Many of the studies judged as at unclear risk of bias for the blinding domains were described as "blind" or "double‐blind". However, details about who was blinded or how (or both) were omitted from the publications. Whilst it is possible that these studies were well conducted but inadequately reported, we cannot confidently exclude the potential for performance and detection bias. In eight (18%) studies, participants and personnel were not blinded. All of these studies but one investigated glucocorticoids given via different modes of administration (e.g. orally, intramuscularly, nebulised), therefore blinding participants and personnel to the treatment assignment would not have been feasible. Studies that are not blinded or that are inadequately blinded can result in exaggerated estimates of treatment effects (<a href="./references#CD001955-bbs2-0125" title="WoodL , EggerM , Lotte GluudL , SchulzKF , JüniP , AltmanDG , et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: a meta-epidemiological study. BMJ2008;336(7644):601-5.">Wood 2008</a>). This association may not be true for RCTs in child health (<a href="./references#CD001955-bbs2-0110" title="HartlingL , HammMP , FernandesRM , DrydenD , VandermeerB . Quantifying bias in randomized controlled trials in child health: a meta‐epidemiological study. PLOS ONE2014;9(2):e88008.">Hartling 2014</a>), therefore we are uncertain as to how the inclusion of unblinded or inadequately blinded trials may have impacted our results. </p> <p>Most studies (60%) were at low risk of bias for incomplete outcome data. Although most studies (93%) were at unclear risk of bias for selective reporting, the outcomes reported in the results matched those reported in the methods sections of the publications in most cases. </p> <p>For the comparison any glucocorticoid versus placebo, we detected between‐study heterogeneity in point estimates of effect as well as heterogeneity in the pooled estimates of effect by glucocorticoid for change in croup score. For this reason, we downgraded the certainty of the evidence for change in croup score after 2, 6, 12, and 24 hours. With respect to the estimates for individual glucocorticoids, after two hours the between‐study estimates for budesonide were heterogeneous. Two studies showed a clear benefit for dexamethasone, whilst <a href="./references#CD001955-bbs2-0025" title="JohnsonDW , SchuhS , KorenG , JaffeeDM . Outpatient treatment of croup with nebulized dexamethasone. Archives of Pediatrics &amp; Adolescent Medicine1996;150(4):349-55. ">Johnson 1996</a> showed the potential for no difference in effect between dexamethasone and placebo. Between‐study estimates for the effectiveness of budesonide compared to placebo after 6, 12, and 24 hours showed a consistent beneficial effect. For dexamethasone, between‐study estimates were highly heterogeneous at all time points and included the potential for benefit, no effect, or harm compared to placebo. In future updates of this review, we may use meta‐regression analyses to explore factors that could explain at least some of the observed heterogeneity (e.g. the 'effective' dosage of the active comparator). If such an analysis is deemed important to clinicians and researchers, it should be planned and documented a priori before future updates of this review. Only one very small study (N = 17) investigated croup score for fluticasone compared to placebo 2, 6, and 24 hours after treatment (<a href="./references#CD001955-bbs2-0039" title="RoordaRJ , WalhofCM . Effects of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report. Pediatric Pulmonology1998;25(2):114-7. ">Roorda 1998</a>). Another single study (N = 42) investigated croup score for prednisolone compared to placebo 6 and 12 hours after treatment (<a href="./references#CD001955-bbs2-0035" title="MassicotteP , TetreaultL . Evaluation of methyl‐prednisolone in the treatment of acute laryngitis in children. Unión Médicale du Canada1973;102(10):2064-72. ">Massicotte 1973</a>). We caution against drawing any conclusions based on the evidence from these small, single studies. </p> <p>Accounting for the pooled estimates of effect by glucocorticoid, the test for subgroup differences between the effects of budesonide, dexamethasone, and fluticasone two hours following their administration indicated marginal differences in croup scores (P = 0.06). Whilst fluticasone (based on one study) compared to placebo showed no reduction in croup scores (P = 0.36), the pooled effect estimate for budesonide indicated a reduction in croup scores (P = 0.005), and a marginal reduction for dexamethasone (P = 0.06). There was a subgroup difference in effect between budesonide, dexamethasone, fluticasone, and prednisolone six hours following their administration (P = 0.009). This was accounted for by the fact that the effect estimate for prednisolone (based on one study) was substantially larger compared to the pooled estimates for budesonide and dexamethasone, and fluticasone (based on one study) had no effect (P = 0.90). There was a subgroup difference in effect between budesonide, dexamethasone, and prednisolone 12 hours following their administration (P = 0.006). This was accounted for by the fact that the effect estimate for prednisolone (based on one study) was substantially larger compared to the pooled estimates for budesonide and dexamethasone. There was a subgroup difference in effect between budesonide, dexamethasone, and fluticasone 24 hours following their administration (P = 0.01). This was accounted for by the fact that the effect estimate for fluticasone (based on one study) indicated no effect (P = 0.36), whilst the pooled estimates for budesonide and dexamethasone both showed beneficial effects. </p> <p>For the comparison any glucocorticoid versus placebo, we also downgraded the certainty of the evidence for return visits or (re)admissions or both due to inconsistency. There was little evidence that publication bias influenced our results for return visits or (re)admissions or both. </p> <p>Similar threats to the certainty of the evidence were present in the other 12 comparisons in this review, including concerns regarding risk of bias, inconsistency, and imprecision. Aside from the comparison of glucocorticoids versus placebo, for which seven to 11 RCTs made up the analyses for the primary outcomes, all of the other comparisons included between one and five studies. Combined with the fact that the studies mostly included small samples of children (median n = 72, interquartile range 54 to 99), many analyses had to be downgraded due to imprecision, as the optimal information size criteria were not met. Since many of the analyses contained only one or two small RCTs, we caution against drawing any firm conclusions from the results of these few small studies. There exist very few within‐study comparisons of one glucocorticoid compared to another, of glucocorticoids given by different modes of administration, or of different doses of the same glucocorticoid. </p> </section> <section id="CD001955-sec-0194"> <h3 class="title" id="CD001955-sec-0194">Potential biases in the review process</h3> <p>We know that the risk of bias of studies used in a meta‐analysis is crucial to the certainty of evidence produced. This may affect the translation and uptake of research evidence to practice. We used the Cochrane risk of bias tool to assess the risk of bias of all included studies, and judged most of the studies as at unclear or high risk of bias. We were unable to update some of the other comparisons due to a lack of new data. These comparison categories are highlighted in the <a href="./full#CD001955-sec-0039">Results</a> section. The lack of new data in these areas may signal areas where more RCTs on glucocorticoids and croup are needed. We also know that some comparisons may not warrant new RCTs at this time because of the considerable high‐certainty evidence that is available. To the best of our knowledge, 26 RCTs have compared any glucocorticoids versus placebo, and the findings have been consistently in support of the use of glucocorticoids in the treatment of croup (<a href="./references#CD001955-bbs2-0128" title="GatesA , GatesM , VandermeerB , JohnsonC , HartlingL , JohnsonDW , et al. Glucocorticoids for croup in children. Cochrane Database of Systematic Reviews2018, Issue 8. Art. No: CD001955. [DOI: 10.1002/14651858.CD001955.pub4]">Gates 2018</a>). That said, other areas that may benefit from more RCTs are comparisons around the lowest optimal glucocorticoids dose, and the most effective mode of administration. </p> </section> <section id="CD001955-sec-0195"> <h3 class="title" id="CD001955-sec-0195">Agreements and disagreements with other studies or reviews</h3> <p>This update strengthens evidence from previous review publications that supported the use of a lower dose of glucocorticoids (<a href="./references#CD001955-bbs2-0005" title="Chub-UppakarnS , SangsupawanichP . A randomized comparison of dexamethasone 0.15 mg/kg versus 0.6 mg/kg for the treatment of moderate to severe croup. International Journal of Pediatric Otorhinolaryngology2007;71(3):473-7. ">Chub‐Uppakarn 2007</a>; <a href="./references#CD001955-bbs2-0106" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8.">Geelhoed 1995</a>). It would be preferable to treat croup with the lowest effective dose of glucocorticoids to limit steroid exposure in these children. Data from <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a> and <a href="./references#CD001955-bbs2-0005" title="Chub-UppakarnS , SangsupawanichP . A randomized comparison of dexamethasone 0.15 mg/kg versus 0.6 mg/kg for the treatment of moderate to severe croup. International Journal of Pediatric Otorhinolaryngology2007;71(3):473-7. ">Chub‐Uppakarn 2007</a> suggest that 0.15 mg/kg is as effective in the treatment of croup as 0.60 mg/kg. Their findings are also supported by <a href="./references#CD001955-bbs2-0106" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8.">Geelhoed 1995</a>, which found no difference in return visits or (re)admissions amongst children treated for croup using 0.30 mg/kg compared to 0.15 mg/kg. Likewise, there was no difference between the two treatment groups in the need for additional treatment with epinephrine or supplemental glucocorticoid. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD001955-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Cumulative meta‐graph by year for change in croup score six hours after treatment for any glucocorticoid compared to placebo." data-id="CD001955-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-FIG-04.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Cumulative meta‐graph by year for change in croup score six hours after treatment for any glucocorticoid compared to placebo. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-FIG-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Cumulative meta‐graph by year for return visits or (re)admissions or both for any glucocorticoid compared to placebo." data-id="CD001955-fig-0005" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-FIG-05.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Cumulative meta‐graph by year for return visits or (re)admissions or both for any glucocorticoid compared to placebo. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-FIG-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Flow diagram of study selection for this review." data-id="CD001955-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Flow diagram of study selection for this review.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph for studies included in the 2022 update synthesis: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD001955-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph for studies included in the 2022 update synthesis: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary for studies included in the 2022 update synthesis: review authors' judgements about each risk of bias item for each included study." data-id="CD001955-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary for studies included in the 2022 update synthesis: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 1: Croup score (change baseline ‐ 2 hours) by score" data-id="CD001955-fig-0006" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 1: Croup score (change baseline ‐ 2 hours) by score </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 2: Croup score (change baseline ‐ 6 hours) by score" data-id="CD001955-fig-0007" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 2: Croup score (change baseline ‐ 6 hours) by score </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 3: Croup score (change baseline ‐ 12 hours) by score" data-id="CD001955-fig-0008" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 3: Croup score (change baseline ‐ 12 hours) by score </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 4: Croup score (change baseline ‐ 24 hours) by score" data-id="CD001955-fig-0009" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 4: Croup score (change baseline ‐ 24 hours) by score </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 5: Croup score (change baseline ‐ 2 hours) by inpatient/outpatient" data-id="CD001955-fig-0010" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 5: Croup score (change baseline ‐ 2 hours) by inpatient/outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 6: Croup score (change baseline ‐ 6 hours) by inpatient/outpatient" data-id="CD001955-fig-0011" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 6: Croup score (change baseline ‐ 6 hours) by inpatient/outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 7: Croup score (change baseline ‐ 24 hours) by inpatient/outpatient" data-id="CD001955-fig-0012" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 7: Croup score (change baseline ‐ 24 hours) by inpatient/outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 8: Croup score (change baseline ‐ 2 hours) by glucocorticoid" data-id="CD001955-fig-0013" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 8: Croup score (change baseline ‐ 2 hours) by glucocorticoid </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 9: Croup score (change baseline ‐ 6 hours) by glucocorticoid" data-id="CD001955-fig-0014" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 9: Croup score (change baseline ‐ 6 hours) by glucocorticoid </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 10: Croup score (change baseline ‐ 12 hours) by glucocorticoid" data-id="CD001955-fig-0015" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 10: Croup score (change baseline ‐ 12 hours) by glucocorticoid </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 11: Croup score (change baseline ‐ 24 hours) by glucocorticoid" data-id="CD001955-fig-0016" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 11: Croup score (change baseline ‐ 24 hours) by glucocorticoid </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 12: Return visits or (re)admissions or both by inpatient/outpatient" data-id="CD001955-fig-0017" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 12: Return visits or (re)admissions or both by inpatient/outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 13: Return visits or (re)admissions or both by glucocorticoid" data-id="CD001955-fig-0018" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 13: Return visits or (re)admissions or both by glucocorticoid </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 14: Return visits or (re)admissions or both by croup severity" data-id="CD001955-fig-0019" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 14: Return visits or (re)admissions or both by croup severity </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 15: Length of stay by inpatient" data-id="CD001955-fig-0020" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 15: Length of stay by inpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 16: Length of stay by glucocorticoid" data-id="CD001955-fig-0021" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 16: Length of stay by glucocorticoid </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.17" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 17: Improvement (at 2 hours) by inpatient" data-id="CD001955-fig-0022" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.17.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 17: Improvement (at 2 hours) by inpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.17.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.18" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 18: Improvement (at 6 hours) by inpatient/outpatient" data-id="CD001955-fig-0023" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.18.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.18.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 18: Improvement (at 6 hours) by inpatient/outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.18.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.19" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 19: Improvement (at 12 hours) by inpatient" data-id="CD001955-fig-0024" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.19.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.19.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 19: Improvement (at 12 hours) by inpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.19.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.20" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 20: Improvement (at 24 hours) by inpatient/outpatient" data-id="CD001955-fig-0025" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.20.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.20.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 20: Improvement (at 24 hours) by inpatient/outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.20.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.21" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 21: Improvement (at 6 hours) by glucocorticoid" data-id="CD001955-fig-0026" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.21.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.21.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 21: Improvement (at 6 hours) by glucocorticoid </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.21.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.22" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 22: Improvement (at 12 hours) by glucocorticoid" data-id="CD001955-fig-0027" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.22.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.22.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 22: Improvement (at 12 hours) by glucocorticoid </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.22.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.23" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 23: Improvement (at 24 hours) by glucocorticoid" data-id="CD001955-fig-0028" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.23.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.23.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 23: Improvement (at 24 hours) by glucocorticoid </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.23.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.24" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 24: Additional treatments: antibiotics" data-id="CD001955-fig-0029" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.24.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.24.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 24: Additional treatments: antibiotics </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.24.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.25" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 25: Additional treatments: epinephrine" data-id="CD001955-fig-0030" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.25.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.25.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 25: Additional treatments: epinephrine </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.25.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.26" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 26: Additional treatments: intubation/tracheostomy" data-id="CD001955-fig-0031" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.26.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.26.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.26</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 26: Additional treatments: intubation/tracheostomy </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.26.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.27" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 27: Additional treatments: mist tent" data-id="CD001955-fig-0032" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.27.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.27.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.27</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 27: Additional treatments: mist tent </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.27.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-001.28" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any glucocorticoid compared to placebo, Outcome 28: Additional treatments: supplemental glucocorticoids" data-id="CD001955-fig-0033" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.28.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-001.28.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.28</div> <div class="figure-caption"> <p>Comparison 1: Any glucocorticoid compared to placebo, Outcome 28: Additional treatments: supplemental glucocorticoids </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-001.28.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any glucocorticoid compared to epinephrine, Outcome 1: Croup score (change baseline ‐ 2 hours) by inpatient/outpatient" data-id="CD001955-fig-0034" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Any glucocorticoid compared to epinephrine, Outcome 1: Croup score (change baseline ‐ 2 hours) by inpatient/outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any glucocorticoid compared to epinephrine, Outcome 2: Croup score (change baseline ‐ 6 hours) by inpatient" data-id="CD001955-fig-0035" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Any glucocorticoid compared to epinephrine, Outcome 2: Croup score (change baseline ‐ 6 hours) by inpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any glucocorticoid compared to epinephrine, Outcome 3: Croup score (change baseline ‐ 12 hours) by inpatient" data-id="CD001955-fig-0036" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Any glucocorticoid compared to epinephrine, Outcome 3: Croup score (change baseline ‐ 12 hours) by inpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any glucocorticoid compared to epinephrine, Outcome 4: Croup score (change baseline ‐ 24 hours) by inpatient" data-id="CD001955-fig-0037" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Any glucocorticoid compared to epinephrine, Outcome 4: Croup score (change baseline ‐ 24 hours) by inpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any glucocorticoid compared to epinephrine, Outcome 5: Croup score (change baseline ‐ 2 hours) by glucocorticoid" data-id="CD001955-fig-0038" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Any glucocorticoid compared to epinephrine, Outcome 5: Croup score (change baseline ‐ 2 hours) by glucocorticoid </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any glucocorticoid compared to epinephrine, Outcome 6: Croup score (change baseline ‐ 12 hours) by glucocorticoid" data-id="CD001955-fig-0039" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Any glucocorticoid compared to epinephrine, Outcome 6: Croup score (change baseline ‐ 12 hours) by glucocorticoid </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any glucocorticoid compared to epinephrine, Outcome 7: Croup score (change baseline ‐ 24 hours) by glucocorticoid" data-id="CD001955-fig-0040" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: Any glucocorticoid compared to epinephrine, Outcome 7: Croup score (change baseline ‐ 24 hours) by glucocorticoid </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-002.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any glucocorticoid compared to epinephrine, Outcome 8: Return visits or (re)admissions or both by inpatient/outpatient" data-id="CD001955-fig-0041" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-002.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-002.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2: Any glucocorticoid compared to epinephrine, Outcome 8: Return visits or (re)admissions or both by inpatient/outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-002.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-002.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any glucocorticoid compared to epinephrine, Outcome 9: Length of stay by inpatient" data-id="CD001955-fig-0042" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-002.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-002.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2: Any glucocorticoid compared to epinephrine, Outcome 9: Length of stay by inpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-002.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-002.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any glucocorticoid compared to epinephrine, Outcome 10: Additional treatments: epinephrine" data-id="CD001955-fig-0043" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-002.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-002.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2: Any glucocorticoid compared to epinephrine, Outcome 10: Additional treatments: epinephrine </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-002.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-002.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any glucocorticoid compared to epinephrine, Outcome 11: Additional treatments: intubation/tracheostomy" data-id="CD001955-fig-0044" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-002.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-002.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2: Any glucocorticoid compared to epinephrine, Outcome 11: Additional treatments: intubation/tracheostomy </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-002.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-002.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any glucocorticoid compared to epinephrine, Outcome 12: Additional treatments: supplemental glucocorticoids" data-id="CD001955-fig-0045" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-002.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-002.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.12</div> <div class="figure-caption"> <p>Comparison 2: Any glucocorticoid compared to epinephrine, Outcome 12: Additional treatments: supplemental glucocorticoids </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-002.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Dexamethasone compared to budesonide, Outcome 1: Croup score (change baseline ‐ 6 hours) by inpatient/outpatient" data-id="CD001955-fig-0046" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Dexamethasone compared to budesonide, Outcome 1: Croup score (change baseline ‐ 6 hours) by inpatient/outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Dexamethasone compared to budesonide, Outcome 2: Croup score (change baseline ‐ 12 hours) by inpatient" data-id="CD001955-fig-0047" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Dexamethasone compared to budesonide, Outcome 2: Croup score (change baseline ‐ 12 hours) by inpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Dexamethasone compared to budesonide, Outcome 3: Return visits or (re)admissions or both by inpatient/outpatient" data-id="CD001955-fig-0048" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Dexamethasone compared to budesonide, Outcome 3: Return visits or (re)admissions or both by inpatient/outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Dexamethasone compared to budesonide, Outcome 4: Length of stay by inpatient/outpatient" data-id="CD001955-fig-0049" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: Dexamethasone compared to budesonide, Outcome 4: Length of stay by inpatient/outpatient</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-003.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Dexamethasone compared to budesonide, Outcome 5: Improvement (at 6 hours) by outpatient" data-id="CD001955-fig-0050" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-003.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-003.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3: Dexamethasone compared to budesonide, Outcome 5: Improvement (at 6 hours) by outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-003.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-003.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Dexamethasone compared to budesonide, Outcome 6: Additional treatments: epinephrine" data-id="CD001955-fig-0051" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-003.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-003.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3: Dexamethasone compared to budesonide, Outcome 6: Additional treatments: epinephrine </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-003.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-003.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Dexamethasone compared to budesonide, Outcome 7: Additional treatments: intubation/tracheostomy" data-id="CD001955-fig-0052" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-003.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-003.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3: Dexamethasone compared to budesonide, Outcome 7: Additional treatments: intubation/tracheostomy </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-003.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-003.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Dexamethasone compared to budesonide, Outcome 8: Additional treatments: supplemental glucocorticoids" data-id="CD001955-fig-0053" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-003.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-003.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3: Dexamethasone compared to budesonide, Outcome 8: Additional treatments: supplemental glucocorticoids </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-003.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Dexamethasone compared to beclomethasone, Outcome 1: Return visits or (re)admissions or both by outpatient" data-id="CD001955-fig-0054" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Dexamethasone compared to beclomethasone, Outcome 1: Return visits or (re)admissions or both by outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Dexamethasone compared to betamethasone, Outcome 1: Croup score (change baseline ‐ 2 hours) by outpatient" data-id="CD001955-fig-0055" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: Dexamethasone compared to betamethasone, Outcome 1: Croup score (change baseline ‐ 2 hours) by outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Dexamethasone compared to betamethasone, Outcome 2: Croup score (change baseline ‐ 6 hours) by outpatient" data-id="CD001955-fig-0056" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: Dexamethasone compared to betamethasone, Outcome 2: Croup score (change baseline ‐ 6 hours) by outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-005.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Dexamethasone compared to betamethasone, Outcome 3: Return visits or (re)admissions or both by outpatient" data-id="CD001955-fig-0057" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-005.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-005.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5: Dexamethasone compared to betamethasone, Outcome 3: Return visits or (re)admissions or both by outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-005.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-005.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Dexamethasone compared to betamethasone, Outcome 4: Additional treatments: epinephrine" data-id="CD001955-fig-0058" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-005.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-005.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5: Dexamethasone compared to betamethasone, Outcome 4: Additional treatments: epinephrine </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-005.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Dexamethasone compared to prednisolone, Outcome 1: Croup score (change baseline ‐ 2 hours) by outpatient" data-id="CD001955-fig-0059" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: Dexamethasone compared to prednisolone, Outcome 1: Croup score (change baseline ‐ 2 hours) by outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-006.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Dexamethasone compared to prednisolone, Outcome 2: Croup score (change baseline ‐ 6 hours) by outpatient" data-id="CD001955-fig-0060" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-006.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-006.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6: Dexamethasone compared to prednisolone, Outcome 2: Croup score (change baseline ‐ 6 hours) by outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-006.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-006.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Dexamethasone compared to prednisolone, Outcome 3: Return visits or (re)admissions or both by outpatient" data-id="CD001955-fig-0061" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-006.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-006.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6: Dexamethasone compared to prednisolone, Outcome 3: Return visits or (re)admissions or both by outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-006.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-006.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Dexamethasone compared to prednisolone, Outcome 4: Length of stay by outpatient" data-id="CD001955-fig-0062" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-006.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-006.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6: Dexamethasone compared to prednisolone, Outcome 4: Length of stay by outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-006.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-006.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Dexamethasone compared to prednisolone, Outcome 5: Additional treatments: epinephrine" data-id="CD001955-fig-0063" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-006.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-006.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6: Dexamethasone compared to prednisolone, Outcome 5: Additional treatments: epinephrine </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-006.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-006.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Dexamethasone compared to prednisolone, Outcome 6: Additional treatments: intubation/tracheotomy" data-id="CD001955-fig-0064" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-006.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-006.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6: Dexamethasone compared to prednisolone, Outcome 6: Additional treatments: intubation/tracheotomy </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-006.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-006.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Dexamethasone compared to prednisolone, Outcome 7: Additional treatments: supplemental glucocorticoids" data-id="CD001955-fig-0065" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-006.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-006.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.7</div> <div class="figure-caption"> <p>Comparison 6: Dexamethasone compared to prednisolone, Outcome 7: Additional treatments: supplemental glucocorticoids </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-006.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-007.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Budesonide and dexamethasone compared to dexamethasone, Outcome 1: Croup score (change baseline ‐ 6 hours) by inpatient/outpatient" data-id="CD001955-fig-0066" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-007.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-007.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7: Budesonide and dexamethasone compared to dexamethasone, Outcome 1: Croup score (change baseline ‐ 6 hours) by inpatient/outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-007.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-007.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Budesonide and dexamethasone compared to dexamethasone, Outcome 2: Return visits or (re)admissions or both by inpatient/outpatient" data-id="CD001955-fig-0067" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-007.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-007.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7: Budesonide and dexamethasone compared to dexamethasone, Outcome 2: Return visits or (re)admissions or both by inpatient/outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-007.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-007.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Budesonide and dexamethasone compared to dexamethasone, Outcome 3: Length of stay by inpatient/outpatient" data-id="CD001955-fig-0068" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-007.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-007.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7: Budesonide and dexamethasone compared to dexamethasone, Outcome 3: Length of stay by inpatient/outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-007.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-007.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Budesonide and dexamethasone compared to dexamethasone, Outcome 4: Improvement (at 6 hours) by outpatient" data-id="CD001955-fig-0069" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-007.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-007.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7: Budesonide and dexamethasone compared to dexamethasone, Outcome 4: Improvement (at 6 hours) by outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-007.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-007.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Budesonide and dexamethasone compared to dexamethasone, Outcome 5: Additional treatments: epinephrine" data-id="CD001955-fig-0070" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-007.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-007.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.5</div> <div class="figure-caption"> <p>Comparison 7: Budesonide and dexamethasone compared to dexamethasone, Outcome 5: Additional treatments: epinephrine </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-007.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-007.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Budesonide and dexamethasone compared to dexamethasone, Outcome 6: Additional treatments: mist tent" data-id="CD001955-fig-0071" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-007.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-007.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.6</div> <div class="figure-caption"> <p>Comparison 7: Budesonide and dexamethasone compared to dexamethasone, Outcome 6: Additional treatments: mist tent </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-007.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-007.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Budesonide and dexamethasone compared to dexamethasone, Outcome 7: Additional treatments: supplemental glucocorticoids" data-id="CD001955-fig-0072" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-007.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-007.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.7</div> <div class="figure-caption"> <p>Comparison 7: Budesonide and dexamethasone compared to dexamethasone, Outcome 7: Additional treatments: supplemental glucocorticoids </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-007.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-008.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Budesonide and dexamethasone compared to budesonide, Outcome 1: Croup score (change baseline ‐ 6 hours) by outpatient" data-id="CD001955-fig-0073" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-008.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-008.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8: Budesonide and dexamethasone compared to budesonide, Outcome 1: Croup score (change baseline ‐ 6 hours) by outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-008.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-008.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Budesonide and dexamethasone compared to budesonide, Outcome 2: Return visits or (re)admissions or both by outpatient" data-id="CD001955-fig-0074" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-008.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-008.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8: Budesonide and dexamethasone compared to budesonide, Outcome 2: Return visits or (re)admissions or both by outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-008.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-008.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Budesonide and dexamethasone compared to budesonide, Outcome 3: Length of stay by outpatient" data-id="CD001955-fig-0075" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-008.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-008.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8: Budesonide and dexamethasone compared to budesonide, Outcome 3: Length of stay by outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-008.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-008.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Budesonide and dexamethasone compared to budesonide, Outcome 4: Improvement (at 6 hours) by outpatient" data-id="CD001955-fig-0076" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-008.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-008.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8: Budesonide and dexamethasone compared to budesonide, Outcome 4: Improvement (at 6 hours) by outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-008.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-008.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Budesonide and dexamethasone compared to budesonide, Outcome 5: Additional treatments: epinephrine" data-id="CD001955-fig-0077" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-008.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-008.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.5</div> <div class="figure-caption"> <p>Comparison 8: Budesonide and dexamethasone compared to budesonide, Outcome 5: Additional treatments: epinephrine </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-008.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-008.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Budesonide and dexamethasone compared to budesonide, Outcome 6: Additional treatments: supplemental glucocorticoids" data-id="CD001955-fig-0078" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-008.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-008.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.6</div> <div class="figure-caption"> <p>Comparison 8: Budesonide and dexamethasone compared to budesonide, Outcome 6: Additional treatments: supplemental glucocorticoids </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-008.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-009.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Oral compared to intramuscular dexamethasone, Outcome 1: Return visits or (re)admissions or both by outpatient" data-id="CD001955-fig-0079" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-009.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-009.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9: Oral compared to intramuscular dexamethasone, Outcome 1: Return visits or (re)admissions or both by outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-009.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-009.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Oral compared to intramuscular dexamethasone, Outcome 2: Improvement (at 24 hours) by outpatient" data-id="CD001955-fig-0080" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-009.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-009.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9: Oral compared to intramuscular dexamethasone, Outcome 2: Improvement (at 24 hours) by outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-009.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-009.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Oral compared to intramuscular dexamethasone, Outcome 3: Additional treatments: antibiotics" data-id="CD001955-fig-0081" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-009.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-009.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9: Oral compared to intramuscular dexamethasone, Outcome 3: Additional treatments: antibiotics </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-009.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-009.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Oral compared to intramuscular dexamethasone, Outcome 4: Additional treatments: epinephrine" data-id="CD001955-fig-0082" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-009.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-009.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9: Oral compared to intramuscular dexamethasone, Outcome 4: Additional treatments: epinephrine </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-009.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-009.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Oral compared to intramuscular dexamethasone, Outcome 5: Additional treatments: mist tent" data-id="CD001955-fig-0083" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-009.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-009.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.5</div> <div class="figure-caption"> <p>Comparison 9: Oral compared to intramuscular dexamethasone, Outcome 5: Additional treatments: mist tent </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-009.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-009.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Oral compared to intramuscular dexamethasone, Outcome 6: Additional treatments: supplemental glucocorticoids" data-id="CD001955-fig-0084" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-009.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-009.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.6</div> <div class="figure-caption"> <p>Comparison 9: Oral compared to intramuscular dexamethasone, Outcome 6: Additional treatments: supplemental glucocorticoids </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-009.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-010.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Oral compared to nebulised dexamethasone, Outcome 1: Return visits or (re)admissions or both by outpatient" data-id="CD001955-fig-0085" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-010.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-010.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10: Oral compared to nebulised dexamethasone, Outcome 1: Return visits or (re)admissions or both by outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-010.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-011.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 11: Dexamethasone 0.30 mg/kg compared to 0.15 mg/kg, Outcome 1: Return visits or (re)admissions or both by outpatient" data-id="CD001955-fig-0086" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-011.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-011.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11: Dexamethasone 0.30 mg/kg compared to 0.15 mg/kg, Outcome 1: Return visits or (re)admissions or both by outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-011.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-011.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 11: Dexamethasone 0.30 mg/kg compared to 0.15 mg/kg, Outcome 2: Additional treatments: epinephrine" data-id="CD001955-fig-0087" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-011.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-011.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.2</div> <div class="figure-caption"> <p>Comparison 11: Dexamethasone 0.30 mg/kg compared to 0.15 mg/kg, Outcome 2: Additional treatments: epinephrine </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-011.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-011.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 11: Dexamethasone 0.30 mg/kg compared to 0.15 mg/kg, Outcome 3: Additional treatments: supplemental glucocorticoids" data-id="CD001955-fig-0088" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-011.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-011.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.3</div> <div class="figure-caption"> <p>Comparison 11: Dexamethasone 0.30 mg/kg compared to 0.15 mg/kg, Outcome 3: Additional treatments: supplemental glucocorticoids </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-011.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0089"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-012.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: Dexamethasone 0.60 mg/kg compared to 0.30 mg/kg, Outcome 1: Return visits or (re)admissions or both by outpatient" data-id="CD001955-fig-0089" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-012.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-012.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.1</div> <div class="figure-caption"> <p>Comparison 12: Dexamethasone 0.60 mg/kg compared to 0.30 mg/kg, Outcome 1: Return visits or (re)admissions or both by outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0089">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-012.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-012.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: Dexamethasone 0.60 mg/kg compared to 0.30 mg/kg, Outcome 2: Additional treatments: epinephrine" data-id="CD001955-fig-0090" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-012.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-012.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.2</div> <div class="figure-caption"> <p>Comparison 12: Dexamethasone 0.60 mg/kg compared to 0.30 mg/kg, Outcome 2: Additional treatments: epinephrine </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-012.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0091"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-012.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: Dexamethasone 0.60 mg/kg compared to 0.30 mg/kg, Outcome 3: Additional treatments: supplemental glucocorticoids" data-id="CD001955-fig-0091" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-012.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-012.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.3</div> <div class="figure-caption"> <p>Comparison 12: Dexamethasone 0.60 mg/kg compared to 0.30 mg/kg, Outcome 3: Additional treatments: supplemental glucocorticoids </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0091">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-012.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0092"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-013.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: Dexamethasone 0.60 mg/kg compared to 0.15 mg/kg, Outcome 1: Croup score (Westley) (change baseline ‐ 2 hours) by inpatient/outpatient" data-id="CD001955-fig-0092" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-013.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-013.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.1</div> <div class="figure-caption"> <p>Comparison 13: Dexamethasone 0.60 mg/kg compared to 0.15 mg/kg, Outcome 1: Croup score (Westley) (change baseline ‐ 2 hours) by inpatient/outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0092">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-013.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0093"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-013.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: Dexamethasone 0.60 mg/kg compared to 0.15 mg/kg, Outcome 2: Croup score (change baseline ‐ 6 hours) by inpatient/outpatient" data-id="CD001955-fig-0093" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-013.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-013.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.2</div> <div class="figure-caption"> <p>Comparison 13: Dexamethasone 0.60 mg/kg compared to 0.15 mg/kg, Outcome 2: Croup score (change baseline ‐ 6 hours) by inpatient/outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0093">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-013.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0094"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-013.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: Dexamethasone 0.60 mg/kg compared to 0.15 mg/kg, Outcome 3: Croup score (change baseline ‐ 12 hours) by inpatient/outpatient" data-id="CD001955-fig-0094" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-013.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-013.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.3</div> <div class="figure-caption"> <p>Comparison 13: Dexamethasone 0.60 mg/kg compared to 0.15 mg/kg, Outcome 3: Croup score (change baseline ‐ 12 hours) by inpatient/outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0094">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-013.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0095"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-013.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: Dexamethasone 0.60 mg/kg compared to 0.15 mg/kg, Outcome 4: Croup score (change baseline ‐ 24 hours) by outpatient" data-id="CD001955-fig-0095" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-013.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-013.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.4</div> <div class="figure-caption"> <p>Comparison 13: Dexamethasone 0.60 mg/kg compared to 0.15 mg/kg, Outcome 4: Croup score (change baseline ‐ 24 hours) by outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0095">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-013.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0096"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-013.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: Dexamethasone 0.60 mg/kg compared to 0.15 mg/kg, Outcome 5: Return visits or (re)admissions or both by outpatient" data-id="CD001955-fig-0096" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-013.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-013.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.5</div> <div class="figure-caption"> <p>Comparison 13: Dexamethasone 0.60 mg/kg compared to 0.15 mg/kg, Outcome 5: Return visits or (re)admissions or both by outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0096">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-013.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0097"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-013.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: Dexamethasone 0.60 mg/kg compared to 0.15 mg/kg, Outcome 6: Length of stay by outpatient" data-id="CD001955-fig-0097" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-013.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-013.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.6</div> <div class="figure-caption"> <p>Comparison 13: Dexamethasone 0.60 mg/kg compared to 0.15 mg/kg, Outcome 6: Length of stay by outpatient </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0097">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-013.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0098"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-013.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: Dexamethasone 0.60 mg/kg compared to 0.15 mg/kg, Outcome 7: Additional treatments: epinephrine" data-id="CD001955-fig-0098" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-013.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-013.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.7</div> <div class="figure-caption"> <p>Comparison 13: Dexamethasone 0.60 mg/kg compared to 0.15 mg/kg, Outcome 7: Additional treatments: epinephrine </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0098">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-013.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0099"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-013.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: Dexamethasone 0.60 mg/kg compared to 0.15 mg/kg, Outcome 8: Additional treatments: intubation/tracheotomy" data-id="CD001955-fig-0099" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-013.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-013.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.8</div> <div class="figure-caption"> <p>Comparison 13: Dexamethasone 0.60 mg/kg compared to 0.15 mg/kg, Outcome 8: Additional treatments: intubation/tracheotomy </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0099">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-013.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001955-fig-0100"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/urn:x-wiley:14651858:media:CD001955:CD001955-CMP-013.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: Dexamethasone 0.60 mg/kg compared to 0.15 mg/kg, Outcome 9: Additional treatments: supplemental glucocorticoids" data-id="CD001955-fig-0100" src="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-013.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_t/tCD001955-CMP-013.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.9</div> <div class="figure-caption"> <p>Comparison 13: Dexamethasone 0.60 mg/kg compared to 0.15 mg/kg, Outcome 9: Additional treatments: supplemental glucocorticoids </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-fig-0100">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/media/CDSR/CD001955/image_n/nCD001955-CMP-013.09.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD001955-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Any glucocorticoid compared to placebo for croup</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Any glucocorticoid compared to placebo for croup</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> any glucocorticoid<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments**</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Placebo</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Any glucocorticoid</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with different scores in different studies. Lower scores mean fewer symptoms.  </p> <p>(Follow‐up: 2 hours) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−1.50 to −0.81</b>. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.65 standard deviations in favour</b><br/>(1.13 more to 0.18 more). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>426<br/>(7 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A standard deviation of 0.65 represents a moderate difference between groups. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with different scores in different studies. Lower scores mean fewer symptoms. </p> <p>(Follow‐up: 6 hours)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−3.23 to −0.65</b>. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.76 standard deviations in favour</b><br/>(1.12 more to 0.40 more). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>‐</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>959<br/>(11 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A standard deviation of 0.76 represents a large difference between groups. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with different scores in different studies. Lower scores mean fewer symptoms.  </p> <p>(Follow‐up: 12 hours)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−7.62 to −1.00</b>. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>1.03 standard deviations in favour</b><br/>(1.53 more to 0.53 more). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>571<br/>(8 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>e,f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A standard deviation of 1.03 represents a large difference between groups.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with different scores in different studies. Lower scores mean fewer symptoms.  </p> <p>(Follow‐up: 24 hours)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−2.56 to −1.05</b>. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.86 standard deviations in favour</b><br/>(1.40 more to 0.31 more). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>‐</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>351<br/>(8 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>g,h</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A standard deviation of 0.86 represents a large difference between groups. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>204 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>106 per 1000</b><br/>(74 to 153) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.52</b><br/>(0.36 to 0.75) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1679<br/>(10 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>i,j</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>13/26 (50%) studies reported collecting adverse events data, and 8/13 (62%) reported no serious adverse events. <a href="./references#CD001955-bbs2-0003" title="BjornsonC , KlassenTP , WilliamsonJ , BrantR , PlintA , BullochB , et al. A randomized trial of single dose of oral dexamethasone for mild croup. New England Journal of Medicine2004;351(13):1306-13. ">Bjornson 2004</a> reported 7 instances of pneumonia (3/359, 0.83% in the dexamethasone group and 4/361, 1.11% in the placebo group). <a href="./references#CD001955-bbs2-0025" title="JohnsonDW , SchuhS , KorenG , JaffeeDM . Outpatient treatment of croup with nebulized dexamethasone. Archives of Pediatrics &amp; Adolescent Medicine1996;150(4):349-55. ">Johnson 1996</a> reported 1 child with neutropenia consistent with bacterial tracheitis in the dexamethasone group (1/28, 3.57%). <a href="./references#CD001955-bbs2-0031" title="KuuselaAL , VesikariT . A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatrica Scandinavica1988;77(1):99-104. ">Kuusela 1988</a> reported 7 secondary bacterial infections (pneumonia, sinusitis, otitis media) requiring antibiotic therapy: 5/35, 14% in the dexamethasone group and 2/16, 12.5% in the placebo group. <a href="./references#CD001955-bbs2-0045" title="SuperDM , CartelliNA , BrooksLJ , LemboRM , KumarML . A prospective randomized double‐blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. Journal of Pediatrics1989;115(2):323-9. ">Super 1989</a> reported 1 child with pneumonitis in the placebo group (1/13, 7.7%) and 2 children with pneumonia in the dexamethasone group (2/16, 12.5%). <a href="./references#CD001955-bbs2-0038" title="RobertsGW , MasterVV , StaugasRE , RaftosJV , ParsonsDW , CoulthardKP , et al. Repeated dose inhaled budesonide versus placebo in the treatment of croup. Journal of Paediatrics and Child Health1999;35(2):170-4. ">Roberts 1999</a> reported 1 instance of exacerbated symptoms, 5 children with emotional distress, 2 with vomiting, and 1 instance of eye irritation in the budesonide group (9/42, 21.4%), and 3 instances of exacerbated symptoms, 6 children with emotional distress, 3 with vomiting, 2 rashes, and 1 instance each of eye irritation and tongue irritation in the placebo group (16/40, 40%).  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1399</p> <p>(13 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>k,l</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/>**We used Cohen's interpretation of effect sizes to determine the magnitude of the difference between groups (0.2 represents a small effect, 0.5 represents a medium effect, 0.8 represents a large effect).  </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for inconsistency. There was considerable heterogeneity (I² = 81%), and variation in point estimates.<br/><sup>b</sup>We downgraded by one level for risk of bias. The contributing studies were at high (n = 3) and unclear (n = 4) risk of bias.<br/><sup>c</sup>We downgraded by one level for inconsistency. There was considerable heterogeneity (I² = 83%), and variation in point estimates and in direction of effects for one study.<br/><sup>d</sup>We downgraded by one level for risk of bias. The contributing studies were at high (n = 3) and unclear (n = 8) risk of bias.<br/><sup>e</sup>We downgraded by one level for inconsistency. There was considerable heterogeneity (I² = 86%), and variation in point estimates.<br/><sup>f</sup>We downgraded by one level for risk of bias. The contributing studies were at high (n = 2) and unclear (n = 6) risk of bias.<br/><sup>g</sup>We downgraded by two levels for inconsistency. There was considerable heterogeneity (I² = 81%), and variation in point estimates. The confidence intervals did not overlap for some studies. There was variation in the direction of effects.<br/><sup>h</sup>We downgraded by one level for risk of bias. The contributing studies were at high (n = 2) and unclear (n = 6) risk of bias.<br/><sup>i</sup>We downgraded by one level for inconsistency. There was substantial heterogeneity (I² = 52%), and variation in point estimates.<br/><sup>j</sup>We downgraded by one level for risk of bias. The contributing studies were at high (n = 3) and unclear (n = 7) risk of bias.<br/><sup>k</sup>We downgraded by one level for imprecision. Narrative synthesis conducted, estimates are not precise.<br/><sup>l</sup>We downgraded by one level for risk of bias. The contributing studies were at high (n = 2) and unclear (n = 11) risk of bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Any glucocorticoid compared to placebo for croup</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001955-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Any glucocorticoid compared to epinephrine for croup </span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Any glucocorticoid compared to epinephrine for croup</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> any glucocorticoid<br/><b>Comparison:</b> epinephrine </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments**</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Epinephrine</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Any glucocorticoid</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with different scores in different studies. Lower scores mean fewer symptoms.  </p> <p>(Follow‐up: 2 hours)<br/>  </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−4.24 to −3.74</b>. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.77 standard deviations not in favour</b><br/>(0.24 more to 1.77 less). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A standard deviation of 0.77 represents a large difference between groups.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with different scores in different studies. Lower scores mean fewer symptoms. </p> <p>(Follow‐up: 6 hours)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−1.25 to −1.10</b>. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.10 standard deviations in favour</b><br/>(1.18 more to 0.97 less). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>‐</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>d,e,f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A standard deviation of 0.10 represents a minimal difference between groups.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with different scores in different studies. Lower scores mean fewer symptoms.  </p> <p>(Follow‐up: 12 hours)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−3.86 to −1.45</b>. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.07 standard deviations in favour</b><br/>(0.57 more to 0.43 less). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>g,h</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A standard deviation of 0.07 represents a minimal difference between groups.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with different scores in different studies. Lower scores mean fewer symptoms.  </p> <p>(Follow‐up: 24 hours)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−4.40 to −2.01</b>. </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.17 standard deviations not in favour</b><br/>(0.18 more to 0.51 less). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>g,i</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A standard deviation of 0.17 represents a small difference between groups.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/>(0 to 0) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RD 0.00</b><br/>(−0.04 to 0.04) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>g,j</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>3/4 (75%) studies reported collecting adverse events data. <a href="./references#CD001955-bbs2-0014" title="FitzgeraldD , MellisC , JohnsonM , AllenH , CooperP , Van AsperenP . Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics1996;97(5):722-5. ">Fitzgerald 1996</a> reported no serious adverse events. <a href="./references#CD001955-bbs2-0031" title="KuuselaAL , VesikariT . A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatrica Scandinavica1988;77(1):99-104. ">Kuusela 1988</a> reported 5 cases of secondary bacterial infections (pneumonia, sinusitis, otitis media) requiring antibiotic therapy in the dexamethasone group (5/16, 31.3%). <a href="./references#CD001955-bbs2-0010" title="EboriadouM , ChryssanthopoulouD , StamoulisP , DamianidouL , HaidopoulouK . The effectiveness of local corticosteroids therapy in the management of mild to moderate viral croup. Minerva Pediatrica2010;62(1):23-8. ">Eboriadou 2010</a> reported 4 cases of tremor and tachycardia (4/25, 16%) in the epinephrine group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>162<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>k,l,</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/>**We used Cohen's interpretation of effect sizes to determine the magnitude of the difference between groups (0.2 represents a small effect, 0.5 represents a medium effect, 0.8 represents a large effect).  </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RD:</b> risk difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for inconsistency. There was considerable heterogeneity (I² = 87%), and variation in point estimates. There was minimal overlap of the confidence intervals.<br/><sup>b</sup>We downgraded by one level for imprecision. The sample size was small (did not meet the optimal information size). The effect estimate included both the null effect and a clinically important benefit for epinephrine compared to glucocorticoids.<br/><sup>c</sup>We downgraded by one level for risk of bias. The contributing studies were at high risk of bias (n = 2).<br/><sup>d</sup>We downgraded by two levels for inconsistency. There was considerable heterogeneity (I² = 78%), and variation in point estimates and in the direction of effects.<br/><sup>e</sup>We downgraded by one level for imprecision. The sample size was small (did not meet optimal information size). The effect estimate included both the null effect and a clinically important effect for glucocorticoids compared to epinephrine.<br/><sup>f</sup>We downgraded by one level for risk of bias. The contributing studies were at unclear risk of bias (n = 2).<br/><sup>g</sup>We downgraded by one level for imprecision. The sample size was small (did not meet optimal information size).<br/><sup>h</sup>We downgraded by one level for risk of bias. The contributing studies were at high (n = 1) and unclear (n = 2) risk of bias.<br/><sup>i</sup>We downgraded by one level for risk of bias. The contributing studies were at high (n = 1) and unclear (n = 2) risk of bias.<br/><sup>j</sup>We downgraded by one level for risk of bias. The contributing studies were at high risk of bias (n = 2).<br/><sup>k</sup>We downgraded by one level for imprecision. Narrative synthesis was conducted, estimates are not precise.<br/><sup>l</sup>We downgraded by one level for risk of bias. The contributing studies were at high (n = 2) and unclear (n = 1) risk of bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Any glucocorticoid compared to epinephrine for croup </span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001955-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Number needed to treat for an additional beneficial outcome for return visits or (re)admissions or both for any glucocorticoid compared to placebo </span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Baseline rate (%) </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>NNTB (95% CI)</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Mean baseline rate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30.62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 (5 to 12)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Smallest baseline rate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.06</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>102 (78 to 179)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>Largest baseline rate</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (2 to 5)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>NNTB: number needed to treat for an additional beneficial outcome</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Number needed to treat for an additional beneficial outcome for return visits or (re)admissions or both for any glucocorticoid compared to placebo </span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001955-tbl-0004"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Dexamethasone compared to budesonide for croup</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Dexamethasone compared to budesonide for croup</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> dexamethasone<br/><b>Comparison:</b> budesonide </p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments**</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Budesonide</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with different scores in different studies. Lower scores mean fewer symptoms.  </p> <p>(Follow‐up: 6 hours)<br/>  </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−2.93 to −2.00</b>. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.46 standard deviations in favour</b> (0.79 more to 0.13 more). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>326<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A standard deviation of 0.46 represents a moderate difference between groups.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with different scores in different studies. Lower scores mean fewer symptoms.  </p> <p>(Follow‐up: 12 hours)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−3.07 to −2.33</b>. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.75 standard deviations in favour</b> (1.19 more to 0.30 more). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A standard deviation of 0.75 represents a large difference between groups.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.69</b><br/>(0.40 to 1.22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>374<br/>(5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>122 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>84 per 1000</b> </p> <p>(49 to 149)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>4/6 (67%) studies reported collecting adverse events data, and 3/4 (75%) studies reported no serious adverse events (<a href="./references#CD001955-bbs2-0009" title="DumanM , OzdemirD , AtaseverS . Nebulized L-epinephrine and steroid combination in the treatment of moderate to severe croup. Clinical Drug Investigation2005;25(3):183-9. ">Duman 2005</a>; <a href="./references#CD001955-bbs2-0026" title="JohnsonDW , JacobsonS , EdneyPC , HadfieldP , MundyME , SchuhS . A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. New England Journal of Medicine1998;339(8):498-503. ">Johnson 1998</a>; <a href="./references#CD001955-bbs2-0047" title="Vad PedersenL , DahlM , Falk-PetersenHE , LarsenSE . Inhaled budesonide versus intramuscular dexamethasone in the treatment of pseudocroup [Inhaleret budesonid versus dexamethasone i.m. til behandling at pseudocroup]. Ugeskrift for Laeger1998;160(15):2253-6. ">Vad Pedersen 1998</a>). <a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a> reported 1 case of oral thrush in the budesonide group (1/65, 1.5%) and 1 case each of hives and violent behaviour in the dexamethasone group (2/69, 2.9%). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>335</p> <p>(4 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>f,g</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/>**We used Cohen's interpretation of effect sizes to determine the magnitude of the difference between groups (0.2 represents a small effect, 0.5 represents a medium effect, 0.8 represents a large effect).  </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for risk of bias. The contributing studies were at high (n = 2) and unclear (n = 2) risk of bias. Allocation concealment was unclear in two studies; blinding was unclear in two studies; and one study was unblinded. There was a baseline imbalance in croup score in one study.<br/><sup>b</sup>We downgraded by one level for inconsistency. There was substantial heterogeneity (I² = 51%), and variation in point estimates.<br/><sup>c</sup>We downgraded by one level for risk of bias. The contributing studies were at high risk of bias. Allocation concealment was unclear in both studies; blinding was unclear in one study, and the other study was unblinded. There was a baseline imbalance in croup score in one study.<br/><sup>d</sup>We downgraded by one level for imprecision. The sample size was small (did not meet the optimal information size).<br/><sup>e</sup>We downgraded by one level for imprecision. The sample size was small (did not meet the optimal information size). The effect estimate included a null effect as well as considerable benefit for dexamethasone compared to budesonide.<br/><sup>f</sup>We downgraded by one level for imprecision. Narrative synthesis was conducted, estimates are not precise.<br/><sup>g</sup>We downgraded by one level for risk of bias. The contributing studies were at high (n = 2) and unclear (n = 2) risk of bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Dexamethasone compared to budesonide for croup</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001955-tbl-0005"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Dexamethasone compared to beclomethasone for croup </span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Dexamethasone compared to beclomethasone for croup</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> dexamethasone<br/><b>Comparison:</b> beclomethasone </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Beclomethasone</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RD 0.00</b><br/>(−0.09 to 0.09) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>39<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> <p>(0 to 0)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events (no events)</p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD001955-bbs2-0010" title="EboriadouM , ChryssanthopoulouD , StamoulisP , DamianidouL , HaidopoulouK . The effectiveness of local corticosteroids therapy in the management of mild to moderate viral croup. Minerva Pediatrica2010;62(1):23-8. ">Eboriadou 2010</a> reported no adverse events related to the glucocorticoids. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b,c</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RD:</b> risk difference </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for imprecision. The sample size was small (did not meet the optimal information size).<br/><sup>b</sup>We downgraded by one level for imprecision. Narrative synthesis was conducted, estimates are not precise.<br/><sup>c</sup>We downgraded by one level for risk of bias. The one contributing study was at high risk of bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Dexamethasone compared to beclomethasone for croup </span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001955-tbl-0006"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Dexamethasone compared to betamethasone for croup </span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Dexamethasone compared to betamethasone for croup</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> dexamethasone<br/><b>Comparison:</b> betamethasone </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Betamethasone</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with the Westley croup score. Lower scores mean fewer symptoms.  </p> <p>(Follow‐up: 2 hours)<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score from 1 study was <b>−1.68</b>. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.62 units in favour</b> (1.17 more to 0.06 more). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,b</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with the Westley croup score. Lower scores mean fewer symptoms.  </p> <p>(Follow‐up: 6 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score from 1 study was <b>−1.89</b>. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.67 units in favour</b> (1.23 more to 0.11 more). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b,c</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.95</b><br/>(0.67 to 1.34) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>52<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>d</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>731 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>694 per 1000</b> </p> <p>(490 to 979)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD001955-bbs2-0002" title="AmirL , HubermannH , HaleviA , MorM , MimouniM , WaismanY . Oral betamethasone versus intramuscular dexamethasone for the treatment of mild to moderate viral croup. Pediatric Emergency Care2006;22(8):541-4. ">Amir 2006</a> did not report collecting adverse events data. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,e</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for risk of bias. The one contributing study was at high risk of bias. Allocation concealment was unclear, and the study was not blinded. There was a baseline imbalance in croup score.<br/><sup>b</sup>We downgraded by one level for imprecision. The sample size was small (did not meet the optimal information size).<br/><sup>c</sup>We downgraded by one level for risk of bias. The one contributing study was at high risk of bias. Allocation concealment was unclear, and the study was not blinded. There was a baseline imbalance in croup score.<br/><sup>d</sup>We downgraded by two levels for imprecision. The sample size was small (did not meet the optimal information size). The effect estimate included both the null effect and appreciable benefit or harm for dexamethasone compared to betamethasone.<br/><sup>e</sup>We downgraded by one level for imprecision. Narrative synthesis was conducted, estimates are not precise. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Dexamethasone compared to betamethasone for croup </span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001955-tbl-0007"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Dexamethasone compared to prednisolone for croup</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Dexamethasone compared to prednisolone for croup</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> dexamethasone<br/><b>Comparison:</b> prednisolone </p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Prednisolone</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with the Westley croup score. Lower scores mean fewer symptoms. </p> <p>(Follow‐up: 2 hours)<br/>  </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score from 1 study was <b>−0.89</b>. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.06 units not in favour</b> (0.06 more to 0.18 less). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1231<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with the Westley croup score. Lower scores mean fewer symptoms. </p> <p>(Follow‐up: 6 hours)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score from 1 study was <b>−2.35</b>. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.21 units not in favour</b> (0.21 more to 0.62 less). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.55</b><br/>(0.28 to 1.11) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1537<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>b</sup> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>212 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>117 per 1000</b><br/>(59 to 236) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a>, <a href="./references#CD001955-bbs2-0015" title="GarbuttJM , ConionB , SterkelR , BatyJ , SchechtmanKB , MandrellK , et al. The comparative effectiveness of prednisolone and dexamethasone for children with croup: a community-based randomized trial. Clinical Pediatrics2013;52(11):1014-21. ">Garbutt 2013</a>, and <a href="./references#CD001955-bbs2-0044" title="SparrowA , GeelhoedG . Prednisolone versus dexamethasone in croup: a randomised equivalence trial. Archives of Disease in Childhood2006;91(7):580-3. ">Sparrow 2006</a> reported no serious adverse events related to the glucocorticoids. <a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a> reported 1 case of insomnia (1/411, 0.24%) and 13 cases of vomiting (13/411, 3.3%) in the prednisolone group, and 29 cases of vomiting (29/820, 3.5%), 1 case of 30‐second febrile convulsion (1/820, 0.1%), and 1 case of hyperactivity (1/820, 0.1%) in the dexamethasone group. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1550<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>c</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for imprecision. The sample size was small (did not meet the optimal information size).<br/><sup>b</sup>We downgraded by one level for inconsistency. There was substantial heterogeneity (I² = 59%), and variation in point estimates.<br/><sup>c</sup>We downgraded by one level for imprecision. Narrative synthesis conducted, estimates are not precise. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Dexamethasone compared to prednisolone for croup</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001955-tbl-0008"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Budesonide compared to dexamethasone for croup</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Budesonide compared to dexamethasone for croup</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> budesonide<br/><b>Comparison:</b> dexamethasone </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Budesonide</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><a href="./references#CD001955-bbs2-0022" title="HuangT , XiaZ , LiW . Efficacy of inhaled budesonide on serum inflammatory factors and quality of life among children with acute infectious laryngitis. American Journal of Otolaryngology - Head and Neck Medicine and Surgery2021;42(1):102820. ">Huang 2021</a> reported no adverse events. </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>We downgraded one level for imprecision. Narrative synthesis was conducted, estimates are not precise. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Budesonide compared to dexamethasone for croup</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001955-tbl-0009"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Budesonide and dexamethasone compared to dexamethasone</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Budesonide and dexamethasone compared to dexamethasone for croup</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> budesonide and dexamethasone<br/><b>Comparison:</b> dexamethasone </p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments**</b> </p> </th> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Budesonide and dexamethasone</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with different scores in different studies. Lower scores mean fewer symptoms. </p> <p>(Follow‐up: 6 hours)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−3.24 to −1.80</b>. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.05 standard deviations not in favour</b> (0.19 more to 0.30 less). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>255<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A standard deviation of 0.05 represents a minimal difference between groups.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.91</b><br/>(0.45 to 1.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>254<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>91 per 1000</b><br/>(45 to 183) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="left" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>1/3 (33%) studies reported collecting adverse events data. <a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a> reported no adverse events in either the dexamethasone group or the dexamethasone and budesonide group. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>133</p> <p>(1 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/>**We used Cohen's interpretation of effect sizes to determine the magnitude of the difference between groups (0.2 represents a small effect, 0.5 represents a medium effect, 0.8 represents a large effect). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for imprecision. The sample size was small (did not meet the optimal information size).<br/><sup>b</sup>We downgraded by two levels for imprecision. The sample size was small (did not meet the optimal information size). The effect estimate included both the null effect and a significant benefit or harm for dexamethasone and budesonide compared to dexamethasone alone.<br/><sup>c</sup>We downgraded by one level for imprecision. Narrative sythesis was conducted, estimates are not precise. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Budesonide and dexamethasone compared to dexamethasone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001955-tbl-0010"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Budesonide and dexamethasone compared to budesonide</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Budesonide and dexamethasone compared to budesonide for croup</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> budesonide and dexamethasone<br/><b>Comparison:</b> budesonide </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Budesonide</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Budesonide and dexamethasone</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with the Westley croup score. Lower scores mean fewer symptoms. </p> <p>(Follow‐up: 6 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score from 1 study was <b>−2.30</b>. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.18 units in favour</b> (0.52 more to 0.17 less). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RD 0.00</b><br/>(−0.03 to 0.03) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>129<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/>(0 to 0) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD001955-bbs2-0029" title="KlassenTP , CraigWR , MoherD , OsmondMH , PasterkampH , SutcliffeT , et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA1998;279(20):1629-32. ">Klassen 1998</a> reported 1 case of oral thrush in the budesonide group (1/65, 1.5%) and no adverse events in the dexamethasone and budesonide group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>b</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RD:</b> risk difference </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for imprecision. The sample size was small (did not meet the optimal information size).<br/><sup>b</sup>We downgraded by one level for imprecision. Narrative synthesis was conducted, estimates are not precise. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Budesonide and dexamethasone compared to budesonide</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001955-tbl-0011"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Oral dexamethasone compared to intramuscular dexamethasone for croup </span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Oral dexamethasone compared to intramuscular dexamethasone for croup</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> oral dexamethasone<br/><b>Comparison:</b> intramuscular dexamethasone </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intramuscular dexamethasone</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Oral dexamethasone</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.81</b><br/>(0.58 to 1.12) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>440<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>259 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>210 per 1000</b><br/>(150 to 290) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign="top"> <p>None of the studies reported collecting adverse events data.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for imprecision. The effect estimate included both a null effect and substantial benefit for oral compared to intramuscular dexamethasone. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Oral dexamethasone compared to intramuscular dexamethasone for croup </span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001955-tbl-0012"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Oral dexamethasone compared to nebulised dexamethasone for croup</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Oral dexamethasone compared to nebulised dexamethasone for croup</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> oral dexamethasone<br/><b>Comparison:</b> nebulised dexamethasone </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies) </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Nebulised dexamethasone</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Oral dexamethasone</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.39</b><br/>(0.17 to 0.89) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>176<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>209 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>81 per 1000</b><br/>(35 to 186) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign="top"> <p>None of the studies reported collecting adverse events data.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for imprecision. The sample size was small (did not meet the optimal information size). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Oral dexamethasone compared to nebulised dexamethasone for croup</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001955-tbl-0013"> <div class="table-heading"><span class="table-label">Table 11.</span> <span class="table-title">Dexamethasone 0.30 mg/kg compared to dexamethasone 0.15 mg/kg for croup</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Dexamethasone 0.30 mg/kg compared to dexamethasone 0.15 mg/kg for croup</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> dexamethasone 0.30 mg/kg<br/><b>Comparison:</b> dexamethasone 0.15 mg/kg </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI) </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone 0.15 mg/kg</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone 0.30 mg/kg</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.94</b><br/>(0.06 to 14.27) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>32 per 1000</b><br/>(2 to 492) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD001955-bbs2-0017" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995b</a> did not report collecting adverse events data. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,b</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>We downgraded by two levels for imprecision. The sample size was small (did not meet the optimal information size). The effect estimate included significant benefit, the null effect, and potential harm for 0.30 mg/kg compared to 0.15 mg/kg dexamethasone.<br/><sup>b</sup>We downgraded by one level for imprecision. Narrative synthesis was conducted, estimates are not precise. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 11.</span> <span class="table-title">Dexamethasone 0.30 mg/kg compared to dexamethasone 0.15 mg/kg for croup</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001955-tbl-0014"> <div class="table-heading"><span class="table-label">Table 12.</span> <span class="table-title">Dexamethasone 0.60 mg/kg compared to dexamethasone 0.30 mg/kg for croup</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Dexamethasone 0.60 mg/kg compared to dexamethasone 0.30 mg/kg for croup</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> dexamethasone 0.60 mg/kg<br/><b>Comparison:</b> dexamethasone 0.30 mg/kg </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI) </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone 0.30</b> mg/kg </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone 0.60</b> mg/kg </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.40</b><br/>(0.25 to 7.81) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>97 per 1000</b><br/>(17 to 539) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD001955-bbs2-0016" title="GeelhoedGC , MacdonaldWB . Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatric Pulmonology1995;20(6):362-8. ">Geelhoed 1995a</a> did not report collecting adverse events data. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,b</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>We downgraded by two levels for imprecision. The sample size was small (did not meet the optimal information size). The effect estimate included significant benefit, the null effect, and potential for harm for 0.60 mg/kg compared to 0.30 mg/kg dexamethasone.<br/><sup>b</sup>We downgraded by one level for imprecision. Narrative synthesis was conducted, estimates are not precise. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 12.</span> <span class="table-title">Dexamethasone 0.60 mg/kg compared to dexamethasone 0.30 mg/kg for croup</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001955-tbl-0015"> <div class="table-heading"><span class="table-label">Table 13.</span> <span class="table-title"> Dexamethasone 0.60 mg/kg compared to dexamethasone 0.15 mg/kg for croup</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Dexamethasone 0.60 mg/kg compared to dexamethasone 0.15 mg/kg for croup</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with croup<br/><b>Setting:</b> emergency department, inpatients and outpatients<br/><b>Intervention:</b> dexamethasone 0.60 mg/kg<br/><b>Comparison:</b> dexamethasone 0.15 mg/kg </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments**</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone 0.15 mg/kg</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Dexamethasone 0.60 mg/kg</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with the Westley croup score. Lower scores mean fewer symptoms. </p> <p>(Follow‐up: 2 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−1.05 to −0.75</b>. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.27 standard deviations in favour</b><br/>(0.76 more to 0.22 less). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>861<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A standard deviation of 0.14 represents a small difference between groups.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with the Westley croup score. Lower scores mean fewer symptoms. </p> <p>(Follow‐up: 6 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−3.10 to −2.09</b>. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.45 units in favour</b> (1.26 more to 0.35 less). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>178<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with the Westley croup score. Lower scores mean fewer symptoms. </p> <p>(Follow‐up: 12 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>−3.50 to −2.95</b>. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.60 units in favour</b> (4.39 more to 3.19 less). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>113<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very Low<sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in croup score. Assessed with the Westley croup score. Lower scores mean fewer symptoms. </p> <p>(Follow‐up: 24 hours)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score from 1 study was <b>−4.00</b>. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in croup score was <b>0.63 units not in favour</b> (0.16 less to 1.10 less). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Return visits or (re)admissions or both</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.91</b><br/>(0.71 to 1.17) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>949<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>208 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>189 per 1000</b><br/>(148 to 243) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD001955-bbs2-0036" title="ParkerCM , CooperMN . Prednisolone versus dexamethasone for croup: a randomized controlled trial. Pediatrics2019;144(3):e20183772. ">Parker 2019</a> reported 16 cases of vomiting (16/410, 4.0%) and 1 case of 30 seconds of febrile convulsion (1/410, 0.2%) in the 0.60 mg/kg dexamethasone group, and 13 cases of vomiting (13/410 (3.3%), 1 case of stridor (1/410, 0.2%), and 1 case of hyperactivity (1/410, 0.2%) in the 0.15 mg/kg dexamethasone group. <a href="./references#CD001955-bbs2-0001" title="AlshehrM , AlmegamsiT , HammdiA . Efficacy of a small dose of oral dexamethasone in croup. Biomedical Research2005;65(1):65-72. ">Alshehr 2005</a> reported 1 case of bacterial tracheitis and 2 cases of bronchopneumonia in the 0.60 mg/kg dexamethasone group (3/36, 8.3%) and no adverse events in the 0.15 mg/kg dexamethasone group. <a href="./references#CD001955-bbs2-0005" title="Chub-UppakarnS , SangsupawanichP . A randomized comparison of dexamethasone 0.15 mg/kg versus 0.6 mg/kg for the treatment of moderate to severe croup. International Journal of Pediatric Otorhinolaryngology2007;71(3):473-7. ">Chub‐Uppakarn 2007</a> and <a href="./references#CD001955-bbs2-0013" title="FifootAA , TingJY . Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emergency Medicine Australasia2007;19(1):51-8. ">Fifoot 2007</a> reported no adverse events in either treatment group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/>**We used Cohen's interpretation of effect sizes to determine the magnitude of the difference between groups (0.2 represents a small effect, 0.5 represents a medium effect, 0.8 represents a large effect). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded by one level for imprecision. The sample size was small (did not meet the optimal information size).<br/><sup>b</sup>We downgraded by two levels level for inconsistency. There was considerable heterogeneity (I² = 99%), and variation in point estimates. The 95% confidence intervals did not overlap.<br/><sup>c</sup>We downgraded by two levels for imprecision. The sample size was small (did not meet the optimal information size). The effect estimate included both the null effect and appreciable benefit and harm for 0.60 mg/kg compared to 0.15 mg/kg dexamethasone.<br/><sup>d</sup>We downgraded by one level for imprecision. Narrative synthesis was conducted, estimates are not precise. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 13.</span> <span class="table-title"> Dexamethasone 0.60 mg/kg compared to dexamethasone 0.15 mg/kg for croup</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/full#CD001955-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001955-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Any glucocorticoid compared to placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Croup score (change baseline ‐ 2 hours) by score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>426</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.65 [‐1.13, ‐0.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Westley score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>264</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.72 [‐1.44, 0.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Non‐Westley score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.51 [‐0.93, ‐0.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Croup score (change baseline ‐ 6 hours) by score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>959</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.76 [‐1.12, ‐0.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 Westley score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>336</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.79 [‐1.02, ‐0.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 Non‐Westley score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>623</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.81 [‐1.43, ‐0.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Croup score (change baseline ‐ 12 hours) by score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>571</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.03 [‐1.53, ‐0.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 Westley score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.54 [‐2.56, ‐0.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 Non‐Westley score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.87 [‐1.45, ‐0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Croup score (change baseline ‐ 24 hours) by score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.86 [‐1.40, ‐0.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 Westley score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.05 [‐1.72, ‐0.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 Non‐Westley score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>182</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.70 [‐1.56, 0.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Croup score (change baseline ‐ 2 hours) by inpatient/outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>426</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.65 [‐1.13, ‐0.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.1 Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.80 [‐1.44, ‐0.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.2 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.32 [‐0.93, 0.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Croup score (change baseline ‐ 6 hours) by inpatient/outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>959</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.76 [‐1.12, ‐0.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.1 Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>723</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.72 [‐1.22, ‐0.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.2 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>236</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.84 [‐1.11, ‐0.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Croup score (change baseline ‐ 24 hours) by inpatient/outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.86 [‐1.40, ‐0.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.1 Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>291</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.82 [‐1.46, ‐0.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.2 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.09 [‐1.71, ‐0.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Croup score (change baseline ‐ 2 hours) by glucocorticoid <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>426</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.66 [‐1.10, ‐0.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.1 Budesonide</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.01 [‐1.71, ‐0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.2 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>163</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.49 [‐1.00, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.3 Fluticasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [‐0.52, 1.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Croup score (change baseline ‐ 6 hours) by glucocorticoid <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>959</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.74 [‐1.07, ‐0.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.1 Budesonide</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>333</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.81 [‐1.04, ‐0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.2 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>567</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.62 [‐1.17, ‐0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.3 Fluticasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.89, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.4 Prednisolone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.87 [‐2.62, ‐1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 Croup score (change baseline ‐ 12 hours) by glucocorticoid <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>571</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.04 [‐1.51, ‐0.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.1 Budesonide</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.97 [‐1.26, ‐0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.2 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>323</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.85 [‐1.55, ‐0.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.3 Prednisolone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.40 [‐3.26, ‐1.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 Croup score (change baseline ‐ 24 hours) by glucocorticoid <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.89 [‐1.41, ‐0.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.1 Budesonide</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.40 [‐1.88, ‐0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.2 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>245</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.89 [‐1.55, ‐0.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.3 Fluticasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [‐0.75, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 Return visits or (re)admissions or both by inpatient/outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1679</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.36, 0.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.1 Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>323</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.12, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.2 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1356</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.35, 0.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 Return visits or (re)admissions or both by glucocorticoid <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1679</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.36, 0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.1 Budesonide</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>225</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.19, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.2 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1454</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.34, 0.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.14 Return visits or (re)admissions or both by croup severity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1679</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.36, 0.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.14.1 Mild croup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1068</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.30, 0.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.14.2 Moderate croup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>611</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.26, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.15 Length of stay by inpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>476</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐14.90 [‐23.58, ‐6.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15.1 Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>476</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐14.90 [‐23.58, ‐6.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.16 Length of stay by glucocorticoid <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>476</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐14.55 [‐22.70, ‐6.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16.1 Budesonide</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐15.29 [‐26.89, ‐3.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16.2 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>328</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐18.25 [‐27.87, ‐8.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16.3 Fluticasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.80 [‐12.34, 21.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.17 Improvement (at 2 hours) by inpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.81 [0.96, 3.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.1 Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.81 [0.96, 3.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.18 Improvement (at 6 hours) by inpatient/outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>332</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.45 [1.12, 1.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.18.1 Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>224</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [0.96, 1.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.18.2 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.78 [1.16, 2.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.19 Improvement (at 12 hours) by inpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>340</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [1.09, 1.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.19.1 Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>340</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [1.09, 1.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.20 Improvement (at 24 hours) by inpatient/outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>251</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [1.01, 1.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.20.1 Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.98, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.20.2 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.00 [1.14, 3.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.21 Improvement (at 6 hours) by glucocorticoid <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>332</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.45 [1.12, 1.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.21.1 Budesonide</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.66 [1.19, 2.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.21.2 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.43 [0.76, 2.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.21.3 Prednisolone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.34 [0.69, 2.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.22 Improvement (at 12 hours) by glucocorticoid <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>340</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [1.09, 1.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.22.1 Budesonide</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [1.08, 1.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.22.2 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>166</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.52 [1.06, 2.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.22.3 Prednisolone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.85, 1.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.23 Improvement (at 24 hours) by glucocorticoid <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>251</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [1.01, 1.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.23.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [1.05, 1.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.23.2 Prednisolone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.91, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.24 Additional treatments: antibiotics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>202</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.04, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.25 Additional treatments: epinephrine <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>709</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.08, 0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.26 Additional treatments: intubation/tracheostomy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.01, 0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.27 Additional treatments: mist tent <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐0.87, 0.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.28 Additional treatments: supplemental glucocorticoids <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>305</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.36, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Any glucocorticoid compared to placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001955-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Any glucocorticoid compared to epinephrine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Croup score (change baseline ‐ 2 hours) by inpatient/outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [‐0.24, 1.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [‐0.22, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.73, 1.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Croup score (change baseline ‐ 6 hours) by inpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐1.18, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐1.18, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Croup score (change baseline ‐ 12 hours) by inpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.57, 0.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.57, 0.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Croup score (change baseline ‐ 24 hours) by inpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [‐0.18, 0.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.1 Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [‐0.18, 0.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Croup score (change baseline ‐ 2 hours) by glucocorticoid <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.13, 1.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.1 Budesonide</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [‐0.22, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.2 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.35, 1.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.3 Beclomethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [0.62, 2.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Croup score (change baseline ‐ 12 hours) by glucocorticoid <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.57, 0.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.1 Budesonide</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.47, 0.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.2 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐1.09, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 Croup score (change baseline ‐ 24 hours) by glucocorticoid <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [‐0.18, 0.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7.1 Budesonide</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [‐0.27, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7.2 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [‐0.38, 0.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.8 Return visits or (re)admissions or both by inpatient/outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.04, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8.1 Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.06, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8.2 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.06, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.9 Length of stay by inpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.00 [‐33.89, 13.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.1 Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.00 [‐33.89, 13.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.10 Additional treatments: epinephrine <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.03, 2.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.11 Additional treatments: intubation/tracheostomy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.06, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.12 Additional treatments: supplemental glucocorticoids <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.48, 1.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Any glucocorticoid compared to epinephrine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001955-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Dexamethasone compared to budesonide</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Croup score (change baseline ‐ 6 hours) by inpatient/outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.46 [‐0.79, ‐0.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.1 Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.63 [‐1.04, ‐0.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.2 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>229</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.36 [‐0.90, 0.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Croup score (change baseline ‐ 12 hours) by inpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.75 [‐1.19, ‐0.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.1 Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.75 [‐1.19, ‐0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Return visits or (re)admissions or both by inpatient/outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>374</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.40, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.1 Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.14, 2.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.2 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.38, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Length of stay by inpatient/outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.51 [‐1.28, 0.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.1 Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.00 [‐1.93, ‐0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.2 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐0.78, 0.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.5 Improvement (at 6 hours) by outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.93, 1.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.1 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.93, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.6 Additional treatments: epinephrine <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.21, 0.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.7 Additional treatments: intubation/tracheostomy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.04, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.8 Additional treatments: supplemental glucocorticoids <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>240</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.18, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Dexamethasone compared to budesonide</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-tbl-0018">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001955-tbl-0019"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Dexamethasone compared to beclomethasone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Return visits or (re)admissions or both by outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.09, 0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.1 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.09, 0.09]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Dexamethasone compared to beclomethasone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-tbl-0019">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001955-tbl-0020"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Dexamethasone compared to betamethasone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 Croup score (change baseline ‐ 2 hours) by outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.62 [‐1.17, ‐0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.1 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.62 [‐1.17, ‐0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 Croup score (change baseline ‐ 6 hours) by outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.67 [‐1.23, ‐0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.1 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.67 [‐1.23, ‐0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.3 Return visits or (re)admissions or both by outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.67, 1.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3.1 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.67, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.4 Additional treatments: epinephrine <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.11 [1.18, 3.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Dexamethasone compared to betamethasone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-tbl-0020">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001955-tbl-0021"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Dexamethasone compared to prednisolone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 Croup score (change baseline ‐ 2 hours) by outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.06, 0.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.1 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.06, 0.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.2 Croup score (change baseline ‐ 6 hours) by outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [‐0.21, 0.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.1 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [‐0.21, 0.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.3 Return visits or (re)admissions or both by outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1537</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.28, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3.1 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1537</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.28, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.4 Length of stay by outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1363</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.42, 0.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4.1 Outpatients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1363</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.42, 0.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.5 Additional treatments: epinephrine <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1463</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.50, 1.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.6 Additional treatments: intubation/tracheotomy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.00, 0.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.7 Additional treatments: supplemental glucocorticoids <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>926</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.53, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Dexamethasone compared to prednisolone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-tbl-0021">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001955-tbl-0022"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Budesonide and dexamethasone compared to dexamethasone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.1 Croup score (change baseline ‐ 6 hours) by inpatient/outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [‐0.19, 0.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1.1 Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [‐0.30, 0.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1.2 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.32, 0.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.2 Return visits or (re)admissions or both by inpatient/outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>254</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.45, 1.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2.1 Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.46, 2.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2.2 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.13, 2.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.3 Length of stay by inpatient/outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [‐0.05, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3.1 Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.30 [‐6.75, 4.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3.2 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [‐0.04, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.4 Improvement (at 6 hours) by outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.65, 1.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4.1 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.65, 1.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.5 Additional treatments: epinephrine <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [0.27, 7.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.6 Additional treatments: mist tent <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.69, 1.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.7 Additional treatments: supplemental glucocorticoids <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>182</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.07, 16.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Budesonide and dexamethasone compared to dexamethasone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-tbl-0022">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001955-tbl-0023"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Budesonide and dexamethasone compared to budesonide</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.1 Croup score (change baseline ‐ 6 hours) by outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.18 [‐0.52, 0.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1.1 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.18 [‐0.52, 0.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.2 Return visits or (re)admissions or both by outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.03, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2.1 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.03, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.3 Length of stay by outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [‐0.36, 0.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3.1 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [‐0.36, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.4 Improvement (at 6 hours) by outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.79, 1.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.4.1 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.79, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.5 Additional treatments: epinephrine <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.15, 6.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.6 Additional treatments: supplemental glucocorticoids <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [0.52, 3.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Budesonide and dexamethasone compared to budesonide</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-tbl-0023">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001955-tbl-0024"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Oral compared to intramuscular dexamethasone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.1 Return visits or (re)admissions or both by outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.58, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1.1 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.58, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.2 Improvement (at 24 hours) by outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.95, 1.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2.1 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.95, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.3 Additional treatments: antibiotics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>277</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.02, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.4 Additional treatments: epinephrine <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>372</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.71, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.5 Additional treatments: mist tent <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>277</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.34 [0.31, 5.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.6 Additional treatments: supplemental glucocorticoids <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>277</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.50, 2.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Oral compared to intramuscular dexamethasone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-tbl-0024">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001955-tbl-0025"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Oral compared to nebulised dexamethasone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.1 Return visits or (re)admissions or both by outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.17, 0.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1.1 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.17, 0.89]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Oral compared to nebulised dexamethasone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-tbl-0025">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001955-tbl-0026"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Dexamethasone 0.30 mg/kg compared to 0.15 mg/kg</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11.1 Return visits or (re)admissions or both by outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.06, 14.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1.1 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.06, 14.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11.2 Additional treatments: epinephrine <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.19, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11.3 Additional treatments: supplemental glucocorticoids <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.06, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Dexamethasone 0.30 mg/kg compared to 0.15 mg/kg</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-tbl-0026">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001955-tbl-0027"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Dexamethasone 0.60 mg/kg compared to 0.30 mg/kg</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.1 Return visits or (re)admissions or both by outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [0.25, 7.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1.1 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [0.25, 7.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.2 Additional treatments: epinephrine <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.27, 2.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.3 Additional treatments: supplemental glucocorticoids <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.81 [0.12, 66.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Dexamethasone 0.60 mg/kg compared to 0.30 mg/kg</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-tbl-0027">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001955-tbl-0028"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Dexamethasone 0.60 mg/kg compared to 0.15 mg/kg</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.1 Croup score (Westley) (change baseline ‐ 2 hours) by inpatient/outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>861</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.27 [‐0.76, 0.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1.1 Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.63 [‐1.25, 0.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1.2 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>820</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.23, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.2 Croup score (change baseline ‐ 6 hours) by inpatient/outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.45 [‐1.26, 0.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2.1 Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.43 [‐2.13, ‐0.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2.2 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>137</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.35, 0.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.3 Croup score (change baseline ‐ 12 hours) by inpatient/outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.60 [‐4.39, 3.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.3.1 Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.55 [‐3.39, ‐1.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.3.2 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [0.81, 1.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.4 Croup score (change baseline ‐ 24 hours) by outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.16, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.4.1 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.16, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.5 Return visits or (re)admissions or both by outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>949</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.71, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.5.1 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>949</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.71, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.6 Length of stay by outpatient <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>892</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [‐0.32, 0.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.6.1 Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>892</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [‐0.32, 0.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.7 Additional treatments: epinephrine <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>885</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.34, 1.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.8 Additional treatments: intubation/tracheotomy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>861</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.00, 0.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.9 Additional treatments: supplemental glucocorticoids <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>617</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.51, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Dexamethasone 0.60 mg/kg compared to 0.15 mg/kg</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001955.pub5/references#CD001955-tbl-0028">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD001955.pub5&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD001955-note-0017">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD001955-note-0028">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD001955-note-0023">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD001955-note-0025">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD001955-note-0022">Hrvatski</a> </li> <li class="section-language"> <a class="" href="hu#CD001955-note-0027">Magyar</a> </li> <li class="section-language"> <a class="" href="id#CD001955-note-0024">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="ja#CD001955-note-0021">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD001955-note-0020">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD001955-note-0026">Polski</a> </li> <li class="section-language"> <a class="" href="th#CD001955-note-0019">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD001955-note-0018">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001955\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001955\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001955\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001955\x2epub5"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001955\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001955\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001955\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001955\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001955\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001955\x2epub5"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001955\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001955\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001955\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001955\x2epub5"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001955\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001955\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001955\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001955\x2epub5"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ZDBB8PHY&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001955.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001955.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD001955.pub5/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD001955.pub5/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001955.pub5%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714294208"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001955.pub5/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714294211"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001955.pub5/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d6b216933f3cd',t:'MTc0MDcxNDI5NC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 